id	sid	tid	token	lemma	pos
njb-115	1	1	nepal	nepal	PROPN
njb-115	1	2	j	j	PROPN
njb-115	1	3	biotechnol	biotechnol	PROPN
njb-115	1	4	.	.	PUNCT
njb-115	2	1	2	2	NUM
njb-115	2	2	0	0	NUM
njb-115	2	3	2	2	NUM
njb-115	2	4	1	1	NUM
njb-115	2	5	j	j	NOUN
njb-115	2	6	u	u	NOUN
njb-115	2	7	l	l	NOUN
njb-115	2	8	;	;	PUNCT
njb-115	2	9	9	9	NUM
njb-115	2	10	(	(	PUNCT
njb-115	2	11	1	1	NUM
njb-115	2	12	):	):	PUNCT
njb-115	2	13	8	8	NUM
njb-115	2	14	-	-	SYM
njb-115	2	15	17	17	NUM
njb-115	2	16	research	research	NOUN
njb-115	2	17	article	article	NOUN
njb-115	2	18	doi	doi	PROPN
njb-115	2	19	:	:	PUNCT
njb-115	2	20	https://doi.org/10.3126/njb.v9i1.38645	https://doi.org/10.3126/njb.v9i1.38645	PROPN
njb-115	2	21	©	©	PROPN
njb-115	2	22	njb	njb	PROPN
njb-115	2	23	,	,	PUNCT
njb-115	2	24	bsn	bsn	PROPN
njb-115	2	25	8	8	NUM
njb-115	2	26	antibiotic	antibiotic	ADJ
njb-115	2	27	susceptibility	susceptibility	NOUN
njb-115	2	28	pattern	pattern	NOUN
njb-115	2	29	of	of	ADP
njb-115	2	30	staphylococcus	staphylococcus	NOUN
njb-115	2	31	aureus	aureus	PROPN
njb-115	2	32	isolated	isolate	VERB
njb-115	2	33	from	from	ADP
njb-115	2	34	pus	pus	PROPN
njb-115	2	35	/	/	SYM
njb-115	2	36	wound	wound	NOUN
njb-115	2	37	swab	swab	NOUN
njb-115	2	38	from	from	ADP
njb-115	2	39	children	child	NOUN
njb-115	2	40	attending	attend	VERB
njb-115	2	41	international	international	ADJ
njb-115	2	42	friendship	friendship	NOUN
njb-115	2	43	children	child	NOUN
njb-115	2	44	's	's	PART
njb-115	2	45	hospital	hospital	NOUN
njb-115	2	46	bidhya	bidhya	PROPN
njb-115	2	47	maharjan1	maharjan1	PROPN
njb-115	2	48	,	,	PUNCT
njb-115	2	49	shovana	shovana	PROPN
njb-115	2	50	thapa	thapa	VERB
njb-115	2	51	karki2	karki2	PROPN
njb-115	2	52	,	,	PUNCT
njb-115	2	53	roshani	roshani	PROPN
njb-115	2	54	maharjan3	maharjan3	NOUN
njb-115	3	1	¹department	¹department	PUNCT
njb-115	3	2	of	of	ADP
njb-115	3	3	microbiology	microbiology	NOUN
njb-115	3	4	,	,	PUNCT
njb-115	3	5	st	st	PROPN
njb-115	3	6	.	.	PROPN
njb-115	3	7	xavier	xavier	PROPN
njb-115	3	8	's	's	PART
njb-115	3	9	college	college	NOUN
njb-115	3	10	,	,	PUNCT
njb-115	3	11	tribhuvan	tribhuvan	PROPN
njb-115	3	12	university	university	PROPN
njb-115	3	13	,	,	PUNCT
njb-115	3	14	maitighar	maitighar	PROPN
njb-115	3	15	,	,	PUNCT
njb-115	3	16	nepal	nepal	ADJ
njb-115	3	17	²department	²department	NOUN
njb-115	3	18	of	of	ADP
njb-115	3	19	pathology	pathology	NOUN
njb-115	3	20	,	,	PUNCT
njb-115	3	21	international	international	ADJ
njb-115	3	22	friendship	friendship	NOUN
njb-115	3	23	children	child	NOUN
njb-115	3	24	's	's	PART
njb-115	3	25	hospital	hospital	NOUN
njb-115	3	26	,	,	PUNCT
njb-115	3	27	maharajgunj	maharajgunj	PROPN
njb-115	3	28	,	,	PUNCT
njb-115	3	29	kathmandu	kathmandu	NOUN
njb-115	3	30	,	,	PUNCT
njb-115	3	31	nepal	nepal	ADJ
njb-115	3	32	3department	3department	NUM
njb-115	3	33	of	of	ADP
njb-115	3	34	microbiology	microbiology	NOUN
njb-115	3	35	,	,	PUNCT
njb-115	3	36	tri	tri	ADJ
njb-115	3	37	-	-	ADJ
njb-115	3	38	chandra	chandra	ADJ
njb-115	3	39	multiple	multiple	ADJ
njb-115	3	40	college	college	NOUN
njb-115	3	41	,	,	PUNCT
njb-115	3	42	tribhuvan	tribhuvan	PROPN
njb-115	3	43	university	university	PROPN
njb-115	3	44	,	,	PUNCT
njb-115	3	45	ghantaghar	ghantaghar	PROPN
njb-115	3	46	,	,	PUNCT
njb-115	3	47	kathmandu	kathmandu	NOUN
njb-115	3	48	,	,	PUNCT
njb-115	3	49	nepal	nepal	ADJ
njb-115	3	50	received	receive	VERB
njb-115	3	51	:	:	PUNCT
njb-115	3	52	04	04	NUM
njb-115	3	53	nov	nov	PROPN
njb-115	3	54	2020	2020	NUM
njb-115	3	55	;	;	PUNCT
njb-115	3	56	revised	revise	VERB
njb-115	3	57	:	:	PUNCT
njb-115	3	58	05	05	NUM
njb-115	3	59	jul	jul	PROPN
njb-115	3	60	2021	2021	NUM
njb-115	3	61	;	;	PUNCT
njb-115	3	62	accepted	accept	VERB
njb-115	3	63	:	:	PUNCT
njb-115	3	64	19	19	NUM
njb-115	3	65	jul	jul	PROPN
njb-115	3	66	2021	2021	NUM
njb-115	3	67	;	;	PUNCT
njb-115	3	68	published	publish	VERB
njb-115	3	69	online	online	ADV
njb-115	3	70	:	:	PUNCT
njb-115	3	71	31	31	NUM
njb-115	3	72	jul	jul	PROPN
njb-115	3	73	2021	2021	NUM
njb-115	3	74	abstract	abstract	ADP
njb-115	3	75	a	a	DET
njb-115	3	76	wound	wound	NOUN
njb-115	3	77	gets	get	AUX
njb-115	3	78	infected	infect	VERB
njb-115	3	79	when	when	SCONJ
njb-115	3	80	the	the	DET
njb-115	3	81	organism	organism	NOUN
njb-115	3	82	gets	get	AUX
njb-115	3	83	invaded	invade	VERB
njb-115	3	84	through	through	ADP
njb-115	3	85	the	the	DET
njb-115	3	86	breached	breached	ADJ
njb-115	3	87	skin	skin	NOUN
njb-115	3	88	,	,	PUNCT
njb-115	3	89	proliferated	proliferate	VERB
njb-115	3	90	and	and	CCONJ
njb-115	3	91	production	production	NOUN
njb-115	3	92	of	of	ADP
njb-115	3	93	various	various	ADJ
njb-115	3	94	enzymes	enzyme	NOUN
njb-115	3	95	,	,	PUNCT
njb-115	3	96	toxins	toxin	NOUN
njb-115	3	97	,	,	PUNCT
njb-115	3	98	etc	etc	X
njb-115	3	99	.	.	X
njb-115	4	1	in	in	ADP
njb-115	4	2	order	order	NOUN
njb-115	4	3	to	to	PART
njb-115	4	4	treat	treat	VERB
njb-115	4	5	the	the	DET
njb-115	4	6	wound	wound	NOUN
njb-115	4	7	infection	infection	NOUN
njb-115	4	8	,	,	PUNCT
njb-115	4	9	antibiotic	antibiotic	ADJ
njb-115	4	10	susceptibility	susceptibility	NOUN
njb-115	4	11	pattern	pattern	NOUN
njb-115	4	12	of	of	ADP
njb-115	4	13	organism	organism	NOUN
njb-115	4	14	should	should	AUX
njb-115	4	15	be	be	AUX
njb-115	4	16	determined	determine	VERB
njb-115	4	17	before	before	ADP
njb-115	4	18	the	the	DET
njb-115	4	19	prescription	prescription	NOUN
njb-115	4	20	of	of	ADP
njb-115	4	21	the	the	DET
njb-115	4	22	medicine	medicine	NOUN
njb-115	4	23	.	.	PUNCT
njb-115	5	1	the	the	DET
njb-115	5	2	present	present	ADJ
njb-115	5	3	study	study	NOUN
njb-115	5	4	was	be	AUX
njb-115	5	5	conducted	conduct	VERB
njb-115	5	6	from	from	ADP
njb-115	5	7	september	september	PROPN
njb-115	5	8	2017	2017	NUM
njb-115	5	9	to	to	ADP
njb-115	5	10	march	march	PROPN
njb-115	5	11	2018	2018	NUM
njb-115	5	12	with	with	ADP
njb-115	5	13	an	an	DET
njb-115	5	14	aim	aim	NOUN
njb-115	5	15	to	to	PART
njb-115	5	16	determine	determine	VERB
njb-115	5	17	antibiotic	antibiotic	ADJ
njb-115	5	18	susceptibility	susceptibility	NOUN
njb-115	5	19	pattern	pattern	NOUN
njb-115	5	20	of	of	ADP
njb-115	5	21	staphylococcus	staphylococcus	PROPN
njb-115	5	22	aureus	aureus	PROPN
njb-115	5	23	identified	identify	VERB
njb-115	5	24	from	from	ADP
njb-115	5	25	the	the	DET
njb-115	5	26	pus	pus	NOUN
njb-115	5	27	/	/	SYM
njb-115	5	28	wound	wound	NOUN
njb-115	5	29	swab	swab	NOUN
njb-115	5	30	among	among	ADP
njb-115	5	31	the	the	DET
njb-115	5	32	patients	patient	NOUN
njb-115	5	33	visiting	visit	VERB
njb-115	5	34	the	the	DET
njb-115	5	35	international	international	ADJ
njb-115	5	36	friendship	friendship	NOUN
njb-115	5	37	children	child	NOUN
njb-115	5	38	's	's	PART
njb-115	5	39	hospital	hospital	NOUN
njb-115	5	40	,	,	PUNCT
njb-115	5	41	kathmandu	kathmandu	PROPN
njb-115	5	42	,	,	PUNCT
njb-115	5	43	nepal	nepal	ADJ
njb-115	5	44	.	.	PUNCT
njb-115	6	1	total	total	ADJ
njb-115	6	2	270	270	NUM
njb-115	6	3	sample	sample	NOUN
njb-115	6	4	were	be	AUX
njb-115	6	5	processed	process	VERB
njb-115	6	6	,	,	PUNCT
njb-115	6	7	isolated	isolate	VERB
njb-115	6	8	and	and	CCONJ
njb-115	6	9	identified	identify	VERB
njb-115	6	10	using	use	VERB
njb-115	6	11	standard	standard	ADJ
njb-115	6	12	microbiological	microbiological	ADJ
njb-115	6	13	procedure	procedure	NOUN
njb-115	6	14	and	and	CCONJ
njb-115	6	15	biochemical	biochemical	ADJ
njb-115	6	16	test	test	NOUN
njb-115	6	17	.	.	PUNCT
njb-115	7	1	antibiotic	antibiotic	ADJ
njb-115	7	2	susceptibility	susceptibility	NOUN
njb-115	7	3	test	test	NOUN
njb-115	7	4	was	be	AUX
njb-115	7	5	carried	carry	VERB
njb-115	7	6	out	out	ADP
njb-115	7	7	by	by	ADP
njb-115	7	8	using	use	VERB
njb-115	7	9	modified	modify	VERB
njb-115	7	10	kirby	kirby	PROPN
njb-115	7	11	bauer	bauer	PROPN
njb-115	7	12	's	's	PART
njb-115	7	13	disc	disc	NOUN
njb-115	7	14	diffusion	diffusion	NOUN
njb-115	7	15	method	method	NOUN
njb-115	7	16	.	.	PUNCT
njb-115	8	1	out	out	ADP
njb-115	8	2	of	of	ADP
njb-115	8	3	total	total	ADJ
njb-115	8	4	sample	sample	NOUN
njb-115	8	5	,	,	PUNCT
njb-115	8	6	51.48	51.48	NUM
njb-115	8	7	%	%	NOUN
njb-115	8	8	(	(	PUNCT
njb-115	8	9	139	139	NUM
njb-115	8	10	)	)	PUNCT
njb-115	8	11	showed	show	VERB
njb-115	8	12	growth	growth	NOUN
njb-115	8	13	.	.	PUNCT
njb-115	9	1	the	the	DET
njb-115	9	2	growth	growth	NOUN
njb-115	9	3	distribution	distribution	NOUN
njb-115	9	4	was	be	AUX
njb-115	9	5	found	find	VERB
njb-115	9	6	to	to	PART
njb-115	9	7	be	be	AUX
njb-115	9	8	high	high	ADJ
njb-115	9	9	in	in	ADP
njb-115	9	10	out	out	ADP
njb-115	9	11	-	-	PUNCT
njb-115	9	12	patient	patient	NOUN
njb-115	9	13	department	department	NOUN
njb-115	9	14	84.9	84.9	NUM
njb-115	9	15	%	%	NOUN
njb-115	9	16	(	(	PUNCT
njb-115	9	17	118	118	NUM
njb-115	9	18	)	)	PUNCT
njb-115	9	19	than	than	ADP
njb-115	9	20	in	in	ADP
njb-115	9	21	-	-	PUNCT
njb-115	9	22	patient	patient	NOUN
njb-115	9	23	department	department	NOUN
njb-115	9	24	15.1	15.1	NUM
njb-115	9	25	%	%	NOUN
njb-115	9	26	(	(	PUNCT
njb-115	9	27	21	21	NUM
njb-115	9	28	)	)	PUNCT
njb-115	9	29	.	.	PUNCT
njb-115	10	1	among	among	ADP
njb-115	10	2	139	139	NUM
njb-115	10	3	positive	positive	ADJ
njb-115	10	4	growth	growth	NOUN
njb-115	10	5	,	,	PUNCT
njb-115	10	6	83.5	83.5	NUM
njb-115	10	7	%	%	NOUN
njb-115	10	8	were	be	AUX
njb-115	10	9	gram	gram	PROPN
njb-115	10	10	positive	positive	ADJ
njb-115	10	11	and	and	CCONJ
njb-115	10	12	16.5	16.5	NUM
njb-115	10	13	%	%	NOUN
njb-115	10	14	were	be	AUX
njb-115	10	15	gram	gram	NOUN
njb-115	10	16	negative	negative	ADJ
njb-115	10	17	.	.	PUNCT
njb-115	11	1	all	all	PRON
njb-115	11	2	together	together	ADV
njb-115	11	3	12	12	NUM
njb-115	11	4	different	different	ADJ
njb-115	11	5	organisms	organism	NOUN
njb-115	11	6	were	be	AUX
njb-115	11	7	identified	identify	VERB
njb-115	11	8	,	,	PUNCT
njb-115	11	9	among	among	ADP
njb-115	11	10	which	which	PRON
njb-115	11	11	s.	s.	PROPN
njb-115	11	12	aureus	aureus	PROPN
njb-115	11	13	was	be	AUX
njb-115	11	14	found	find	VERB
njb-115	11	15	to	to	PART
njb-115	11	16	be	be	AUX
njb-115	11	17	predominant	predominant	ADJ
njb-115	11	18	organism	organism	NOUN
njb-115	11	19	105	105	NUM
njb-115	11	20	(	(	PUNCT
njb-115	11	21	75.5	75.5	NUM
njb-115	11	22	%	%	NOUN
njb-115	11	23	)	)	PUNCT
njb-115	11	24	.	.	PUNCT
njb-115	12	1	s.	s.	PROPN
njb-115	12	2	aureus	aureus	PROPN
njb-115	12	3	was	be	AUX
njb-115	12	4	found	find	VERB
njb-115	12	5	to	to	PART
njb-115	12	6	be	be	AUX
njb-115	12	7	sensitive	sensitive	ADJ
njb-115	12	8	towards	towards	ADP
njb-115	12	9	linezolid	linezolid	NOUN
njb-115	12	10	followed	follow	VERB
njb-115	12	11	by	by	ADP
njb-115	12	12	doxycycline	doxycycline	NOUN
njb-115	12	13	whereas	whereas	SCONJ
njb-115	12	14	it	it	PRON
njb-115	12	15	was	be	AUX
njb-115	12	16	found	find	VERB
njb-115	12	17	resistant	resistant	ADJ
njb-115	12	18	towards	towards	ADP
njb-115	12	19	ciprofloxacin	ciprofloxacin	NOUN
njb-115	12	20	.	.	PUNCT
njb-115	13	1	among	among	ADP
njb-115	13	2	s.	s.	PROPN
njb-115	13	3	aureus	aureus	PROPN
njb-115	13	4	identified	identify	VERB
njb-115	13	5	,	,	PUNCT
njb-115	13	6	50	50	NUM
njb-115	13	7	%	%	NOUN
njb-115	13	8	were	be	AUX
njb-115	13	9	multidrug	multidrug	NOUN
njb-115	13	10	resistant	resistant	ADJ
njb-115	13	11	(	(	PUNCT
njb-115	13	12	mdr	mdr	PROPN
njb-115	13	13	)	)	PUNCT
njb-115	13	14	s.	s.	PROPN
njb-115	13	15	aureus	aureus	PROPN
njb-115	13	16	and	and	CCONJ
njb-115	13	17	55	55	NUM
njb-115	13	18	%	%	NOUN
njb-115	13	19	were	be	AUX
njb-115	13	20	methicillin	methicillin	PROPN
njb-115	13	21	resistance	resistance	NOUN
njb-115	13	22	s.	s.	PROPN
njb-115	13	23	aureus	aureus	PROPN
njb-115	13	24	(	(	PUNCT
njb-115	13	25	mrsa	mrsa	PROPN
njb-115	13	26	)	)	PUNCT
njb-115	13	27	.	.	PUNCT
njb-115	14	1	mrsa	mrsa	PROPN
njb-115	14	2	was	be	AUX
njb-115	14	3	found	find	VERB
njb-115	14	4	to	to	PART
njb-115	14	5	be	be	AUX
njb-115	14	6	sensitive	sensitive	ADJ
njb-115	14	7	towards	towards	ADP
njb-115	14	8	linezolid	linezolid	NOUN
njb-115	14	9	followed	follow	VERB
njb-115	14	10	by	by	ADP
njb-115	14	11	doxycycline	doxycycline	NOUN
njb-115	14	12	and	and	CCONJ
njb-115	14	13	resistant	resistant	ADJ
njb-115	14	14	towards	towards	ADP
njb-115	14	15	ciprofloxacin	ciprofloxacin	NOUN
njb-115	14	16	.	.	PUNCT
njb-115	15	1	the	the	DET
njb-115	15	2	association	association	NOUN
njb-115	15	3	between	between	ADP
njb-115	15	4	mdr	mdr	PROPN
njb-115	15	5	and	and	CCONJ
njb-115	15	6	mrsa	mrsa	PROPN
njb-115	15	7	was	be	AUX
njb-115	15	8	found	find	VERB
njb-115	15	9	positively	positively	ADV
njb-115	15	10	significant	significant	ADJ
njb-115	15	11	(	(	PUNCT
njb-115	15	12	i.e.	i.e.	X
njb-115	15	13	p	p	X
njb-115	15	14	-	-	PUNCT
njb-115	15	15	value	value	NOUN
njb-115	15	16	=	=	NOUN
njb-115	15	17	0.000	0.000	NUM
njb-115	15	18	)	)	PUNCT
njb-115	15	19	.	.	PUNCT
njb-115	16	1	all	all	DET
njb-115	16	2	strains	strain	NOUN
njb-115	16	3	of	of	ADP
njb-115	16	4	s.	s.	PROPN
njb-115	16	5	aureus	aureus	PROPN
njb-115	16	6	were	be	AUX
njb-115	16	7	found	find	VERB
njb-115	16	8	to	to	PART
njb-115	16	9	be	be	AUX
njb-115	16	10	sensitive	sensitive	ADJ
njb-115	16	11	towards	towards	ADP
njb-115	16	12	vancomycin	vancomycin	PROPN
njb-115	16	13	.	.	PUNCT
njb-115	17	1	22.86	22.86	NUM
njb-115	17	2	%	%	NOUN
njb-115	17	3	were	be	AUX
njb-115	17	4	double	double	ADJ
njb-115	17	5	disk	disk	NOUN
njb-115	17	6	diffusion	diffusion	NOUN
njb-115	17	7	test	test	NOUN
njb-115	17	8	(	(	PUNCT
njb-115	17	9	d	d	NOUN
njb-115	17	10	-	-	NOUN
njb-115	17	11	test	test	NOUN
njb-115	17	12	)	)	PUNCT
njb-115	17	13	positive	positive	ADJ
njb-115	17	14	.	.	PUNCT
njb-115	18	1	the	the	DET
njb-115	18	2	prevalence	prevalence	NOUN
njb-115	18	3	of	of	ADP
njb-115	18	4	d	d	NOUN
njb-115	18	5	-	-	NOUN
njb-115	18	6	test	test	NOUN
njb-115	18	7	was	be	AUX
njb-115	18	8	found	find	VERB
njb-115	18	9	to	to	PART
njb-115	18	10	be	be	AUX
njb-115	18	11	high	high	ADJ
njb-115	18	12	in	in	ADP
njb-115	18	13	mrsa	mrsa	PROPN
njb-115	18	14	(	(	PUNCT
njb-115	18	15	75	75	NUM
njb-115	18	16	%	%	NOUN
njb-115	18	17	)	)	PUNCT
njb-115	18	18	.	.	PUNCT
njb-115	19	1	the	the	DET
njb-115	19	2	relationship	relationship	NOUN
njb-115	19	3	between	between	ADP
njb-115	19	4	d	d	NOUN
njb-115	19	5	-	-	NOUN
njb-115	19	6	test	test	NOUN
njb-115	19	7	and	and	CCONJ
njb-115	19	8	mrsa	mrsa	PROPN
njb-115	19	9	was	be	AUX
njb-115	19	10	found	find	VERB
njb-115	19	11	to	to	PART
njb-115	19	12	be	be	AUX
njb-115	19	13	significantly	significantly	ADV
njb-115	19	14	correlated	correlate	VERB
njb-115	19	15	with	with	ADP
njb-115	19	16	each	each	DET
njb-115	19	17	other	other	ADJ
njb-115	19	18	(	(	PUNCT
njb-115	19	19	r	r	NOUN
njb-115	19	20	=	=	X
njb-115	19	21	0.39	0.39	NUM
njb-115	19	22	)	)	PUNCT
njb-115	19	23	.	.	PUNCT
njb-115	20	1	linezolid	linezolid	NOUN
njb-115	20	2	,	,	PUNCT
njb-115	20	3	chloramphenicol	chloramphenicol	NOUN
njb-115	20	4	,	,	PUNCT
njb-115	20	5	vancomycin	vancomycin	PROPN
njb-115	20	6	and	and	CCONJ
njb-115	20	7	doxycycline	doxycycline	NOUN
njb-115	20	8	is	be	AUX
njb-115	20	9	a	a	DET
njb-115	20	10	drug	drug	NOUN
njb-115	20	11	of	of	ADP
njb-115	20	12	a	a	DET
njb-115	20	13	choice	choice	NOUN
njb-115	20	14	for	for	ADP
njb-115	20	15	both	both	DET
njb-115	20	16	s.	s.	PROPN
njb-115	20	17	aureus	aureus	PROPN
njb-115	20	18	and	and	CCONJ
njb-115	20	19	mrsa	mrsa	PROPN
njb-115	20	20	infection	infection	NOUN
njb-115	20	21	.	.	PUNCT
njb-115	21	1	keywords	keyword	NOUN
njb-115	21	2	:	:	PUNCT
njb-115	21	3	pus	pus	PROPN
njb-115	21	4	/	/	SYM
njb-115	21	5	wound	wound	PROPN
njb-115	21	6	swab	swab	NOUN
njb-115	21	7	,	,	PUNCT
njb-115	21	8	staphylococcus	staphylococcus	NOUN
njb-115	21	9	aureus	aureus	NOUN
njb-115	21	10	,	,	PUNCT
njb-115	21	11	antibiotic	antibiotic	ADJ
njb-115	21	12	susceptibility	susceptibility	NOUN
njb-115	21	13	test	test	NOUN
njb-115	21	14	(	(	PUNCT
njb-115	21	15	ast	ast	PROPN
njb-115	21	16	)	)	PUNCT
njb-115	21	17	,	,	PUNCT
njb-115	21	18	multidrug	multidrug	VERB
njb-115	21	19	resistance	resistance	NOUN
njb-115	21	20	(	(	PUNCT
njb-115	21	21	mdr	mdr	PROPN
njb-115	21	22	)	)	PUNCT
njb-115	21	23	,	,	PUNCT
njb-115	21	24	methicillin	methicillin	NOUN
njb-115	21	25	resistance	resistance	NOUN
njb-115	21	26	staphylococcus	staphylococcus	PROPN
njb-115	21	27	aureus	aureus	PROPN
njb-115	21	28	(	(	PUNCT
njb-115	21	29	mrsa	mrsa	PROPN
njb-115	21	30	)	)	PUNCT
njb-115	21	31	,	,	PUNCT
njb-115	21	32	d	d	NOUN
njb-115	21	33	-	-	PUNCT
njb-115	21	34	test	test	NOUN
njb-115	21	35	corresponding	correspond	VERB
njb-115	21	36	author	author	NOUN
njb-115	21	37	,	,	PUNCT
njb-115	21	38	email	email	NOUN
njb-115	21	39	:	:	PUNCT
njb-115	21	40	23bidhya@gmail.com	23bidhya@gmail.com	NUM
njb-115	21	41	introduction	introduction	NOUN
njb-115	21	42	human	human	ADJ
njb-115	21	43	skin	skin	NOUN
njb-115	21	44	acts	act	VERB
njb-115	21	45	as	as	ADP
njb-115	21	46	an	an	DET
njb-115	21	47	excellent	excellent	ADJ
njb-115	21	48	barrier	barrier	NOUN
njb-115	21	49	to	to	ADP
njb-115	21	50	infection	infection	NOUN
njb-115	21	51	,	,	PUNCT
njb-115	21	52	protect	protect	VERB
njb-115	21	53	underlying	underlie	VERB
njb-115	21	54	tissues	tissue	NOUN
njb-115	21	55	,	,	PUNCT
njb-115	21	56	bones	bone	NOUN
njb-115	21	57	,	,	PUNCT
njb-115	21	58	organs	organ	NOUN
njb-115	21	59	,	,	PUNCT
njb-115	21	60	etc	etc	X
njb-115	21	61	.	.	X
njb-115	21	62	and	and	CCONJ
njb-115	21	63	prevents	prevent	VERB
njb-115	21	64	the	the	DET
njb-115	21	65	entry	entry	NOUN
njb-115	21	66	of	of	ADP
njb-115	21	67	microbes	microbe	NOUN
njb-115	21	68	(	(	PUNCT
njb-115	21	69	i.e.	i.e.	X
njb-115	21	70	potential	potential	ADJ
njb-115	21	71	pathogens	pathogen	NOUN
njb-115	21	72	)	)	PUNCT
njb-115	21	73	into	into	ADP
njb-115	21	74	our	our	PRON
njb-115	21	75	body	body	NOUN
njb-115	21	76	unless	unless	SCONJ
njb-115	21	77	the	the	DET
njb-115	21	78	mechanism	mechanism	NOUN
njb-115	21	79	is	be	AUX
njb-115	21	80	breached	breach	VERB
njb-115	21	81	due	due	ADP
njb-115	21	82	to	to	ADP
njb-115	21	83	injury	injury	NOUN
njb-115	21	84	,	,	PUNCT
njb-115	21	85	trauma	trauma	NOUN
njb-115	21	86	or	or	CCONJ
njb-115	21	87	surgical	surgical	ADJ
njb-115	21	88	intervention	intervention	NOUN
njb-115	21	89	[	[	PUNCT
njb-115	21	90	1	1	NUM
njb-115	21	91	,	,	PUNCT
njb-115	21	92	2	2	NUM
njb-115	21	93	,	,	PUNCT
njb-115	21	94	3	3	NUM
njb-115	21	95	]	]	PUNCT
njb-115	21	96	.	.	PUNCT
njb-115	22	1	a	a	DET
njb-115	22	2	break	break	NOUN
njb-115	22	3	in	in	ADP
njb-115	22	4	the	the	DET
njb-115	22	5	integrity	integrity	NOUN
njb-115	22	6	of	of	ADP
njb-115	22	7	the	the	DET
njb-115	22	8	skin	skin	NOUN
njb-115	22	9	or	or	CCONJ
njb-115	22	10	tissues	tissue	NOUN
njb-115	22	11	which	which	PRON
njb-115	22	12	may	may	AUX
njb-115	22	13	be	be	AUX
njb-115	22	14	associated	associate	VERB
njb-115	22	15	with	with	ADP
njb-115	22	16	disruption	disruption	NOUN
njb-115	22	17	of	of	ADP
njb-115	22	18	the	the	DET
njb-115	22	19	structure	structure	NOUN
njb-115	22	20	and	and	CCONJ
njb-115	22	21	compromises	compromise	VERB
njb-115	22	22	its	its	PRON
njb-115	22	23	protective	protective	ADJ
njb-115	22	24	function	function	NOUN
njb-115	22	25	is	be	AUX
njb-115	22	26	called	call	VERB
njb-115	22	27	a	a	DET
njb-115	22	28	wound	wound	NOUN
njb-115	22	29	[	[	X
njb-115	22	30	4	4	NUM
njb-115	22	31	]	]	PUNCT
njb-115	22	32	.	.	PUNCT
njb-115	23	1	a	a	DET
njb-115	23	2	wound	wound	NOUN
njb-115	23	3	gets	get	AUX
njb-115	23	4	infected	infect	VERB
njb-115	23	5	when	when	SCONJ
njb-115	23	6	proliferating	proliferate	VERB
njb-115	23	7	microorganisms	microorganism	NOUN
njb-115	23	8	invade	invade	VERB
njb-115	23	9	to	to	ADP
njb-115	23	10	a	a	DET
njb-115	23	11	level	level	NOUN
njb-115	23	12	that	that	PRON
njb-115	23	13	invokes	invoke	VERB
njb-115	23	14	a	a	DET
njb-115	23	15	local	local	ADJ
njb-115	23	16	or	or	CCONJ
njb-115	23	17	systemic	systemic	ADJ
njb-115	23	18	response	response	NOUN
njb-115	23	19	in	in	ADP
njb-115	23	20	the	the	DET
njb-115	23	21	host	host	NOUN
njb-115	23	22	[	[	PUNCT
njb-115	23	23	5	5	NUM
njb-115	23	24	]	]	PUNCT
njb-115	23	25	.	.	PUNCT
njb-115	24	1	during	during	ADP
njb-115	24	2	wound	wound	ADJ
njb-115	24	3	infection	infection	NOUN
njb-115	24	4	,	,	PUNCT
njb-115	24	5	the	the	DET
njb-115	24	6	bacteria	bacteria	NOUN
njb-115	24	7	multiplies	multiplie	NOUN
njb-115	24	8	,	,	PUNCT
njb-115	24	9	healing	healing	NOUN
njb-115	24	10	is	be	AUX
njb-115	24	11	disrupted	disrupt	VERB
njb-115	24	12	and	and	CCONJ
njb-115	24	13	wound	wound	NOUN
njb-115	24	14	tissues	tissue	NOUN
njb-115	24	15	get	get	VERB
njb-115	24	16	damage	damage	NOUN
njb-115	24	17	and	and	CCONJ
njb-115	24	18	also	also	ADV
njb-115	24	19	spread	spread	VERB
njb-115	24	20	to	to	ADP
njb-115	24	21	nearby	nearby	ADJ
njb-115	24	22	tissues	tissue	NOUN
njb-115	24	23	.	.	PUNCT
njb-115	25	1	the	the	DET
njb-115	25	2	consequences	consequence	NOUN
njb-115	25	3	of	of	ADP
njb-115	25	4	any	any	DET
njb-115	25	5	tissue	tissue	NOUN
njb-115	25	6	damage	damage	NOUN
njb-115	25	7	,	,	PUNCT
njb-115	25	8	wound	wound	NOUN
njb-115	25	9	infection	infection	NOUN
njb-115	25	10	or	or	CCONJ
njb-115	25	11	any	any	DET
njb-115	25	12	internal	internal	ADJ
njb-115	25	13	tissue	tissue	NOUN
njb-115	25	14	injury	injury	NOUN
njb-115	25	15	is	be	AUX
njb-115	25	16	pus	pus	NOUN
njb-115	25	17	[	[	PUNCT
njb-115	25	18	6	6	NUM
njb-115	25	19	]	]	PUNCT
njb-115	25	20	.	.	PUNCT
njb-115	26	1	pus	pus	PROPN
njb-115	26	2	is	be	AUX
njb-115	26	3	defined	define	VERB
njb-115	26	4	as	as	ADP
njb-115	26	5	the	the	DET
njb-115	26	6	accumulation	accumulation	NOUN
njb-115	26	7	of	of	ADP
njb-115	26	8	dead	dead	ADJ
njb-115	26	9	cells	cell	NOUN
njb-115	26	10	and	and	CCONJ
njb-115	26	11	microorganisms	microorganism	NOUN
njb-115	26	12	,	,	PUNCT
njb-115	26	13	together	together	ADV
njb-115	26	14	with	with	ADP
njb-115	26	15	accumulated	accumulate	VERB
njb-115	26	16	fluid	fluid	NOUN
njb-115	26	17	and	and	CCONJ
njb-115	26	18	various	various	ADJ
njb-115	26	19	proteins	protein	NOUN
njb-115	26	20	[	[	PUNCT
njb-115	26	21	7	7	NUM
njb-115	26	22	]	]	X
njb-115	26	23	.	.	PUNCT
njb-115	27	1	wound	wound	NOUN
njb-115	27	2	infection	infection	NOUN
njb-115	27	3	is	be	AUX
njb-115	27	4	a	a	DET
njb-115	27	5	common	common	ADJ
njb-115	27	6	problem	problem	NOUN
njb-115	27	7	during	during	ADP
njb-115	27	8	injury	injury	NOUN
njb-115	27	9	,	,	PUNCT
njb-115	27	10	mainly	mainly	ADV
njb-115	27	11	in	in	ADP
njb-115	27	12	the	the	DET
njb-115	27	13	case	case	NOUN
njb-115	27	14	of	of	ADP
njb-115	27	15	children	child	NOUN
njb-115	27	16	[	[	PUNCT
njb-115	27	17	4	4	NUM
njb-115	27	18	,	,	PUNCT
njb-115	27	19	8	8	NUM
njb-115	27	20	]	]	PUNCT
njb-115	27	21	.	.	PUNCT
njb-115	28	1	injuries	injury	NOUN
njb-115	28	2	in	in	ADP
njb-115	28	3	the	the	DET
njb-115	28	4	children	child	NOUN
njb-115	28	5	may	may	AUX
njb-115	28	6	be	be	AUX
njb-115	28	7	due	due	ADJ
njb-115	28	8	to	to	ADP
njb-115	28	9	falls	fall	NOUN
njb-115	28	10	followed	follow	VERB
njb-115	28	11	by	by	ADP
njb-115	28	12	burns	burn	NOUN
njb-115	28	13	,	,	PUNCT
njb-115	28	14	cuts	cut	NOUN
njb-115	28	15	and	and	CCONJ
njb-115	28	16	animal	animal	NOUN
njb-115	28	17	bites	bite	NOUN
njb-115	28	18	which	which	PRON
njb-115	28	19	causes	cause	VERB
njb-115	28	20	both	both	DET
njb-115	28	21	financial	financial	ADJ
njb-115	28	22	and	and	CCONJ
njb-115	28	23	psychological	psychological	ADJ
njb-115	28	24	strain	strain	NOUN
njb-115	28	25	on	on	ADP
njb-115	28	26	the	the	DET
njb-115	28	27	family	family	NOUN
njb-115	28	28	because	because	SCONJ
njb-115	28	29	it	it	PRON
njb-115	28	30	drags	drag	VERB
njb-115	28	31	the	the	DET
njb-115	28	32	patient	patient	NOUN
njb-115	28	33	to	to	ADP
njb-115	28	34	the	the	DET
njb-115	28	35	health	health	NOUN
njb-115	28	36	care	care	NOUN
njb-115	28	37	facilities	facility	NOUN
njb-115	28	38	[	[	PUNCT
njb-115	28	39	9	9	NUM
njb-115	28	40	,	,	PUNCT
njb-115	28	41	10	10	NUM
njb-115	28	42	]	]	PUNCT
njb-115	28	43	.	.	PUNCT
njb-115	29	1	wound	wound	NOUN
njb-115	29	2	infection	infection	NOUN
njb-115	29	3	account	account	NOUN
njb-115	29	4	for	for	ADP
njb-115	29	5	70	70	NUM
njb-115	29	6	-	-	SYM
njb-115	29	7	80	80	NUM
njb-115	29	8	%	%	NOUN
njb-115	29	9	mortality	mortality	NOUN
njb-115	29	10	and	and	CCONJ
njb-115	29	11	also	also	ADV
njb-115	29	12	an	an	DET
njb-115	29	13	important	important	ADJ
njb-115	29	14	cause	cause	NOUN
njb-115	29	15	of	of	ADP
njb-115	29	16	morbidity	morbidity	NOUN
njb-115	29	17	among	among	ADP
njb-115	29	18	surgical	surgical	ADJ
njb-115	29	19	patients	patient	NOUN
njb-115	29	20	and	and	CCONJ
njb-115	29	21	75	75	NUM
njb-115	29	22	%	%	NOUN
njb-115	29	23	of	of	ADP
njb-115	29	24	mortality	mortality	NOUN
njb-115	29	25	following	follow	VERB
njb-115	29	26	burn	burn	NOUN
njb-115	29	27	injuries	injury	NOUN
njb-115	29	28	[	[	PUNCT
njb-115	29	29	11	11	NUM
njb-115	29	30	,	,	PUNCT
njb-115	29	31	12	12	NUM
njb-115	29	32	,	,	PUNCT
njb-115	29	33	13	13	NUM
njb-115	29	34	]	]	PUNCT
njb-115	29	35	.	.	PUNCT
njb-115	30	1	the	the	DET
njb-115	30	2	common	common	ADJ
njb-115	30	3	organism	organism	NOUN
njb-115	30	4	responsible	responsible	ADJ
njb-115	30	5	for	for	ADP
njb-115	30	6	pus	pus	NOUN
njb-115	30	7	formation	formation	NOUN
njb-115	30	8	or	or	CCONJ
njb-115	30	9	wound	wound	NOUN
njb-115	30	10	infection	infection	NOUN
njb-115	30	11	are	be	AUX
njb-115	30	12	:	:	PUNCT
njb-115	30	13	coagulase	coagulase	PROPN
njb-115	30	14	negative	negative	PROPN
njb-115	30	15	s.	s.	PROPN
njb-115	30	16	aureus	aureus	PROPN
njb-115	30	17	(	(	PUNCT
njb-115	30	18	cons	con	NOUN
njb-115	30	19	)	)	PUNCT
njb-115	30	20	.	.	PUNCT
njb-115	31	1	s.	s.	PROPN
njb-115	31	2	aureus	aureus	PROPN
njb-115	31	3	,	,	PUNCT
njb-115	31	4	bacillus	bacillus	PROPN
njb-115	31	5	spp	spp	PROPN
njb-115	31	6	.	.	PROPN
njb-115	31	7	,	,	PUNCT
njb-115	31	8	clostridium	clostridium	PROPN
njb-115	31	9	spp	spp	PROPN
njb-115	31	10	.	.	PROPN
njb-115	31	11	,	,	PUNCT
njb-115	31	12	peptostreptococcus	peptostreptococcus	PROPN
njb-115	31	13	spp	spp	PROPN
njb-115	31	14	.	.	PROPN
njb-115	31	15	,	,	PUNCT
njb-115	31	16	actinomyces	actinomyce	NOUN
njb-115	31	17	spp	spp	PROPN
njb-115	31	18	.	.	PROPN
njb-115	31	19	,	,	PUNCT
njb-115	31	20	e.	e.	PROPN
njb-115	31	21	coli	coli	PROPN
njb-115	31	22	,	,	PUNCT
njb-115	31	23	proteus	proteus	PROPN
njb-115	31	24	spp	spp	PROPN
njb-115	31	25	.	.	PROPN
njb-115	31	26	,	,	PUNCT
njb-115	31	27	neisseria	neisseria	PROPN
njb-115	31	28	spp	spp	PROPN
njb-115	31	29	.	.	PROPN
njb-115	31	30	,	,	PUNCT
njb-115	31	31	vibrio	vibrio	PROPN
njb-115	31	32	vulnificus	vulnificus	PROPN
njb-115	31	33	,	,	PUNCT
njb-115	31	34	candida	candida	PROPN
njb-115	31	35	spp	spp	PROPN
njb-115	31	36	.	.	PROPN
njb-115	31	37	,	,	PUNCT
njb-115	31	38	etc	etc	X
njb-115	31	39	.	.	PUNCT
njb-115	32	1	[	[	X
njb-115	32	2	14	14	NUM
njb-115	32	3	]	]	PUNCT
njb-115	32	4	.	.	PUNCT
njb-115	32	5	nepal	nepal	ADJ
njb-115	32	6	journal	journal	PROPN
njb-115	32	7	of	of	ADP
njb-115	32	8	biotechnology	biotechnology	NOUN
njb-115	32	9	publisher	publisher	NOUN
njb-115	32	10	:	:	PUNCT
njb-115	32	11	biotechnology	biotechnology	NOUN
njb-115	32	12	society	society	NOUN
njb-115	32	13	of	of	ADP
njb-115	32	14	nepal	nepal	PROPN
njb-115	32	15	issn	issn	PROPN
njb-115	32	16	(	(	PUNCT
njb-115	32	17	online	online	ADV
njb-115	32	18	):	):	PUNCT
njb-115	32	19	2467	2467	NUM
njb-115	32	20	-	-	SYM
njb-115	32	21	9313	9313	NUM
njb-115	32	22	journal	journal	NOUN
njb-115	32	23	homepage	homepage	NOUN
njb-115	32	24	:	:	PUNCT
njb-115	32	25	www.nepjol.info/index.php/njb	www.nepjol.info/index.php/njb	PROPN
njb-115	32	26	issn	issn	PROPN
njb-115	32	27	(	(	PUNCT
njb-115	32	28	print	print	NOUN
njb-115	32	29	):	):	PUNCT
njb-115	32	30	2091	2091	NUM
njb-115	32	31	-	-	SYM
njb-115	32	32	1130	1130	NUM
njb-115	32	33	https://orcid.org/0000-0002-9769-1201	https://orcid.org/0000-0002-9769-1201	PROPN
njb-115	32	34	mailto:23bidhya@gmail.com	mailto:23bidhya@gmail.com	X
njb-115	32	35	nepal	nepal	PROPN
njb-115	32	36	j	j	PROPN
njb-115	32	37	biotechnol	biotechnol	PROPN
njb-115	32	38	.	.	PUNCT
njb-115	33	1	2	2	NUM
njb-115	33	2	0	0	NUM
njb-115	33	3	2	2	NUM
njb-115	33	4	1	1	NUM
njb-115	33	5	j	j	NOUN
njb-115	33	6	u	u	NOUN
njb-115	33	7	l	l	NOUN
njb-115	33	8	;	;	PUNCT
njb-115	33	9	9	9	NUM
njb-115	33	10	(	(	PUNCT
njb-115	33	11	1):8	1):8	NUM
njb-115	33	12	1	1	NUM
njb-115	33	13	7	7	NUM
njb-115	33	14	maharjan	maharjan	NOUN
njb-115	33	15	et	et	NOUN
njb-115	33	16	al	al	PROPN
njb-115	33	17	.	.	PUNCT
njb-115	34	1	©	©	PROPN
njb-115	34	2	njb	njb	PROPN
njb-115	34	3	,	,	PUNCT
njb-115	34	4	bsn	bsn	PROPN
njb-115	34	5	9	9	NUM
njb-115	34	6	s.	s.	PROPN
njb-115	34	7	aureus	aureus	PROPN
njb-115	34	8	is	be	AUX
njb-115	34	9	a	a	DET
njb-115	34	10	versatile	versatile	ADJ
njb-115	34	11	pathogen	pathogen	NOUN
njb-115	34	12	capable	capable	ADJ
njb-115	34	13	of	of	ADP
njb-115	34	14	causing	cause	VERB
njb-115	34	15	a	a	DET
njb-115	34	16	wide	wide	ADJ
njb-115	34	17	range	range	NOUN
njb-115	34	18	of	of	ADP
njb-115	34	19	human	human	ADJ
njb-115	34	20	diseases	disease	NOUN
njb-115	34	21	[	[	X
njb-115	34	22	15	15	NUM
njb-115	34	23	]	]	PUNCT
njb-115	34	24	.	.	PUNCT
njb-115	35	1	it	it	PRON
njb-115	35	2	is	be	AUX
njb-115	35	3	a	a	DET
njb-115	35	4	significant	significant	ADJ
njb-115	35	5	human	human	ADJ
njb-115	35	6	pathogen	pathogen	NOUN
njb-115	35	7	that	that	PRON
njb-115	35	8	causes	cause	VERB
njb-115	35	9	wound	wound	NOUN
njb-115	35	10	infection	infection	NOUN
njb-115	35	11	,	,	PUNCT
njb-115	35	12	soft	soft	ADJ
njb-115	35	13	tissue	tissue	NOUN
njb-115	35	14	infection	infection	NOUN
njb-115	35	15	and	and	CCONJ
njb-115	35	16	produces	produce	VERB
njb-115	35	17	the	the	DET
njb-115	35	18	pus	pus	NOUN
njb-115	35	19	[	[	PUNCT
njb-115	35	20	16	16	NUM
njb-115	35	21	,	,	PUNCT
njb-115	35	22	17	17	NUM
njb-115	35	23	]	]	PUNCT
njb-115	35	24	.	.	PUNCT
njb-115	36	1	it	it	PRON
njb-115	36	2	belongs	belong	VERB
njb-115	36	3	to	to	ADP
njb-115	36	4	the	the	DET
njb-115	36	5	family	family	NOUN
njb-115	36	6	micrococcaceae	micrococcaceae	PROPN
njb-115	36	7	,	,	PUNCT
njb-115	36	8	gram	gram	PROPN
njb-115	36	9	positive	positive	ADJ
njb-115	36	10	cocci	cocci	NOUN
njb-115	36	11	having	have	VERB
njb-115	36	12	grape	grape	NOUN
njb-115	36	13	like	like	ADP
njb-115	36	14	cluster	cluster	NOUN
njb-115	36	15	arrangement	arrangement	NOUN
njb-115	36	16	of	of	ADP
njb-115	36	17	0.5	0.5	NUM
njb-115	36	18	-	-	SYM
njb-115	36	19	1.5	1.5	NUM
njb-115	36	20	µm	µm	NOUN
njb-115	36	21	diameter	diameter	NOUN
njb-115	36	22	,	,	PUNCT
njb-115	36	23	aerobic	aerobic	ADJ
njb-115	36	24	,	,	PUNCT
njb-115	36	25	facultatively	facultatively	NOUN
njb-115	36	26	anaerobic	anaerobic	PROPN
njb-115	36	27	,	,	PUNCT
njb-115	36	28	ꞵ	ꞵ	PUNCT
njb-115	36	29	-	-	PUNCT
njb-115	36	30	hemolytic	hemolytic	ADJ
njb-115	36	31	,	,	PUNCT
njb-115	36	32	fermentative	fermentative	ADJ
njb-115	36	33	,	,	PUNCT
njb-115	36	34	oxidase	oxidase	NOUN
njb-115	36	35	negative	negative	ADJ
njb-115	36	36	,	,	PUNCT
njb-115	36	37	non	non	ADJ
njb-115	36	38	-	-	ADJ
njb-115	36	39	sporing	sporing	ADJ
njb-115	36	40	,	,	PUNCT
njb-115	36	41	non	non	ADJ
njb-115	36	42	-	-	ADJ
njb-115	36	43	motile	motile	ADJ
njb-115	36	44	,	,	PUNCT
njb-115	36	45	noncapsulated	noncapsulated	ADJ
njb-115	36	46	,	,	PUNCT
njb-115	36	47	yellow	yellow	ADJ
njb-115	36	48	zone	zone	NOUN
njb-115	36	49	formation	formation	NOUN
njb-115	36	50	around	around	ADP
njb-115	36	51	the	the	DET
njb-115	36	52	colonies	colony	NOUN
njb-115	36	53	on	on	ADP
njb-115	36	54	msa	msa	ADJ
njb-115	36	55	and	and	CCONJ
njb-115	36	56	oil	oil	NOUN
njb-115	36	57	paint	paint	NOUN
njb-115	36	58	appearance	appearance	NOUN
njb-115	36	59	on	on	ADP
njb-115	36	60	na	na	DET
njb-115	36	61	slopes	slope	NOUN
njb-115	36	62	[	[	PUNCT
njb-115	36	63	18	18	NUM
njb-115	36	64	,	,	PUNCT
njb-115	36	65	19	19	NUM
njb-115	36	66	]	]	PUNCT
njb-115	36	67	.	.	PUNCT
njb-115	37	1	there	there	PRON
njb-115	37	2	has	have	AUX
njb-115	37	3	been	be	AUX
njb-115	37	4	a	a	DET
njb-115	37	5	huge	huge	ADJ
njb-115	37	6	problem	problem	NOUN
njb-115	37	7	all	all	ADV
njb-115	37	8	over	over	ADP
njb-115	37	9	the	the	DET
njb-115	37	10	world	world	NOUN
njb-115	37	11	in	in	ADP
njb-115	37	12	the	the	DET
njb-115	37	13	treatment	treatment	NOUN
njb-115	37	14	of	of	ADP
njb-115	37	15	infectious	infectious	ADJ
njb-115	37	16	disease	disease	NOUN
njb-115	37	17	due	due	ADP
njb-115	37	18	to	to	AUX
njb-115	37	19	increase	increase	VERB
njb-115	37	20	in	in	ADP
njb-115	37	21	antibiotic	antibiotic	ADJ
njb-115	37	22	resistant	resistant	ADJ
njb-115	37	23	cases	case	NOUN
njb-115	37	24	[	[	PUNCT
njb-115	37	25	20	20	NUM
njb-115	37	26	]	]	PUNCT
njb-115	37	27	.	.	PUNCT
njb-115	38	1	multi	multi	ADJ
njb-115	38	2	-	-	ADJ
njb-115	38	3	drug	drug	ADJ
njb-115	38	4	resistant	resistant	ADJ
njb-115	38	5	(	(	PUNCT
njb-115	38	6	mdr	mdr	PROPN
njb-115	38	7	)	)	PUNCT
njb-115	38	8	is	be	AUX
njb-115	38	9	defined	define	VERB
njb-115	38	10	as	as	ADP
njb-115	38	11	the	the	DET
njb-115	38	12	non	non	NOUN
njb-115	38	13	-	-	NOUN
njb-115	38	14	susceptibility	susceptibility	NOUN
njb-115	38	15	of	of	ADP
njb-115	38	16	organism	organism	NOUN
njb-115	38	17	to	to	ADP
njb-115	38	18	at	at	ADV
njb-115	38	19	least	least	ADV
njb-115	38	20	one	one	NUM
njb-115	38	21	agent	agent	NOUN
njb-115	38	22	in	in	ADP
njb-115	38	23	3	3	NUM
njb-115	38	24	or	or	CCONJ
njb-115	38	25	more	more	ADJ
njb-115	38	26	antimicrobial	antimicrobial	ADJ
njb-115	38	27	categories	category	NOUN
njb-115	38	28	,	,	PUNCT
njb-115	38	29	extremely	extremely	ADV
njb-115	38	30	drug	drug	NOUN
njb-115	38	31	resistance	resistance	NOUN
njb-115	38	32	(	(	PUNCT
njb-115	38	33	xdr	xdr	PROPN
njb-115	38	34	)	)	PUNCT
njb-115	38	35	is	be	AUX
njb-115	38	36	non	non	ADJ
njb-115	38	37	-	-	ADJ
njb-115	38	38	susceptibility	susceptibility	NOUN
njb-115	38	39	to	to	ADP
njb-115	38	40	at	at	ADV
njb-115	38	41	least	least	ADV
njb-115	38	42	1	1	NUM
njb-115	38	43	agent	agent	NOUN
njb-115	38	44	in	in	ADP
njb-115	38	45	all	all	DET
njb-115	38	46	but	but	CCONJ
njb-115	38	47	2	2	NUM
njb-115	38	48	or	or	CCONJ
njb-115	38	49	fewer	few	ADJ
njb-115	38	50	antimicrobial	antimicrobial	ADJ
njb-115	38	51	categories	category	NOUN
njb-115	38	52	and	and	CCONJ
njb-115	38	53	pan	pan	NOUN
njb-115	38	54	drug	drug	NOUN
njb-115	38	55	resistance	resistance	NOUN
njb-115	38	56	(	(	PUNCT
njb-115	38	57	pdr	pdr	PROPN
njb-115	38	58	)	)	PUNCT
njb-115	38	59	is	be	AUX
njb-115	38	60	nonsusceptibility	nonsusceptibility	ADJ
njb-115	38	61	to	to	ADP
njb-115	38	62	all	all	DET
njb-115	38	63	agents	agent	NOUN
njb-115	38	64	in	in	ADP
njb-115	38	65	all	all	DET
njb-115	38	66	antimicrobial	antimicrobial	ADJ
njb-115	38	67	categories	category	NOUN
njb-115	39	1	[	[	X
njb-115	39	2	21	21	NUM
njb-115	39	3	]	]	PUNCT
njb-115	39	4	.	.	PUNCT
njb-115	40	1	methicillin	methicillin	PROPN
njb-115	40	2	resistant	resistant	ADJ
njb-115	40	3	s.	s.	PROPN
njb-115	40	4	aureus	aureus	PROPN
njb-115	40	5	(	(	PUNCT
njb-115	40	6	mrsa	mrsa	PROPN
njb-115	40	7	)	)	PUNCT
njb-115	40	8	has	have	AUX
njb-115	40	9	been	be	AUX
njb-115	40	10	identified	identify	VERB
njb-115	40	11	as	as	ADP
njb-115	40	12	one	one	NUM
njb-115	40	13	of	of	ADP
njb-115	40	14	the	the	DET
njb-115	40	15	major	major	ADJ
njb-115	40	16	risk	risk	NOUN
njb-115	40	17	pathogens	pathogen	NOUN
njb-115	40	18	associated	associate	VERB
njb-115	40	19	with	with	ADP
njb-115	40	20	the	the	DET
njb-115	40	21	development	development	NOUN
njb-115	40	22	of	of	ADP
njb-115	40	23	antimicrobial	antimicrobial	ADJ
njb-115	40	24	resistant	resistant	ADJ
njb-115	40	25	[	[	X
njb-115	40	26	22	22	NUM
njb-115	40	27	]	]	PUNCT
njb-115	40	28	.	.	PUNCT
njb-115	41	1	mrsa	mrsa	PROPN
njb-115	41	2	is	be	AUX
njb-115	41	3	defined	define	VERB
njb-115	41	4	as	as	ADP
njb-115	41	5	a	a	DET
njb-115	41	6	strain	strain	NOUN
njb-115	41	7	of	of	ADP
njb-115	41	8	s.	s.	PROPN
njb-115	41	9	aureus	aureus	PROPN
njb-115	41	10	that	that	PRON
njb-115	41	11	is	be	AUX
njb-115	41	12	resistant	resistant	ADJ
njb-115	41	13	to	to	ADP
njb-115	41	14	a	a	DET
njb-115	41	15	large	large	ADJ
njb-115	41	16	group	group	NOUN
njb-115	41	17	of	of	ADP
njb-115	41	18	antibiotics	antibiotic	NOUN
njb-115	41	19	called	call	VERB
njb-115	41	20	ꞵ	ꞵ	PROPN
njb-115	41	21	-	-	PUNCT
njb-115	41	22	lactams	lactams	PROPN
njb-115	41	23	,	,	PUNCT
njb-115	41	24	which	which	PRON
njb-115	41	25	include	include	VERB
njb-115	41	26	penicillin	penicillin	NOUN
njb-115	41	27	and	and	CCONJ
njb-115	41	28	cephalosporin	cephalosporin	NOUN
njb-115	41	29	[	[	PUNCT
njb-115	41	30	23	23	NUM
njb-115	41	31	]	]	PUNCT
njb-115	41	32	.	.	PUNCT
njb-115	42	1	in	in	ADP
njb-115	42	2	nepal	nepal	ADJ
njb-115	42	3	,	,	PUNCT
njb-115	42	4	various	various	ADJ
njb-115	42	5	laboratories	laboratory	NOUN
njb-115	42	6	have	have	AUX
njb-115	42	7	reported	report	VERB
njb-115	42	8	the	the	DET
njb-115	42	9	emergence	emergence	NOUN
njb-115	42	10	of	of	ADP
njb-115	42	11	mrsa	mrsa	PROPN
njb-115	42	12	mainly	mainly	ADV
njb-115	42	13	community	community	NOUN
njb-115	42	14	-	-	PUNCT
njb-115	42	15	associated	associate	VERB
njb-115	42	16	mrsa	mrsa	PROPN
njb-115	42	17	(	(	PUNCT
njb-115	42	18	camrsa	camrsa	PROPN
njb-115	42	19	)	)	PUNCT
njb-115	42	20	which	which	PRON
njb-115	42	21	have	have	AUX
njb-115	42	22	been	be	AUX
njb-115	42	23	detected	detect	VERB
njb-115	42	24	in	in	ADP
njb-115	42	25	the	the	DET
njb-115	42	26	lumbini	lumbini	PROPN
njb-115	42	27	medical	medical	PROPN
njb-115	42	28	college	college	NOUN
njb-115	42	29	and	and	CCONJ
njb-115	42	30	teaching	teaching	NOUN
njb-115	42	31	hospital	hospital	NOUN
njb-115	42	32	while	while	SCONJ
njb-115	42	33	doing	do	VERB
njb-115	42	34	cross	cross	ADJ
njb-115	42	35	-	-	ADJ
njb-115	42	36	sectional	sectional	ADJ
njb-115	42	37	studies	study	NOUN
njb-115	42	38	of	of	ADP
njb-115	42	39	prevalence	prevalence	NOUN
njb-115	42	40	of	of	ADP
njb-115	42	41	mrsa	mrsa	PROPN
njb-115	43	1	[	[	X
njb-115	43	2	24	24	NUM
njb-115	43	3	]	]	PUNCT
njb-115	43	4	.	.	PUNCT
njb-115	44	1	in	in	ADP
njb-115	44	2	another	another	DET
njb-115	44	3	study	study	NOUN
njb-115	44	4	,	,	PUNCT
njb-115	44	5	study	study	NOUN
njb-115	44	6	carried	carry	VERB
njb-115	44	7	out	out	ADP
njb-115	44	8	to	to	PART
njb-115	44	9	assess	assess	VERB
njb-115	44	10	the	the	DET
njb-115	44	11	extent	extent	NOUN
njb-115	44	12	of	of	ADP
njb-115	44	13	mrsa	mrsa	PROPN
njb-115	44	14	in	in	ADP
njb-115	44	15	the	the	DET
njb-115	44	16	kathmandu	kathmandu	NOUN
njb-115	44	17	model	model	NOUN
njb-115	44	18	hospital	hospital	PROPN
njb-115	44	19	kathmandu	kathmandu	PROPN
njb-115	44	20	,	,	PUNCT
njb-115	44	21	mrsa	mrsa	PROPN
njb-115	44	22	were	be	AUX
njb-115	44	23	more	more	ADV
njb-115	44	24	frequently	frequently	ADV
njb-115	44	25	isolated	isolate	VERB
njb-115	44	26	from	from	ADP
njb-115	44	27	pus	pus	NOUN
njb-115	44	28	samples	sample	NOUN
njb-115	44	29	and	and	CCONJ
njb-115	44	30	that	that	SCONJ
njb-115	44	31	too	too	ADV
njb-115	44	32	from	from	ADP
njb-115	44	33	hospitalized	hospitalize	VERB
njb-115	44	34	patients	patient	NOUN
njb-115	44	35	[	[	X
njb-115	44	36	23	23	NUM
njb-115	44	37	]	]	PUNCT
njb-115	44	38	.	.	PUNCT
njb-115	45	1	vancomycin	vancomycin	PROPN
njb-115	45	2	is	be	AUX
njb-115	45	3	a	a	DET
njb-115	45	4	glycopeptide	glycopeptide	NOUN
njb-115	45	5	antibiotic	antibiotic	NOUN
njb-115	45	6	that	that	PRON
njb-115	45	7	inhibits	inhibit	VERB
njb-115	45	8	cell	cell	NOUN
njb-115	45	9	wall	wall	NOUN
njb-115	45	10	biosynthesis	biosynthesis	NOUN
njb-115	45	11	,	,	PUNCT
njb-115	45	12	remains	remain	VERB
njb-115	45	13	a	a	DET
njb-115	45	14	drug	drug	NOUN
njb-115	45	15	of	of	ADP
njb-115	45	16	choice	choice	NOUN
njb-115	45	17	for	for	ADP
njb-115	45	18	treatment	treatment	NOUN
njb-115	45	19	of	of	ADP
njb-115	45	20	severe	severe	ADJ
njb-115	45	21	mrsa	mrsa	PROPN
njb-115	45	22	infections	infection	NOUN
njb-115	45	23	.	.	PUNCT
njb-115	46	1	s.	s.	PROPN
njb-115	46	2	aureus	aureus	PROPN
njb-115	46	3	isolates	isolate	VERB
njb-115	46	4	with	with	ADP
njb-115	46	5	complete	complete	ADJ
njb-115	46	6	resistance	resistance	NOUN
njb-115	46	7	to	to	ADP
njb-115	46	8	vancomycin	vancomycin	PROPN
njb-115	46	9	(	(	PUNCT
njb-115	46	10	mic≥16µg	mic≥16µg	X
njb-115	46	11	/	/	SYM
njb-115	46	12	ml	ml	PROPN
njb-115	46	13	)	)	PUNCT
njb-115	46	14	are	be	AUX
njb-115	46	15	termed	term	VERB
njb-115	46	16	as	as	ADP
njb-115	46	17	vancomycin	vancomycin	PROPN
njb-115	46	18	resistant	resistant	ADJ
njb-115	46	19	s.	s.	PROPN
njb-115	46	20	aureus	aureus	PROPN
njb-115	46	21	(	(	PUNCT
njb-115	46	22	vrsa	vrsa	PROPN
njb-115	46	23	)	)	PUNCT
njb-115	46	24	.	.	PUNCT
njb-115	47	1	vrsa	vrsa	PROPN
njb-115	47	2	was	be	AUX
njb-115	47	3	first	first	ADV
njb-115	47	4	reported	report	VERB
njb-115	47	5	in	in	ADP
njb-115	47	6	the	the	DET
njb-115	47	7	u.s	u.s	PROPN
njb-115	47	8	in	in	ADP
njb-115	47	9	2002	2002	NUM
njb-115	48	1	[	[	PUNCT
njb-115	48	2	25	25	NUM
njb-115	48	3	]	]	PUNCT
njb-115	48	4	.	.	PUNCT
njb-115	49	1	in	in	ADP
njb-115	49	2	one	one	NUM
njb-115	49	3	of	of	ADP
njb-115	49	4	the	the	DET
njb-115	49	5	studies	study	NOUN
njb-115	49	6	conducted	conduct	VERB
njb-115	49	7	in	in	ADP
njb-115	49	8	the	the	DET
njb-115	49	9	manmohan	manmohan	PROPN
njb-115	49	10	memorial	memorial	PROPN
njb-115	49	11	college	college	NOUN
njb-115	49	12	and	and	CCONJ
njb-115	49	13	teaching	teaching	NOUN
njb-115	49	14	hospital	hospital	NOUN
njb-115	49	15	,	,	PUNCT
njb-115	49	16	kathmandu	kathmandu	NOUN
njb-115	49	17	,	,	PUNCT
njb-115	49	18	nepal	nepal	ADJ
njb-115	49	19	,	,	PUNCT
njb-115	49	20	there	there	ADV
njb-115	49	21	all	all	DET
njb-115	49	22	the	the	DET
njb-115	49	23	mrsa	mrsa	PROPN
njb-115	49	24	identified	identify	VERB
njb-115	49	25	was	be	AUX
njb-115	49	26	found	find	VERB
njb-115	49	27	to	to	PART
njb-115	49	28	be	be	AUX
njb-115	49	29	susceptible	susceptible	ADJ
njb-115	49	30	towards	towards	ADP
njb-115	49	31	the	the	DET
njb-115	49	32	vancomycin	vancomycin	PROPN
njb-115	49	33	[	[	PUNCT
njb-115	49	34	26	26	NUM
njb-115	49	35	]	]	PUNCT
njb-115	49	36	.	.	PUNCT
njb-115	50	1	d	d	X
njb-115	50	2	-	-	PUNCT
njb-115	50	3	test	test	NOUN
njb-115	50	4	is	be	AUX
njb-115	50	5	a	a	DET
njb-115	50	6	simple	simple	ADJ
njb-115	50	7	disc	disc	NOUN
njb-115	50	8	diffusion	diffusion	NOUN
njb-115	50	9	test	test	NOUN
njb-115	50	10	to	to	PART
njb-115	50	11	study	study	VERB
njb-115	50	12	the	the	DET
njb-115	50	13	macrolide	macrolide	PROPN
njb-115	50	14	lincosamide	lincosamide	PROPN
njb-115	50	15	streptogramin	streptogramin	PROPN
njb-115	50	16	b	b	PROPN
njb-115	50	17	resistance	resistance	NOUN
njb-115	50	18	(	(	PUNCT
njb-115	50	19	mlsb	mlsb	PROPN
njb-115	50	20	)	)	PUNCT
njb-115	50	21	,	,	PUNCT
njb-115	50	22	both	both	CCONJ
njb-115	50	23	constitutive	constitutive	ADJ
njb-115	50	24	and	and	CCONJ
njb-115	50	25	inducible	inducible	VERB
njb-115	50	26	as	as	ADV
njb-115	50	27	well	well	ADV
njb-115	50	28	as	as	ADP
njb-115	50	29	macrolide	macrolide	PROPN
njb-115	50	30	streptogramin	streptogramin	NOUN
njb-115	50	31	b	b	PROPN
njb-115	50	32	resistance	resistance	NOUN
njb-115	50	33	(	(	PUNCT
njb-115	50	34	msb	msb	PROPN
njb-115	50	35	)	)	PUNCT
njb-115	50	36	in	in	ADP
njb-115	50	37	s.	s.	PROPN
njb-115	50	38	aureus	aureus	PROPN
njb-115	50	39	.	.	PUNCT
njb-115	51	1	macrolide	macrolide	PROPN
njb-115	51	2	group	group	PROPN
njb-115	51	3	(	(	PUNCT
njb-115	51	4	erythromycin	erythromycin	PROPN
njb-115	51	5	,	,	PUNCT
njb-115	51	6	azithromycin	azithromycin	PROPN
njb-115	51	7	,	,	PUNCT
njb-115	51	8	rokitamycin	rokitamycin	PROPN
njb-115	51	9	)	)	PUNCT
njb-115	51	10	is	be	AUX
njb-115	51	11	a	a	DET
njb-115	51	12	drug	drug	NOUN
njb-115	51	13	used	use	VERB
njb-115	51	14	to	to	PART
njb-115	51	15	treat	treat	VERB
njb-115	51	16	of	of	ADP
njb-115	51	17	s.	s.	PROPN
njb-115	51	18	aureus	aureus	PROPN
njb-115	51	19	infection	infection	NOUN
njb-115	51	20	and	and	CCONJ
njb-115	51	21	also	also	ADV
njb-115	51	22	used	use	VERB
njb-115	51	23	for	for	ADP
njb-115	51	24	those	those	PRON
njb-115	51	25	allergic	allergic	ADJ
njb-115	51	26	to	to	ADP
njb-115	51	27	the	the	DET
njb-115	51	28	penicillin	penicillin	NOUN
njb-115	51	29	[	[	PUNCT
njb-115	51	30	24	24	NUM
njb-115	51	31	]	]	PUNCT
njb-115	51	32	.	.	PUNCT
njb-115	52	1	after	after	ADP
njb-115	52	2	a	a	DET
njb-115	52	3	few	few	ADJ
njb-115	52	4	years	year	NOUN
njb-115	52	5	of	of	ADP
njb-115	52	6	drug	drug	NOUN
njb-115	52	7	's	's	PART
njb-115	52	8	introduction	introduction	NOUN
njb-115	52	9	in	in	ADP
njb-115	52	10	therapy	therapy	NOUN
njb-115	52	11	,	,	PUNCT
njb-115	52	12	staphylococci	staphylococci	PROPN
njb-115	52	13	developed	develop	VERB
njb-115	52	14	resistance	resistance	NOUN
njb-115	52	15	to	to	ADP
njb-115	52	16	erythromycin	erythromycin	PROPN
njb-115	52	17	in	in	ADP
njb-115	52	18	1956	1956	NUM
njb-115	52	19	.	.	PUNCT
njb-115	53	1	these	these	DET
njb-115	53	2	resistant	resistant	ADJ
njb-115	53	3	strains	strain	NOUN
njb-115	53	4	were	be	AUX
njb-115	53	5	found	find	VERB
njb-115	53	6	in	in	ADP
njb-115	53	7	france	france	PROPN
njb-115	53	8	,	,	PUNCT
njb-115	53	9	u.k	u.k	PROPN
njb-115	53	10	and	and	CCONJ
njb-115	53	11	in	in	ADP
njb-115	53	12	the	the	DET
njb-115	53	13	u.s.a	u.s.a	NOUN
njb-115	54	1	[	[	PUNCT
njb-115	54	2	27	27	NUM
njb-115	54	3	]	]	PUNCT
njb-115	54	4	.	.	PUNCT
njb-115	55	1	lincosamide	lincosamide	PROPN
njb-115	55	2	(	(	PUNCT
njb-115	55	3	clindamycin	clindamycin	PROPN
njb-115	55	4	)	)	PUNCT
njb-115	55	5	is	be	AUX
njb-115	55	6	used	use	VERB
njb-115	55	7	for	for	ADP
njb-115	55	8	the	the	DET
njb-115	55	9	treatment	treatment	NOUN
njb-115	55	10	of	of	ADP
njb-115	55	11	mrsa	mrsa	PROPN
njb-115	55	12	infection	infection	NOUN
njb-115	55	13	[	[	X
njb-115	55	14	28	28	NUM
njb-115	55	15	]	]	PUNCT
njb-115	55	16	.	.	PUNCT
njb-115	56	1	since	since	SCONJ
njb-115	56	2	these	these	DET
njb-115	56	3	both	both	DET
njb-115	56	4	antibiotics	antibiotic	NOUN
njb-115	56	5	have	have	VERB
njb-115	56	6	the	the	DET
njb-115	56	7	same	same	ADJ
njb-115	56	8	site	site	NOUN
njb-115	56	9	of	of	ADP
njb-115	56	10	drug	drug	NOUN
njb-115	56	11	target	target	NOUN
njb-115	56	12	,	,	PUNCT
njb-115	56	13	there	there	PRON
njb-115	56	14	is	be	VERB
njb-115	56	15	a	a	DET
njb-115	56	16	high	high	ADJ
njb-115	56	17	chance	chance	NOUN
njb-115	56	18	of	of	ADP
njb-115	56	19	cross	cross	NOUN
njb-115	56	20	resistant	resistant	ADJ
njb-115	56	21	among	among	ADP
njb-115	56	22	these	these	DET
njb-115	56	23	antibiotics	antibiotic	NOUN
njb-115	56	24	due	due	ADP
njb-115	56	25	to	to	ADP
njb-115	56	26	modification	modification	NOUN
njb-115	56	27	of	of	ADP
njb-115	56	28	drug	drug	NOUN
njb-115	56	29	target	target	NOUN
njb-115	56	30	[	[	PUNCT
njb-115	56	31	29	29	NUM
njb-115	56	32	]	]	PUNCT
njb-115	56	33	.	.	PUNCT
njb-115	57	1	this	this	DET
njb-115	57	2	study	study	NOUN
njb-115	57	3	helps	help	VERB
njb-115	57	4	to	to	PART
njb-115	57	5	perceive	perceive	VERB
njb-115	57	6	the	the	DET
njb-115	57	7	current	current	ADJ
njb-115	57	8	status	status	NOUN
njb-115	57	9	in	in	ADP
njb-115	57	10	prevalence	prevalence	NOUN
njb-115	57	11	of	of	ADP
njb-115	57	12	s.	s.	PROPN
njb-115	57	13	aureus	aureus	PROPN
njb-115	57	14	in	in	ADP
njb-115	57	15	pus	pus	PROPN
njb-115	57	16	/	/	SYM
njb-115	57	17	wound	wound	NOUN
njb-115	57	18	swab	swab	NOUN
njb-115	57	19	,	,	PUNCT
njb-115	57	20	the	the	DET
njb-115	57	21	antibiotic	antibiotic	ADJ
njb-115	57	22	susceptibility	susceptibility	NOUN
njb-115	57	23	pattern	pattern	NOUN
njb-115	57	24	of	of	ADP
njb-115	57	25	the	the	DET
njb-115	57	26	isolated	isolated	ADJ
njb-115	57	27	s.	s.	PROPN
njb-115	57	28	aureus	aureus	PROPN
njb-115	57	29	and	and	CCONJ
njb-115	57	30	also	also	ADV
njb-115	57	31	any	any	DET
njb-115	57	32	presence	presence	NOUN
njb-115	57	33	of	of	ADP
njb-115	57	34	multidrug	multidrug	NOUN
njb-115	57	35	resistant	resistant	ADJ
njb-115	57	36	strain	strain	NOUN
njb-115	57	37	among	among	ADP
njb-115	57	38	the	the	DET
njb-115	57	39	isolates	isolate	NOUN
njb-115	57	40	.	.	PUNCT
njb-115	58	1	it	it	PRON
njb-115	58	2	also	also	ADV
njb-115	58	3	helps	help	VERB
njb-115	58	4	to	to	PART
njb-115	58	5	know	know	VERB
njb-115	58	6	the	the	DET
njb-115	58	7	resistant	resistant	ADJ
njb-115	58	8	towards	towards	ADP
njb-115	58	9	commonly	commonly	ADV
njb-115	58	10	used	use	VERB
njb-115	58	11	antibiotic	antibiotic	ADJ
njb-115	58	12	and	and	CCONJ
njb-115	58	13	aware	aware	ADJ
njb-115	58	14	the	the	DET
njb-115	58	15	practitioner	practitioner	NOUN
njb-115	58	16	from	from	ADP
njb-115	58	17	misusing	misuse	VERB
njb-115	58	18	the	the	DET
njb-115	58	19	antibiotic	antibiotic	NOUN
njb-115	58	20	.	.	PUNCT
njb-115	59	1	hence	hence	ADV
njb-115	59	2	,	,	PUNCT
njb-115	59	3	the	the	DET
njb-115	59	4	aim	aim	NOUN
njb-115	59	5	of	of	ADP
njb-115	59	6	the	the	DET
njb-115	59	7	study	study	NOUN
njb-115	59	8	was	be	AUX
njb-115	59	9	to	to	PART
njb-115	59	10	assess	assess	VERB
njb-115	59	11	the	the	DET
njb-115	59	12	prevalence	prevalence	NOUN
njb-115	59	13	of	of	ADP
njb-115	59	14	s.	s.	PROPN
njb-115	59	15	aureus	aureus	PROPN
njb-115	59	16	and	and	CCONJ
njb-115	59	17	the	the	DET
njb-115	59	18	antibiotic	antibiotic	ADJ
njb-115	59	19	susceptibility	susceptibility	NOUN
njb-115	59	20	pattern	pattern	NOUN
njb-115	59	21	of	of	ADP
njb-115	59	22	s.	s.	PROPN
njb-115	59	23	aureus	aureus	PROPN
njb-115	59	24	isolated	isolate	VERB
njb-115	59	25	from	from	ADP
njb-115	59	26	the	the	DET
njb-115	59	27	pus	pus	NOUN
njb-115	59	28	/	/	SYM
njb-115	59	29	wound	wound	NOUN
njb-115	59	30	swab	swab	NOUN
njb-115	59	31	from	from	ADP
njb-115	59	32	children	child	NOUN
njb-115	59	33	attending	attend	VERB
njb-115	59	34	international	international	ADJ
njb-115	59	35	friendship	friendship	NOUN
njb-115	59	36	children	child	NOUN
njb-115	59	37	's	's	PART
njb-115	59	38	hospital	hospital	NOUN
njb-115	59	39	(	(	PUNCT
njb-115	59	40	ifch	ifch	NOUN
njb-115	59	41	)	)	PUNCT
njb-115	59	42	,	,	PUNCT
njb-115	59	43	maharajgunj	maharajgunj	PROPN
njb-115	59	44	,	,	PUNCT
njb-115	59	45	kathmandu	kathmandu	NOUN
njb-115	59	46	.	.	PUNCT
njb-115	60	1	materials	material	NOUN
njb-115	60	2	and	and	CCONJ
njb-115	60	3	methods	method	NOUN
njb-115	60	4	sample	sample	VERB
njb-115	60	5	collection	collection	NOUN
njb-115	60	6	and	and	CCONJ
njb-115	60	7	identification	identification	NOUN
njb-115	60	8	of	of	ADP
njb-115	60	9	isolates	isolate	NOUN
njb-115	60	10	the	the	DET
njb-115	60	11	research	research	NOUN
njb-115	60	12	was	be	AUX
njb-115	60	13	conducted	conduct	VERB
njb-115	60	14	at	at	ADP
njb-115	60	15	the	the	DET
njb-115	60	16	microbiology	microbiology	NOUN
njb-115	60	17	laboratory	laboratory	NOUN
njb-115	60	18	of	of	ADP
njb-115	60	19	international	international	ADJ
njb-115	60	20	friendship	friendship	NOUN
njb-115	60	21	children	child	NOUN
njb-115	60	22	's	's	PART
njb-115	60	23	hospital	hospital	NOUN
njb-115	60	24	,	,	PUNCT
njb-115	60	25	maharajgunj	maharajgunj	NOUN
njb-115	60	26	,	,	PUNCT
njb-115	60	27	kathmandu	kathmandu	NOUN
njb-115	60	28	from	from	ADP
njb-115	60	29	september	september	PROPN
njb-115	60	30	2017	2017	NUM
njb-115	60	31	to	to	ADP
njb-115	60	32	march	march	PROPN
njb-115	60	33	2018	2018	NUM
njb-115	60	34	.	.	PUNCT
njb-115	61	1	a	a	DET
njb-115	61	2	hospital	hospital	NOUN
njb-115	61	3	based	base	VERB
njb-115	61	4	cross	cross	ADJ
njb-115	61	5	-	-	ADJ
njb-115	61	6	sectional	sectional	ADJ
njb-115	61	7	study	study	NOUN
njb-115	61	8	was	be	AUX
njb-115	61	9	carried	carry	VERB
njb-115	61	10	out	out	ADP
njb-115	61	11	among	among	ADP
njb-115	61	12	the	the	DET
njb-115	61	13	patients	patient	NOUN
njb-115	61	14	visiting	visit	VERB
njb-115	61	15	to	to	ADP
njb-115	61	16	the	the	DET
njb-115	61	17	hospital	hospital	NOUN
njb-115	61	18	having	have	VERB
njb-115	61	19	wound	wound	NOUN
njb-115	61	20	infection	infection	NOUN
njb-115	61	21	below	below	ADP
njb-115	61	22	16	16	NUM
njb-115	61	23	years	year	NOUN
njb-115	61	24	,	,	PUNCT
njb-115	61	25	requesting	request	VERB
njb-115	61	26	for	for	ADP
njb-115	61	27	culture	culture	NOUN
njb-115	61	28	and	and	CCONJ
njb-115	61	29	susceptibility	susceptibility	NOUN
njb-115	61	30	testing	testing	NOUN
njb-115	61	31	.	.	PUNCT
njb-115	62	1	in	in	ADP
njb-115	62	2	total	total	ADJ
njb-115	62	3	,	,	PUNCT
njb-115	62	4	270	270	NUM
njb-115	62	5	pus	pus	NOUN
njb-115	62	6	/	/	SYM
njb-115	62	7	wound	wound	NOUN
njb-115	62	8	swab	swab	NOUN
njb-115	62	9	samples	sample	NOUN
njb-115	62	10	were	be	AUX
njb-115	62	11	collected	collect	VERB
njb-115	62	12	using	use	VERB
njb-115	62	13	aseptic	aseptic	ADJ
njb-115	62	14	technique	technique	NOUN
njb-115	62	15	.	.	PUNCT
njb-115	63	1	out	out	ADP
njb-115	63	2	of	of	ADP
njb-115	63	3	total	total	ADJ
njb-115	63	4	sample	sample	NOUN
njb-115	63	5	,	,	PUNCT
njb-115	63	6	228	228	NUM
njb-115	63	7	samples	sample	NOUN
njb-115	63	8	were	be	AUX
njb-115	63	9	collected	collect	VERB
njb-115	63	10	from	from	ADP
njb-115	63	11	out	out	ADP
njb-115	63	12	-	-	PUNCT
njb-115	63	13	patient	patient	NOUN
njb-115	63	14	department	department	NOUN
njb-115	63	15	(	(	PUNCT
njb-115	63	16	opd	opd	PROPN
njb-115	63	17	)	)	PUNCT
njb-115	63	18	and	and	CCONJ
njb-115	63	19	42	42	NUM
njb-115	63	20	samples	sample	NOUN
njb-115	63	21	were	be	AUX
njb-115	63	22	collected	collect	VERB
njb-115	63	23	from	from	ADP
njb-115	63	24	in	in	ADP
njb-115	63	25	-	-	PUNCT
njb-115	63	26	patient	patient	NOUN
njb-115	63	27	department	department	NOUN
njb-115	63	28	(	(	PUNCT
njb-115	63	29	ipd	ipd	PROPN
njb-115	63	30	)	)	PUNCT
njb-115	63	31	.	.	PUNCT
njb-115	64	1	within	within	ADP
njb-115	64	2	ipd	ipd	PROPN
njb-115	64	3	also	also	ADV
njb-115	64	4	,	,	PUNCT
njb-115	64	5	12	12	NUM
njb-115	64	6	samples	sample	NOUN
njb-115	64	7	were	be	AUX
njb-115	64	8	collected	collect	VERB
njb-115	64	9	from	from	ADP
njb-115	64	10	general	general	ADJ
njb-115	64	11	ward	ward	NOUN
njb-115	64	12	(	(	PUNCT
njb-115	64	13	gw	gw	PROPN
njb-115	64	14	)	)	PUNCT
njb-115	64	15	,	,	PUNCT
njb-115	64	16	4	4	NUM
njb-115	64	17	samples	sample	NOUN
njb-115	64	18	from	from	ADP
njb-115	64	19	special	special	ADJ
njb-115	64	20	ward	ward	NOUN
njb-115	64	21	(	(	PUNCT
njb-115	64	22	sp	sp	PROPN
njb-115	64	23	.	.	PROPN
njb-115	64	24	ward	ward	PROPN
njb-115	64	25	)	)	PUNCT
njb-115	64	26	,	,	PUNCT
njb-115	64	27	12	12	NUM
njb-115	64	28	samples	sample	NOUN
njb-115	64	29	from	from	ADP
njb-115	64	30	surgical	surgical	ADJ
njb-115	64	31	/	/	SYM
njb-115	64	32	burn	burn	NOUN
njb-115	64	33	ward	ward	NOUN
njb-115	64	34	(	(	PUNCT
njb-115	64	35	s	s	PROPN
njb-115	64	36	/	/	SYM
njb-115	64	37	b	b	PROPN
njb-115	64	38	ward	ward	NOUN
njb-115	64	39	)	)	PUNCT
njb-115	64	40	,	,	PUNCT
njb-115	64	41	6	6	NUM
njb-115	64	42	samples	sample	NOUN
njb-115	64	43	from	from	ADP
njb-115	64	44	infant	infant	NOUN
njb-115	64	45	icu	icu	PROPN
njb-115	64	46	(	(	PUNCT
njb-115	64	47	iicu	iicu	PROPN
njb-115	64	48	)	)	PUNCT
njb-115	64	49	,	,	PUNCT
njb-115	64	50	3	3	NUM
njb-115	64	51	samples	sample	NOUN
njb-115	64	52	from	from	ADP
njb-115	64	53	pediatric	pediatric	ADJ
njb-115	64	54	icu	icu	PROPN
njb-115	64	55	(	(	PUNCT
njb-115	64	56	picu	picu	PROPN
njb-115	64	57	)	)	PUNCT
njb-115	64	58	,	,	PUNCT
njb-115	64	59	4	4	NUM
njb-115	64	60	samples	sample	NOUN
njb-115	64	61	surgical	surgical	ADJ
njb-115	64	62	icu	icu	PROPN
njb-115	64	63	(	(	PUNCT
njb-115	64	64	sicu	sicu	PROPN
njb-115	64	65	)	)	PUNCT
njb-115	64	66	and	and	CCONJ
njb-115	64	67	1	1	NUM
njb-115	64	68	sample	sample	NOUN
njb-115	64	69	from	from	ADP
njb-115	64	70	neonates	neonates	PROPN
njb-115	64	71	icu	icu	PROPN
njb-115	64	72	(	(	PUNCT
njb-115	64	73	nicu	nicu	PROPN
njb-115	64	74	)	)	PUNCT
njb-115	64	75	.	.	PUNCT
njb-115	65	1	here	here	ADV
njb-115	65	2	,	,	PUNCT
njb-115	65	3	130	130	NUM
njb-115	65	4	samples	sample	NOUN
njb-115	65	5	were	be	AUX
njb-115	65	6	of	of	ADP
njb-115	65	7	male	male	NOUN
njb-115	65	8	and	and	CCONJ
njb-115	65	9	140	140	NUM
njb-115	65	10	samples	sample	NOUN
njb-115	65	11	were	be	AUX
njb-115	65	12	of	of	ADP
njb-115	65	13	female	female	NOUN
njb-115	65	14	.	.	PUNCT
njb-115	66	1	17	17	NUM
njb-115	66	2	samples	sample	NOUN
njb-115	66	3	were	be	AUX
njb-115	66	4	of	of	ADP
njb-115	66	5	age	age	NOUN
njb-115	66	6	group	group	NOUN
njb-115	66	7	0	0	NUM
njb-115	66	8	-	-	SYM
njb-115	66	9	1	1	NUM
njb-115	66	10	month	month	NOUN
njb-115	66	11	,	,	PUNCT
njb-115	66	12	54	54	NUM
njb-115	66	13	of	of	ADP
njb-115	66	14	1	1	NUM
njb-115	66	15	month-1year	month-1year	NOUN
njb-115	66	16	,	,	PUNCT
njb-115	66	17	75	75	NUM
njb-115	66	18	of	of	ADP
njb-115	66	19	1	1	NUM
njb-115	66	20	-	-	SYM
njb-115	66	21	3	3	NUM
njb-115	66	22	years	year	NOUN
njb-115	66	23	,	,	PUNCT
njb-115	66	24	54	54	NUM
njb-115	66	25	of	of	ADP
njb-115	66	26	4	4	NUM
njb-115	66	27	-	-	SYM
njb-115	66	28	6	6	NUM
njb-115	66	29	years	year	NOUN
njb-115	66	30	,	,	PUNCT
njb-115	66	31	57	57	NUM
njb-115	66	32	of	of	ADP
njb-115	66	33	6	6	NUM
njb-115	66	34	-	-	SYM
njb-115	66	35	12	12	NUM
njb-115	66	36	years	year	NOUN
njb-115	66	37	and	and	CCONJ
njb-115	66	38	13	13	NUM
njb-115	66	39	of	of	ADP
njb-115	66	40	12	12	NUM
njb-115	66	41	-	-	SYM
njb-115	66	42	15	15	NUM
njb-115	66	43	years	year	NOUN
njb-115	66	44	.	.	PUNCT
njb-115	67	1	the	the	DET
njb-115	67	2	specimens	specimen	NOUN
njb-115	67	3	were	be	AUX
njb-115	67	4	well	well	ADV
njb-115	67	5	labelled	label	VERB
njb-115	67	6	and	and	CCONJ
njb-115	67	7	then	then	ADV
njb-115	67	8	transported	transport	VERB
njb-115	67	9	to	to	ADP
njb-115	67	10	the	the	DET
njb-115	67	11	laboratory	laboratory	NOUN
njb-115	67	12	and	and	CCONJ
njb-115	67	13	processed	process	VERB
njb-115	67	14	immediately	immediately	ADV
njb-115	67	15	.	.	PUNCT
njb-115	68	1	after	after	ADP
njb-115	68	2	macroscopic	macroscopic	ADJ
njb-115	68	3	and	and	CCONJ
njb-115	68	4	microscopic	microscopic	ADJ
njb-115	68	5	observation	observation	NOUN
njb-115	68	6	,	,	PUNCT
njb-115	68	7	it	it	PRON
njb-115	68	8	was	be	AUX
njb-115	68	9	cultured	cultured	ADJ
njb-115	68	10	on	on	ADP
njb-115	68	11	blood	blood	NOUN
njb-115	68	12	agar	agar	NOUN
njb-115	68	13	(	(	PUNCT
njb-115	68	14	ba	ba	NOUN
njb-115	68	15	)	)	PUNCT
njb-115	68	16	and	and	CCONJ
njb-115	68	17	mac	mac	ADJ
njb-115	68	18	-	-	PUNCT
njb-115	68	19	conkey	conkey	NOUN
njb-115	68	20	agar	agar	NOUN
njb-115	68	21	(	(	PUNCT
njb-115	68	22	ma	ma	PROPN
njb-115	68	23	)	)	PUNCT
njb-115	68	24	and	and	CCONJ
njb-115	68	25	incubated	incubate	VERB
njb-115	68	26	at	at	ADP
njb-115	68	27	37	37	NUM
njb-115	68	28	°	°	NOUN
njb-115	68	29	c	c	NOUN
njb-115	68	30	for	for	ADP
njb-115	68	31	24	24	NUM
njb-115	68	32	hrs	hr	NOUN
njb-115	68	33	.	.	PUNCT
njb-115	69	1	the	the	DET
njb-115	69	2	isolates	isolate	NOUN
njb-115	69	3	were	be	AUX
njb-115	69	4	identified	identify	VERB
njb-115	69	5	by	by	ADP
njb-115	69	6	colony	colony	NOUN
njb-115	69	7	morphology	morphology	NOUN
njb-115	69	8	,	,	PUNCT
njb-115	69	9	gram	gram	NOUN
njb-115	69	10	staining	staining	NOUN
njb-115	69	11	and	and	CCONJ
njb-115	69	12	nepal	nepal	ADJ
njb-115	69	13	j	j	NOUN
njb-115	69	14	biotechnol	biotechnol	PROPN
njb-115	69	15	.	.	PUNCT
njb-115	70	1	2	2	NUM
njb-115	70	2	0	0	NUM
njb-115	70	3	2	2	NUM
njb-115	70	4	1	1	NUM
njb-115	70	5	j	j	NOUN
njb-115	70	6	u	u	NOUN
njb-115	70	7	l	l	NOUN
njb-115	70	8	;	;	PUNCT
njb-115	70	9	9	9	NUM
njb-115	70	10	(	(	PUNCT
njb-115	70	11	1):8	1):8	NUM
njb-115	70	12	1	1	NUM
njb-115	70	13	7	7	NUM
njb-115	70	14	maharjan	maharjan	NOUN
njb-115	70	15	et	et	NOUN
njb-115	70	16	al	al	PROPN
njb-115	70	17	.	.	PUNCT
njb-115	71	1	©	©	PROPN
njb-115	71	2	njb	njb	PROPN
njb-115	71	3	,	,	PUNCT
njb-115	71	4	bsn	bsn	PROPN
njb-115	71	5	10	10	NUM
njb-115	71	6	various	various	ADJ
njb-115	71	7	biochemical	biochemical	ADJ
njb-115	71	8	tests	test	NOUN
njb-115	71	9	[	[	PUNCT
njb-115	71	10	30	30	NUM
njb-115	71	11	]	]	PUNCT
njb-115	71	12	.	.	PUNCT
njb-115	72	1	the	the	DET
njb-115	72	2	gram	gram	NOUN
njb-115	72	3	-	-	PUNCT
njb-115	72	4	positive	positive	ADJ
njb-115	72	5	cocci	cocci	NOUN
njb-115	72	6	in	in	ADP
njb-115	72	7	cluster	cluster	NOUN
njb-115	72	8	observed	observe	VERB
njb-115	72	9	under	under	ADP
njb-115	72	10	microscope	microscope	PROPN
njb-115	72	11	was	be	AUX
njb-115	72	12	considered	consider	VERB
njb-115	72	13	as	as	ADP
njb-115	72	14	staphylococcus	staphylococcus	NOUN
njb-115	72	15	species	specie	NOUN
njb-115	72	16	and	and	CCONJ
njb-115	72	17	was	be	AUX
njb-115	72	18	subjected	subject	VERB
njb-115	72	19	under	under	ADP
njb-115	72	20	different	different	ADJ
njb-115	72	21	biochemical	biochemical	ADJ
njb-115	72	22	test	test	NOUN
njb-115	72	23	for	for	ADP
njb-115	72	24	the	the	DET
njb-115	72	25	confirmation	confirmation	NOUN
njb-115	72	26	of	of	ADP
njb-115	72	27	s.	s.	PROPN
njb-115	72	28	aureus	aureus	PROPN
njb-115	72	29	.	.	PUNCT
njb-115	73	1	the	the	DET
njb-115	73	2	staphylococcus	staphylococcus	NOUN
njb-115	73	3	species	specie	NOUN
njb-115	73	4	showing	show	VERB
njb-115	73	5	catalase	catalase	NOUN
njb-115	73	6	positive	positive	ADJ
njb-115	73	7	,	,	PUNCT
njb-115	73	8	oxidase	oxidase	NOUN
njb-115	73	9	negative	negative	ADJ
njb-115	73	10	,	,	PUNCT
njb-115	73	11	fermentative	fermentative	ADJ
njb-115	73	12	,	,	PUNCT
njb-115	73	13	yellow	yellow	ADJ
njb-115	73	14	colony	colony	NOUN
njb-115	73	15	on	on	ADP
njb-115	73	16	mannitol	mannitol	ADJ
njb-115	73	17	salt	salt	NOUN
njb-115	73	18	agar	agar	NOUN
njb-115	73	19	(	(	PUNCT
njb-115	73	20	msa	msa	PROPN
njb-115	73	21	)	)	PUNCT
njb-115	73	22	,	,	PUNCT
njb-115	73	23	coagulase	coagulase	PROPN
njb-115	73	24	positive	positive	ADJ
njb-115	73	25	and	and	CCONJ
njb-115	73	26	dnase	dnase	PROPN
njb-115	73	27	positive	positive	ADJ
njb-115	73	28	were	be	AUX
njb-115	73	29	confirmed	confirm	VERB
njb-115	73	30	as	as	ADP
njb-115	73	31	s.	s.	PROPN
njb-115	73	32	aureus	aureus	PROPN
njb-115	73	33	[	[	PUNCT
njb-115	73	34	30	30	NUM
njb-115	73	35	]	]	PUNCT
njb-115	73	36	.	.	PUNCT
njb-115	74	1	for	for	ADP
njb-115	74	2	gram	gram	ADJ
njb-115	74	3	negative	negative	ADJ
njb-115	74	4	organism	organism	NOUN
njb-115	74	5	,	,	PUNCT
njb-115	74	6	different	different	ADJ
njb-115	74	7	biochemical	biochemical	ADJ
njb-115	74	8	tests	test	NOUN
njb-115	74	9	such	such	ADJ
njb-115	74	10	as	as	ADP
njb-115	74	11	:	:	PUNCT
njb-115	74	12	catalase	catalase	NOUN
njb-115	74	13	test	test	NOUN
njb-115	74	14	,	,	PUNCT
njb-115	74	15	oxidase	oxidase	NOUN
njb-115	74	16	test	test	NOUN
njb-115	74	17	,	,	PUNCT
njb-115	74	18	sulphur	sulphur	NOUN
njb-115	74	19	indole	indole	NOUN
njb-115	74	20	motility	motility	NOUN
njb-115	74	21	(	(	PUNCT
njb-115	74	22	sim	sim	NOUN
njb-115	74	23	)	)	PUNCT
njb-115	74	24	test	test	NOUN
njb-115	74	25	,	,	PUNCT
njb-115	74	26	methyl	methyl	PROPN
njb-115	74	27	red	red	PROPN
njb-115	74	28	(	(	PUNCT
njb-115	74	29	mr	mr	PROPN
njb-115	74	30	)	)	PUNCT
njb-115	74	31	test	test	PROPN
njb-115	74	32	,	,	PUNCT
njb-115	74	33	voges	voge	NOUN
njb-115	74	34	-	-	PUNCT
njb-115	74	35	proskauer	proskauer	PROPN
njb-115	74	36	(	(	PUNCT
njb-115	74	37	vp	vp	PROPN
njb-115	74	38	)	)	PUNCT
njb-115	74	39	test	test	NOUN
njb-115	74	40	,	,	PUNCT
njb-115	74	41	citrate	citrate	NOUN
njb-115	74	42	test	test	NOUN
njb-115	74	43	,	,	PUNCT
njb-115	74	44	oxidative	oxidative	NOUN
njb-115	74	45	/	/	SYM
njb-115	74	46	fermentative	fermentative	ADJ
njb-115	74	47	(	(	PUNCT
njb-115	74	48	o	o	NOUN
njb-115	74	49	/	/	SYM
njb-115	74	50	f	f	PROPN
njb-115	74	51	)	)	PUNCT
njb-115	74	52	test	test	NOUN
njb-115	74	53	,	,	PUNCT
njb-115	74	54	urease	urease	VERB
njb-115	74	55	test	test	NOUN
njb-115	74	56	and	and	CCONJ
njb-115	74	57	triple	triple	ADJ
njb-115	74	58	sugar	sugar	NOUN
njb-115	74	59	iron	iron	NOUN
njb-115	74	60	(	(	PUNCT
njb-115	74	61	tsia	tsia	NOUN
njb-115	74	62	)	)	PUNCT
njb-115	74	63	test	test	NOUN
njb-115	74	64	were	be	AUX
njb-115	74	65	performed	perform	VERB
njb-115	74	66	for	for	ADP
njb-115	74	67	the	the	DET
njb-115	74	68	identification	identification	NOUN
njb-115	74	69	of	of	ADP
njb-115	74	70	the	the	DET
njb-115	74	71	organism	organism	NOUN
njb-115	74	72	.	.	PUNCT
njb-115	75	1	antibiotic	antibiotic	ADJ
njb-115	75	2	susceptibility	susceptibility	NOUN
njb-115	75	3	test	test	VERB
njb-115	75	4	the	the	DET
njb-115	75	5	antibiotic	antibiotic	ADJ
njb-115	75	6	susceptibility	susceptibility	NOUN
njb-115	75	7	testing	testing	NOUN
njb-115	75	8	was	be	AUX
njb-115	75	9	done	do	VERB
njb-115	75	10	by	by	ADP
njb-115	75	11	using	use	VERB
njb-115	75	12	modified	modify	VERB
njb-115	75	13	kirby	kirby	PROPN
njb-115	75	14	-	-	PUNCT
njb-115	75	15	bauer	bauer	NOUN
njb-115	75	16	disc	disc	NOUN
njb-115	75	17	diffusion	diffusion	NOUN
njb-115	75	18	method	method	NOUN
njb-115	75	19	[	[	PUNCT
njb-115	75	20	31	31	NUM
njb-115	75	21	]	]	PUNCT
njb-115	75	22	on	on	ADP
njb-115	75	23	mueller	mueller	PROPN
njb-115	75	24	hinton	hinton	PROPN
njb-115	75	25	agar	agar	VERB
njb-115	75	26	using	use	VERB
njb-115	75	27	antibiotic	antibiotic	ADJ
njb-115	75	28	discs	disc	NOUN
njb-115	75	29	of	of	ADP
njb-115	75	30	hi	hi	ADJ
njb-115	75	31	-	-	PUNCT
njb-115	75	32	media	medium	NOUN
njb-115	75	33	laboratories	laboratory	NOUN
njb-115	75	34	pvt	pvt	PROPN
njb-115	75	35	.	.	PROPN
njb-115	75	36	ltd	ltd	PROPN
njb-115	75	37	.	.	PUNCT
njb-115	76	1	the	the	DET
njb-115	76	2	antibiotic	antibiotic	ADJ
njb-115	76	3	used	use	VERB
njb-115	76	4	was	be	AUX
njb-115	76	5	selected	select	VERB
njb-115	76	6	by	by	ADP
njb-115	76	7	following	follow	VERB
njb-115	76	8	clinical	clinical	ADJ
njb-115	76	9	and	and	CCONJ
njb-115	76	10	laboratory	laboratory	PROPN
njb-115	76	11	standards	standards	PROPN
njb-115	76	12	institute	institute	PROPN
njb-115	76	13	(	(	PUNCT
njb-115	76	14	clsi	clsi	PROPN
njb-115	76	15	)	)	PUNCT
njb-115	76	16	2017	2017	NUM
njb-115	76	17	guideline	guideline	NOUN
njb-115	76	18	[	[	PUNCT
njb-115	76	19	31	31	NUM
njb-115	76	20	]	]	PUNCT
njb-115	76	21	for	for	ADP
njb-115	76	22	s.	s.	PROPN
njb-115	76	23	aureus	aureus	PROPN
njb-115	76	24	.	.	PUNCT
njb-115	77	1	the	the	DET
njb-115	77	2	antibiotics	antibiotic	NOUN
njb-115	77	3	used	use	VERB
njb-115	77	4	were	be	AUX
njb-115	77	5	cotrimoxazole	cotrimoxazole	PROPN
njb-115	77	6	(	(	PUNCT
njb-115	77	7	1.25/23	1.25/23	NUM
njb-115	77	8	mcg	mcg	NOUN
njb-115	77	9	)	)	PUNCT
njb-115	77	10	,	,	PUNCT
njb-115	77	11	chloramphenicol	chloramphenicol	NOUN
njb-115	77	12	(	(	PUNCT
njb-115	77	13	30	30	NUM
njb-115	77	14	mcg	mcg	NOUN
njb-115	77	15	)	)	PUNCT
njb-115	77	16	,	,	PUNCT
njb-115	77	17	ciprofloxacin	ciprofloxacin	NOUN
njb-115	77	18	(	(	PUNCT
njb-115	77	19	5	5	NUM
njb-115	77	20	mcg	mcg	NOUN
njb-115	77	21	)	)	PUNCT
njb-115	77	22	,	,	PUNCT
njb-115	77	23	gentamycin	gentamycin	PROPN
njb-115	77	24	(	(	PUNCT
njb-115	77	25	10	10	NUM
njb-115	77	26	mcg	mcg	NOUN
njb-115	77	27	)	)	PUNCT
njb-115	77	28	,	,	PUNCT
njb-115	77	29	doxycycline	doxycycline	NOUN
njb-115	77	30	(	(	PUNCT
njb-115	77	31	30	30	NUM
njb-115	77	32	mcg	mcg	NOUN
njb-115	77	33	)	)	PUNCT
njb-115	77	34	,	,	PUNCT
njb-115	77	35	linezolid	linezolid	NOUN
njb-115	77	36	(	(	PUNCT
njb-115	77	37	30	30	NUM
njb-115	77	38	mcg	mcg	NOUN
njb-115	77	39	)	)	PUNCT
njb-115	77	40	,	,	PUNCT
njb-115	77	41	vancomycin	vancomycin	PROPN
njb-115	77	42	(	(	PUNCT
njb-115	77	43	30	30	NUM
njb-115	77	44	mcg	mcg	NOUN
njb-115	77	45	)	)	PUNCT
njb-115	77	46	,	,	PUNCT
njb-115	77	47	azithromycin	azithromycin	PROPN
njb-115	77	48	(	(	PUNCT
njb-115	77	49	15	15	NUM
njb-115	77	50	mcg	mcg	NOUN
njb-115	77	51	)	)	PUNCT
njb-115	77	52	,	,	PUNCT
njb-115	77	53	meropenem	meropenem	PROPN
njb-115	77	54	(	(	PUNCT
njb-115	77	55	10	10	NUM
njb-115	77	56	mcg	mcg	NOUN
njb-115	77	57	)	)	PUNCT
njb-115	77	58	and	and	CCONJ
njb-115	77	59	piperacillin	piperacillin	PROPN
njb-115	77	60	(	(	PUNCT
njb-115	77	61	100/10	100/10	NUM
njb-115	77	62	mcg	mcg	NOUN
njb-115	77	63	)	)	PUNCT
njb-115	77	64	.	.	PUNCT
njb-115	78	1	novobiocin	novobiocin	PROPN
njb-115	78	2	(	(	PUNCT
njb-115	78	3	30	30	NUM
njb-115	78	4	mcg	mcg	NOUN
njb-115	78	5	)	)	PUNCT
njb-115	78	6	was	be	AUX
njb-115	78	7	used	use	VERB
njb-115	78	8	to	to	PART
njb-115	78	9	identify	identify	VERB
njb-115	78	10	s.	s.	PROPN
njb-115	78	11	epidermidis	epidermidis	PROPN
njb-115	78	12	and	and	CCONJ
njb-115	78	13	s.	s.	PROPN
njb-115	78	14	saprophyticus	saprophyticus	PROPN
njb-115	78	15	.	.	PUNCT
njb-115	79	1	if	if	SCONJ
njb-115	79	2	the	the	DET
njb-115	79	3	identified	identify	VERB
njb-115	79	4	s.	s.	PROPN
njb-115	79	5	aureus	aureus	PROPN
njb-115	79	6	was	be	AUX
njb-115	79	7	found	find	VERB
njb-115	79	8	to	to	PART
njb-115	79	9	be	be	AUX
njb-115	79	10	resistant	resistant	ADJ
njb-115	79	11	to	to	ADP
njb-115	79	12	at	at	ADV
njb-115	79	13	least	least	ADV
njb-115	79	14	one	one	NUM
njb-115	79	15	agent	agent	NOUN
njb-115	79	16	in	in	ADP
njb-115	79	17	three	three	NUM
njb-115	79	18	or	or	CCONJ
njb-115	79	19	more	more	ADJ
njb-115	79	20	antimicrobial	antimicrobial	ADJ
njb-115	79	21	categories	category	NOUN
njb-115	79	22	,	,	PUNCT
njb-115	79	23	then	then	ADV
njb-115	79	24	the	the	DET
njb-115	79	25	organism	organism	NOUN
njb-115	79	26	was	be	AUX
njb-115	79	27	considered	consider	VERB
njb-115	79	28	as	as	ADP
njb-115	79	29	multidrug	multidrug	NOUN
njb-115	79	30	resistant	resistant	ADJ
njb-115	79	31	(	(	PUNCT
njb-115	79	32	mdr	mdr	PROPN
njb-115	79	33	)	)	PUNCT
njb-115	79	34	and	and	CCONJ
njb-115	79	35	if	if	SCONJ
njb-115	79	36	the	the	DET
njb-115	79	37	identified	identify	VERB
njb-115	79	38	s.	s.	PROPN
njb-115	79	39	aureus	aureus	PROPN
njb-115	79	40	was	be	AUX
njb-115	79	41	found	find	VERB
njb-115	79	42	to	to	PART
njb-115	79	43	be	be	AUX
njb-115	79	44	resistant	resistant	ADJ
njb-115	79	45	to	to	ADP
njb-115	79	46	at	at	ADV
njb-115	79	47	least	least	ADV
njb-115	79	48	1	1	NUM
njb-115	79	49	agent	agent	NOUN
njb-115	79	50	in	in	ADP
njb-115	79	51	all	all	DET
njb-115	79	52	but	but	CCONJ
njb-115	79	53	2	2	NUM
njb-115	79	54	or	or	CCONJ
njb-115	79	55	fewer	few	ADJ
njb-115	79	56	antimicrobial	antimicrobial	ADJ
njb-115	79	57	categories	category	NOUN
njb-115	79	58	,	,	PUNCT
njb-115	79	59	then	then	ADV
njb-115	79	60	it	it	PRON
njb-115	79	61	was	be	AUX
njb-115	79	62	considered	consider	VERB
njb-115	79	63	as	as	ADP
njb-115	79	64	extremely	extremely	ADV
njb-115	79	65	drug	drug	NOUN
njb-115	79	66	resistant	resistant	ADJ
njb-115	79	67	(	(	PUNCT
njb-115	79	68	xdr	xdr	NOUN
njb-115	79	69	)	)	PUNCT
njb-115	80	1	[	[	PUNCT
njb-115	80	2	21	21	NUM
njb-115	80	3	]	]	PUNCT
njb-115	80	4	.	.	PUNCT
njb-115	81	1	after	after	ADP
njb-115	81	2	screening	screen	VERB
njb-115	81	3	mdr	mdr	PROPN
njb-115	81	4	,	,	PUNCT
njb-115	81	5	the	the	DET
njb-115	81	6	identified	identify	VERB
njb-115	81	7	s.	s.	PROPN
njb-115	81	8	aureus	aureus	PROPN
njb-115	81	9	was	be	AUX
njb-115	81	10	then	then	ADV
njb-115	81	11	screened	screen	VERB
njb-115	81	12	for	for	ADP
njb-115	81	13	methicillin	methicillin	PROPN
njb-115	81	14	resistant	resistant	ADJ
njb-115	81	15	s.	s.	PROPN
njb-115	81	16	aureus	aureus	PROPN
njb-115	81	17	(	(	PUNCT
njb-115	81	18	mrsa	mrsa	PROPN
njb-115	81	19	)	)	PUNCT
njb-115	81	20	using	use	VERB
njb-115	81	21	cefoxitin	cefoxitin	NOUN
njb-115	81	22	disc	disc	NOUN
njb-115	81	23	(	(	PUNCT
njb-115	81	24	30	30	NUM
njb-115	81	25	mcg).the	mcg).the	DET
njb-115	81	26	organisms	organism	NOUN
njb-115	81	27	resistant	resistant	ADJ
njb-115	81	28	i.e.	i.e.	X
njb-115	81	29	≤21	≤21	ADJ
njb-115	81	30	mm	mm	NOUN
njb-115	81	31	zone	zone	NOUN
njb-115	81	32	of	of	ADP
njb-115	81	33	inhibition	inhibition	NOUN
njb-115	81	34	(	(	PUNCT
njb-115	81	35	zoi	zoi	NOUN
njb-115	81	36	)	)	PUNCT
njb-115	81	37	towards	towards	ADP
njb-115	81	38	the	the	DET
njb-115	81	39	cefoxitin	cefoxitin	NOUN
njb-115	81	40	were	be	AUX
njb-115	81	41	confirmed	confirm	VERB
njb-115	81	42	as	as	ADP
njb-115	81	43	mrsa	mrsa	PROPN
njb-115	81	44	and	and	CCONJ
njb-115	81	45	those	those	DET
njb-115	81	46	sensitive	sensitive	ADJ
njb-115	81	47	were	be	AUX
njb-115	81	48	confirmed	confirm	VERB
njb-115	81	49	as	as	ADP
njb-115	81	50	methicillin	methicillin	PROPN
njb-115	81	51	sensitive	sensitive	PROPN
njb-115	81	52	s.	s.	PROPN
njb-115	81	53	aureus	aureus	PROPN
njb-115	81	54	(	(	PUNCT
njb-115	81	55	mssa	mssa	ADJ
njb-115	81	56	)	)	PUNCT
njb-115	82	1	[	[	PUNCT
njb-115	82	2	25	25	NUM
njb-115	82	3	]	]	PUNCT
njb-115	82	4	.	.	PUNCT
njb-115	83	1	if	if	SCONJ
njb-115	83	2	the	the	DET
njb-115	83	3	organism	organism	NOUN
njb-115	83	4	was	be	AUX
njb-115	83	5	found	find	VERB
njb-115	83	6	to	to	PART
njb-115	83	7	be	be	AUX
njb-115	83	8	vancomycin	vancomycin	PROPN
njb-115	83	9	resistant	resistant	ADJ
njb-115	83	10	in	in	ADP
njb-115	83	11	disc	disc	NOUN
njb-115	83	12	diffusion	diffusion	NOUN
njb-115	83	13	method	method	NOUN
njb-115	83	14	,	,	PUNCT
njb-115	83	15	it	it	PRON
njb-115	83	16	was	be	AUX
njb-115	83	17	further	far	ADV
njb-115	83	18	processed	process	VERB
njb-115	83	19	for	for	ADP
njb-115	83	20	the	the	DET
njb-115	83	21	confirmation	confirmation	NOUN
njb-115	83	22	of	of	ADP
njb-115	83	23	vancomycin	vancomycin	PROPN
njb-115	83	24	resistant	resistant	ADJ
njb-115	83	25	s.	s.	PROPN
njb-115	83	26	aureus	aureus	PROPN
njb-115	83	27	(	(	PUNCT
njb-115	83	28	vrsa	vrsa	PROPN
njb-115	83	29	)	)	PUNCT
njb-115	83	30	by	by	ADP
njb-115	83	31	using	use	VERB
njb-115	83	32	minimum	minimum	ADJ
njb-115	83	33	inhibitory	inhibitory	ADJ
njb-115	83	34	concentration	concentration	NOUN
njb-115	83	35	(	(	PUNCT
njb-115	83	36	mic	mic	ADJ
njb-115	83	37	)	)	PUNCT
njb-115	83	38	method	method	NOUN
njb-115	83	39	[	[	PUNCT
njb-115	83	40	31	31	NUM
njb-115	83	41	]	]	PUNCT
njb-115	83	42	.	.	PUNCT
njb-115	84	1	s.	s.	PROPN
njb-115	84	2	aureus	aureus	PROPN
njb-115	84	3	atcc	atcc	PROPN
njb-115	84	4	25923	25923	NUM
njb-115	84	5	was	be	AUX
njb-115	84	6	used	use	VERB
njb-115	84	7	as	as	ADP
njb-115	84	8	control	control	NOUN
njb-115	84	9	strain	strain	NOUN
njb-115	84	10	.	.	PUNCT
njb-115	85	1	d	d	X
njb-115	85	2	-	-	PUNCT
njb-115	85	3	test	test	NOUN
njb-115	85	4	d	d	NOUN
njb-115	85	5	-	-	NOUN
njb-115	85	6	test	test	NOUN
njb-115	85	7	was	be	AUX
njb-115	85	8	performed	perform	VERB
njb-115	85	9	by	by	ADP
njb-115	85	10	using	use	VERB
njb-115	85	11	erythromycin	erythromycin	PROPN
njb-115	85	12	disc	disc	NOUN
njb-115	85	13	(	(	PUNCT
njb-115	85	14	15	15	NUM
njb-115	85	15	mcg	mcg	NOUN
njb-115	85	16	)	)	PUNCT
njb-115	85	17	and	and	CCONJ
njb-115	85	18	clindamycin	clindamycin	PROPN
njb-115	85	19	disc	disc	NOUN
njb-115	85	20	(	(	PUNCT
njb-115	85	21	2	2	NUM
njb-115	85	22	mcg	mcg	NOUN
njb-115	85	23	)	)	PUNCT
njb-115	85	24	.	.	PUNCT
njb-115	86	1	the	the	DET
njb-115	86	2	antibiotic	antibiotic	ADJ
njb-115	86	3	discs	disc	NOUN
njb-115	86	4	were	be	AUX
njb-115	86	5	placed	place	VERB
njb-115	86	6	on	on	ADP
njb-115	86	7	a	a	DET
njb-115	86	8	lawn	lawn	NOUN
njb-115	86	9	cultured	cultured	ADJ
njb-115	86	10	mha	mha	NOUN
njb-115	86	11	plate	plate	NOUN
njb-115	86	12	at	at	ADP
njb-115	86	13	15	15	NUM
njb-115	86	14	mm	mm	NOUN
njb-115	86	15	apart	apart	ADV
njb-115	86	16	and	and	CCONJ
njb-115	86	17	was	be	AUX
njb-115	86	18	incubated	incubate	VERB
njb-115	86	19	at	at	ADP
njb-115	86	20	37	37	NUM
njb-115	86	21	°	°	NOUN
njb-115	86	22	c	c	NOUN
njb-115	86	23	at	at	ADP
njb-115	86	24	18	18	NUM
njb-115	86	25	-	-	SYM
njb-115	86	26	24	24	NUM
njb-115	86	27	hrs	hrs	NOUN
njb-115	86	28	[	[	PUNCT
njb-115	86	29	24	24	NUM
njb-115	86	30	]	]	PUNCT
njb-115	86	31	.	.	PUNCT
njb-115	87	1	the	the	DET
njb-115	87	2	organisms	organism	NOUN
njb-115	87	3	that	that	PRON
njb-115	87	4	showed	show	VERB
njb-115	87	5	flattening	flatten	VERB
njb-115	87	6	zone	zone	NOUN
njb-115	87	7	of	of	ADP
njb-115	87	8	clindamycin	clindamycin	PROPN
njb-115	87	9	adjacent	adjacent	ADJ
njb-115	87	10	to	to	ADP
njb-115	87	11	the	the	DET
njb-115	87	12	erythromycin	erythromycin	PROPN
njb-115	87	13	disc	disc	NOUN
njb-115	87	14	were	be	AUX
njb-115	87	15	considered	consider	VERB
njb-115	87	16	as	as	ADP
njb-115	87	17	dtest	dt	ADJ
njb-115	87	18	positive	positive	ADJ
njb-115	87	19	(	(	PUNCT
njb-115	87	20	mlsbi	mlsbi	ADV
njb-115	87	21	resistant	resistant	ADJ
njb-115	87	22	,	,	PUNCT
njb-115	87	23	i.e.	i.e.	X
njb-115	87	24	inducible	inducible	ADJ
njb-115	87	25	macrolidelincosamide	macrolidelincosamide	NOUN
njb-115	87	26	-	-	PUNCT
njb-115	87	27	streptogramin	streptogramin	NOUN
njb-115	87	28	b	b	PROPN
njb-115	87	29	resistance	resistance	NOUN
njb-115	87	30	)	)	PUNCT
njb-115	87	31	.	.	PUNCT
njb-115	88	1	if	if	SCONJ
njb-115	88	2	the	the	DET
njb-115	88	3	organism	organism	NOUN
njb-115	88	4	was	be	AUX
njb-115	88	5	found	find	VERB
njb-115	88	6	to	to	PART
njb-115	88	7	be	be	AUX
njb-115	88	8	resistant	resistant	ADJ
njb-115	88	9	towards	towards	ADP
njb-115	88	10	both	both	DET
njb-115	88	11	discs	disc	NOUN
njb-115	88	12	then	then	ADV
njb-115	88	13	,	,	PUNCT
njb-115	88	14	it	it	PRON
njb-115	88	15	was	be	AUX
njb-115	88	16	taken	take	VERB
njb-115	88	17	as	as	ADP
njb-115	88	18	constitutive	constitutive	ADJ
njb-115	88	19	mlsb	mlsb	NOUN
njb-115	88	20	(	(	PUNCT
njb-115	88	21	mlsbc	mlsbc	NOUN
njb-115	88	22	)	)	PUNCT
njb-115	88	23	and	and	CCONJ
njb-115	88	24	if	if	SCONJ
njb-115	88	25	organism	organism	NOUN
njb-115	88	26	showed	show	VERB
njb-115	88	27	sensitive	sensitive	ADJ
njb-115	88	28	towards	towards	ADP
njb-115	88	29	clindamycin	clindamycin	PROPN
njb-115	88	30	but	but	CCONJ
njb-115	88	31	resistant	resistant	ADJ
njb-115	88	32	towards	towards	ADP
njb-115	88	33	erythromycin	erythromycin	PROPN
njb-115	88	34	,	,	PUNCT
njb-115	88	35	then	then	ADV
njb-115	88	36	it	it	PRON
njb-115	88	37	was	be	AUX
njb-115	88	38	taken	take	VERB
njb-115	88	39	as	as	ADP
njb-115	88	40	d	d	NOUN
njb-115	88	41	-	-	PUNCT
njb-115	88	42	test	test	NOUN
njb-115	88	43	negative	negative	ADJ
njb-115	89	1	[	[	X
njb-115	89	2	24	24	NUM
njb-115	89	3	]	]	PUNCT
njb-115	89	4	.	.	PUNCT
njb-115	90	1	data	datum	NOUN
njb-115	90	2	analysis	analysis	NOUN
njb-115	90	3	all	all	DET
njb-115	90	4	the	the	DET
njb-115	90	5	data	datum	NOUN
njb-115	90	6	was	be	AUX
njb-115	90	7	entered	enter	VERB
njb-115	90	8	in	in	ADP
njb-115	90	9	statistical	statistical	ADJ
njb-115	90	10	package	package	NOUN
njb-115	90	11	for	for	ADP
njb-115	90	12	the	the	DET
njb-115	90	13	social	social	ADJ
njb-115	90	14	science	science	NOUN
njb-115	90	15	(	(	PUNCT
njb-115	90	16	spss	spss	PROPN
njb-115	90	17	)	)	PUNCT
njb-115	90	18	version	version	NOUN
njb-115	90	19	16	16	NUM
njb-115	90	20	.	.	PUNCT
njb-115	91	1	most	most	ADJ
njb-115	91	2	of	of	ADP
njb-115	91	3	the	the	DET
njb-115	91	4	data	datum	NOUN
njb-115	91	5	was	be	AUX
njb-115	91	6	analysed	analyse	VERB
njb-115	91	7	by	by	ADP
njb-115	91	8	using	use	VERB
njb-115	91	9	spss	spss	PROPN
njb-115	91	10	version	version	NOUN
njb-115	91	11	16	16	NUM
njb-115	91	12	(	(	PUNCT
njb-115	91	13	spss	spss	PROPN
njb-115	91	14	for	for	ADP
njb-115	91	15	windows	window	NOUN
njb-115	91	16	,	,	PUNCT
njb-115	91	17	chicago	chicago	PROPN
njb-115	91	18	,	,	PUNCT
njb-115	91	19	spss	spss	PROPN
njb-115	91	20	inc	inc	PROPN
njb-115	91	21	)	)	PUNCT
njb-115	91	22	.	.	PUNCT
njb-115	92	1	the	the	DET
njb-115	92	2	association	association	PROPN
njb-115	92	3	between	between	ADP
njb-115	92	4	mdr	mdr	PROPN
njb-115	92	5	and	and	CCONJ
njb-115	92	6	mrsa	mrsa	PROPN
njb-115	92	7	was	be	AUX
njb-115	92	8	determined	determine	VERB
njb-115	92	9	by	by	ADP
njb-115	92	10	performing	perform	VERB
njb-115	92	11	chi	chi	ADJ
njb-115	92	12	-	-	PUNCT
njb-115	92	13	square	square	ADJ
njb-115	92	14	test	test	NOUN
njb-115	92	15	analysed	analyse	VERB
njb-115	92	16	by	by	ADP
njb-115	92	17	spss	spss	PROPN
njb-115	92	18	version	version	PROPN
njb-115	92	19	16	16	NUM
njb-115	92	20	whereas	whereas	SCONJ
njb-115	92	21	the	the	DET
njb-115	92	22	correlation	correlation	NOUN
njb-115	92	23	coefficient	coefficient	NOUN
njb-115	92	24	between	between	ADP
njb-115	92	25	d	d	NOUN
njb-115	92	26	-	-	NOUN
njb-115	92	27	test	test	NOUN
njb-115	92	28	and	and	CCONJ
njb-115	92	29	mrsa	mrsa	PROPN
njb-115	92	30	was	be	AUX
njb-115	92	31	calculated	calculate	VERB
njb-115	92	32	by	by	ADP
njb-115	92	33	using	use	VERB
njb-115	92	34	statistical	statistical	ADJ
njb-115	92	35	method	method	NOUN
njb-115	92	36	,	,	PUNCT
njb-115	92	37	i.e.	i.e.	X
njb-115	92	38	karl	karl	PROPN
njb-115	92	39	pearson	pearson	PROPN
njb-115	92	40	's	's	PART
njb-115	92	41	correlation	correlation	NOUN
njb-115	92	42	coefficient	coefficient	NOUN
njb-115	92	43	.	.	PUNCT
njb-115	93	1	in	in	ADP
njb-115	93	2	the	the	DET
njb-115	93	3	study	study	NOUN
njb-115	93	4	,	,	PUNCT
njb-115	93	5	we	we	PRON
njb-115	93	6	used	use	VERB
njb-115	93	7	pearson	pearson	PROPN
njb-115	93	8	's	's	PART
njb-115	93	9	chi	chi	ADJ
njb-115	93	10	-	-	PUNCT
njb-115	93	11	square	square	ADJ
njb-115	93	12	test	test	NOUN
njb-115	93	13	to	to	PART
njb-115	93	14	test	test	VERB
njb-115	93	15	whether	whether	SCONJ
njb-115	93	16	mrsa	mrsa	PROPN
njb-115	93	17	influences	influence	VERB
njb-115	93	18	the	the	DET
njb-115	93	19	increase	increase	NOUN
njb-115	93	20	in	in	ADP
njb-115	93	21	mdr	mdr	NOUN
njb-115	93	22	cases	case	NOUN
njb-115	93	23	or	or	CCONJ
njb-115	93	24	not	not	PART
njb-115	93	25	whereas	whereas	SCONJ
njb-115	93	26	karl	karl	PROPN
njb-115	93	27	pearson	pearson	PROPN
njb-115	93	28	's	's	PART
njb-115	93	29	correlation	correlation	NOUN
njb-115	93	30	coefficient	coefficient	NOUN
njb-115	93	31	test	test	NOUN
njb-115	93	32	was	be	AUX
njb-115	93	33	used	use	VERB
njb-115	93	34	to	to	PART
njb-115	93	35	test	test	VERB
njb-115	93	36	whether	whether	SCONJ
njb-115	93	37	there	there	PRON
njb-115	93	38	is	be	VERB
njb-115	93	39	significant	significant	ADJ
njb-115	93	40	correlation	correlation	NOUN
njb-115	93	41	between	between	ADP
njb-115	93	42	mrsa	mrsa	PROPN
njb-115	93	43	and	and	CCONJ
njb-115	93	44	d	d	NOUN
njb-115	93	45	-	-	NOUN
njb-115	93	46	test	test	NOUN
njb-115	93	47	.	.	PUNCT
njb-115	94	1	results	result	VERB
njb-115	94	2	growth	growth	NOUN
njb-115	94	3	pattern	pattern	NOUN
njb-115	94	4	of	of	ADP
njb-115	94	5	culture	culture	NOUN
njb-115	94	6	and	and	CCONJ
njb-115	94	7	distribution	distribution	NOUN
njb-115	94	8	of	of	ADP
njb-115	94	9	culture	culture	NOUN
njb-115	94	10	positive	positive	ADJ
njb-115	94	11	within	within	ADP
njb-115	94	12	the	the	DET
njb-115	94	13	departments	department	NOUN
njb-115	94	14	out	out	ADP
njb-115	94	15	of	of	ADP
njb-115	94	16	270	270	NUM
njb-115	94	17	pus	pus	NOUN
njb-115	94	18	/	/	SYM
njb-115	94	19	wound	wound	NOUN
njb-115	94	20	swab	swab	NOUN
njb-115	94	21	samples	sample	NOUN
njb-115	94	22	,	,	PUNCT
njb-115	94	23	139	139	NUM
njb-115	94	24	(	(	PUNCT
njb-115	94	25	51.48	51.48	NUM
njb-115	94	26	%	%	NOUN
njb-115	94	27	)	)	PUNCT
njb-115	94	28	were	be	AUX
njb-115	94	29	found	find	VERB
njb-115	94	30	to	to	PART
njb-115	94	31	be	be	AUX
njb-115	94	32	culture	culture	NOUN
njb-115	94	33	positive	positive	ADJ
njb-115	94	34	while	while	SCONJ
njb-115	94	35	remaining	remain	VERB
njb-115	94	36	131	131	NUM
njb-115	94	37	(	(	PUNCT
njb-115	94	38	48.52	48.52	NUM
njb-115	94	39	%	%	NOUN
njb-115	94	40	)	)	PUNCT
njb-115	94	41	showed	show	VERB
njb-115	94	42	no	no	DET
njb-115	94	43	growth	growth	NOUN
njb-115	94	44	.	.	PUNCT
njb-115	95	1	opd	opd	PROPN
njb-115	95	2	showed	show	VERB
njb-115	95	3	highest	high	ADJ
njb-115	95	4	positive	positive	ADJ
njb-115	95	5	culture	culture	NOUN
njb-115	95	6	118	118	NUM
njb-115	95	7	(	(	PUNCT
njb-115	95	8	85	85	NUM
njb-115	95	9	%	%	NOUN
njb-115	95	10	)	)	PUNCT
njb-115	95	11	compared	compare	VERB
njb-115	95	12	to	to	ADP
njb-115	95	13	that	that	PRON
njb-115	95	14	of	of	ADP
njb-115	95	15	the	the	DET
njb-115	95	16	ipd	ipd	PROPN
njb-115	95	17	21	21	NUM
njb-115	95	18	(	(	PUNCT
njb-115	95	19	15	15	NUM
njb-115	95	20	%	%	NOUN
njb-115	95	21	)	)	PUNCT
njb-115	95	22	.	.	PUNCT
njb-115	96	1	within	within	ADP
njb-115	96	2	the	the	DET
njb-115	96	3	hospital	hospital	NOUN
njb-115	96	4	department	department	NOUN
njb-115	96	5	,	,	PUNCT
njb-115	96	6	highest	high	ADJ
njb-115	96	7	growth	growth	NOUN
njb-115	96	8	was	be	AUX
njb-115	96	9	seen	see	VERB
njb-115	96	10	in	in	ADP
njb-115	96	11	the	the	DET
njb-115	96	12	department	department	NOUN
njb-115	96	13	of	of	ADP
njb-115	96	14	neonates	neonates	PROPN
njb-115	96	15	icu	icu	PROPN
njb-115	96	16	(	(	PUNCT
njb-115	96	17	nicu	nicu	PROPN
njb-115	96	18	)	)	PUNCT
njb-115	96	19	100	100	NUM
njb-115	96	20	%	%	NOUN
njb-115	96	21	(	(	PUNCT
njb-115	96	22	1/1	1/1	NUM
njb-115	96	23	)	)	PUNCT
njb-115	96	24	followed	follow	VERB
njb-115	96	25	by	by	ADP
njb-115	96	26	surgical	surgical	ADJ
njb-115	96	27	icu	icu	PROPN
njb-115	96	28	(	(	PUNCT
njb-115	96	29	sicu)75	sicu)75	PROPN
njb-115	96	30	%	%	NOUN
njb-115	96	31	(	(	PUNCT
njb-115	96	32	3/4	3/4	NUM
njb-115	96	33	)	)	PUNCT
njb-115	96	34	,	,	PUNCT
njb-115	96	35	infant	infant	NOUN
njb-115	96	36	icu	icu	PROPN
njb-115	96	37	(	(	PUNCT
njb-115	96	38	iicu	iicu	PROPN
njb-115	96	39	)	)	PUNCT
njb-115	96	40	66.67	66.67	NUM
njb-115	96	41	%	%	NOUN
njb-115	96	42	(	(	PUNCT
njb-115	96	43	4/6	4/6	NUM
njb-115	96	44	)	)	PUNCT
njb-115	96	45	,	,	PUNCT
njb-115	96	46	opd	opd	PROPN
njb-115	96	47	51.75	51.75	NUM
njb-115	96	48	%	%	NOUN
njb-115	96	49	(	(	PUNCT
njb-115	96	50	118/228	118/228	PROPN
njb-115	96	51	)	)	PUNCT
njb-115	96	52	,	,	PUNCT
njb-115	96	53	surgical	surgical	ADJ
njb-115	96	54	/	/	SYM
njb-115	96	55	burn	burn	NOUN
njb-115	96	56	ward	ward	NOUN
njb-115	96	57	(	(	PUNCT
njb-115	96	58	s	s	PROPN
njb-115	96	59	/	/	SYM
njb-115	96	60	b	b	PROPN
njb-115	96	61	ward	ward	NOUN
njb-115	96	62	)	)	PUNCT
njb-115	96	63	50	50	NUM
njb-115	96	64	%	%	NOUN
njb-115	96	65	(	(	PUNCT
njb-115	96	66	6/12	6/12	X
njb-115	96	67	)	)	PUNCT
njb-115	96	68	,	,	PUNCT
njb-115	96	69	general	general	ADJ
njb-115	96	70	ward	ward	NOUN
njb-115	96	71	(	(	PUNCT
njb-115	96	72	gw	gw	NOUN
njb-115	96	73	)	)	PUNCT
njb-115	96	74	41.67	41.67	NUM
njb-115	96	75	%	%	NOUN
njb-115	96	76	(	(	PUNCT
njb-115	96	77	5/12	5/12	NUM
njb-115	96	78	)	)	PUNCT
njb-115	96	79	,	,	PUNCT
njb-115	96	80	pediatric	pediatric	PROPN
njb-115	96	81	icu	icu	PROPN
njb-115	96	82	(	(	PUNCT
njb-115	96	83	picu	picu	PROPN
njb-115	96	84	)	)	PUNCT
njb-115	96	85	33.33	33.33	NUM
njb-115	96	86	%	%	NOUN
njb-115	96	87	(	(	PUNCT
njb-115	96	88	1/3	1/3	NUM
njb-115	96	89	)	)	PUNCT
njb-115	96	90	and	and	CCONJ
njb-115	96	91	lowest	low	ADJ
njb-115	96	92	in	in	ADP
njb-115	96	93	special	special	ADJ
njb-115	96	94	ward	ward	NOUN
njb-115	96	95	(	(	PUNCT
njb-115	96	96	sp	sp	PROPN
njb-115	96	97	.	.	PROPN
njb-115	96	98	ward	ward	PROPN
njb-115	96	99	)	)	PUNCT
njb-115	96	100	25	25	NUM
njb-115	96	101	%	%	NOUN
njb-115	96	102	(	(	PUNCT
njb-115	96	103	1/4	1/4	NUM
njb-115	96	104	)	)	PUNCT
njb-115	96	105	(	(	PUNCT
njb-115	96	106	figure	figure	NOUN
njb-115	96	107	1	1	NUM
njb-115	96	108	)	)	PUNCT
njb-115	96	109	.	.	PUNCT
njb-115	97	1	bacteriological	bacteriological	ADJ
njb-115	97	2	profile	profile	NOUN
njb-115	97	3	of	of	ADP
njb-115	97	4	pus	pus	NOUN
njb-115	97	5	/	/	SYM
njb-115	97	6	wound	wound	NOUN
njb-115	97	7	swab	swab	NOUN
njb-115	97	8	in	in	ADP
njb-115	97	9	the	the	DET
njb-115	97	10	study	study	NOUN
njb-115	97	11	,	,	PUNCT
njb-115	97	12	116	116	NUM
njb-115	97	13	(	(	PUNCT
njb-115	97	14	83.5	83.5	NUM
njb-115	97	15	%	%	NOUN
njb-115	97	16	)	)	PUNCT
njb-115	97	17	out	out	ADP
njb-115	97	18	of	of	ADP
njb-115	97	19	139	139	NUM
njb-115	97	20	were	be	AUX
njb-115	97	21	gram	gram	ADJ
njb-115	97	22	positive	positive	ADJ
njb-115	97	23	and	and	CCONJ
njb-115	97	24	23	23	NUM
njb-115	97	25	(	(	PUNCT
njb-115	97	26	16.5	16.5	NUM
njb-115	97	27	%	%	NOUN
njb-115	97	28	)	)	PUNCT
njb-115	97	29	were	be	AUX
njb-115	97	30	gram	gram	NOUN
njb-115	97	31	negative	negative	ADJ
njb-115	97	32	.	.	PUNCT
njb-115	98	1	out	out	ADP
njb-115	98	2	of	of	ADP
njb-115	98	3	total	total	ADJ
njb-115	98	4	139	139	NUM
njb-115	98	5	culture	culture	NOUN
njb-115	98	6	positive	positive	ADJ
njb-115	98	7	cases	case	NOUN
njb-115	98	8	,	,	PUNCT
njb-115	98	9	s.	s.	PROPN
njb-115	98	10	aureus	aureus	PROPN
njb-115	98	11	105	105	NUM
njb-115	98	12	(	(	PUNCT
njb-115	98	13	75.5	75.5	NUM
njb-115	98	14	%	%	NOUN
njb-115	98	15	)	)	PUNCT
njb-115	98	16	was	be	AUX
njb-115	98	17	found	find	VERB
njb-115	98	18	to	to	PART
njb-115	98	19	be	be	AUX
njb-115	98	20	common	common	ADJ
njb-115	98	21	isolates	isolate	NOUN
njb-115	98	22	followed	follow	VERB
njb-115	98	23	by	by	ADP
njb-115	98	24	escherichia	escherichia	NOUN
njb-115	98	25	coli	coli	PROPN
njb-115	98	26	7	7	NUM
njb-115	98	27	(	(	PUNCT
njb-115	98	28	5.04	5.04	NUM
njb-115	98	29	%	%	NOUN
njb-115	98	30	)	)	PUNCT
njb-115	98	31	and	and	CCONJ
njb-115	98	32	staphylococcus	staphylococcus	NOUN
njb-115	98	33	epidermidis	epidermidi	NOUN
njb-115	98	34	7	7	NUM
njb-115	98	35	(	(	PUNCT
njb-115	98	36	5.04	5.04	NUM
njb-115	98	37	%	%	NOUN
njb-115	98	38	)	)	PUNCT
njb-115	98	39	;	;	PUNCT
njb-115	98	40	pseudomonas	pseudomonas	PROPN
njb-115	98	41	aeruginosa	aeruginosa	PROPN
njb-115	98	42	6	6	NUM
njb-115	98	43	(	(	PUNCT
njb-115	98	44	4.3	4.3	NUM
njb-115	98	45	%	%	NOUN
njb-115	98	46	)	)	PUNCT
njb-115	98	47	;	;	PUNCT
njb-115	98	48	unidentified	unidentified	ADJ
njb-115	98	49	organism	organism	NOUN
njb-115	98	50	4	4	NUM
njb-115	98	51	(	(	PUNCT
njb-115	98	52	2.9	2.9	NUM
njb-115	98	53	%	%	NOUN
njb-115	98	54	)	)	PUNCT
njb-115	98	55	;	;	PUNCT
njb-115	98	56	enterococcus	enterococcus	NOUN
njb-115	98	57	2	2	NUM
njb-115	98	58	(	(	PUNCT
njb-115	98	59	1.45	1.45	NUM
njb-115	98	60	%	%	NOUN
njb-115	98	61	)	)	PUNCT
njb-115	98	62	,	,	PUNCT
njb-115	98	63	proteus	proteus	NOUN
njb-115	98	64	mirabilis	mirabilis	PROPN
njb-115	98	65	2	2	NUM
njb-115	98	66	(	(	PUNCT
njb-115	98	67	1.45	1.45	NUM
njb-115	98	68	%	%	NOUN
njb-115	98	69	)	)	PUNCT
njb-115	98	70	and	and	CCONJ
njb-115	98	71	staphylococcus	staphylococcus	PROPN
njb-115	98	72	saprophyticus	saprophyticus	PROPN
njb-115	98	73	2	2	NUM
njb-115	98	74	(	(	PUNCT
njb-115	98	75	1.45	1.45	NUM
njb-115	98	76	%	%	NOUN
njb-115	98	77	)	)	PUNCT
njb-115	98	78	;	;	PUNCT
njb-115	98	79	salmonella	salmonella	NOUN
njb-115	98	80	typhi	typhi	PROPN
njb-115	98	81	1	1	NUM
njb-115	98	82	nepal	nepal	PROPN
njb-115	98	83	j	j	NOUN
njb-115	98	84	biotechnol	biotechnol	PROPN
njb-115	98	85	.	.	PUNCT
njb-115	99	1	2	2	NUM
njb-115	99	2	0	0	NUM
njb-115	99	3	2	2	NUM
njb-115	99	4	1	1	NUM
njb-115	99	5	j	j	NOUN
njb-115	99	6	u	u	NOUN
njb-115	99	7	l	l	NOUN
njb-115	99	8	;	;	PUNCT
njb-115	99	9	9	9	NUM
njb-115	99	10	(	(	PUNCT
njb-115	99	11	1):8	1):8	NUM
njb-115	99	12	1	1	NUM
njb-115	99	13	7	7	NUM
njb-115	99	14	maharjan	maharjan	NOUN
njb-115	99	15	et	et	NOUN
njb-115	99	16	al	al	PROPN
njb-115	99	17	.	.	PUNCT
njb-115	100	1	©	©	PROPN
njb-115	100	2	njb	njb	PROPN
njb-115	100	3	,	,	PUNCT
njb-115	100	4	bsn	bsn	PROPN
njb-115	100	5	11	11	NUM
njb-115	100	6	(	(	PUNCT
njb-115	100	7	0.72	0.72	NUM
njb-115	100	8	%	%	NOUN
njb-115	100	9	)	)	PUNCT
njb-115	100	10	,	,	PUNCT
njb-115	100	11	klebsiella	klebsiella	PROPN
njb-115	100	12	oxytoca	oxytoca	PROPN
njb-115	100	13	1	1	NUM
njb-115	100	14	(	(	PUNCT
njb-115	100	15	0.72	0.72	NUM
njb-115	100	16	%	%	NOUN
njb-115	100	17	)	)	PUNCT
njb-115	100	18	,	,	PUNCT
njb-115	100	19	klebsiella	klebsiella	PROPN
njb-115	100	20	pneumoniae	pneumoniae	PROPN
njb-115	100	21	1	1	NUM
njb-115	100	22	(	(	PUNCT
njb-115	100	23	0.72	0.72	NUM
njb-115	100	24	%	%	NOUN
njb-115	100	25	)	)	PUNCT
njb-115	100	26	and	and	CCONJ
njb-115	100	27	citrobacter	citrobacter	NOUN
njb-115	100	28	species	specie	NOUN
njb-115	100	29	1	1	NUM
njb-115	100	30	(	(	PUNCT
njb-115	100	31	0.72	0.72	NUM
njb-115	100	32	%	%	NOUN
njb-115	100	33	)	)	PUNCT
njb-115	100	34	(	(	PUNCT
njb-115	100	35	table	table	NOUN
njb-115	100	36	1	1	NUM
njb-115	100	37	)	)	PUNCT
njb-115	100	38	.	.	PUNCT
njb-115	101	1	figure	figure	VERB
njb-115	101	2	1	1	NUM
njb-115	101	3	.	.	PUNCT
njb-115	102	1	distribution	distribution	NOUN
njb-115	102	2	of	of	ADP
njb-115	102	3	culture	culture	NOUN
njb-115	102	4	positive	positive	ADJ
njb-115	102	5	cases	case	NOUN
njb-115	102	6	within	within	ADP
njb-115	102	7	the	the	DET
njb-115	102	8	departments	department	NOUN
njb-115	102	9	.	.	PUNCT
njb-115	103	1	table	table	NOUN
njb-115	103	2	1	1	NUM
njb-115	103	3	.	.	PUNCT
njb-115	104	1	bacteriological	bacteriological	ADJ
njb-115	104	2	profile	profile	NOUN
njb-115	104	3	of	of	ADP
njb-115	104	4	pus	pus	NOUN
njb-115	104	5	/	/	SYM
njb-115	104	6	wound	wound	PROPN
njb-115	104	7	swab	swab	NOUN
njb-115	104	8	microorganism	microorganism	NOUN
njb-115	104	9	identified	identify	VERB
njb-115	104	10	number	number	NOUN
njb-115	104	11	percentage	percentage	NOUN
njb-115	104	12	s.	s.	PROPN
njb-115	104	13	aureus	aureus	PROPN
njb-115	104	14	105	105	NUM
njb-115	104	15	75.5	75.5	NUM
njb-115	104	16	%	%	NOUN
njb-115	104	17	e.	e.	PROPN
njb-115	104	18	coli	coli	PROPN
njb-115	104	19	7	7	NUM
njb-115	104	20	5.04	5.04	NUM
njb-115	104	21	%	%	NOUN
njb-115	104	22	citrobacter	citrobacter	NOUN
njb-115	104	23	spp	spp	PROPN
njb-115	104	24	.	.	PROPN
njb-115	105	1	1	1	NUM
njb-115	105	2	0.72	0.72	NUM
njb-115	105	3	%	%	NOUN
njb-115	105	4	p.	p.	PROPN
njb-115	105	5	aeruginosa	aeruginosa	PROPN
njb-115	105	6	6	6	NUM
njb-115	105	7	4.3	4.3	NUM
njb-115	105	8	%	%	NOUN
njb-115	105	9	enterococcus	enterococcus	NOUN
njb-115	105	10	2	2	NUM
njb-115	105	11	1.45	1.45	NUM
njb-115	105	12	%	%	NOUN
njb-115	105	13	s.	s.	PROPN
njb-115	105	14	saprophyticus	saprophyticus	PROPN
njb-115	105	15	2	2	NUM
njb-115	105	16	1.45	1.45	NUM
njb-115	105	17	%	%	NOUN
njb-115	105	18	s.	s.	PROPN
njb-115	105	19	epidermidis	epidermidis	PROPN
njb-115	105	20	7	7	NUM
njb-115	105	21	5.04	5.04	NUM
njb-115	105	22	%	%	NOUN
njb-115	105	23	s.	s.	PROPN
njb-115	105	24	typhi	typhi	PROPN
njb-115	105	25	1	1	NUM
njb-115	105	26	0.72	0.72	NUM
njb-115	105	27	%	%	NOUN
njb-115	105	28	p.	p.	NOUN
njb-115	105	29	mirabilis	mirabilis	PROPN
njb-115	105	30	2	2	NUM
njb-115	105	31	1.45	1.45	NUM
njb-115	105	32	%	%	NOUN
njb-115	105	33	k.	k.	NOUN
njb-115	105	34	oxytoca	oxytoca	PROPN
njb-115	105	35	1	1	NUM
njb-115	105	36	0.72	0.72	NUM
njb-115	105	37	%	%	NOUN
njb-115	105	38	k.	k.	NOUN
njb-115	105	39	pneumoniae	pneumoniae	NOUN
njb-115	105	40	1	1	NUM
njb-115	105	41	0.72	0.72	NUM
njb-115	105	42	%	%	NOUN
njb-115	105	43	unidentified	unidentified	ADJ
njb-115	105	44	4	4	NUM
njb-115	105	45	2.8	2.8	NUM
njb-115	105	46	%	%	NOUN
njb-115	105	47	total	total	VERB
njb-115	105	48	139	139	NUM
njb-115	105	49	100.00	100.00	NUM
njb-115	105	50	%	%	NOUN
njb-115	105	51	distribution	distribution	NOUN
njb-115	105	52	of	of	ADP
njb-115	105	53	s.	s.	PROPN
njb-115	105	54	aureus	aureus	PROPN
njb-115	105	55	according	accord	VERB
njb-115	105	56	to	to	ADP
njb-115	105	57	the	the	DET
njb-115	105	58	gender	gender	NOUN
njb-115	105	59	,	,	PUNCT
njb-115	105	60	age	age	NOUN
njb-115	105	61	and	and	CCONJ
njb-115	105	62	within	within	ADP
njb-115	105	63	the	the	DET
njb-115	105	64	hospital	hospital	NOUN
njb-115	105	65	departments	department	NOUN
njb-115	105	66	among	among	ADP
njb-115	105	67	105	105	NUM
njb-115	105	68	positive	positive	ADJ
njb-115	105	69	sample	sample	NOUN
njb-115	105	70	showing	show	VERB
njb-115	105	71	s.	s.	PROPN
njb-115	105	72	aureus	aureus	PROPN
njb-115	105	73	,	,	PUNCT
njb-115	105	74	51	51	NUM
njb-115	105	75	%	%	NOUN
njb-115	105	76	(	(	PUNCT
njb-115	105	77	54	54	NUM
njb-115	105	78	)	)	PUNCT
njb-115	105	79	were	be	AUX
njb-115	105	80	found	find	VERB
njb-115	105	81	to	to	PART
njb-115	105	82	be	be	AUX
njb-115	105	83	female	female	ADJ
njb-115	105	84	patient	patient	NOUN
njb-115	105	85	and	and	CCONJ
njb-115	105	86	49	49	NUM
njb-115	105	87	%	%	NOUN
njb-115	105	88	(	(	PUNCT
njb-115	105	89	51/105	51/105	NUM
njb-115	105	90	)	)	PUNCT
njb-115	105	91	were	be	AUX
njb-115	105	92	male	male	ADJ
njb-115	105	93	patient	patient	NOUN
njb-115	105	94	.	.	PUNCT
njb-115	106	1	the	the	DET
njb-115	106	2	highest	high	ADJ
njb-115	106	3	prevalence	prevalence	NOUN
njb-115	106	4	of	of	ADP
njb-115	106	5	s.	s.	PROPN
njb-115	106	6	aureus	aureus	PROPN
njb-115	106	7	was	be	AUX
njb-115	106	8	found	find	VERB
njb-115	106	9	among	among	ADP
njb-115	106	10	age	age	NOUN
njb-115	106	11	group	group	NOUN
njb-115	106	12	12	12	NUM
njb-115	106	13	-	-	SYM
njb-115	106	14	15	15	NUM
njb-115	106	15	yrs	yrs	NOUN
njb-115	106	16	.	.	PUNCT
njb-115	107	1	87.5	87.5	NUM
njb-115	107	2	%	%	NOUN
njb-115	107	3	(	(	PUNCT
njb-115	107	4	7/8	7/8	NUM
njb-115	107	5	)	)	PUNCT
njb-115	107	6	followed	follow	VERB
njb-115	107	7	by	by	ADP
njb-115	107	8	the	the	DET
njb-115	107	9	age	age	NOUN
njb-115	107	10	group	group	NOUN
njb-115	107	11	1	1	NUM
njb-115	107	12	-	-	SYM
njb-115	107	13	3	3	NUM
njb-115	107	14	yrs	yrs	NOUN
njb-115	107	15	.	.	PUNCT
njb-115	108	1	84.21	84.21	NUM
njb-115	108	2	%	%	NOUN
njb-115	108	3	(	(	PUNCT
njb-115	108	4	32/38	32/38	NUM
njb-115	108	5	)	)	PUNCT
njb-115	108	6	,	,	PUNCT
njb-115	108	7	age	age	NOUN
njb-115	108	8	group	group	NOUN
njb-115	108	9	1	1	NUM
njb-115	108	10	month-1	month-1	NUM
njb-115	108	11	yrs	yr	NOUN
njb-115	108	12	.	.	PUNCT
njb-115	109	1	76.92	76.92	NUM
njb-115	109	2	%	%	NOUN
njb-115	109	3	(	(	PUNCT
njb-115	109	4	20/26	20/26	NUM
njb-115	109	5	)	)	PUNCT
njb-115	109	6	,	,	PUNCT
njb-115	109	7	age	age	NOUN
njb-115	109	8	group	group	NOUN
njb-115	109	9	6	6	NUM
njb-115	109	10	-	-	SYM
njb-115	109	11	12	12	NUM
njb-115	109	12	yrs	yr	NOUN
njb-115	109	13	.	.	PUNCT
njb-115	110	1	75	75	NUM
njb-115	110	2	%	%	NOUN
njb-115	110	3	(	(	PUNCT
njb-115	110	4	24/32	24/32	NUM
njb-115	110	5	)	)	PUNCT
njb-115	110	6	,	,	PUNCT
njb-115	110	7	0	0	NUM
njb-115	110	8	-	-	SYM
njb-115	110	9	1	1	NUM
njb-115	110	10	month	month	NOUN
njb-115	110	11	71.42	71.42	NUM
njb-115	110	12	%	%	NOUN
njb-115	110	13	(	(	PUNCT
njb-115	110	14	10/14	10/14	NUM
njb-115	110	15	)	)	PUNCT
njb-115	110	16	and	and	CCONJ
njb-115	110	17	age	age	NOUN
njb-115	110	18	group	group	NOUN
njb-115	110	19	4	4	NUM
njb-115	110	20	-	-	SYM
njb-115	110	21	6	6	NUM
njb-115	110	22	yrs	yrs	NOUN
njb-115	110	23	.	.	PUNCT
njb-115	111	1	57.14	57.14	NUM
njb-115	111	2	%	%	NOUN
njb-115	111	3	(	(	PUNCT
njb-115	111	4	12/21	12/21	NUM
njb-115	111	5	)	)	PUNCT
njb-115	111	6	(	(	PUNCT
njb-115	111	7	figure	figure	NOUN
njb-115	111	8	2	2	NUM
njb-115	111	9	)	)	PUNCT
njb-115	111	10	.	.	PUNCT
njb-115	112	1	most	most	ADJ
njb-115	112	2	of	of	ADP
njb-115	112	3	the	the	DET
njb-115	112	4	s.	s.	PROPN
njb-115	112	5	aureus	aureus	PROPN
njb-115	112	6	was	be	AUX
njb-115	112	7	highly	highly	ADV
njb-115	112	8	isolated	isolated	ADJ
njb-115	112	9	from	from	ADP
njb-115	112	10	iicu	iicu	PROPN
njb-115	112	11	department	department	PROPN
njb-115	112	12	100	100	NUM
njb-115	112	13	%	%	NOUN
njb-115	112	14	(	(	PUNCT
njb-115	112	15	4/4	4/4	NUM
njb-115	112	16	)	)	PUNCT
njb-115	112	17	,	,	PUNCT
njb-115	112	18	picu	picu	PROPN
njb-115	112	19	100	100	NUM
njb-115	112	20	%	%	NOUN
njb-115	112	21	(	(	PUNCT
njb-115	112	22	1/1	1/1	NUM
njb-115	112	23	)	)	PUNCT
njb-115	112	24	,	,	PUNCT
njb-115	112	25	nicu	nicu	PROPN
njb-115	112	26	100	100	NUM
njb-115	112	27	%	%	NOUN
njb-115	112	28	(	(	PUNCT
njb-115	112	29	1/1	1/1	NUM
njb-115	112	30	)	)	PUNCT
njb-115	112	31	followed	follow	VERB
njb-115	112	32	by	by	ADP
njb-115	112	33	gw	gw	PROPN
njb-115	112	34	80	80	NUM
njb-115	112	35	%	%	NOUN
njb-115	112	36	(	(	PUNCT
njb-115	112	37	4/5	4/5	NUM
njb-115	112	38	)	)	PUNCT
njb-115	112	39	,	,	PUNCT
njb-115	112	40	opd	opd	PROPN
njb-115	112	41	78.81	78.81	NUM
njb-115	112	42	%	%	NOUN
njb-115	112	43	(	(	PUNCT
njb-115	112	44	93/118	93/118	NUM
njb-115	112	45	)	)	PUNCT
njb-115	112	46	,	,	PUNCT
njb-115	112	47	s	s	PROPN
njb-115	112	48	/	/	SYM
njb-115	112	49	b	b	PROPN
njb-115	112	50	ward	ward	NOUN
njb-115	112	51	33.33	33.33	NUM
njb-115	112	52	%	%	NOUN
njb-115	112	53	(	(	PUNCT
njb-115	112	54	2/6	2/6	NUM
njb-115	112	55	)	)	PUNCT
njb-115	112	56	and	and	CCONJ
njb-115	112	57	no	no	DET
njb-115	112	58	s.	s.	PROPN
njb-115	112	59	aureus	aureus	PROPN
njb-115	112	60	were	be	AUX
njb-115	112	61	isolated	isolate	VERB
njb-115	112	62	from	from	ADP
njb-115	112	63	sp	sp	PROPN
njb-115	112	64	.	.	PROPN
njb-115	112	65	ward	ward	PROPN
njb-115	112	66	)	)	PUNCT
njb-115	112	67	0	0	NUM
njb-115	112	68	%	%	NOUN
njb-115	112	69	(	(	PUNCT
njb-115	112	70	0/1	0/1	NUM
njb-115	112	71	)	)	PUNCT
njb-115	112	72	and	and	CCONJ
njb-115	112	73	sicu	sicu	PROPN
njb-115	112	74	0	0	NUM
njb-115	112	75	%	%	NOUN
njb-115	112	76	(	(	PUNCT
njb-115	112	77	0/3	0/3	NUM
njb-115	112	78	)	)	PUNCT
njb-115	112	79	(	(	PUNCT
njb-115	112	80	table	table	NOUN
njb-115	112	81	2	2	NUM
njb-115	112	82	)	)	PUNCT
njb-115	112	83	.	.	PUNCT
njb-115	113	1	figure	figure	VERB
njb-115	113	2	2	2	NUM
njb-115	113	3	.	.	PUNCT
njb-115	113	4	distribution	distribution	NOUN
njb-115	113	5	of	of	ADP
njb-115	113	6	s.	s.	PROPN
njb-115	113	7	aureus	aureus	PROPN
njb-115	113	8	within	within	ADP
njb-115	113	9	the	the	DET
njb-115	113	10	age	age	NOUN
njb-115	113	11	group	group	NOUN
njb-115	113	12	of	of	ADP
njb-115	113	13	the	the	DET
njb-115	113	14	patient	patient	NOUN
njb-115	113	15	table	table	NOUN
njb-115	113	16	2	2	NUM
njb-115	113	17	.	.	PUNCT
njb-115	113	18	distribution	distribution	NOUN
njb-115	113	19	of	of	ADP
njb-115	113	20	s.	s.	PROPN
njb-115	113	21	aureus	aureus	PROPN
njb-115	113	22	within	within	ADP
njb-115	113	23	hospital	hospital	NOUN
njb-115	113	24	departments	department	NOUN
njb-115	113	25	departments	departments	PROPN
njb-115	113	26	s.	s.	PROPN
njb-115	113	27	aureus	aureus	PROPN
njb-115	113	28	total	total	ADJ
njb-115	113	29	number	number	NOUN
njb-115	113	30	percentage	percentage	NOUN
njb-115	113	31	opd	opd	NOUN
njb-115	113	32	118	118	NUM
njb-115	113	33	93	93	NUM
njb-115	113	34	78.81	78.81	NUM
njb-115	113	35	%	%	NOUN
njb-115	113	36	general	general	ADJ
njb-115	113	37	ward	ward	NOUN
njb-115	113	38	5	5	NUM
njb-115	113	39	4	4	NUM
njb-115	113	40	80	80	NUM
njb-115	113	41	%	%	NOUN
njb-115	113	42	special	special	ADJ
njb-115	113	43	ward	ward	NOUN
njb-115	113	44	1	1	NUM
njb-115	113	45	0	0	NUM
njb-115	113	46	0	0	NUM
njb-115	113	47	%	%	NOUN
njb-115	113	48	surgical	surgical	ADJ
njb-115	113	49	/	/	SYM
njb-115	113	50	burn	burn	NOUN
njb-115	113	51	ward	ward	NOUN
njb-115	113	52	6	6	NUM
njb-115	113	53	2	2	NUM
njb-115	113	54	33.33	33.33	NUM
njb-115	113	55	%	%	NOUN
njb-115	113	56	infant	infant	NOUN
njb-115	113	57	icu	icu	PROPN
njb-115	113	58	4	4	NUM
njb-115	113	59	4	4	NUM
njb-115	113	60	100	100	NUM
njb-115	113	61	%	%	NOUN
njb-115	113	62	pediatric	pediatric	ADJ
njb-115	113	63	icu	icu	PROPN
njb-115	113	64	1	1	NUM
njb-115	113	65	1	1	NUM
njb-115	113	66	100	100	NUM
njb-115	113	67	%	%	NOUN
njb-115	113	68	surgical	surgical	ADJ
njb-115	113	69	icu	icu	PROPN
njb-115	113	70	3	3	NUM
njb-115	113	71	0	0	NUM
njb-115	113	72	0	0	NUM
njb-115	113	73	%	%	NOUN
njb-115	113	74	neonates	neonates	PROPN
njb-115	113	75	icu	icu	PROPN
njb-115	113	76	1	1	NUM
njb-115	113	77	1	1	NUM
njb-115	113	78	100	100	NUM
njb-115	113	79	%	%	NOUN
njb-115	113	80	total	total	NOUN
njb-115	113	81	139	139	NUM
njb-115	113	82	105	105	NUM
njb-115	113	83	75.5	75.5	NUM
njb-115	113	84	%	%	NOUN
njb-115	113	85	table	table	NOUN
njb-115	113	86	3	3	NUM
njb-115	113	87	.	.	PUNCT
njb-115	114	1	antibiotic	antibiotic	ADJ
njb-115	114	2	susceptible	susceptible	ADJ
njb-115	114	3	pattern	pattern	NOUN
njb-115	114	4	of	of	ADP
njb-115	114	5	s.	s.	PROPN
njb-115	114	6	aureus	aureus	PROPN
njb-115	114	7	(	(	PUNCT
njb-115	114	8	n=	n=	PROPN
njb-115	114	9	105	105	NUM
njb-115	114	10	)	)	PUNCT
njb-115	114	11	antibiotic	antibiotic	ADJ
njb-115	114	12	used	use	VERB
njb-115	114	13	antibiotic	antibiotic	ADJ
njb-115	114	14	susceptible	susceptible	ADJ
njb-115	114	15	pattern	pattern	NOUN
njb-115	114	16	resistant	resistant	ADJ
njb-115	114	17	intermediate	intermediate	ADJ
njb-115	114	18	sensitive	sensitive	ADJ
njb-115	114	19	gentamycin	gentamycin	X
njb-115	114	20	11(10	11(10	NUM
njb-115	114	21	%	%	NOUN
njb-115	114	22	)	)	PUNCT
njb-115	114	23	9(9	9(9	NUM
njb-115	114	24	%	%	NOUN
njb-115	114	25	)	)	PUNCT
njb-115	114	26	85(81	85(81	NUM
njb-115	114	27	%	%	NOUN
njb-115	114	28	)	)	PUNCT
njb-115	114	29	ciprofloxacin	ciprofloxacin	VERB
njb-115	114	30	71(68	71(68	NUM
njb-115	114	31	%	%	NOUN
njb-115	114	32	)	)	PUNCT
njb-115	114	33	10(10	10(10	NUM
njb-115	114	34	%	%	NOUN
njb-115	114	35	)	)	PUNCT
njb-115	114	36	24(23	24(23	NUM
njb-115	114	37	%	%	NOUN
njb-115	114	38	)	)	PUNCT
njb-115	115	1	chloramphenicol	chloramphenicol	NOUN
njb-115	115	2	4(4	4(4	NUM
njb-115	115	3	%	%	INTJ
njb-115	115	4	)	)	PUNCT
njb-115	116	1	4(4	4(4	NUM
njb-115	116	2	%	%	INTJ
njb-115	116	3	)	)	PUNCT
njb-115	116	4	97(92	97(92	NUM
njb-115	116	5	%	%	NOUN
njb-115	116	6	)	)	PUNCT
njb-115	116	7	cotrimoxazole	cotrimoxazole	PROPN
njb-115	116	8	26(25	26(25	NUM
njb-115	116	9	%	%	NOUN
njb-115	116	10	)	)	PUNCT
njb-115	116	11	8(8	8(8	NUM
njb-115	116	12	%	%	NOUN
njb-115	116	13	)	)	PUNCT
njb-115	116	14	71(68	71(68	NUM
njb-115	116	15	%	%	NOUN
njb-115	116	16	)	)	PUNCT
njb-115	116	17	cefoxitin	cefoxitin	NOUN
njb-115	116	18	58(55	58(55	NUM
njb-115	116	19	%	%	NOUN
njb-115	116	20	)	)	PUNCT
njb-115	116	21	0(0	0(0	NUM
njb-115	116	22	%	%	NOUN
njb-115	116	23	)	)	PUNCT
njb-115	116	24	47(45	47(45	NUM
njb-115	116	25	%	%	NOUN
njb-115	116	26	)	)	PUNCT
njb-115	116	27	erythromycin	erythromycin	PROPN
njb-115	116	28	58(55	58(55	NUM
njb-115	116	29	%	%	NOUN
njb-115	116	30	)	)	PUNCT
njb-115	117	1	18(17	18(17	NUM
njb-115	117	2	%	%	NOUN
njb-115	117	3	)	)	PUNCT
njb-115	117	4	29(28	29(28	NUM
njb-115	117	5	%	%	NOUN
njb-115	117	6	)	)	PUNCT
njb-115	117	7	clindamycin	clindamycin	PROPN
njb-115	117	8	28(27	28(27	NUM
njb-115	117	9	%	%	NOUN
njb-115	117	10	)	)	PUNCT
njb-115	118	1	2(2	2(2	PUNCT
njb-115	118	2	%	%	INTJ
njb-115	118	3	)	)	PUNCT
njb-115	118	4	75(71	75(71	NUM
njb-115	118	5	%	%	NOUN
njb-115	118	6	)	)	PUNCT
njb-115	119	1	piperacillin	piperacillin	NOUN
njb-115	119	2	4(4	4(4	NUM
njb-115	120	1	%	%	INTJ
njb-115	120	2	)	)	PUNCT
njb-115	120	3	5(5	5(5	NUM
njb-115	120	4	%	%	NOUN
njb-115	120	5	)	)	PUNCT
njb-115	120	6	96(91	96(91	NUM
njb-115	120	7	%	%	NOUN
njb-115	120	8	)	)	PUNCT
njb-115	120	9	meropenem	meropenem	PROPN
njb-115	120	10	1(1	1(1	X
njb-115	120	11	%	%	INTJ
njb-115	120	12	)	)	PUNCT
njb-115	121	1	2(2	2(2	PUNCT
njb-115	121	2	%	%	INTJ
njb-115	121	3	)	)	PUNCT
njb-115	121	4	102(97	102(97	NUM
njb-115	121	5	%	%	NOUN
njb-115	121	6	)	)	PUNCT
njb-115	121	7	azithromycin	azithromycin	PROPN
njb-115	121	8	54(51	54(51	NUM
njb-115	121	9	%	%	NOUN
njb-115	121	10	)	)	PUNCT
njb-115	121	11	7(7	7(7	NUM
njb-115	121	12	%	%	NOUN
njb-115	121	13	)	)	PUNCT
njb-115	122	1	44(42	44(42	NUM
njb-115	122	2	%	%	NOUN
njb-115	122	3	)	)	PUNCT
njb-115	122	4	doxycycline	doxycycline	NOUN
njb-115	122	5	0(0	0(0	NUM
njb-115	122	6	%	%	NOUN
njb-115	122	7	)	)	PUNCT
njb-115	123	1	2(2	2(2	PUNCT
njb-115	123	2	%	%	INTJ
njb-115	123	3	)	)	PUNCT
njb-115	123	4	103(98	103(98	NUM
njb-115	123	5	%	%	NOUN
njb-115	123	6	)	)	PUNCT
njb-115	123	7	linezolid	linezolid	NOUN
njb-115	123	8	1(1	1(1	X
njb-115	123	9	%	%	NOUN
njb-115	123	10	)	)	PUNCT
njb-115	123	11	0(0	0(0	NUM
njb-115	123	12	%	%	NOUN
njb-115	123	13	)	)	PUNCT
njb-115	124	1	104(99	104(99	NUM
njb-115	124	2	%	%	NOUN
njb-115	124	3	)	)	PUNCT
njb-115	125	1	vancomycin	vancomycin	PROPN
njb-115	125	2	9(9	9(9	NUM
njb-115	125	3	%	%	NOUN
njb-115	125	4	)	)	PUNCT
njb-115	125	5	0(0	0(0	NUM
njb-115	125	6	%	%	NOUN
njb-115	125	7	)	)	PUNCT
njb-115	125	8	96(91	96(91	NUM
njb-115	125	9	%	%	NOUN
njb-115	125	10	)	)	PUNCT
njb-115	125	11	antibiotic	antibiotic	ADJ
njb-115	125	12	susceptibility	susceptibility	NOUN
njb-115	125	13	pattern	pattern	NOUN
njb-115	125	14	of	of	ADP
njb-115	125	15	s.	s.	PROPN
njb-115	125	16	aureus	aureus	PROPN
njb-115	125	17	and	and	CCONJ
njb-115	125	18	multidrug	multidrug	VERB
njb-115	125	19	resistant	resistant	ADJ
njb-115	125	20	(	(	PUNCT
njb-115	125	21	mdr	mdr	PROPN
njb-115	125	22	)	)	PUNCT
njb-115	125	23	s.	s.	PROPN
njb-115	125	24	aureus	aureus	PROPN
njb-115	125	25	while	while	SCONJ
njb-115	125	26	performing	perform	VERB
njb-115	125	27	antibiotic	antibiotic	ADJ
njb-115	125	28	susceptibility	susceptibility	NOUN
njb-115	125	29	test	test	NOUN
njb-115	125	30	(	(	PUNCT
njb-115	125	31	figure	figure	NOUN
njb-115	125	32	3	3	NUM
njb-115	125	33	)	)	PUNCT
njb-115	125	34	,	,	PUNCT
njb-115	125	35	out	out	ADP
njb-115	125	36	of	of	ADP
njb-115	125	37	105	105	NUM
njb-115	125	38	s.	s.	PROPN
njb-115	125	39	aureus	aureus	PROPN
njb-115	125	40	,	,	PUNCT
njb-115	125	41	104	104	NUM
njb-115	125	42	(	(	PUNCT
njb-115	125	43	99	99	NUM
njb-115	125	44	%	%	NOUN
njb-115	125	45	)	)	PUNCT
njb-115	125	46	were	be	AUX
njb-115	125	47	found	find	VERB
njb-115	125	48	to	to	PART
njb-115	125	49	be	be	AUX
njb-115	125	50	sensitive	sensitive	ADJ
njb-115	125	51	towards	towards	ADP
njb-115	125	52	linezolid	linezolid	NOUN
njb-115	125	53	followed	follow	VERB
njb-115	125	54	by	by	ADP
njb-115	125	55	doxycycline	doxycycline	NOUN
njb-115	125	56	103	103	NUM
njb-115	125	57	(	(	PUNCT
njb-115	125	58	98	98	NUM
njb-115	125	59	%	%	NOUN
njb-115	125	60	)	)	PUNCT
njb-115	125	61	,	,	PUNCT
njb-115	125	62	meropenem	meropenem	PROPN
njb-115	125	63	102	102	NUM
njb-115	125	64	(	(	PUNCT
njb-115	125	65	97	97	NUM
njb-115	125	66	%	%	NOUN
njb-115	125	67	)	)	PUNCT
njb-115	125	68	,	,	PUNCT
njb-115	125	69	chloramphenicol	chloramphenicol	NOUN
njb-115	125	70	97	97	NUM
njb-115	125	71	(	(	PUNCT
njb-115	125	72	92	92	NUM
njb-115	125	73	%	%	NOUN
njb-115	125	74	)	)	PUNCT
njb-115	125	75	and	and	CCONJ
njb-115	125	76	vancomycin	vancomycin	PROPN
njb-115	125	77	96	96	NUM
njb-115	125	78	(	(	PUNCT
njb-115	125	79	91	91	NUM
njb-115	125	80	%	%	NOUN
njb-115	125	81	)	)	PUNCT
njb-115	125	82	.	.	PUNCT
njb-115	126	1	the	the	DET
njb-115	126	2	organism	organism	NOUN
njb-115	126	3	was	be	AUX
njb-115	126	4	found	find	VERB
njb-115	126	5	to	to	PART
njb-115	126	6	be	be	AUX
njb-115	126	7	14	14	NUM
njb-115	126	8	26	26	NUM
njb-115	126	9	38	38	NUM
njb-115	126	10	21	21	NUM
njb-115	126	11	32	32	NUM
njb-115	126	12	8	8	NUM
njb-115	126	13	139	139	NUM
njb-115	126	14	10	10	NUM
njb-115	126	15	20	20	NUM
njb-115	126	16	32	32	NUM
njb-115	126	17	12	12	NUM
njb-115	126	18	24	24	NUM
njb-115	126	19	7	7	NUM
njb-115	126	20	105	105	NUM
njb-115	126	21	71.42	71.42	NUM
njb-115	126	22	%	%	NOUN
njb-115	126	23	76.92	76.92	NUM
njb-115	126	24	%	%	NOUN
njb-115	126	25	84.21	84.21	NUM
njb-115	126	26	%	%	NOUN
njb-115	126	27	57.14	57.14	NUM
njb-115	126	28	%	%	NOUN
njb-115	126	29	75	75	NUM
njb-115	126	30	%	%	NOUN
njb-115	126	31	87.50	87.50	NUM
njb-115	126	32	%	%	NOUN
njb-115	126	33	100.00	100.00	NUM
njb-115	126	34	%	%	NOUN
njb-115	126	35	0	0	NUM
njb-115	126	36	50	50	NUM
njb-115	126	37	100	100	NUM
njb-115	126	38	150	150	NUM
njb-115	126	39	200	200	NUM
njb-115	126	40	250	250	NUM
njb-115	126	41	300	300	NUM
njb-115	126	42	total	total	ADJ
njb-115	126	43	s.	s.	PROPN
njb-115	126	44	aureus	aureus	PROPN
njb-115	126	45	number	number	NOUN
njb-115	126	46	s.	s.	PROPN
njb-115	126	47	aureus	aureus	PROPN
njb-115	126	48	percentage	percentage	NOUN
njb-115	126	49	228	228	NUM
njb-115	126	50	12	12	NUM
njb-115	126	51	4	4	NUM
njb-115	126	52	12	12	NUM
njb-115	126	53	6	6	NUM
njb-115	126	54	3	3	NUM
njb-115	126	55	4	4	NUM
njb-115	126	56	1	1	NUM
njb-115	126	57	118	118	NUM
njb-115	126	58	5	5	NUM
njb-115	126	59	1	1	NUM
njb-115	126	60	6	6	NUM
njb-115	126	61	4	4	NUM
njb-115	126	62	1	1	NUM
njb-115	126	63	3	3	NUM
njb-115	126	64	1	1	NUM
njb-115	126	65	51.75	51.75	NUM
njb-115	126	66	%	%	NOUN
njb-115	126	67	41.67	41.67	NUM
njb-115	126	68	%	%	NOUN
njb-115	126	69	25	25	NUM
njb-115	126	70	%	%	NOUN
njb-115	126	71	50	50	NUM
njb-115	126	72	%	%	NOUN
njb-115	126	73	66.67	66.67	NUM
njb-115	126	74	%	%	NOUN
njb-115	126	75	33.33	33.33	NUM
njb-115	126	76	%	%	NOUN
njb-115	126	77	75	75	NUM
njb-115	126	78	%	%	NOUN
njb-115	126	79	100	100	NUM
njb-115	126	80	%	%	NOUN
njb-115	126	81	0	0	NUM
njb-115	126	82	%	%	NOUN
njb-115	126	83	10	10	NUM
njb-115	126	84	%	%	NOUN
njb-115	126	85	20	20	NUM
njb-115	126	86	%	%	NOUN
njb-115	126	87	30	30	NUM
njb-115	126	88	%	%	NOUN
njb-115	126	89	40	40	NUM
njb-115	126	90	%	%	NOUN
njb-115	126	91	50	50	NUM
njb-115	126	92	%	%	NOUN
njb-115	126	93	60	60	NUM
njb-115	126	94	%	%	NOUN
njb-115	126	95	70	70	NUM
njb-115	126	96	%	%	NOUN
njb-115	126	97	80	80	NUM
njb-115	126	98	%	%	NOUN
njb-115	126	99	90	90	NUM
njb-115	126	100	%	%	NOUN
njb-115	126	101	100	100	NUM
njb-115	126	102	%	%	NOUN
njb-115	126	103	growth	growth	NOUN
njb-115	126	104	percentage	percentage	NOUN
njb-115	126	105	growth	growth	NOUN
njb-115	126	106	number	number	NOUN
njb-115	126	107	departments	department	NOUN
njb-115	126	108	total	total	NOUN
njb-115	126	109	nepal	nepal	PROPN
njb-115	126	110	j	j	PROPN
njb-115	126	111	biotechnol	biotechnol	PROPN
njb-115	126	112	.	.	PUNCT
njb-115	127	1	2	2	NUM
njb-115	127	2	0	0	NUM
njb-115	127	3	2	2	NUM
njb-115	127	4	1	1	NUM
njb-115	127	5	j	j	NOUN
njb-115	127	6	u	u	NOUN
njb-115	127	7	l	l	NOUN
njb-115	127	8	;	;	PUNCT
njb-115	127	9	9	9	NUM
njb-115	127	10	(	(	PUNCT
njb-115	127	11	1):8	1):8	NUM
njb-115	127	12	1	1	NUM
njb-115	127	13	7	7	NUM
njb-115	127	14	maharjan	maharjan	NOUN
njb-115	127	15	et	et	NOUN
njb-115	127	16	al	al	PROPN
njb-115	127	17	.	.	PUNCT
njb-115	128	1	©	©	PROPN
njb-115	128	2	njb	njb	PROPN
njb-115	128	3	,	,	PUNCT
njb-115	128	4	bsn	bsn	PROPN
njb-115	128	5	12	12	NUM
njb-115	128	6	resistant	resistant	ADJ
njb-115	128	7	towards	towards	ADP
njb-115	128	8	ciprofloxacin	ciprofloxacin	NOUN
njb-115	128	9	71	71	NUM
njb-115	128	10	(	(	PUNCT
njb-115	128	11	68	68	NUM
njb-115	128	12	%	%	NOUN
njb-115	128	13	)	)	PUNCT
njb-115	128	14	followed	follow	VERB
njb-115	128	15	by	by	ADP
njb-115	128	16	cefoxitin	cefoxitin	NOUN
njb-115	128	17	58	58	NUM
njb-115	128	18	(	(	PUNCT
njb-115	128	19	55	55	NUM
njb-115	128	20	%	%	NOUN
njb-115	128	21	)	)	PUNCT
njb-115	128	22	and	and	CCONJ
njb-115	128	23	erythromycin	erythromycin	PROPN
njb-115	128	24	58	58	NUM
njb-115	128	25	(	(	PUNCT
njb-115	128	26	55	55	NUM
njb-115	128	27	%	%	NOUN
njb-115	128	28	)	)	PUNCT
njb-115	128	29	respectively	respectively	ADV
njb-115	128	30	(	(	PUNCT
njb-115	128	31	table	table	NOUN
njb-115	128	32	3	3	NUM
njb-115	128	33	)	)	PUNCT
njb-115	128	34	.	.	PUNCT
njb-115	129	1	in	in	ADP
njb-115	129	2	our	our	PRON
njb-115	129	3	study	study	NOUN
njb-115	129	4	,	,	PUNCT
njb-115	129	5	50	50	NUM
njb-115	129	6	%	%	NOUN
njb-115	129	7	(	(	PUNCT
njb-115	129	8	52	52	NUM
njb-115	129	9	)	)	PUNCT
njb-115	129	10	were	be	AUX
njb-115	129	11	found	find	VERB
njb-115	129	12	to	to	PART
njb-115	129	13	be	be	AUX
njb-115	129	14	multidrug	multidrug	NOUN
njb-115	129	15	resistant	resistant	ADJ
njb-115	129	16	.	.	PUNCT
njb-115	130	1	among	among	ADP
njb-115	130	2	multidrug	multidrug	NOUN
njb-115	130	3	resistant	resistant	ADJ
njb-115	130	4	also	also	ADV
njb-115	130	5	,	,	PUNCT
njb-115	130	6	one	one	NUM
njb-115	130	7	strain	strain	NOUN
njb-115	130	8	was	be	AUX
njb-115	130	9	found	find	VERB
njb-115	130	10	to	to	PART
njb-115	130	11	be	be	AUX
njb-115	130	12	resistant	resistant	ADJ
njb-115	130	13	to	to	ADP
njb-115	130	14	all	all	DET
njb-115	130	15	the	the	DET
njb-115	130	16	antimicrobial	antimicrobial	ADJ
njb-115	130	17	agent	agent	NOUN
njb-115	130	18	used	use	VERB
njb-115	130	19	to	to	PART
njb-115	130	20	be	be	AUX
njb-115	130	21	tested	test	VERB
njb-115	130	22	,	,	PUNCT
njb-115	130	23	i.e.	i.e.	X
njb-115	130	24	extremely	extremely	ADV
njb-115	130	25	drug	drug	NOUN
njb-115	130	26	resistant	resistant	ADJ
njb-115	130	27	(	(	PUNCT
njb-115	130	28	xdr	xdr	PROPN
njb-115	130	29	)	)	PUNCT
njb-115	130	30	.	.	PUNCT
njb-115	131	1	figure	figure	NOUN
njb-115	131	2	3	3	NUM
njb-115	131	3	.	.	PUNCT
njb-115	132	1	antibiotic	antibiotic	ADJ
njb-115	132	2	susceptibility	susceptibility	NOUN
njb-115	132	3	test	test	NOUN
njb-115	132	4	of	of	ADP
njb-115	132	5	staphylococcus	staphylococcus	NOUN
njb-115	132	6	aureus	aureus	PROPN
njb-115	132	7	on	on	ADP
njb-115	132	8	mha	mha	PROPN
njb-115	132	9	.	.	PUNCT
njb-115	133	1	(	(	PUNCT
njb-115	133	2	va	va	X
njb-115	133	3	=	=	X
njb-115	133	4	vancomycin	vancomycin	PROPN
njb-115	133	5	,	,	PUNCT
njb-115	133	6	azm	azm	PROPN
njb-115	133	7	=	=	X
njb-115	133	8	azithromycin	azithromycin	PROPN
njb-115	133	9	,	,	PUNCT
njb-115	133	10	ptz	ptz	PROPN
njb-115	133	11	=	=	NOUN
njb-115	133	12	piperacillin	piperacillin	NOUN
njb-115	133	13	,	,	PUNCT
njb-115	133	14	dox	dox	NOUN
njb-115	133	15	=	=	SYM
njb-115	133	16	doxycycline	doxycycline	NOUN
njb-115	133	17	and	and	CCONJ
njb-115	133	18	lz	lz	ADP
njb-115	133	19	=	=	PROPN
njb-115	133	20	linezolid	linezolid	NOUN
njb-115	133	21	)	)	PUNCT
njb-115	133	22	.	.	PUNCT
njb-115	134	1	distribution	distribution	NOUN
njb-115	134	2	of	of	ADP
njb-115	134	3	mrsa	mrsa	PROPN
njb-115	134	4	among	among	ADP
njb-115	134	5	s.	s.	PROPN
njb-115	134	6	aureus	aureus	PROPN
njb-115	134	7	positive	positive	ADJ
njb-115	134	8	sample	sample	NOUN
njb-115	134	9	and	and	CCONJ
njb-115	134	10	its	its	PRON
njb-115	134	11	antibiotic	antibiotic	ADJ
njb-115	134	12	susceptibility	susceptibility	NOUN
njb-115	134	13	pattern	pattern	NOUN
njb-115	134	14	in	in	ADP
njb-115	134	15	the	the	DET
njb-115	134	16	study	study	NOUN
njb-115	134	17	,	,	PUNCT
njb-115	134	18	55	55	NUM
njb-115	134	19	%	%	NOUN
njb-115	134	20	(	(	PUNCT
njb-115	134	21	58	58	NUM
njb-115	134	22	)	)	PUNCT
njb-115	134	23	were	be	AUX
njb-115	134	24	found	find	VERB
njb-115	134	25	to	to	PART
njb-115	134	26	be	be	AUX
njb-115	134	27	cefoxitin	cefoxitin	NOUN
njb-115	134	28	resistant	resistant	ADJ
njb-115	134	29	showing	show	VERB
njb-115	134	30	methicillin	methicillin	NOUN
njb-115	134	31	resistant	resistant	ADJ
njb-115	134	32	strains	strain	NOUN
njb-115	134	33	(	(	PUNCT
njb-115	134	34	mrsa	mrsa	PROPN
njb-115	134	35	)	)	PUNCT
njb-115	134	36	whereas	whereas	SCONJ
njb-115	134	37	45	45	NUM
njb-115	134	38	%	%	NOUN
njb-115	134	39	(	(	PUNCT
njb-115	134	40	47	47	NUM
njb-115	134	41	)	)	PUNCT
njb-115	134	42	were	be	AUX
njb-115	134	43	found	find	VERB
njb-115	134	44	to	to	PART
njb-115	134	45	be	be	AUX
njb-115	134	46	cefoxitin	cefoxitin	NOUN
njb-115	134	47	sensitive	sensitive	ADJ
njb-115	134	48	showing	show	VERB
njb-115	134	49	methicillin	methicillin	NOUN
njb-115	134	50	sensitive	sensitive	ADJ
njb-115	134	51	strains	strain	NOUN
njb-115	134	52	(	(	PUNCT
njb-115	134	53	mssa	mssa	ADJ
njb-115	134	54	)	)	PUNCT
njb-115	134	55	.	.	PUNCT
njb-115	135	1	all	all	DET
njb-115	135	2	the	the	DET
njb-115	135	3	resistant	resistant	ADJ
njb-115	135	4	strains	strain	NOUN
njb-115	135	5	were	be	AUX
njb-115	135	6	further	far	ADV
njb-115	135	7	tested	test	VERB
njb-115	135	8	for	for	ADP
njb-115	135	9	vancomycin	vancomycin	PROPN
njb-115	135	10	susceptible	susceptible	ADJ
njb-115	135	11	test	test	NOUN
njb-115	135	12	.	.	PUNCT
njb-115	136	1	table	table	NOUN
njb-115	136	2	4	4	NUM
njb-115	136	3	.	.	PUNCT
njb-115	137	1	antibiotic	antibiotic	ADJ
njb-115	137	2	susceptibility	susceptibility	NOUN
njb-115	137	3	pattern	pattern	NOUN
njb-115	137	4	of	of	ADP
njb-115	137	5	mrsa	mrsa	PROPN
njb-115	137	6	(	(	PUNCT
njb-115	137	7	n=58	n=58	PROPN
njb-115	137	8	)	)	PUNCT
njb-115	137	9	antibiotics	antibiotic	NOUN
njb-115	137	10	resistant	resistant	ADJ
njb-115	137	11	intermediate	intermediate	ADJ
njb-115	137	12	sensitive	sensitive	ADJ
njb-115	137	13	cotrimoxazole	cotrimoxazole	PROPN
njb-115	137	14	18(31.04	18(31.04	NUM
njb-115	137	15	%	%	NOUN
njb-115	137	16	)	)	PUNCT
njb-115	137	17	3(5.17	3(5.17	NUM
njb-115	137	18	%	%	NOUN
njb-115	137	19	)	)	PUNCT
njb-115	137	20	37(63.79	37(63.79	NUM
njb-115	137	21	%	%	NOUN
njb-115	137	22	)	)	PUNCT
njb-115	137	23	chloramphenicol	chloramphenicol	NOUN
njb-115	137	24	3(5.17	3(5.17	NUM
njb-115	137	25	%	%	NOUN
njb-115	137	26	)	)	PUNCT
njb-115	137	27	3(5.17	3(5.17	NUM
njb-115	137	28	%	%	NOUN
njb-115	137	29	)	)	PUNCT
njb-115	138	1	52(89.66	52(89.66	NUM
njb-115	138	2	%	%	NOUN
njb-115	138	3	)	)	PUNCT
njb-115	139	1	gentamycin	gentamycin	PROPN
njb-115	139	2	6(10.35	6(10.35	NUM
njb-115	139	3	%	%	NOUN
njb-115	139	4	)	)	PUNCT
njb-115	139	5	7(12.07	7(12.07	NUM
njb-115	139	6	%	%	NOUN
njb-115	139	7	)	)	PUNCT
njb-115	139	8	45(77.58	45(77.58	NUM
njb-115	139	9	%	%	NOUN
njb-115	139	10	)	)	PUNCT
njb-115	139	11	ciprofloxacin	ciprofloxacin	NOUN
njb-115	139	12	51(87.93	51(87.93	NUM
njb-115	139	13	%	%	NOUN
njb-115	139	14	)	)	PUNCT
njb-115	139	15	6(10.35	6(10.35	NUM
njb-115	139	16	%	%	NOUN
njb-115	139	17	)	)	PUNCT
njb-115	139	18	1(1.72	1(1.72	NUM
njb-115	139	19	%	%	NOUN
njb-115	139	20	)	)	PUNCT
njb-115	140	1	clindamycin	clindamycin	PROPN
njb-115	140	2	21(36.21	21(36.21	NUM
njb-115	140	3	%	%	NOUN
njb-115	140	4	)	)	PUNCT
njb-115	140	5	0(0	0(0	NUM
njb-115	140	6	%	%	NOUN
njb-115	140	7	)	)	PUNCT
njb-115	140	8	37(63.79	37(63.79	NUM
njb-115	140	9	%	%	NOUN
njb-115	140	10	)	)	PUNCT
njb-115	140	11	erythromycin	erythromycin	PROPN
njb-115	140	12	38(65.53	38(65.53	NUM
njb-115	140	13	%	%	NOUN
njb-115	140	14	)	)	PUNCT
njb-115	140	15	8(13.79	8(13.79	NUM
njb-115	140	16	%	%	NOUN
njb-115	140	17	)	)	PUNCT
njb-115	140	18	12(20.68	12(20.68	NUM
njb-115	140	19	%	%	NOUN
njb-115	140	20	)	)	PUNCT
njb-115	141	1	piperacillin	piperacillin	NOUN
njb-115	141	2	4(6.9	4(6.9	NUM
njb-115	141	3	%	%	NOUN
njb-115	141	4	)	)	PUNCT
njb-115	141	5	4(6.9	4(6.9	NUM
njb-115	141	6	%	%	NOUN
njb-115	141	7	)	)	PUNCT
njb-115	141	8	50(86.20	50(86.20	NUM
njb-115	141	9	%	%	NOUN
njb-115	141	10	)	)	PUNCT
njb-115	141	11	meropenem	meropenem	PROPN
njb-115	141	12	1(1.72	1(1.72	NUM
njb-115	141	13	%	%	NOUN
njb-115	141	14	)	)	PUNCT
njb-115	141	15	1(1.72	1(1.72	NUM
njb-115	141	16	%	%	NOUN
njb-115	141	17	)	)	PUNCT
njb-115	141	18	56(96.56	56(96.56	NUM
njb-115	141	19	%	%	NOUN
njb-115	141	20	)	)	PUNCT
njb-115	141	21	azithromycin	azithromycin	PROPN
njb-115	141	22	43(74.13	43(74.13	NUM
njb-115	141	23	%	%	NOUN
njb-115	141	24	)	)	PUNCT
njb-115	141	25	5(8.62	5(8.62	NUM
njb-115	141	26	%	%	NOUN
njb-115	141	27	)	)	PUNCT
njb-115	141	28	10(17.25	10(17.25	NUM
njb-115	141	29	%	%	NOUN
njb-115	141	30	)	)	PUNCT
njb-115	141	31	linezolid	linezolid	NOUN
njb-115	141	32	1(1.72	1(1.72	NUM
njb-115	141	33	%	%	NOUN
njb-115	141	34	)	)	PUNCT
njb-115	141	35	0(0	0(0	NUM
njb-115	141	36	%	%	NOUN
njb-115	141	37	)	)	PUNCT
njb-115	142	1	57(98.28	57(98.28	NUM
njb-115	142	2	%	%	NOUN
njb-115	142	3	)	)	PUNCT
njb-115	142	4	doxycycline	doxycycline	NOUN
njb-115	142	5	0(0	0(0	NUM
njb-115	142	6	%	%	NOUN
njb-115	142	7	)	)	PUNCT
njb-115	142	8	2(3.44	2(3.44	NUM
njb-115	142	9	%	%	NOUN
njb-115	142	10	)	)	PUNCT
njb-115	142	11	56(96.56	56(96.56	NUM
njb-115	142	12	%	%	NOUN
njb-115	142	13	)	)	PUNCT
njb-115	143	1	vancomycin	vancomycin	PROPN
njb-115	143	2	9(15.52	9(15.52	NUM
njb-115	143	3	%	%	NOUN
njb-115	143	4	)	)	PUNCT
njb-115	144	1	49(84.48	49(84.48	NUM
njb-115	144	2	%	%	NOUN
njb-115	144	3	)	)	PUNCT
njb-115	144	4	here	here	ADV
njb-115	144	5	,	,	PUNCT
njb-115	144	6	mrsa	mrsa	PROPN
njb-115	144	7	was	be	AUX
njb-115	144	8	found	find	VERB
njb-115	144	9	sensitive	sensitive	ADJ
njb-115	144	10	towards	towards	ADP
njb-115	144	11	linezolid	linezolid	NOUN
njb-115	144	12	98.28	98.28	NUM
njb-115	144	13	%	%	NOUN
njb-115	144	14	(	(	PUNCT
njb-115	144	15	57	57	NUM
njb-115	144	16	)	)	PUNCT
njb-115	144	17	followed	follow	VERB
njb-115	144	18	by	by	ADP
njb-115	144	19	doxycycline	doxycycline	NOUN
njb-115	144	20	96.56	96.56	NUM
njb-115	144	21	%	%	NOUN
njb-115	144	22	(	(	PUNCT
njb-115	144	23	56	56	NUM
njb-115	144	24	)	)	PUNCT
njb-115	144	25	,	,	PUNCT
njb-115	144	26	meropenem	meropenem	PROPN
njb-115	144	27	96.56	96.56	NUM
njb-115	144	28	%	%	NOUN
njb-115	144	29	(	(	PUNCT
njb-115	144	30	56	56	NUM
njb-115	144	31	)	)	PUNCT
njb-115	144	32	,	,	PUNCT
njb-115	144	33	chloramphenicol	chloramphenicol	NOUN
njb-115	144	34	89.66	89.66	NUM
njb-115	144	35	%	%	NOUN
njb-115	144	36	(	(	PUNCT
njb-115	144	37	52	52	NUM
njb-115	144	38	)	)	PUNCT
njb-115	144	39	,	,	PUNCT
njb-115	144	40	piperacillin	piperacillin	NOUN
njb-115	144	41	86.20	86.20	NUM
njb-115	144	42	%	%	NOUN
njb-115	144	43	(	(	PUNCT
njb-115	144	44	50	50	NUM
njb-115	144	45	)	)	PUNCT
njb-115	144	46	,	,	PUNCT
njb-115	144	47	vancomycin	vancomycin	PROPN
njb-115	144	48	84.48	84.48	NUM
njb-115	144	49	%	%	NOUN
njb-115	144	50	(	(	PUNCT
njb-115	144	51	49	49	NUM
njb-115	144	52	)	)	PUNCT
njb-115	144	53	,	,	PUNCT
njb-115	144	54	gentamycin	gentamycin	PROPN
njb-115	144	55	77.58	77.58	NUM
njb-115	144	56	%	%	NOUN
njb-115	144	57	(	(	PUNCT
njb-115	144	58	45	45	NUM
njb-115	144	59	)	)	PUNCT
njb-115	144	60	,	,	PUNCT
njb-115	144	61	cotrimoxazole	cotrimoxazole	PROPN
njb-115	144	62	63.79	63.79	NUM
njb-115	144	63	%	%	NOUN
njb-115	144	64	(	(	PUNCT
njb-115	144	65	37	37	NUM
njb-115	144	66	)	)	PUNCT
njb-115	144	67	and	and	CCONJ
njb-115	144	68	clindamycin	clindamycin	PROPN
njb-115	144	69	63.79	63.79	NUM
njb-115	144	70	%	%	NOUN
njb-115	144	71	(	(	PUNCT
njb-115	144	72	37	37	NUM
njb-115	144	73	)	)	PUNCT
njb-115	144	74	.	.	PUNCT
njb-115	145	1	mrsa	mrsa	PROPN
njb-115	145	2	was	be	AUX
njb-115	145	3	found	find	VERB
njb-115	145	4	to	to	PART
njb-115	145	5	be	be	AUX
njb-115	145	6	resistant	resistant	ADJ
njb-115	145	7	towards	towards	ADP
njb-115	145	8	ciprofloxacin	ciprofloxacin	NOUN
njb-115	145	9	87.93	87.93	NUM
njb-115	145	10	%	%	NOUN
njb-115	145	11	(	(	PUNCT
njb-115	145	12	51	51	NUM
njb-115	145	13	)	)	PUNCT
njb-115	145	14	followed	follow	VERB
njb-115	145	15	by	by	ADP
njb-115	145	16	azithromycin	azithromycin	PROPN
njb-115	145	17	74.13	74.13	NUM
njb-115	145	18	%	%	NOUN
njb-115	145	19	(	(	PUNCT
njb-115	145	20	43	43	NUM
njb-115	145	21	)	)	PUNCT
njb-115	145	22	,	,	PUNCT
njb-115	145	23	erythromycin	erythromycin	PROPN
njb-115	145	24	65.53	65.53	NUM
njb-115	145	25	%	%	NOUN
njb-115	145	26	(	(	PUNCT
njb-115	145	27	38	38	NUM
njb-115	145	28	)	)	PUNCT
njb-115	145	29	and	and	CCONJ
njb-115	145	30	was	be	AUX
njb-115	145	31	found	find	VERB
njb-115	145	32	to	to	PART
njb-115	145	33	be	be	AUX
njb-115	145	34	zero	zero	NUM
njb-115	145	35	resistant	resistant	ADJ
njb-115	145	36	towards	towards	ADP
njb-115	145	37	doxycycline	doxycycline	NOUN
njb-115	145	38	.	.	PUNCT
njb-115	146	1	(	(	PUNCT
njb-115	146	2	table	table	NOUN
njb-115	146	3	4	4	NUM
njb-115	146	4	)	)	PUNCT
njb-115	146	5	.	.	PUNCT
njb-115	147	1	vrsa	vrsa	NOUN
njb-115	147	2	and	and	CCONJ
njb-115	147	3	mic	mic	NOUN
njb-115	147	4	among	among	ADP
njb-115	147	5	isolated	isolated	ADJ
njb-115	147	6	s.	s.	PROPN
njb-115	147	7	aureus	aureus	PROPN
njb-115	147	8	,	,	PUNCT
njb-115	147	9	9	9	NUM
njb-115	147	10	were	be	AUX
njb-115	147	11	found	find	VERB
njb-115	147	12	to	to	PART
njb-115	147	13	be	be	AUX
njb-115	147	14	resistant	resistant	ADJ
njb-115	147	15	towards	towards	ADP
njb-115	147	16	the	the	DET
njb-115	147	17	vancomycin	vancomycin	PROPN
njb-115	147	18	disc	disc	NOUN
njb-115	147	19	.	.	PUNCT
njb-115	148	1	while	while	SCONJ
njb-115	148	2	performing	perform	VERB
njb-115	148	3	minimum	minimum	ADJ
njb-115	148	4	inhibitory	inhibitory	ADJ
njb-115	148	5	concentration	concentration	NOUN
njb-115	148	6	test	test	NOUN
njb-115	148	7	,	,	PUNCT
njb-115	148	8	all	all	DET
njb-115	148	9	positive	positive	ADJ
njb-115	148	10	strains	strain	NOUN
njb-115	148	11	were	be	AUX
njb-115	148	12	found	find	VERB
njb-115	148	13	to	to	PART
njb-115	148	14	be	be	AUX
njb-115	148	15	sensitive	sensitive	ADJ
njb-115	148	16	towards	towards	ADP
njb-115	148	17	vancomycin	vancomycin	PROPN
njb-115	148	18	in	in	ADP
njb-115	148	19	a	a	DET
njb-115	148	20	very	very	ADV
njb-115	148	21	low	low	ADJ
njb-115	148	22	concentration	concentration	NOUN
njb-115	148	23	,	,	PUNCT
njb-115	148	24	i.e.	i.e.	X
njb-115	148	25	0.25	0.25	NUM
njb-115	148	26	µg	µg	PROPN
njb-115	148	27	/	/	SYM
njb-115	148	28	ml	ml	NOUN
njb-115	148	29	and	and	CCONJ
njb-115	148	30	minimum	minimum	ADJ
njb-115	148	31	bactericidal	bactericidal	ADJ
njb-115	148	32	concentration	concentration	NOUN
njb-115	148	33	was	be	AUX
njb-115	148	34	found	find	VERB
njb-115	148	35	to	to	PART
njb-115	148	36	be	be	AUX
njb-115	148	37	0.25	0.25	NUM
njb-115	148	38	µg	µg	PROPN
njb-115	148	39	/	/	SYM
njb-115	148	40	ml	ml	PROPN
njb-115	148	41	.	.	PROPN
njb-115	148	42	association	association	PROPN
njb-115	148	43	between	between	ADP
njb-115	148	44	mdr	mdr	PROPN
njb-115	148	45	and	and	CCONJ
njb-115	148	46	mrsa	mrsa	PROPN
njb-115	148	47	in	in	ADP
njb-115	148	48	the	the	DET
njb-115	148	49	study	study	NOUN
njb-115	148	50	,	,	PUNCT
njb-115	148	51	44	44	NUM
njb-115	148	52	(	(	PUNCT
njb-115	148	53	84.61	84.61	NUM
njb-115	148	54	%	%	NOUN
njb-115	148	55	)	)	PUNCT
njb-115	148	56	mrsa	mrsa	PROPN
njb-115	148	57	were	be	AUX
njb-115	148	58	found	find	VERB
njb-115	148	59	to	to	PART
njb-115	148	60	be	be	AUX
njb-115	148	61	mdr	mdr	NOUN
njb-115	148	62	and	and	CCONJ
njb-115	148	63	14	14	NUM
njb-115	148	64	(	(	PUNCT
njb-115	148	65	26.42	26.42	NUM
njb-115	148	66	%	%	NOUN
njb-115	148	67	)	)	PUNCT
njb-115	148	68	mrsa	mrsa	PROPN
njb-115	148	69	were	be	AUX
njb-115	148	70	found	find	VERB
njb-115	148	71	to	to	PART
njb-115	148	72	be	be	AUX
njb-115	148	73	mdr	mdr	NOUN
njb-115	148	74	negative	negative	ADJ
njb-115	148	75	.	.	PUNCT
njb-115	149	1	by	by	ADP
njb-115	149	2	analyzing	analyze	VERB
njb-115	149	3	the	the	DET
njb-115	149	4	data	datum	NOUN
njb-115	149	5	of	of	ADP
njb-115	149	6	mdr	mdr	PROPN
njb-115	149	7	and	and	CCONJ
njb-115	149	8	mrsa	mrsa	PROPN
njb-115	149	9	using	use	VERB
njb-115	149	10	chisquare	chisquare	PROPN
njb-115	149	11	test	test	PROPN
njb-115	149	12	,	,	PUNCT
njb-115	149	13	the	the	DET
njb-115	149	14	value	value	NOUN
njb-115	149	15	was	be	AUX
njb-115	149	16	found	find	VERB
njb-115	149	17	to	to	PART
njb-115	149	18	be	be	AUX
njb-115	149	19	chi	chi	NOUN
njb-115	149	20	-	-	PUNCT
njb-115	149	21	square	square	ADJ
njb-115	149	22	(	(	PUNCT
njb-115	149	23	1	1	NUM
njb-115	149	24	,	,	PUNCT
njb-115	149	25	n=105	n=105	NOUN
njb-115	149	26	)	)	PUNCT
njb-115	149	27	=	=	NOUN
njb-115	149	28	35.958	35.958	NUM
njb-115	149	29	,	,	PUNCT
njb-115	149	30	p˂.01	p˂.01	PROPN
njb-115	149	31	.	.	PUNCT
njb-115	150	1	therefore	therefore	ADV
njb-115	150	2	,	,	PUNCT
njb-115	150	3	mdr	mdr	PROPN
njb-115	150	4	was	be	AUX
njb-115	150	5	found	find	VERB
njb-115	150	6	to	to	PART
njb-115	150	7	be	be	AUX
njb-115	150	8	statistically	statistically	ADV
njb-115	150	9	significant	significant	ADJ
njb-115	150	10	associated	associate	VERB
njb-115	150	11	with	with	ADP
njb-115	150	12	mrsa	mrsa	PROPN
njb-115	150	13	.	.	PUNCT
njb-115	151	1	d	d	X
njb-115	151	2	-	-	PUNCT
njb-115	151	3	test	test	NOUN
njb-115	151	4	of	of	ADP
njb-115	151	5	s.	s.	PROPN
njb-115	151	6	aureus	aureus	PROPN
njb-115	151	7	and	and	CCONJ
njb-115	151	8	correlation	correlation	NOUN
njb-115	151	9	between	between	ADP
njb-115	151	10	dtest	dt	ADJ
njb-115	151	11	positive	positive	ADJ
njb-115	151	12	and	and	CCONJ
njb-115	151	13	mrsa	mrsa	PROPN
njb-115	151	14	in	in	ADP
njb-115	151	15	d	d	NOUN
njb-115	151	16	-	-	NOUN
njb-115	151	17	test	test	NOUN
njb-115	151	18	(	(	PUNCT
njb-115	151	19	figure	figure	NOUN
njb-115	151	20	4	4	NUM
njb-115	151	21	)	)	PUNCT
njb-115	151	22	,	,	PUNCT
njb-115	151	23	out	out	ADP
njb-115	151	24	of	of	ADP
njb-115	151	25	total	total	ADJ
njb-115	151	26	105	105	NUM
njb-115	151	27	s.	s.	PROPN
njb-115	151	28	aureus	aureus	PROPN
njb-115	151	29	identified	identify	VERB
njb-115	151	30	,	,	PUNCT
njb-115	151	31	24	24	NUM
njb-115	151	32	(	(	PUNCT
njb-115	151	33	22.86	22.86	NUM
njb-115	151	34	%	%	NOUN
njb-115	151	35	)	)	PUNCT
njb-115	151	36	were	be	AUX
njb-115	151	37	found	find	VERB
njb-115	151	38	to	to	PART
njb-115	151	39	be	be	AUX
njb-115	151	40	d	d	NOUN
njb-115	151	41	-	-	NOUN
njb-115	151	42	test	test	ADJ
njb-115	151	43	positive	positive	ADJ
njb-115	151	44	,	,	PUNCT
njb-115	151	45	21	21	NUM
njb-115	151	46	(	(	PUNCT
njb-115	151	47	20.0	20.0	NUM
njb-115	151	48	%	%	NOUN
njb-115	151	49	)	)	PUNCT
njb-115	151	50	were	be	AUX
njb-115	151	51	d	d	NOUN
njb-115	151	52	-	-	ADJ
njb-115	151	53	test	test	NOUN
njb-115	151	54	negative	negative	NOUN
njb-115	151	55	,	,	PUNCT
njb-115	151	56	31	31	NUM
njb-115	151	57	(	(	PUNCT
njb-115	151	58	29.52	29.52	NUM
njb-115	151	59	%	%	NOUN
njb-115	151	60	)	)	PUNCT
njb-115	151	61	were	be	AUX
njb-115	151	62	sensitive	sensitive	ADJ
njb-115	151	63	to	to	ADP
njb-115	151	64	both	both	DET
njb-115	151	65	erythromycin	erythromycin	PROPN
njb-115	151	66	and	and	CCONJ
njb-115	151	67	clindamycin	clindamycin	PROPN
njb-115	151	68	and	and	CCONJ
njb-115	151	69	29	29	NUM
njb-115	151	70	(	(	PUNCT
njb-115	151	71	27.62	27.62	NUM
njb-115	151	72	%	%	NOUN
njb-115	151	73	)	)	PUNCT
njb-115	151	74	were	be	AUX
njb-115	151	75	constitutive	constitutive	ADJ
njb-115	151	76	resistant	resistant	ADJ
njb-115	151	77	(	(	PUNCT
njb-115	151	78	table	table	NOUN
njb-115	151	79	5	5	NUM
njb-115	151	80	)	)	PUNCT
njb-115	151	81	.	.	PUNCT
njb-115	152	1	figure	figure	VERB
njb-115	152	2	4	4	NUM
njb-115	152	3	.	.	PUNCT
njb-115	153	1	double	double	ADJ
njb-115	153	2	disk	disk	NOUN
njb-115	153	3	diffusion	diffusion	NOUN
njb-115	153	4	test	test	NOUN
njb-115	153	5	(	(	PUNCT
njb-115	153	6	d	d	NOUN
njb-115	153	7	-	-	NOUN
njb-115	153	8	test	test	NOUN
njb-115	153	9	)	)	PUNCT
njb-115	153	10	on	on	ADP
njb-115	153	11	mha	mha	VERB
njb-115	153	12	medium	medium	NOUN
njb-115	153	13	showing	showing	NOUN
njb-115	153	14	sensitive	sensitive	ADJ
njb-115	153	15	(	(	PUNCT
njb-115	153	16	k	k	NOUN
njb-115	153	17	)	)	PUNCT
njb-115	153	18	and	and	CCONJ
njb-115	153	19	positive	positive	ADJ
njb-115	153	20	result	result	NOUN
njb-115	153	21	(	(	PUNCT
njb-115	153	22	l	l	NOUN
njb-115	153	23	)	)	PUNCT
njb-115	153	24	.	.	PUNCT
njb-115	154	1	cd	cd	PROPN
njb-115	154	2	=	=	PROPN
njb-115	154	3	clindamycin	clindamycin	PROPN
njb-115	154	4	and	and	CCONJ
njb-115	154	5	e	e	NOUN
njb-115	154	6	=	=	X
njb-115	154	7	erythromycin	erythromycin	PROPN
njb-115	154	8	)	)	PUNCT
njb-115	154	9	table	table	NOUN
njb-115	154	10	5	5	NUM
njb-115	154	11	.	.	PUNCT
njb-115	155	1	correlation	correlation	NOUN
njb-115	155	2	between	between	ADP
njb-115	155	3	mrsa	mrsa	PROPN
njb-115	155	4	and	and	CCONJ
njb-115	155	5	d	d	NOUN
njb-115	155	6	-	-	NOUN
njb-115	155	7	test	test	NOUN
njb-115	155	8	d	d	NOUN
njb-115	155	9	-	-	PUNCT
njb-115	155	10	test	test	PROPN
njb-115	155	11	positive	positive	ADJ
njb-115	155	12	d	d	NOUN
njb-115	155	13	-	-	NOUN
njb-115	155	14	test	test	NOUN
njb-115	155	15	negative	negative	ADJ
njb-115	155	16	constitutive	constitutive	ADJ
njb-115	155	17	resistant	resistant	ADJ
njb-115	155	18	sensitive	sensitive	ADJ
njb-115	155	19	total	total	ADJ
njb-115	155	20	r	r	NOUN
njb-115	155	21	value	value	NOUN
njb-115	155	22	mrsa	mrsa	PROPN
njb-115	155	23	18	18	NUM
njb-115	155	24	(	(	PUNCT
njb-115	155	25	75	75	NUM
njb-115	155	26	%	%	NOUN
njb-115	155	27	)	)	PUNCT
njb-115	155	28	8(38.1	8(38.1	NUM
njb-115	155	29	%	%	NOUN
njb-115	155	30	)	)	PUNCT
njb-115	155	31	20	20	NUM
njb-115	155	32	(	(	PUNCT
njb-115	155	33	69	69	NUM
njb-115	155	34	%	%	NOUN
njb-115	155	35	)	)	PUNCT
njb-115	155	36	12	12	NUM
njb-115	155	37	(	(	PUNCT
njb-115	155	38	38.71	38.71	NUM
njb-115	155	39	%	%	NOUN
njb-115	155	40	)	)	PUNCT
njb-115	155	41	58	58	NUM
njb-115	155	42	0.39	0.39	NUM
njb-115	155	43	mssa	mssa	ADJ
njb-115	155	44	6	6	NUM
njb-115	155	45	(	(	PUNCT
njb-115	155	46	25	25	NUM
njb-115	155	47	%	%	NOUN
njb-115	155	48	)	)	PUNCT
njb-115	155	49	13	13	NUM
njb-115	155	50	(	(	PUNCT
njb-115	155	51	61.9	61.9	NUM
njb-115	155	52	%	%	NOUN
njb-115	155	53	)	)	PUNCT
njb-115	155	54	9	9	NUM
njb-115	155	55	(	(	PUNCT
njb-115	155	56	31	31	NUM
njb-115	155	57	%	%	NOUN
njb-115	155	58	)	)	PUNCT
njb-115	155	59	19	19	NUM
njb-115	155	60	(	(	PUNCT
njb-115	155	61	61.29	61.29	NUM
njb-115	155	62	%	%	NOUN
njb-115	155	63	)	)	PUNCT
njb-115	155	64	47	47	NUM
njb-115	155	65	total	total	NOUN
njb-115	155	66	24	24	NUM
njb-115	155	67	21	21	NUM
njb-115	155	68	29	29	NUM
njb-115	155	69	31	31	NUM
njb-115	155	70	105	105	NUM
njb-115	155	71	(	(	PUNCT
njb-115	155	72	100	100	NUM
njb-115	155	73	%	%	NOUN
njb-115	155	74	)	)	PUNCT
njb-115	155	75	nepal	nepal	PROPN
njb-115	155	76	j	j	PROPN
njb-115	155	77	biotechnol	biotechnol	PROPN
njb-115	155	78	.	.	PUNCT
njb-115	156	1	2	2	NUM
njb-115	156	2	0	0	NUM
njb-115	156	3	2	2	NUM
njb-115	156	4	1	1	NUM
njb-115	156	5	j	j	NOUN
njb-115	156	6	u	u	NOUN
njb-115	156	7	l	l	NOUN
njb-115	156	8	;	;	PUNCT
njb-115	156	9	9	9	NUM
njb-115	156	10	(	(	PUNCT
njb-115	156	11	1):8	1):8	NUM
njb-115	156	12	1	1	NUM
njb-115	156	13	7	7	NUM
njb-115	156	14	maharjan	maharjan	NOUN
njb-115	156	15	et	et	NOUN
njb-115	156	16	al	al	PROPN
njb-115	156	17	.	.	PUNCT
njb-115	157	1	©	©	PROPN
njb-115	157	2	njb	njb	PROPN
njb-115	157	3	,	,	PUNCT
njb-115	157	4	bsn	bsn	PROPN
njb-115	157	5	13	13	NUM
njb-115	157	6	here	here	ADV
njb-115	157	7	,	,	PUNCT
njb-115	157	8	18	18	NUM
njb-115	157	9	(	(	PUNCT
njb-115	157	10	75	75	NUM
njb-115	157	11	%	%	NOUN
njb-115	157	12	)	)	PUNCT
njb-115	157	13	mrsa	mrsa	PROPN
njb-115	157	14	were	be	AUX
njb-115	157	15	d	d	NOUN
njb-115	157	16	-	-	ADJ
njb-115	157	17	test	test	ADJ
njb-115	157	18	positive	positive	ADJ
njb-115	157	19	,	,	PUNCT
njb-115	157	20	8	8	NUM
njb-115	157	21	(	(	PUNCT
njb-115	157	22	38.1	38.1	NUM
njb-115	157	23	%	%	NOUN
njb-115	157	24	)	)	PUNCT
njb-115	157	25	mrsa	mrsa	PROPN
njb-115	157	26	were	be	AUX
njb-115	157	27	d	d	NOUN
njb-115	157	28	-	-	ADJ
njb-115	157	29	test	test	NOUN
njb-115	157	30	negative	negative	ADJ
njb-115	157	31	,	,	PUNCT
njb-115	157	32	20	20	NUM
njb-115	157	33	(	(	PUNCT
njb-115	157	34	69	69	NUM
njb-115	157	35	%	%	NOUN
njb-115	157	36	)	)	PUNCT
njb-115	157	37	mrsa	mrsa	PROPN
njb-115	157	38	were	be	AUX
njb-115	157	39	constitutive	constitutive	ADJ
njb-115	157	40	resistant	resistant	ADJ
njb-115	157	41	and	and	CCONJ
njb-115	157	42	12	12	NUM
njb-115	157	43	(	(	PUNCT
njb-115	157	44	38.71	38.71	NUM
njb-115	157	45	%	%	NOUN
njb-115	157	46	)	)	PUNCT
njb-115	157	47	mrsa	mrsa	PROPN
njb-115	157	48	were	be	AUX
njb-115	157	49	sensitive	sensitive	ADJ
njb-115	157	50	as	as	SCONJ
njb-115	157	51	shown	show	VERB
njb-115	157	52	in	in	ADP
njb-115	157	53	table	table	NOUN
njb-115	157	54	5	5	NUM
njb-115	157	55	.	.	PUNCT
njb-115	158	1	the	the	DET
njb-115	158	2	correlation	correlation	NOUN
njb-115	158	3	coefficient	coefficient	NOUN
njb-115	158	4	(	(	PUNCT
njb-115	158	5	r	r	NOUN
njb-115	158	6	)	)	PUNCT
njb-115	158	7	between	between	ADP
njb-115	158	8	d	d	NOUN
njb-115	158	9	-	-	NOUN
njb-115	158	10	test	test	NOUN
njb-115	158	11	and	and	CCONJ
njb-115	158	12	mrsa	mrsa	PROPN
njb-115	158	13	was	be	AUX
njb-115	158	14	found	find	VERB
njb-115	158	15	to	to	PART
njb-115	158	16	be	be	AUX
njb-115	158	17	0.39	0.39	NUM
njb-115	158	18	(	(	PUNCT
njb-115	158	19	r	r	NOUN
njb-115	158	20	=	=	NOUN
njb-115	158	21	.313	.313	NUM
njb-115	158	22	,	,	PUNCT
njb-115	158	23	p˂.01	p˂.01	PROPN
njb-115	158	24	)	)	PUNCT
njb-115	158	25	,	,	PUNCT
njb-115	158	26	i.e.	i.e.	X
njb-115	158	27	d	d	X
njb-115	158	28	-	-	NOUN
njb-115	158	29	test	test	NOUN
njb-115	158	30	and	and	CCONJ
njb-115	158	31	mrsa	mrsa	PROPN
njb-115	158	32	was	be	AUX
njb-115	158	33	found	find	VERB
njb-115	158	34	to	to	PART
njb-115	158	35	be	be	AUX
njb-115	158	36	positive	positive	ADJ
njb-115	158	37	but	but	CCONJ
njb-115	158	38	lowly	lowly	ADV
njb-115	158	39	correlated	correlate	VERB
njb-115	158	40	with	with	ADP
njb-115	158	41	each	each	DET
njb-115	158	42	other	other	ADJ
njb-115	158	43	.	.	PUNCT
njb-115	159	1	discussion	discussion	NOUN
njb-115	159	2	out	out	ADP
njb-115	159	3	of	of	ADP
njb-115	159	4	total	total	ADJ
njb-115	159	5	sample	sample	NOUN
njb-115	159	6	,	,	PUNCT
njb-115	159	7	139	139	NUM
njb-115	159	8	(	(	PUNCT
njb-115	159	9	51.48	51.48	NUM
njb-115	159	10	%	%	NOUN
njb-115	159	11	)	)	PUNCT
njb-115	159	12	showed	show	VERB
njb-115	159	13	growth	growth	NOUN
njb-115	159	14	and	and	CCONJ
njb-115	159	15	131	131	NUM
njb-115	159	16	(	(	PUNCT
njb-115	159	17	48.52	48.52	NUM
njb-115	159	18	%	%	NOUN
njb-115	159	19	)	)	PUNCT
njb-115	159	20	showed	show	VERB
njb-115	159	21	no	no	DET
njb-115	159	22	growth	growth	NOUN
njb-115	159	23	.	.	PUNCT
njb-115	160	1	the	the	DET
njb-115	160	2	growth	growth	NOUN
njb-115	160	3	result	result	NOUN
njb-115	160	4	was	be	AUX
njb-115	160	5	found	find	VERB
njb-115	160	6	nearly	nearly	ADV
njb-115	160	7	similar	similar	ADJ
njb-115	160	8	to	to	ADP
njb-115	160	9	the	the	DET
njb-115	160	10	study	study	NOUN
njb-115	160	11	conducted	conduct	VERB
njb-115	160	12	by	by	ADP
njb-115	160	13	hanumanthappa	hanumanthappa	PROPN
njb-115	160	14	et	et	PROPN
njb-115	160	15	al	al	PROPN
njb-115	160	16	,	,	PUNCT
njb-115	160	17	where	where	SCONJ
njb-115	160	18	they	they	PRON
njb-115	160	19	found	find	VERB
njb-115	160	20	56	56	NUM
njb-115	160	21	%	%	NOUN
njb-115	160	22	growth	growth	NOUN
njb-115	160	23	rate	rate	NOUN
njb-115	160	24	[	[	PUNCT
njb-115	160	25	32	32	NUM
njb-115	160	26	]	]	PUNCT
njb-115	160	27	.	.	PUNCT
njb-115	161	1	the	the	DET
njb-115	161	2	result	result	NOUN
njb-115	161	3	was	be	AUX
njb-115	161	4	lower	low	ADJ
njb-115	161	5	to	to	ADP
njb-115	161	6	the	the	DET
njb-115	161	7	study	study	NOUN
njb-115	161	8	conducted	conduct	VERB
njb-115	161	9	by	by	ADP
njb-115	161	10	rai	rai	PROPN
njb-115	161	11	et	et	PROPN
njb-115	161	12	al	al	PROPN
njb-115	162	1	[	[	PUNCT
njb-115	162	2	10	10	NUM
njb-115	162	3	]	]	PUNCT
njb-115	162	4	58.6	58.6	NUM
njb-115	162	5	%	%	NOUN
njb-115	162	6	;	;	PUNCT
njb-115	163	1	khan	khan	PROPN
njb-115	163	2	et	et	PROPN
njb-115	163	3	al	al	PROPN
njb-115	164	1	[	[	X
njb-115	164	2	33	33	NUM
njb-115	164	3	]	]	SYM
njb-115	164	4	65.2	65.2	NUM
njb-115	164	5	%	%	NOUN
njb-115	164	6	and	and	CCONJ
njb-115	164	7	patil	patil	PROPN
njb-115	164	8	et	et	PROPN
njb-115	164	9	al	al	PROPN
njb-115	165	1	[	[	PUNCT
njb-115	165	2	34	34	NUM
njb-115	165	3	]	]	SYM
njb-115	165	4	86	86	NUM
njb-115	165	5	%	%	NOUN
njb-115	165	6	.	.	PUNCT
njb-115	166	1	the	the	DET
njb-115	166	2	lower	low	ADJ
njb-115	166	3	growth	growth	NOUN
njb-115	166	4	might	might	AUX
njb-115	166	5	be	be	AUX
njb-115	166	6	due	due	ADJ
njb-115	166	7	to	to	ADP
njb-115	166	8	difficult	difficult	ADJ
njb-115	166	9	-	-	PUNCT
njb-115	166	10	togrow	togrow	ADJ
njb-115	166	11	fastidious	fastidious	ADJ
njb-115	166	12	organisms	organism	NOUN
njb-115	166	13	,	,	PUNCT
njb-115	166	14	inappropriate	inappropriate	ADJ
njb-115	166	15	methods	method	NOUN
njb-115	166	16	of	of	ADP
njb-115	166	17	collection	collection	NOUN
njb-115	166	18	and	and	CCONJ
njb-115	166	19	transportation	transportation	NOUN
njb-115	166	20	of	of	ADP
njb-115	166	21	specimens	specimen	NOUN
njb-115	166	22	or	or	CCONJ
njb-115	166	23	the	the	DET
njb-115	166	24	administration	administration	NOUN
njb-115	166	25	of	of	ADP
njb-115	166	26	antibiotics	antibiotic	NOUN
njb-115	166	27	prior	prior	ADV
njb-115	166	28	to	to	ADP
njb-115	166	29	specimen	specimen	NOUN
njb-115	166	30	collection	collection	NOUN
njb-115	166	31	.	.	PUNCT
njb-115	167	1	among	among	ADP
njb-115	167	2	139	139	NUM
njb-115	167	3	positive	positive	ADJ
njb-115	167	4	growth	growth	NOUN
njb-115	167	5	result	result	NOUN
njb-115	167	6	,	,	PUNCT
njb-115	167	7	118	118	NUM
njb-115	167	8	(	(	PUNCT
njb-115	167	9	85.65	85.65	NUM
njb-115	167	10	%	%	NOUN
njb-115	167	11	)	)	PUNCT
njb-115	167	12	were	be	AUX
njb-115	167	13	found	find	VERB
njb-115	167	14	to	to	PART
njb-115	167	15	be	be	AUX
njb-115	167	16	positive	positive	ADJ
njb-115	167	17	from	from	ADP
njb-115	167	18	out	out	ADP
njb-115	167	19	-	-	PUNCT
njb-115	167	20	patient	patient	NOUN
njb-115	167	21	department	department	NOUN
njb-115	167	22	and	and	CCONJ
njb-115	167	23	21	21	NUM
njb-115	167	24	(	(	PUNCT
njb-115	167	25	14.4	14.4	NUM
njb-115	167	26	%	%	NOUN
njb-115	167	27	)	)	PUNCT
njb-115	167	28	from	from	ADP
njb-115	167	29	in	in	ADP
njb-115	167	30	-	-	PUNCT
njb-115	167	31	patient	patient	NOUN
njb-115	167	32	department	department	NOUN
njb-115	167	33	.	.	PUNCT
njb-115	168	1	high	high	ADJ
njb-115	168	2	prevalence	prevalence	NOUN
njb-115	168	3	of	of	ADP
njb-115	168	4	growth	growth	NOUN
njb-115	168	5	in	in	ADP
njb-115	168	6	opd	opd	NOUN
njb-115	168	7	might	might	AUX
njb-115	168	8	be	be	AUX
njb-115	168	9	due	due	ADJ
njb-115	168	10	to	to	PART
njb-115	168	11	increase	increase	VERB
njb-115	168	12	in	in	ADP
njb-115	168	13	community	community	NOUN
njb-115	168	14	acquired	acquire	VERB
njb-115	168	15	infection	infection	NOUN
njb-115	168	16	.	.	PUNCT
njb-115	169	1	higher	high	ADJ
njb-115	169	2	positive	positive	ADJ
njb-115	169	3	growth	growth	NOUN
njb-115	169	4	in	in	ADP
njb-115	169	5	opd	opd	PROPN
njb-115	169	6	was	be	AUX
njb-115	169	7	also	also	ADV
njb-115	169	8	found	find	VERB
njb-115	169	9	in	in	ADP
njb-115	169	10	the	the	DET
njb-115	169	11	study	study	NOUN
njb-115	169	12	carried	carry	VERB
njb-115	169	13	by	by	ADP
njb-115	169	14	kc	kc	PROPN
njb-115	169	15	et	et	PROPN
njb-115	169	16	al	al	PROPN
njb-115	170	1	[	[	PUNCT
njb-115	170	2	35	35	NUM
njb-115	170	3	]	]	PUNCT
njb-115	170	4	and	and	CCONJ
njb-115	170	5	found	find	VERB
njb-115	170	6	contrary	contrary	ADJ
njb-115	170	7	to	to	ADP
njb-115	170	8	the	the	DET
njb-115	170	9	study	study	NOUN
njb-115	170	10	carried	carry	VERB
njb-115	170	11	out	out	ADP
njb-115	170	12	by	by	ADP
njb-115	170	13	pant	pant	NOUN
njb-115	170	14	et	et	PROPN
njb-115	170	15	al	al	PROPN
njb-115	170	16	,	,	PUNCT
njb-115	170	17	where	where	SCONJ
njb-115	170	18	they	they	PRON
njb-115	170	19	found	find	VERB
njb-115	170	20	63.1	63.1	NUM
njb-115	170	21	%	%	NOUN
njb-115	170	22	from	from	ADP
njb-115	170	23	ipd	ipd	PROPN
njb-115	170	24	and	and	CCONJ
njb-115	170	25	56.2	56.2	NUM
njb-115	170	26	%	%	NOUN
njb-115	170	27	from	from	ADP
njb-115	170	28	opd	opd	PROPN
njb-115	171	1	[	[	PUNCT
njb-115	171	2	36	36	NUM
njb-115	171	3	]	]	PUNCT
njb-115	171	4	.	.	PUNCT
njb-115	172	1	out	out	ADP
njb-115	172	2	of	of	ADP
njb-115	172	3	total	total	ADJ
njb-115	172	4	growth	growth	NOUN
njb-115	172	5	139	139	NUM
njb-115	172	6	,	,	PUNCT
njb-115	172	7	116	116	NUM
njb-115	172	8	(	(	PUNCT
njb-115	172	9	83.5	83.5	NUM
njb-115	172	10	%	%	NOUN
njb-115	172	11	)	)	PUNCT
njb-115	172	12	were	be	AUX
njb-115	172	13	found	find	VERB
njb-115	172	14	to	to	PART
njb-115	172	15	be	be	AUX
njb-115	172	16	gram	gram	NOUN
njb-115	172	17	-	-	PUNCT
njb-115	172	18	positive	positive	ADJ
njb-115	172	19	and	and	CCONJ
njb-115	172	20	23	23	NUM
njb-115	172	21	(	(	PUNCT
njb-115	172	22	16.5	16.5	NUM
njb-115	172	23	%	%	NOUN
njb-115	172	24	)	)	PUNCT
njb-115	172	25	were	be	AUX
njb-115	172	26	found	find	VERB
njb-115	172	27	to	to	PART
njb-115	172	28	be	be	AUX
njb-115	172	29	gram	gram	NOUN
njb-115	172	30	negative	negative	ADJ
njb-115	172	31	.	.	PUNCT
njb-115	173	1	the	the	DET
njb-115	173	2	high	high	ADJ
njb-115	173	3	prevalence	prevalence	NOUN
njb-115	173	4	of	of	ADP
njb-115	173	5	gram	gram	NOUN
njb-115	173	6	-	-	PUNCT
njb-115	173	7	positive	positive	ADJ
njb-115	173	8	organism	organism	NOUN
njb-115	173	9	might	might	AUX
njb-115	173	10	be	be	AUX
njb-115	173	11	due	due	ADJ
njb-115	173	12	to	to	ADP
njb-115	173	13	the	the	DET
njb-115	173	14	presence	presence	NOUN
njb-115	173	15	of	of	ADP
njb-115	173	16	gram	gram	NOUN
njb-115	173	17	-	-	PUNCT
njb-115	173	18	positive	positive	ADJ
njb-115	173	19	bacteria	bacteria	NOUN
njb-115	173	20	as	as	ADP
njb-115	173	21	a	a	DET
njb-115	173	22	normal	normal	ADJ
njb-115	173	23	flora	flora	NOUN
njb-115	173	24	of	of	ADP
njb-115	173	25	the	the	DET
njb-115	173	26	human	human	ADJ
njb-115	173	27	body	body	NOUN
njb-115	173	28	.	.	PUNCT
njb-115	174	1	the	the	DET
njb-115	174	2	result	result	NOUN
njb-115	174	3	was	be	AUX
njb-115	174	4	found	find	VERB
njb-115	174	5	to	to	PART
njb-115	174	6	be	be	AUX
njb-115	174	7	similar	similar	ADJ
njb-115	174	8	to	to	ADP
njb-115	174	9	the	the	DET
njb-115	174	10	research	research	NOUN
njb-115	174	11	conducted	conduct	VERB
njb-115	174	12	by	by	ADP
njb-115	174	13	kc	kc	PROPN
njb-115	174	14	et	et	PROPN
njb-115	174	15	al	al	PROPN
njb-115	175	1	[	[	PUNCT
njb-115	175	2	35	35	NUM
njb-115	175	3	]	]	PUNCT
njb-115	175	4	;	;	PUNCT
njb-115	175	5	devi	devi	PROPN
njb-115	175	6	et	et	PROPN
njb-115	175	7	al	al	PROPN
njb-115	175	8	[	[	PUNCT
njb-115	175	9	37	37	NUM
njb-115	175	10	]	]	PUNCT
njb-115	175	11	and	and	CCONJ
njb-115	175	12	pant	pant	NOUN
njb-115	175	13	et	et	PROPN
njb-115	175	14	al	al	PROPN
njb-115	176	1	[	[	PUNCT
njb-115	176	2	36	36	NUM
njb-115	176	3	]	]	PUNCT
njb-115	176	4	.	.	PUNCT
njb-115	177	1	the	the	DET
njb-115	177	2	result	result	NOUN
njb-115	177	3	was	be	AUX
njb-115	177	4	found	find	VERB
njb-115	177	5	contrast	contrast	NOUN
njb-115	177	6	to	to	ADP
njb-115	177	7	the	the	DET
njb-115	177	8	study	study	NOUN
njb-115	177	9	conducted	conduct	VERB
njb-115	177	10	by	by	ADP
njb-115	177	11	patil	patil	PROPN
njb-115	177	12	et	et	PROPN
njb-115	177	13	al	al	PROPN
njb-115	177	14	(	(	PUNCT
njb-115	177	15	2019)78	2019)78	NUM
njb-115	177	16	%	%	NOUN
njb-115	177	17	gram	gram	NOUN
njb-115	177	18	negative	negative	NOUN
njb-115	177	19	and	and	CCONJ
njb-115	177	20	22	22	NUM
njb-115	177	21	%	%	NOUN
njb-115	177	22	gram	gram	NOUN
njb-115	177	23	-	-	PUNCT
njb-115	177	24	positive	positive	ADJ
njb-115	177	25	bacteria	bacteria	NOUN
njb-115	177	26	[	[	PUNCT
njb-115	177	27	34	34	NUM
njb-115	177	28	]	]	PUNCT
njb-115	177	29	.	.	PUNCT
njb-115	178	1	the	the	DET
njb-115	178	2	predominance	predominance	NOUN
njb-115	178	3	of	of	ADP
njb-115	178	4	s.	s.	PROPN
njb-115	178	5	aureus	aureus	PROPN
njb-115	178	6	(	(	PUNCT
njb-115	178	7	75.5	75.5	NUM
njb-115	178	8	%	%	NOUN
njb-115	178	9	)	)	PUNCT
njb-115	178	10	in	in	ADP
njb-115	178	11	the	the	DET
njb-115	178	12	study	study	NOUN
njb-115	178	13	might	might	AUX
njb-115	178	14	be	be	AUX
njb-115	178	15	due	due	ADJ
njb-115	178	16	to	to	ADP
njb-115	178	17	s.	s.	PROPN
njb-115	178	18	aureus	aureus	PROPN
njb-115	178	19	being	be	AUX
njb-115	178	20	normal	normal	ADJ
njb-115	178	21	flora	flora	NOUN
njb-115	178	22	of	of	ADP
njb-115	178	23	skin	skin	NOUN
njb-115	178	24	,	,	PUNCT
njb-115	178	25	glands	gland	NOUN
njb-115	178	26	,	,	PUNCT
njb-115	178	27	nails	nail	NOUN
njb-115	178	28	,	,	PUNCT
njb-115	178	29	etc	etc	X
njb-115	178	30	.	.	X
njb-115	178	31	and	and	CCONJ
njb-115	178	32	having	have	VERB
njb-115	178	33	various	various	ADJ
njb-115	178	34	virulence	virulence	NOUN
njb-115	178	35	factors	factor	NOUN
njb-115	178	36	.	.	PUNCT
njb-115	179	1	the	the	DET
njb-115	179	2	result	result	NOUN
njb-115	179	3	was	be	AUX
njb-115	179	4	seems	seem	VERB
njb-115	179	5	to	to	PART
njb-115	179	6	be	be	AUX
njb-115	179	7	related	relate	VERB
njb-115	179	8	to	to	ADP
njb-115	179	9	the	the	DET
njb-115	179	10	study	study	NOUN
njb-115	179	11	conducted	conduct	VERB
njb-115	179	12	by	by	ADP
njb-115	179	13	sultana	sultana	PROPN
njb-115	179	14	et	et	PROPN
njb-115	179	15	al	al	PROPN
njb-115	179	16	(	(	PUNCT
njb-115	179	17	2015	2015	NUM
njb-115	179	18	)	)	PUNCT
njb-115	179	19	40.45	40.45	NUM
njb-115	179	20	%	%	NOUN
njb-115	179	21	s.	s.	PROPN
njb-115	179	22	aureus	aureus	PROPN
njb-115	179	23	followed	follow	VERB
njb-115	179	24	by	by	ADP
njb-115	179	25	e.	e.	PROPN
njb-115	179	26	coli	coli	PROPN
njb-115	179	27	28.18	28.18	NUM
njb-115	179	28	%	%	NOUN
njb-115	179	29	[	[	PUNCT
njb-115	179	30	38	38	NUM
njb-115	179	31	]	]	PUNCT
njb-115	179	32	;	;	PUNCT
njb-115	179	33	barakoti	barakoti	PROPN
njb-115	179	34	et	et	X
njb-115	179	35	al	al	PROPN
njb-115	179	36	(	(	PUNCT
njb-115	179	37	2017	2017	NUM
njb-115	179	38	)	)	PUNCT
njb-115	179	39	41.45	41.45	NUM
njb-115	179	40	%	%	NOUN
njb-115	179	41	s.	s.	PROPN
njb-115	179	42	aureus	aureus	PROPN
njb-115	179	43	followed	follow	VERB
njb-115	179	44	by	by	ADP
njb-115	179	45	e.	e.	PROPN
njb-115	179	46	coli	coli	PROPN
njb-115	179	47	22.79	22.79	NUM
njb-115	179	48	%	%	NOUN
njb-115	179	49	[	[	PUNCT
njb-115	179	50	39	39	NUM
njb-115	179	51	]	]	PUNCT
njb-115	179	52	;	;	PUNCT
njb-115	179	53	bankar	bankar	PROPN
njb-115	179	54	et	et	PROPN
njb-115	179	55	al	al	PROPN
njb-115	179	56	(	(	PUNCT
njb-115	179	57	2018	2018	NUM
njb-115	179	58	)	)	PUNCT
njb-115	179	59	34.21	34.21	NUM
njb-115	179	60	%	%	NOUN
njb-115	179	61	s.	s.	PROPN
njb-115	179	62	aureus	aureus	PROPN
njb-115	179	63	followed	follow	VERB
njb-115	179	64	by	by	ADP
njb-115	179	65	e.	e.	PROPN
njb-115	179	66	coli	coli	PROPN
njb-115	179	67	23.02%[40	23.02%[40	NUM
njb-115	179	68	]	]	PUNCT
njb-115	179	69	and	and	CCONJ
njb-115	179	70	shahi	shahi	PROPN
njb-115	179	71	et	et	PROPN
njb-115	179	72	al	al	PROPN
njb-115	179	73	(	(	PUNCT
njb-115	179	74	2018)70.6	2018)70.6	PROPN
njb-115	179	75	%	%	NOUN
njb-115	179	76	s.	s.	PROPN
njb-115	179	77	aureus	aureus	PROPN
njb-115	180	1	[	[	PUNCT
njb-115	180	2	41	41	NUM
njb-115	180	3	]	]	PUNCT
njb-115	180	4	.	.	PUNCT
njb-115	181	1	however	however	ADV
njb-115	181	2	mahat	mahat	PROPN
njb-115	181	3	et	et	PROPN
njb-115	181	4	al	al	PROPN
njb-115	181	5	[	[	PUNCT
njb-115	181	6	42	42	NUM
njb-115	181	7	]	]	PUNCT
njb-115	181	8	and	and	CCONJ
njb-115	181	9	patil	patil	PROPN
njb-115	181	10	et	et	PROPN
njb-115	181	11	al	al	PROPN
njb-115	182	1	[	[	PUNCT
njb-115	182	2	34	34	NUM
njb-115	182	3	]	]	PUNCT
njb-115	182	4	pseudomonas	pseudomona	NOUN
njb-115	182	5	spp	spp	PROPN
njb-115	182	6	.	.	PUNCT
njb-115	183	1	as	as	ADP
njb-115	183	2	predominant	predominant	ADJ
njb-115	183	3	organism	organism	NOUN
njb-115	183	4	.	.	PUNCT
njb-115	184	1	the	the	DET
njb-115	184	2	infection	infection	NOUN
njb-115	184	3	in	in	ADP
njb-115	184	4	the	the	DET
njb-115	184	5	age	age	NOUN
njb-115	184	6	group	group	NOUN
njb-115	184	7	12	12	NUM
njb-115	184	8	-	-	SYM
njb-115	184	9	15	15	NUM
njb-115	184	10	yrs	yr	NOUN
njb-115	184	11	.	.	PUNCT
njb-115	184	12	might	might	AUX
njb-115	184	13	be	be	AUX
njb-115	184	14	due	due	ADJ
njb-115	184	15	to	to	ADP
njb-115	184	16	the	the	DET
njb-115	184	17	various	various	ADJ
njb-115	184	18	activities	activity	NOUN
njb-115	184	19	performed	perform	VERB
njb-115	184	20	in	in	ADP
njb-115	184	21	the	the	DET
njb-115	184	22	school	school	NOUN
njb-115	184	23	,	,	PUNCT
njb-115	184	24	environment	environment	NOUN
njb-115	184	25	,	,	PUNCT
njb-115	184	26	involved	involve	VERB
njb-115	184	27	in	in	ADP
njb-115	184	28	fight	fight	NOUN
njb-115	184	29	,	,	PUNCT
njb-115	184	30	their	their	PRON
njb-115	184	31	playmates	playmate	NOUN
njb-115	184	32	and	and	CCONJ
njb-115	184	33	contact	contact	NOUN
njb-115	184	34	with	with	ADP
njb-115	184	35	various	various	ADJ
njb-115	184	36	object	object	NOUN
njb-115	184	37	.	.	PUNCT
njb-115	185	1	the	the	DET
njb-115	185	2	children	child	NOUN
njb-115	185	3	under	under	ADP
njb-115	185	4	5	5	NUM
njb-115	185	5	years	year	NOUN
njb-115	185	6	are	be	AUX
njb-115	185	7	also	also	ADV
njb-115	185	8	prone	prone	ADJ
njb-115	185	9	to	to	PART
njb-115	185	10	get	get	VERB
njb-115	185	11	pus	pus	NOUN
njb-115	185	12	/	/	SYM
njb-115	185	13	wound	wound	NOUN
njb-115	185	14	infection	infection	NOUN
njb-115	185	15	because	because	SCONJ
njb-115	185	16	of	of	ADP
njb-115	185	17	unintentional	unintentional	ADJ
njb-115	185	18	falls	fall	NOUN
njb-115	185	19	,	,	PUNCT
njb-115	185	20	burns	burn	NOUN
njb-115	185	21	,	,	PUNCT
njb-115	185	22	etc	etc	X
njb-115	185	23	.	.	X
njb-115	185	24	and	and	CCONJ
njb-115	185	25	not	not	PART
njb-115	185	26	only	only	ADV
njb-115	185	27	that	that	SCONJ
njb-115	185	28	these	these	DET
njb-115	185	29	group	group	NOUN
njb-115	185	30	also	also	ADV
njb-115	185	31	has	have	VERB
njb-115	185	32	low	low	ADJ
njb-115	185	33	immune	immune	ADJ
njb-115	185	34	power	power	NOUN
njb-115	185	35	to	to	PART
njb-115	185	36	overcome	overcome	VERB
njb-115	185	37	any	any	DET
njb-115	185	38	kind	kind	NOUN
njb-115	185	39	of	of	ADP
njb-115	185	40	infection	infection	NOUN
njb-115	185	41	,	,	PUNCT
njb-115	185	42	therefore	therefore	ADV
njb-115	185	43	it	it	PRON
njb-115	185	44	is	be	AUX
njb-115	185	45	likely	likely	ADJ
njb-115	185	46	to	to	PART
njb-115	185	47	get	get	AUX
njb-115	185	48	infected	infect	VERB
njb-115	185	49	.	.	PUNCT
njb-115	186	1	the	the	DET
njb-115	186	2	outcomes	outcome	NOUN
njb-115	186	3	were	be	AUX
njb-115	186	4	found	find	VERB
njb-115	186	5	to	to	PART
njb-115	186	6	be	be	AUX
njb-115	186	7	contrast	contrast	NOUN
njb-115	186	8	with	with	ADP
njb-115	186	9	the	the	DET
njb-115	186	10	study	study	NOUN
njb-115	186	11	conducted	conduct	VERB
njb-115	186	12	in	in	ADP
njb-115	186	13	2017	2017	NUM
njb-115	186	14	by	by	ADP
njb-115	186	15	pokhrel	pokhrel	PROPN
njb-115	186	16	et	et	PROPN
njb-115	186	17	al	al	PROPN
njb-115	186	18	,	,	PUNCT
njb-115	186	19	where	where	SCONJ
njb-115	186	20	they	they	PRON
njb-115	186	21	got	get	VERB
njb-115	186	22	higher	high	ADJ
njb-115	186	23	prevalence	prevalence	NOUN
njb-115	186	24	of	of	ADP
njb-115	186	25	s.	s.	PROPN
njb-115	186	26	aureus	aureus	PROPN
njb-115	186	27	in	in	ADP
njb-115	186	28	age	age	NOUN
njb-115	186	29	group	group	NOUN
njb-115	186	30	1	1	NUM
njb-115	186	31	-	-	PUNCT
njb-115	186	32	3yrs	3yrs	NUM
njb-115	186	33	[	[	PUNCT
njb-115	186	34	43	43	NUM
njb-115	186	35	]	]	PUNCT
njb-115	186	36	;	;	PUNCT
njb-115	186	37	rai	rai	PROPN
njb-115	186	38	et	et	PROPN
njb-115	186	39	al	al	PROPN
njb-115	186	40	in	in	ADP
njb-115	186	41	age	age	NOUN
njb-115	186	42	less	less	ADJ
njb-115	186	43	than	than	ADP
njb-115	186	44	1	1	NUM
njb-115	186	45	year	year	NOUN
njb-115	186	46	[	[	NOUN
njb-115	186	47	10	10	NUM
njb-115	186	48	]	]	PUNCT
njb-115	186	49	and	and	CCONJ
njb-115	186	50	pant	pant	NOUN
njb-115	186	51	et	et	PROPN
njb-115	186	52	al	al	PROPN
njb-115	186	53	in	in	ADP
njb-115	186	54	age	age	NOUN
njb-115	186	55	group	group	NOUN
njb-115	186	56	15yrs	15yr	NOUN
njb-115	187	1	[	[	X
njb-115	187	2	36	36	NUM
njb-115	187	3	]	]	PUNCT
njb-115	187	4	.	.	PUNCT
njb-115	188	1	the	the	DET
njb-115	188	2	distribution	distribution	NOUN
njb-115	188	3	of	of	ADP
njb-115	188	4	s.	s.	PROPN
njb-115	188	5	aureus	aureus	PROPN
njb-115	188	6	among	among	ADP
njb-115	188	7	gender	gender	NOUN
njb-115	188	8	was	be	AUX
njb-115	188	9	found	find	VERB
njb-115	188	10	to	to	PART
njb-115	188	11	be	be	AUX
njb-115	188	12	high	high	ADJ
njb-115	188	13	in	in	ADP
njb-115	188	14	female	female	ADJ
njb-115	188	15	patient	patient	NOUN
njb-115	188	16	54	54	NUM
njb-115	188	17	(	(	PUNCT
njb-115	188	18	51	51	NUM
njb-115	188	19	%	%	NOUN
njb-115	188	20	)	)	PUNCT
njb-115	188	21	than	than	ADP
njb-115	188	22	the	the	DET
njb-115	188	23	male	male	ADJ
njb-115	188	24	patient	patient	NOUN
njb-115	188	25	51	51	NUM
njb-115	188	26	(	(	PUNCT
njb-115	188	27	49	49	NUM
njb-115	188	28	%	%	NOUN
njb-115	188	29	)	)	PUNCT
njb-115	188	30	.	.	PUNCT
njb-115	189	1	the	the	DET
njb-115	189	2	finding	finding	NOUN
njb-115	189	3	resembled	resemble	VERB
njb-115	189	4	with	with	ADP
njb-115	189	5	the	the	DET
njb-115	189	6	research	research	NOUN
njb-115	189	7	conducted	conduct	VERB
njb-115	189	8	by	by	ADP
njb-115	189	9	muluye	muluye	PROPN
njb-115	189	10	et	et	X
njb-115	189	11	al	al	PROPN
njb-115	189	12	[	[	PUNCT
njb-115	189	13	20	20	NUM
njb-115	189	14	]	]	PUNCT
njb-115	189	15	and	and	CCONJ
njb-115	189	16	bhatt	bhatt	VERB
njb-115	189	17	et	et	X
njb-115	189	18	al	al	PROPN
njb-115	190	1	[	[	PUNCT
njb-115	190	2	44	44	NUM
njb-115	190	3	]	]	PUNCT
njb-115	190	4	.	.	PUNCT
njb-115	191	1	the	the	DET
njb-115	191	2	result	result	NOUN
njb-115	191	3	obtained	obtain	VERB
njb-115	191	4	from	from	ADP
njb-115	191	5	our	our	PRON
njb-115	191	6	study	study	NOUN
njb-115	191	7	was	be	AUX
njb-115	191	8	contrast	contrast	ADJ
njb-115	191	9	to	to	ADP
njb-115	191	10	the	the	DET
njb-115	191	11	research	research	NOUN
njb-115	191	12	conducted	conduct	VERB
njb-115	191	13	by	by	ADP
njb-115	191	14	shrestha	shrestha	PROPN
njb-115	191	15	et	et	X
njb-115	191	16	al	al	PROPN
njb-115	191	17	[	[	PUNCT
njb-115	191	18	28	28	NUM
njb-115	191	19	]	]	PUNCT
njb-115	191	20	and	and	CCONJ
njb-115	191	21	garoy	garoy	PROPN
njb-115	191	22	et	et	PROPN
njb-115	191	23	al	al	PROPN
njb-115	192	1	[	[	PUNCT
njb-115	192	2	45	45	NUM
njb-115	192	3	]	]	PUNCT
njb-115	192	4	.	.	PUNCT
njb-115	193	1	the	the	DET
njb-115	193	2	high	high	ADJ
njb-115	193	3	prevalence	prevalence	NOUN
njb-115	193	4	of	of	ADP
njb-115	193	5	s.	s.	PROPN
njb-115	193	6	aureus	aureus	PROPN
njb-115	193	7	in	in	ADP
njb-115	193	8	icu	icu	PROPN
njb-115	193	9	departments	department	NOUN
njb-115	193	10	might	might	AUX
njb-115	193	11	be	be	AUX
njb-115	193	12	due	due	ADJ
njb-115	193	13	to	to	ADP
njb-115	193	14	the	the	DET
njb-115	193	15	colonization	colonization	NOUN
njb-115	193	16	of	of	ADP
njb-115	193	17	s.	s.	PROPN
njb-115	193	18	aureus	aureus	PROPN
njb-115	193	19	from	from	ADP
njb-115	193	20	patient	patient	NOUN
njb-115	193	21	's	's	PART
njb-115	193	22	own	own	ADJ
njb-115	193	23	flora	flora	NOUN
njb-115	193	24	,	,	PUNCT
njb-115	193	25	transmission	transmission	NOUN
njb-115	193	26	through	through	ADP
njb-115	193	27	staff	staff	NOUN
njb-115	193	28	hands	hand	NOUN
njb-115	193	29	,	,	PUNCT
njb-115	193	30	air	air	NOUN
njb-115	193	31	,	,	PUNCT
njb-115	193	32	procedure	procedure	NOUN
njb-115	193	33	of	of	ADP
njb-115	193	34	surgery	surgery	NOUN
njb-115	193	35	,	,	PUNCT
njb-115	193	36	inanimate	inanimate	ADJ
njb-115	193	37	object	object	NOUN
njb-115	193	38	,	,	PUNCT
njb-115	193	39	longer	long	ADJ
njb-115	193	40	period	period	NOUN
njb-115	193	41	of	of	ADP
njb-115	193	42	hospital	hospital	NOUN
njb-115	193	43	stays	stay	NOUN
njb-115	193	44	,	,	PUNCT
njb-115	193	45	etc	etc	X
njb-115	193	46	.	.	X
njb-115	194	1	similar	similar	ADJ
njb-115	194	2	study	study	NOUN
njb-115	194	3	was	be	AUX
njb-115	194	4	carried	carry	VERB
njb-115	194	5	out	out	ADP
njb-115	194	6	by	by	ADP
njb-115	194	7	bhatta	bhatta	PROPN
njb-115	194	8	et	et	PROPN
njb-115	194	9	al	al	PROPN
njb-115	194	10	.	.	PUNCT
njb-115	195	1	(	(	PUNCT
njb-115	195	2	2014	2014	NUM
njb-115	195	3	)	)	PUNCT
njb-115	195	4	who	who	PRON
njb-115	195	5	had	have	AUX
njb-115	195	6	reported	report	VERB
njb-115	195	7	higher	high	ADJ
njb-115	195	8	prevalence	prevalence	NOUN
njb-115	195	9	of	of	ADP
njb-115	195	10	s.	s.	PROPN
njb-115	195	11	aureus	aureus	PROPN
njb-115	195	12	in	in	ADP
njb-115	195	13	hospital	hospital	NOUN
njb-115	195	14	setting	set	VERB
njb-115	195	15	accounting	accounting	NOUN
njb-115	196	1	[	[	PUNCT
njb-115	196	2	44	44	NUM
njb-115	196	3	]	]	PUNCT
njb-115	196	4	.	.	PUNCT
njb-115	197	1	s.	s.	PROPN
njb-115	197	2	aureus	aureus	PROPN
njb-115	197	3	was	be	AUX
njb-115	197	4	found	find	VERB
njb-115	197	5	to	to	PART
njb-115	197	6	be	be	AUX
njb-115	197	7	highly	highly	ADV
njb-115	197	8	sensitive	sensitive	ADJ
njb-115	197	9	towards	towards	ADP
njb-115	197	10	linezolid	linezolid	NOUN
njb-115	197	11	(	(	PUNCT
njb-115	197	12	99	99	NUM
njb-115	197	13	%	%	NOUN
njb-115	197	14	)	)	PUNCT
njb-115	197	15	followed	follow	VERB
njb-115	197	16	by	by	ADP
njb-115	197	17	doxycycline	doxycycline	NOUN
njb-115	197	18	(	(	PUNCT
njb-115	197	19	98	98	NUM
njb-115	197	20	%	%	NOUN
njb-115	197	21	)	)	PUNCT
njb-115	197	22	.	.	PUNCT
njb-115	198	1	the	the	DET
njb-115	198	2	outcome	outcome	NOUN
njb-115	198	3	was	be	AUX
njb-115	198	4	found	find	VERB
njb-115	198	5	similar	similar	ADJ
njb-115	198	6	to	to	ADP
njb-115	198	7	the	the	DET
njb-115	198	8	study	study	NOUN
njb-115	198	9	conducted	conduct	VERB
njb-115	198	10	by	by	ADP
njb-115	198	11	nirmala	nirmala	PROPN
njb-115	198	12	et	et	PROPN
njb-115	198	13	al	al	PROPN
njb-115	198	14	[	[	PUNCT
njb-115	198	15	2	2	NUM
njb-115	198	16	]	]	PUNCT
njb-115	198	17	of	of	ADP
njb-115	198	18	100	100	NUM
njb-115	198	19	%	%	NOUN
njb-115	198	20	sensitive	sensitive	ADJ
njb-115	198	21	towards	towards	ADP
njb-115	198	22	linezolid	linezolid	NOUN
njb-115	198	23	and	and	CCONJ
njb-115	198	24	vancomycin	vancomycin	PROPN
njb-115	198	25	and	and	CCONJ
njb-115	198	26	by	by	ADP
njb-115	198	27	khan	khan	PROPN
njb-115	198	28	et	et	PROPN
njb-115	198	29	al	al	PROPN
njb-115	199	1	[	[	PUNCT
njb-115	199	2	33	33	NUM
njb-115	199	3	]	]	PUNCT
njb-115	199	4	.	.	PUNCT
njb-115	200	1	it	it	PRON
njb-115	200	2	was	be	AUX
njb-115	200	3	found	find	VERB
njb-115	200	4	to	to	PART
njb-115	200	5	be	be	AUX
njb-115	200	6	a	a	DET
njb-115	200	7	bit	bit	NOUN
njb-115	200	8	different	different	ADJ
njb-115	200	9	from	from	ADP
njb-115	200	10	the	the	DET
njb-115	200	11	research	research	NOUN
njb-115	200	12	carried	carry	VERB
njb-115	200	13	out	out	ADP
njb-115	200	14	in	in	ADP
njb-115	200	15	2018	2018	NUM
njb-115	200	16	by	by	ADP
njb-115	200	17	tadesse	tadesse	PROPN
njb-115	200	18	et	et	X
njb-115	200	19	al	al	PROPN
njb-115	201	1	[	[	PUNCT
njb-115	201	2	46	46	NUM
njb-115	201	3	]	]	X
njb-115	201	4	in	in	ADP
njb-115	201	5	which	which	PRON
njb-115	201	6	they	they	PRON
njb-115	201	7	found	find	VERB
njb-115	201	8	100	100	NUM
njb-115	201	9	%	%	NOUN
njb-115	201	10	sensitive	sensitive	ADJ
njb-115	201	11	towards	towards	ADP
njb-115	201	12	ampicillin	ampicillin	PROPN
njb-115	201	13	.	.	PUNCT
njb-115	202	1	from	from	ADP
njb-115	202	2	the	the	DET
njb-115	202	3	study	study	NOUN
njb-115	202	4	,	,	PUNCT
njb-115	202	5	out	out	ADP
njb-115	202	6	of	of	ADP
njb-115	202	7	105	105	NUM
njb-115	202	8	isolates	isolate	NOUN
njb-115	202	9	,	,	PUNCT
njb-115	202	10	52	52	NUM
njb-115	202	11	(	(	PUNCT
njb-115	202	12	50	50	NUM
njb-115	202	13	%	%	NOUN
njb-115	202	14	)	)	PUNCT
njb-115	202	15	were	be	AUX
njb-115	202	16	found	find	VERB
njb-115	202	17	to	to	PART
njb-115	202	18	be	be	AUX
njb-115	202	19	mdr	mdr	PROPN
njb-115	202	20	.	.	PUNCT
njb-115	203	1	among	among	ADP
njb-115	203	2	mdr	mdr	PROPN
njb-115	203	3	also	also	ADV
njb-115	203	4	one	one	NUM
njb-115	203	5	strain	strain	NOUN
njb-115	203	6	was	be	AUX
njb-115	203	7	found	find	VERB
njb-115	203	8	to	to	PART
njb-115	203	9	be	be	AUX
njb-115	203	10	resistant	resistant	ADJ
njb-115	203	11	to	to	ADP
njb-115	203	12	all	all	DET
njb-115	203	13	the	the	DET
njb-115	203	14	antimicrobial	antimicrobial	ADJ
njb-115	203	15	agents	agent	NOUN
njb-115	203	16	to	to	PART
njb-115	203	17	be	be	AUX
njb-115	203	18	tested	test	VERB
njb-115	203	19	(	(	PUNCT
njb-115	203	20	extremely	extremely	ADV
njb-115	203	21	drug	drug	NOUN
njb-115	203	22	-	-	PUNCT
njb-115	203	23	resistant	resistant	ADJ
njb-115	203	24	)	)	PUNCT
njb-115	203	25	.	.	PUNCT
njb-115	204	1	mdr	mdr	NOUN
njb-115	204	2	cases	case	NOUN
njb-115	204	3	may	may	AUX
njb-115	204	4	be	be	AUX
njb-115	204	5	due	due	ADJ
njb-115	204	6	to	to	ADP
njb-115	204	7	accumulation	accumulation	NOUN
njb-115	204	8	of	of	ADP
njb-115	204	9	multiple	multiple	ADJ
njb-115	204	10	genes	gene	NOUN
njb-115	204	11	,	,	PUNCT
njb-115	204	12	expression	expression	NOUN
njb-115	204	13	of	of	ADP
njb-115	204	14	genes	gene	NOUN
njb-115	204	15	that	that	PRON
njb-115	204	16	code	code	NOUN
njb-115	204	17	for	for	ADP
njb-115	204	18	multidrug	multidrug	NOUN
njb-115	204	19	efflux	efflux	NOUN
njb-115	204	20	pumps	pump	NOUN
njb-115	204	21	,	,	PUNCT
njb-115	204	22	extruding	extrude	VERB
njb-115	204	23	a	a	DET
njb-115	204	24	wide	wide	ADJ
njb-115	204	25	range	range	NOUN
njb-115	204	26	of	of	ADP
njb-115	204	27	drugs	drug	NOUN
njb-115	204	28	,	,	PUNCT
njb-115	204	29	mutational	mutational	ADJ
njb-115	204	30	alteration	alteration	NOUN
njb-115	204	31	of	of	ADP
njb-115	204	32	the	the	DET
njb-115	204	33	target	target	NOUN
njb-115	204	34	protein	protein	NOUN
njb-115	204	35	,	,	PUNCT
njb-115	204	36	enzymatic	enzymatic	ADJ
njb-115	204	37	inactivation	inactivation	NOUN
njb-115	204	38	of	of	ADP
njb-115	204	39	drugs	drug	NOUN
njb-115	204	40	,	,	PUNCT
njb-115	204	41	etc	etc	X
njb-115	204	42	.	.	PUNCT
njb-115	205	1	[	[	X
njb-115	205	2	47	47	NUM
njb-115	205	3	]	]	PUNCT
njb-115	205	4	.	.	PUNCT
njb-115	206	1	here	here	ADV
njb-115	206	2	,	,	PUNCT
njb-115	206	3	44	44	NUM
njb-115	206	4	(	(	PUNCT
njb-115	206	5	84.61	84.61	NUM
njb-115	206	6	%	%	NOUN
njb-115	206	7	)	)	PUNCT
njb-115	206	8	mdr	mdr	PROPN
njb-115	206	9	were	be	AUX
njb-115	206	10	found	find	VERB
njb-115	206	11	to	to	PART
njb-115	206	12	be	be	AUX
njb-115	206	13	mrsa	mrsa	PROPN
njb-115	206	14	and	and	CCONJ
njb-115	206	15	8	8	NUM
njb-115	206	16	(	(	PUNCT
njb-115	206	17	15.39	15.39	NUM
njb-115	206	18	%	%	NOUN
njb-115	206	19	)	)	PUNCT
njb-115	206	20	mdr	mdr	PROPN
njb-115	206	21	were	be	AUX
njb-115	206	22	found	find	VERB
njb-115	206	23	be	be	AUX
njb-115	206	24	mssa	mssa	ADJ
njb-115	206	25	.	.	PUNCT
njb-115	207	1	the	the	DET
njb-115	207	2	increase	increase	NOUN
njb-115	207	3	in	in	ADP
njb-115	207	4	mdr	mdr	PROPN
njb-115	207	5	in	in	ADP
njb-115	207	6	mrsa	mrsa	PROPN
njb-115	207	7	may	may	AUX
njb-115	207	8	be	be	AUX
njb-115	207	9	due	due	ADJ
njb-115	207	10	to	to	ADP
njb-115	207	11	a	a	DET
njb-115	207	12	distinctive	distinctive	ADJ
njb-115	207	13	feature	feature	NOUN
njb-115	207	14	of	of	ADP
njb-115	207	15	mrsa	mrsa	PROPN
njb-115	207	16	,	,	PUNCT
njb-115	207	17	i.e.	i.e.	X
njb-115	207	18	their	their	PRON
njb-115	207	19	resistance	resistance	NOUN
njb-115	207	20	to	to	ADP
njb-115	207	21	β	β	NOUN
njb-115	207	22	-	-	PUNCT
njb-115	207	23	lactam	lactam	NOUN
njb-115	207	24	antibiotics	antibiotic	NOUN
njb-115	207	25	.	.	PUNCT
njb-115	208	1	therefore	therefore	ADV
njb-115	208	2	,	,	PUNCT
njb-115	208	3	once	once	SCONJ
njb-115	208	4	the	the	DET
njb-115	208	5	s.	s.	PROPN
njb-115	208	6	aureus	aureus	PROPN
njb-115	208	7	is	be	AUX
njb-115	208	8	resistant	resistant	ADJ
njb-115	208	9	to	to	ADP
njb-115	208	10	methicillin	methicillin	PROPN
njb-115	208	11	,	,	PUNCT
njb-115	208	12	it	it	PRON
njb-115	208	13	may	may	AUX
njb-115	208	14	also	also	ADV
njb-115	208	15	show	show	VERB
njb-115	208	16	resistance	resistance	NOUN
njb-115	208	17	towards	towards	ADP
njb-115	208	18	other	other	ADJ
njb-115	208	19	antibiotic	antibiotic	ADJ
njb-115	208	20	classes	class	NOUN
njb-115	208	21	like	like	VERB
njb-115	208	22	:	:	PUNCT
njb-115	208	23	aminoglycosides	aminoglycoside	NOUN
njb-115	208	24	,	,	PUNCT
njb-115	208	25	macrolides	macrolide	NOUN
njb-115	208	26	,	,	PUNCT
njb-115	208	27	tetracycline	tetracycline	NOUN
njb-115	208	28	,	,	PUNCT
njb-115	208	29	chloramphenicol	chloramphenicol	NOUN
njb-115	208	30	and	and	CCONJ
njb-115	208	31	lincosamide	lincosamide	NOUN
njb-115	208	32	.	.	PUNCT
njb-115	209	1	our	our	PRON
njb-115	209	2	result	result	NOUN
njb-115	209	3	was	be	AUX
njb-115	209	4	lower	low	ADJ
njb-115	209	5	in	in	ADP
njb-115	209	6	comparison	comparison	NOUN
njb-115	209	7	to	to	ADP
njb-115	209	8	upreti	upreti	PROPN
njb-115	209	9	et	et	PROPN
njb-115	209	10	al	al	PROPN
njb-115	210	1	[	[	PUNCT
njb-115	210	2	48	48	NUM
njb-115	210	3	]	]	PUNCT
njb-115	210	4	with	with	ADP
njb-115	210	5	68.2	68.2	NUM
njb-115	210	6	%	%	NOUN
njb-115	210	7	mdr	mdr	NOUN
njb-115	210	8	,	,	PUNCT
njb-115	210	9	pahadi	pahadi	PROPN
njb-115	210	10	et	et	PROPN
njb-115	210	11	al	al	PROPN
njb-115	210	12	[	[	PUNCT
njb-115	210	13	49	49	NUM
njb-115	210	14	]	]	PUNCT
njb-115	210	15	with	with	ADP
njb-115	210	16	86.41	86.41	NUM
njb-115	210	17	%	%	NOUN
njb-115	210	18	were	be	AUX
njb-115	210	19	mdr	mdr	PROPN
njb-115	210	20	;	;	PUNCT
njb-115	210	21	tadesse	tadesse	PROPN
njb-115	210	22	et	et	PROPN
njb-115	210	23	al	al	PROPN
njb-115	210	24	nepal	nepal	PROPN
njb-115	210	25	j	j	PROPN
njb-115	210	26	biotechnol	biotechnol	PROPN
njb-115	210	27	.	.	PUNCT
njb-115	211	1	2	2	NUM
njb-115	211	2	0	0	NUM
njb-115	211	3	2	2	NUM
njb-115	211	4	1	1	NUM
njb-115	211	5	j	j	NOUN
njb-115	211	6	u	u	NOUN
njb-115	211	7	l	l	NOUN
njb-115	211	8	;	;	PUNCT
njb-115	211	9	9	9	NUM
njb-115	211	10	(	(	PUNCT
njb-115	211	11	1):8	1):8	NUM
njb-115	211	12	1	1	NUM
njb-115	211	13	7	7	NUM
njb-115	211	14	maharjan	maharjan	NOUN
njb-115	211	15	et	et	NOUN
njb-115	211	16	al	al	PROPN
njb-115	211	17	.	.	PUNCT
njb-115	212	1	©	©	PROPN
njb-115	212	2	njb	njb	PROPN
njb-115	212	3	,	,	PUNCT
njb-115	212	4	bsn	bsn	PROPN
njb-115	212	5	14	14	NUM
njb-115	213	1	[	[	PUNCT
njb-115	213	2	46	46	NUM
njb-115	213	3	]	]	PUNCT
njb-115	213	4	82.3	82.3	NUM
njb-115	213	5	%	%	NOUN
njb-115	213	6	mdr	mdr	NOUN
njb-115	213	7	;	;	PUNCT
njb-115	213	8	whereas	whereas	SCONJ
njb-115	213	9	higher	high	ADJ
njb-115	213	10	than	than	SCONJ
njb-115	213	11	he	he	PRON
njb-115	213	12	study	study	NOUN
njb-115	213	13	conducted	conduct	VERB
njb-115	213	14	by	by	ADP
njb-115	213	15	kadariya	kadariya	PROPN
njb-115	213	16	et	et	PROPN
njb-115	213	17	al	al	PROPN
njb-115	214	1	[	[	PUNCT
njb-115	214	2	50	50	NUM
njb-115	214	3	]	]	PUNCT
njb-115	214	4	with	with	ADP
njb-115	214	5	44.2	44.2	NUM
njb-115	214	6	%	%	NOUN
njb-115	214	7	were	be	AUX
njb-115	214	8	mdr	mdr	PROPN
njb-115	214	9	and	and	CCONJ
njb-115	214	10	mama	mama	PROPN
njb-115	214	11	et	et	X
njb-115	214	12	al	al	PROPN
njb-115	214	13	with	with	SCONJ
njb-115	214	14	27.8	27.8	NUM
njb-115	214	15	%	%	NOUN
njb-115	214	16	were	be	AUX
njb-115	214	17	mdr	mdr	PROPN
njb-115	215	1	[	[	PUNCT
njb-115	215	2	51	51	NUM
njb-115	215	3	]	]	PUNCT
njb-115	215	4	.	.	PUNCT
njb-115	216	1	the	the	DET
njb-115	216	2	strong	strong	PROPN
njb-115	216	3	association	association	NOUN
njb-115	216	4	between	between	ADP
njb-115	216	5	the	the	DET
njb-115	216	6	mdr	mdr	NOUN
njb-115	216	7	and	and	CCONJ
njb-115	216	8	mrsa	mrsa	PROPN
njb-115	216	9	was	be	AUX
njb-115	216	10	found	find	VERB
njb-115	216	11	(	(	PUNCT
njb-115	216	12	p˂.01	p˂.01	PROPN
njb-115	216	13	)	)	PUNCT
njb-115	216	14	while	while	SCONJ
njb-115	216	15	performing	perform	VERB
njb-115	216	16	pearson	pearson	PROPN
njb-115	216	17	chi	chi	PROPN
njb-115	216	18	-	-	PUNCT
njb-115	216	19	square	square	ADJ
njb-115	216	20	test	test	NOUN
njb-115	216	21	.	.	PUNCT
njb-115	217	1	hence	hence	ADV
njb-115	217	2	,	,	PUNCT
njb-115	217	3	we	we	PRON
njb-115	217	4	can	can	AUX
njb-115	217	5	say	say	VERB
njb-115	217	6	that	that	SCONJ
njb-115	217	7	the	the	DET
njb-115	217	8	prevalence	prevalence	NOUN
njb-115	217	9	of	of	ADP
njb-115	217	10	mdr	mdr	NOUN
njb-115	217	11	increases	increase	VERB
njb-115	217	12	as	as	SCONJ
njb-115	217	13	the	the	DET
njb-115	217	14	prevalence	prevalence	NOUN
njb-115	217	15	of	of	ADP
njb-115	217	16	mrsa	mrsa	PROPN
njb-115	217	17	increased	increase	VERB
njb-115	217	18	.	.	PUNCT
njb-115	218	1	the	the	DET
njb-115	218	2	data	datum	NOUN
njb-115	218	3	obtained	obtain	VERB
njb-115	218	4	from	from	ADP
njb-115	218	5	the	the	DET
njb-115	218	6	research	research	NOUN
njb-115	218	7	was	be	AUX
njb-115	218	8	found	find	VERB
njb-115	218	9	to	to	PART
njb-115	218	10	be	be	AUX
njb-115	218	11	similar	similar	ADJ
njb-115	218	12	to	to	ADP
njb-115	218	13	the	the	DET
njb-115	218	14	study	study	NOUN
njb-115	218	15	conducted	conduct	VERB
njb-115	218	16	by	by	ADP
njb-115	218	17	joachim	joachim	PROPN
njb-115	218	18	et	et	PROPN
njb-115	218	19	al	al	PROPN
njb-115	218	20	in	in	ADP
njb-115	218	21	which	which	PRON
njb-115	218	22	21.3	21.3	NUM
njb-115	218	23	%	%	NOUN
njb-115	218	24	were	be	AUX
njb-115	218	25	mdr	mdr	NOUN
njb-115	218	26	,	,	PUNCT
njb-115	218	27	out	out	ADP
njb-115	218	28	of	of	ADP
njb-115	218	29	which	which	PRON
njb-115	218	30	72.7	72.7	NUM
njb-115	218	31	%	%	NOUN
njb-115	218	32	of	of	ADP
njb-115	218	33	mrsa	mrsa	PROPN
njb-115	218	34	strains	strain	NOUN
njb-115	218	35	were	be	AUX
njb-115	218	36	mdr	mdr	NOUN
njb-115	218	37	showing	show	VERB
njb-115	218	38	statistically	statistically	ADV
njb-115	218	39	significant	significant	ADJ
njb-115	218	40	association	association	NOUN
njb-115	218	41	between	between	ADP
njb-115	218	42	mrsa	mrsa	PROPN
njb-115	218	43	and	and	CCONJ
njb-115	218	44	mdr	mdr	PROPN
njb-115	218	45	among	among	ADP
njb-115	218	46	s.	s.	PROPN
njb-115	218	47	aureus	aureus	PROPN
njb-115	218	48	isolates	isolate	NOUN
njb-115	218	49	(	(	PUNCT
njb-115	218	50	p=0.001	p=0.001	NOUN
njb-115	218	51	)	)	PUNCT
njb-115	219	1	[	[	X
njb-115	219	2	52	52	NUM
njb-115	219	3	]	]	PUNCT
njb-115	219	4	.	.	PUNCT
njb-115	220	1	the	the	DET
njb-115	220	2	prevalence	prevalence	NOUN
njb-115	220	3	of	of	ADP
njb-115	220	4	mrsa	mrsa	PROPN
njb-115	220	5	was	be	AUX
njb-115	220	6	found	find	VERB
njb-115	220	7	to	to	PART
njb-115	220	8	be	be	AUX
njb-115	220	9	58	58	NUM
njb-115	220	10	(	(	PUNCT
njb-115	220	11	55	55	NUM
njb-115	220	12	%	%	NOUN
njb-115	220	13	)	)	PUNCT
njb-115	220	14	and	and	CCONJ
njb-115	220	15	methicillin	methicillin	PROPN
njb-115	220	16	sensitive	sensitive	PROPN
njb-115	220	17	s.	s.	PROPN
njb-115	220	18	aureus	aureus	PROPN
njb-115	220	19	(	(	PUNCT
njb-115	220	20	mssa	mssa	PROPN
njb-115	220	21	)	)	PUNCT
njb-115	220	22	was	be	AUX
njb-115	220	23	found	find	VERB
njb-115	220	24	to	to	PART
njb-115	220	25	be	be	AUX
njb-115	220	26	47	47	NUM
njb-115	220	27	(	(	PUNCT
njb-115	220	28	45	45	NUM
njb-115	220	29	%	%	NOUN
njb-115	220	30	)	)	PUNCT
njb-115	220	31	.	.	PUNCT
njb-115	221	1	the	the	DET
njb-115	221	2	study	study	NOUN
njb-115	221	3	resembles	resemble	VERB
njb-115	221	4	to	to	ADP
njb-115	221	5	the	the	DET
njb-115	221	6	study	study	NOUN
njb-115	221	7	carried	carry	VERB
njb-115	221	8	out	out	ADP
njb-115	221	9	by	by	ADP
njb-115	221	10	devi	devi	PROPN
njb-115	221	11	et	et	PROPN
njb-115	221	12	al	al	PROPN
njb-115	221	13	(	(	PUNCT
njb-115	221	14	2017	2017	NUM
njb-115	221	15	)	)	PUNCT
njb-115	221	16	,	,	PUNCT
njb-115	221	17	where	where	SCONJ
njb-115	221	18	50.79	50.79	NUM
njb-115	221	19	%	%	NOUN
njb-115	221	20	were	be	AUX
njb-115	221	21	mrsa	mrsa	PROPN
njb-115	221	22	and	and	CCONJ
njb-115	221	23	49.21	49.21	NUM
njb-115	221	24	%	%	NOUN
njb-115	221	25	were	be	AUX
njb-115	221	26	mssa	mssa	ADJ
njb-115	222	1	[	[	X
njb-115	222	2	37	37	NUM
njb-115	222	3	]	]	PUNCT
njb-115	222	4	.	.	PUNCT
njb-115	223	1	however	however	ADV
njb-115	223	2	,	,	PUNCT
njb-115	223	3	the	the	DET
njb-115	223	4	study	study	NOUN
njb-115	223	5	was	be	AUX
njb-115	223	6	in	in	ADP
njb-115	223	7	contradiction	contradiction	NOUN
njb-115	223	8	to	to	ADP
njb-115	223	9	the	the	DET
njb-115	223	10	study	study	NOUN
njb-115	223	11	carried	carry	VERB
njb-115	223	12	by	by	ADP
njb-115	223	13	kayastha	kayastha	PROPN
njb-115	223	14	et	et	PROPN
njb-115	223	15	al	al	PROPN
njb-115	223	16	(	(	PUNCT
njb-115	223	17	2010	2010	NUM
njb-115	223	18	)	)	PUNCT
njb-115	223	19	8.92	8.92	NUM
njb-115	223	20	%	%	NOUN
njb-115	223	21	mrsa	mrsa	PROPN
njb-115	223	22	[	[	PUNCT
njb-115	223	23	23	23	NUM
njb-115	223	24	]	]	PUNCT
njb-115	223	25	;	;	PUNCT
njb-115	223	26	ansari	ansari	PROPN
njb-115	223	27	et	et	X
njb-115	223	28	al	al	PROPN
njb-115	223	29	(	(	PUNCT
njb-115	223	30	2014	2014	NUM
njb-115	223	31	)	)	PUNCT
njb-115	223	32	43.1	43.1	NUM
njb-115	223	33	%	%	NOUN
njb-115	223	34	mrsa	mrsa	PROPN
njb-115	224	1	[	[	PUNCT
njb-115	224	2	53	53	NUM
njb-115	224	3	]	]	PUNCT
njb-115	224	4	;	;	PUNCT
njb-115	224	5	jaiswal	jaiswal	PROPN
njb-115	224	6	et	et	PROPN
njb-115	224	7	al	al	PROPN
njb-115	224	8	(	(	PUNCT
njb-115	224	9	2016	2016	NUM
njb-115	224	10	)	)	PUNCT
njb-115	224	11	72	72	NUM
njb-115	224	12	%	%	NOUN
njb-115	224	13	mrsa	mrsa	PROPN
njb-115	224	14	[	[	X
njb-115	224	15	54	54	NUM
njb-115	224	16	]	]	PUNCT
njb-115	224	17	and	and	CCONJ
njb-115	224	18	adhikari	adhikari	PROPN
njb-115	224	19	et	et	PROPN
njb-115	224	20	al	al	PROPN
njb-115	224	21	(	(	PUNCT
njb-115	224	22	2017	2017	NUM
njb-115	224	23	)	)	PUNCT
njb-115	224	24	35.50	35.50	NUM
njb-115	224	25	%	%	NOUN
njb-115	224	26	mrsa	mrsa	PROPN
njb-115	225	1	[	[	X
njb-115	225	2	55	55	NUM
njb-115	225	3	]	]	PUNCT
njb-115	225	4	.	.	PUNCT
njb-115	226	1	since	since	SCONJ
njb-115	226	2	our	our	PRON
njb-115	226	3	research	research	NOUN
njb-115	226	4	was	be	AUX
njb-115	226	5	conducted	conduct	VERB
njb-115	226	6	from	from	ADP
njb-115	226	7	september	september	PROPN
njb-115	226	8	2017	2017	NUM
njb-115	226	9	to	to	ADP
njb-115	226	10	march	march	PROPN
njb-115	226	11	2018	2018	NUM
njb-115	226	12	,	,	PUNCT
njb-115	226	13	the	the	DET
njb-115	226	14	prevalence	prevalence	NOUN
njb-115	226	15	of	of	ADP
njb-115	226	16	mrsa	mrsa	PROPN
njb-115	226	17	seems	seem	VERB
njb-115	226	18	to	to	PART
njb-115	226	19	be	be	AUX
njb-115	226	20	increasing	increase	VERB
njb-115	226	21	in	in	ADP
njb-115	226	22	nepal	nepal	ADJ
njb-115	226	23	as	as	ADV
njb-115	226	24	well	well	ADV
njb-115	226	25	[	[	X
njb-115	226	26	56	56	NUM
njb-115	226	27	,	,	PUNCT
njb-115	226	28	53	53	NUM
njb-115	226	29	,	,	PUNCT
njb-115	226	30	55	55	NUM
njb-115	226	31	,	,	PUNCT
njb-115	226	32	57	57	NUM
njb-115	226	33	,	,	PUNCT
njb-115	226	34	48	48	NUM
njb-115	226	35	,	,	PUNCT
njb-115	226	36	45	45	NUM
njb-115	226	37	,	,	PUNCT
njb-115	226	38	41	41	NUM
njb-115	226	39	]	]	PUNCT
njb-115	226	40	.	.	PUNCT
njb-115	227	1	the	the	DET
njb-115	227	2	development	development	NOUN
njb-115	227	3	of	of	ADP
njb-115	227	4	resistance	resistance	NOUN
njb-115	227	5	of	of	ADP
njb-115	227	6	s.	s.	PROPN
njb-115	227	7	aureus	aureus	PROPN
njb-115	227	8	towards	towards	ADP
njb-115	227	9	methicillin	methicillin	PROPN
njb-115	227	10	may	may	AUX
njb-115	227	11	be	be	AUX
njb-115	227	12	due	due	ADJ
njb-115	227	13	to	to	ADP
njb-115	227	14	the	the	DET
njb-115	227	15	acquisition	acquisition	NOUN
njb-115	227	16	of	of	ADP
njb-115	227	17	staphylococcal	staphylococcal	PROPN
njb-115	227	18	chromosome	chromosome	PROPN
njb-115	227	19	cassette	cassette	PROPN
njb-115	227	20	mec	mec	PROPN
njb-115	227	21	(	(	PUNCT
njb-115	227	22	scc	scc	PROPN
njb-115	227	23	mec	mec	PROPN
njb-115	227	24	)	)	PUNCT
njb-115	227	25	in	in	ADP
njb-115	227	26	its	its	PRON
njb-115	227	27	chromosome	chromosome	NOUN
njb-115	227	28	,	,	PUNCT
njb-115	227	29	which	which	PRON
njb-115	227	30	carries	carry	VERB
njb-115	227	31	a	a	DET
njb-115	227	32	mec	mec	PROPN
njb-115	227	33	a	a	DET
njb-115	227	34	gene	gene	NOUN
njb-115	227	35	facilitating	facilitate	VERB
njb-115	227	36	resistance	resistance	NOUN
njb-115	227	37	to	to	ADP
njb-115	227	38	methicillin	methicillin	NOUN
njb-115	227	39	via	via	ADP
njb-115	227	40	penicillin	penicillin	NOUN
njb-115	227	41	binding	bind	VERB
njb-115	227	42	protein	protein	NOUN
njb-115	227	43	(	(	PUNCT
njb-115	227	44	pbp-2a	pbp-2a	ADJ
njb-115	227	45	)	)	PUNCT
njb-115	227	46	.	.	PUNCT
njb-115	228	1	although	although	SCONJ
njb-115	228	2	the	the	DET
njb-115	228	3	acquisition	acquisition	NOUN
njb-115	228	4	of	of	ADP
njb-115	228	5	the	the	DET
njb-115	228	6	meca	meca	PROPN
njb-115	228	7	gene	gene	NOUN
njb-115	228	8	,	,	PUNCT
njb-115	228	9	the	the	DET
njb-115	228	10	organism	organism	NOUN
njb-115	228	11	can	can	AUX
njb-115	228	12	not	not	PART
njb-115	228	13	exhibit	exhibit	VERB
njb-115	228	14	resistant	resistant	ADJ
njb-115	228	15	towards	towards	ADP
njb-115	228	16	methicillin	methicillin	NOUN
njb-115	228	17	unless	unless	SCONJ
njb-115	228	18	the	the	DET
njb-115	228	19	gene	gene	NOUN
njb-115	228	20	is	be	AUX
njb-115	228	21	activated	activate	VERB
njb-115	228	22	.	.	PUNCT
njb-115	229	1	mrsa	mrsa	PROPN
njb-115	229	2	was	be	AUX
njb-115	229	3	found	find	VERB
njb-115	229	4	to	to	PART
njb-115	229	5	be	be	AUX
njb-115	229	6	sensitive	sensitive	ADJ
njb-115	229	7	towards	towards	ADP
njb-115	229	8	linezolid	linezolid	NOUN
njb-115	229	9	98.28	98.28	NUM
njb-115	229	10	%	%	NOUN
njb-115	229	11	(	(	PUNCT
njb-115	229	12	57	57	NUM
njb-115	229	13	)	)	PUNCT
njb-115	229	14	followed	follow	VERB
njb-115	229	15	by	by	ADP
njb-115	229	16	doxycycline	doxycycline	NOUN
njb-115	229	17	96.56	96.56	NUM
njb-115	229	18	%	%	NOUN
njb-115	229	19	(	(	PUNCT
njb-115	229	20	56	56	NUM
njb-115	229	21	)	)	PUNCT
njb-115	229	22	and	and	CCONJ
njb-115	229	23	resistant	resistant	ADJ
njb-115	229	24	towards	towards	ADP
njb-115	229	25	ciprofloxacin	ciprofloxacin	NOUN
njb-115	229	26	87.93	87.93	NUM
njb-115	229	27	%	%	NOUN
njb-115	229	28	(	(	PUNCT
njb-115	229	29	51	51	NUM
njb-115	229	30	)	)	PUNCT
njb-115	229	31	followed	follow	VERB
njb-115	229	32	by	by	ADP
njb-115	229	33	azithromycin	azithromycin	PROPN
njb-115	229	34	74.13	74.13	NUM
njb-115	229	35	%	%	NOUN
njb-115	229	36	.	.	PUNCT
njb-115	230	1	similar	similar	ADJ
njb-115	230	2	sensitive	sensitive	ADJ
njb-115	230	3	pattern	pattern	NOUN
njb-115	230	4	in	in	ADP
njb-115	230	5	mrsa	mrsa	PROPN
njb-115	230	6	was	be	AUX
njb-115	230	7	found	find	VERB
njb-115	230	8	in	in	ADP
njb-115	230	9	the	the	DET
njb-115	230	10	study	study	NOUN
njb-115	230	11	carried	carry	VERB
njb-115	230	12	out	out	ADP
njb-115	230	13	by	by	ADP
njb-115	230	14	choudhury	choudhury	PROPN
njb-115	230	15	et	et	PROPN
njb-115	230	16	al	al	PROPN
njb-115	230	17	(	(	PUNCT
njb-115	230	18	2016	2016	NUM
njb-115	230	19	)	)	PUNCT
njb-115	230	20	in	in	ADP
njb-115	230	21	which	which	PRON
njb-115	230	22	organism	organism	NOUN
njb-115	230	23	was	be	AUX
njb-115	230	24	found	find	VERB
njb-115	230	25	sensitive	sensitive	ADJ
njb-115	230	26	towards	towards	ADP
njb-115	230	27	linezolid	linezolid	NOUN
njb-115	230	28	(	(	PUNCT
njb-115	230	29	99.3	99.3	NUM
njb-115	230	30	%	%	NOUN
njb-115	230	31	)	)	PUNCT
njb-115	230	32	,	,	PUNCT
njb-115	230	33	vancomycin	vancomycin	PROPN
njb-115	230	34	(	(	PUNCT
njb-115	230	35	99.3	99.3	NUM
njb-115	230	36	%	%	NOUN
njb-115	230	37	)	)	PUNCT
njb-115	230	38	and	and	CCONJ
njb-115	230	39	resistant	resistant	ADJ
njb-115	230	40	towards	towards	ADP
njb-115	230	41	cefuroxime	cefuroxime	NOUN
njb-115	230	42	(	(	PUNCT
njb-115	230	43	59.50	59.50	NUM
njb-115	230	44	%	%	NOUN
njb-115	230	45	)	)	PUNCT
njb-115	231	1	[	[	X
njb-115	231	2	58	58	NUM
njb-115	231	3	]	]	PUNCT
njb-115	231	4	.	.	PUNCT
njb-115	232	1	in	in	ADP
njb-115	232	2	our	our	PRON
njb-115	232	3	study	study	NOUN
njb-115	232	4	,	,	PUNCT
njb-115	232	5	vancomycin	vancomycin	PROPN
njb-115	232	6	resistant	resistant	ADJ
njb-115	232	7	was	be	AUX
njb-115	232	8	found	find	VERB
njb-115	232	9	to	to	PART
njb-115	232	10	be	be	AUX
njb-115	232	11	9	9	NUM
njb-115	232	12	%	%	NOUN
njb-115	232	13	(	(	PUNCT
njb-115	232	14	9/105	9/105	NUM
njb-115	232	15	)	)	PUNCT
njb-115	232	16	from	from	ADP
njb-115	232	17	disc	disc	NOUN
njb-115	232	18	diffusion	diffusion	NOUN
njb-115	232	19	method	method	NOUN
njb-115	232	20	but	but	CCONJ
njb-115	232	21	while	while	SCONJ
njb-115	232	22	performing	perform	VERB
njb-115	232	23	the	the	DET
njb-115	232	24	mic	mic	NOUN
njb-115	232	25	,	,	PUNCT
njb-115	232	26	s.	s.	PROPN
njb-115	232	27	aureus	aureus	PROPN
njb-115	232	28	was	be	AUX
njb-115	232	29	found	find	VERB
njb-115	232	30	to	to	PART
njb-115	232	31	be	be	AUX
njb-115	232	32	100	100	NUM
njb-115	232	33	%	%	NOUN
njb-115	232	34	sensitive	sensitive	ADJ
njb-115	232	35	towards	towards	ADP
njb-115	232	36	vancomycin	vancomycin	PROPN
njb-115	232	37	,	,	PUNCT
njb-115	232	38	i.e.	i.e.	X
njb-115	232	39	0.25	0.25	NUM
njb-115	232	40	μg	μg	PROPN
njb-115	232	41	/	/	SYM
njb-115	232	42	ml	ml	PROPN
njb-115	232	43	and	and	CCONJ
njb-115	232	44	mbc	mbc	PROPN
njb-115	232	45	was	be	AUX
njb-115	232	46	found	find	VERB
njb-115	232	47	to	to	PART
njb-115	232	48	be	be	AUX
njb-115	232	49	0.25	0.25	NUM
njb-115	232	50	μg	μg	PROPN
njb-115	232	51	/	/	SYM
njb-115	232	52	ml	ml	PROPN
njb-115	232	53	.	.	PUNCT
njb-115	233	1	hence	hence	ADV
njb-115	233	2	,	,	PUNCT
njb-115	233	3	isolated	isolate	VERB
njb-115	233	4	s.	s.	PROPN
njb-115	233	5	aureus	aureus	PROPN
njb-115	233	6	was	be	AUX
njb-115	233	7	found	find	VERB
njb-115	233	8	to	to	PART
njb-115	233	9	be	be	AUX
njb-115	233	10	100	100	NUM
njb-115	233	11	%	%	NOUN
njb-115	233	12	susceptibility	susceptibility	NOUN
njb-115	233	13	towards	towards	ADP
njb-115	233	14	vancomycin	vancomycin	PROPN
njb-115	233	15	.	.	PUNCT
njb-115	234	1	therefore	therefore	ADV
njb-115	234	2	,	,	PUNCT
njb-115	234	3	we	we	PRON
njb-115	234	4	need	need	VERB
njb-115	234	5	to	to	PART
njb-115	234	6	perform	perform	VERB
njb-115	234	7	mic	mic	NOUN
njb-115	234	8	for	for	ADP
njb-115	234	9	the	the	DET
njb-115	234	10	confirmation	confirmation	NOUN
njb-115	234	11	of	of	ADP
njb-115	234	12	vancomycin	vancomycin	PROPN
njb-115	234	13	resistant	resistant	ADJ
njb-115	234	14	strain	strain	NOUN
njb-115	234	15	.	.	PUNCT
njb-115	235	1	the	the	DET
njb-115	235	2	cause	cause	NOUN
njb-115	235	3	of	of	ADP
njb-115	235	4	vancomycin	vancomycin	PROPN
njb-115	235	5	resistance	resistance	NOUN
njb-115	235	6	may	may	AUX
njb-115	235	7	be	be	AUX
njb-115	235	8	due	due	ADJ
njb-115	235	9	to	to	ADP
njb-115	235	10	the	the	DET
njb-115	235	11	activation	activation	NOUN
njb-115	235	12	of	of	ADP
njb-115	235	13	van	van	PROPN
njb-115	235	14	a	a	PROPN
njb-115	235	15	and	and	CCONJ
njb-115	235	16	van	van	PROPN
njb-115	235	17	b	b	PROPN
njb-115	235	18	gene	gene	NOUN
njb-115	235	19	.	.	PUNCT
njb-115	236	1	the	the	DET
njb-115	236	2	finding	finding	NOUN
njb-115	236	3	was	be	AUX
njb-115	236	4	found	find	VERB
njb-115	236	5	to	to	PART
njb-115	236	6	be	be	AUX
njb-115	236	7	similar	similar	ADJ
njb-115	236	8	to	to	ADP
njb-115	236	9	the	the	DET
njb-115	236	10	research	research	NOUN
njb-115	236	11	conducted	conduct	VERB
njb-115	236	12	by	by	ADP
njb-115	236	13	kshetry	kshetry	PROPN
njb-115	236	14	et	et	PROPN
njb-115	236	15	al	al	PROPN
njb-115	236	16	,	,	PUNCT
njb-115	236	17	where	where	SCONJ
njb-115	236	18	organism	organism	NOUN
njb-115	236	19	was	be	AUX
njb-115	236	20	found	find	VERB
njb-115	236	21	sensitive	sensitive	ADJ
njb-115	236	22	towards	towards	ADP
njb-115	236	23	vancomycin	vancomycin	PROPN
njb-115	236	24	while	while	SCONJ
njb-115	236	25	performing	perform	VERB
njb-115	236	26	mic	mic	NOUN
njb-115	236	27	test	test	NOUN
njb-115	236	28	[	[	X
njb-115	236	29	59	59	NUM
njb-115	236	30	]	]	PUNCT
njb-115	236	31	and	and	CCONJ
njb-115	236	32	study	study	VERB
njb-115	236	33	by	by	ADP
njb-115	236	34	bamigboye	bamigboye	PROPN
njb-115	236	35	et	et	PROPN
njb-115	236	36	al	al	PROPN
njb-115	236	37	showed	show	VERB
njb-115	236	38	1.4	1.4	NUM
njb-115	236	39	%	%	NOUN
njb-115	236	40	vrsa	vrsa	NOUN
njb-115	236	41	but	but	CCONJ
njb-115	236	42	found	find	VERB
njb-115	236	43	to	to	PART
njb-115	236	44	be	be	AUX
njb-115	236	45	van	van	PROPN
njb-115	236	46	a	a	PROPN
njb-115	236	47	and	and	CCONJ
njb-115	236	48	van	van	PROPN
njb-115	236	49	b	b	PROPN
njb-115	236	50	gene	gene	NOUN
njb-115	236	51	negative	negative	ADJ
njb-115	237	1	[	[	X
njb-115	237	2	25	25	NUM
njb-115	237	3	]	]	PUNCT
njb-115	237	4	.	.	PUNCT
njb-115	238	1	from	from	ADP
njb-115	238	2	the	the	DET
njb-115	238	3	study	study	NOUN
njb-115	238	4	,	,	PUNCT
njb-115	238	5	only	only	ADV
njb-115	238	6	22.86	22.86	NUM
njb-115	238	7	%	%	NOUN
njb-115	238	8	(	(	PUNCT
njb-115	238	9	24	24	NUM
njb-115	238	10	)	)	PUNCT
njb-115	238	11	were	be	AUX
njb-115	238	12	found	find	VERB
njb-115	238	13	to	to	PART
njb-115	238	14	be	be	AUX
njb-115	238	15	d	d	NOUN
njb-115	238	16	-	-	NOUN
njb-115	238	17	test	test	ADJ
njb-115	238	18	positive	positive	ADJ
njb-115	238	19	,	,	PUNCT
njb-115	238	20	20	20	NUM
njb-115	238	21	%	%	NOUN
njb-115	238	22	(	(	PUNCT
njb-115	238	23	21	21	NUM
njb-115	238	24	)	)	PUNCT
njb-115	238	25	were	be	AUX
njb-115	238	26	found	find	VERB
njb-115	238	27	to	to	PART
njb-115	238	28	be	be	AUX
njb-115	238	29	d	d	NOUN
njb-115	238	30	-	-	ADJ
njb-115	238	31	test	test	NOUN
njb-115	238	32	negative	negative	ADJ
njb-115	238	33	,	,	PUNCT
njb-115	238	34	29.52	29.52	NUM
njb-115	238	35	%	%	NOUN
njb-115	238	36	(	(	PUNCT
njb-115	238	37	31	31	NUM
njb-115	238	38	)	)	PUNCT
njb-115	238	39	were	be	AUX
njb-115	238	40	found	find	VERB
njb-115	238	41	to	to	PART
njb-115	238	42	be	be	AUX
njb-115	238	43	susceptible	susceptible	ADJ
njb-115	238	44	to	to	ADP
njb-115	238	45	both	both	PRON
njb-115	238	46	erythromycin	erythromycin	PROPN
njb-115	238	47	and	and	CCONJ
njb-115	238	48	clindamycin	clindamycin	PROPN
njb-115	238	49	and	and	CCONJ
njb-115	238	50	27.62	27.62	NUM
njb-115	238	51	%	%	NOUN
njb-115	238	52	(	(	PUNCT
njb-115	238	53	29	29	NUM
njb-115	238	54	)	)	PUNCT
njb-115	238	55	were	be	AUX
njb-115	238	56	found	find	VERB
njb-115	238	57	to	to	PART
njb-115	238	58	be	be	AUX
njb-115	238	59	constitutive	constitutive	ADJ
njb-115	238	60	resistant	resistant	ADJ
njb-115	238	61	.	.	PUNCT
njb-115	239	1	the	the	DET
njb-115	239	2	resistance	resistance	NOUN
njb-115	239	3	of	of	ADP
njb-115	239	4	the	the	DET
njb-115	239	5	erythromycin	erythromycin	PROPN
njb-115	239	6	and	and	CCONJ
njb-115	239	7	clindamycin	clindamycin	PROPN
njb-115	239	8	may	may	AUX
njb-115	239	9	be	be	AUX
njb-115	239	10	due	due	ADJ
njb-115	239	11	to	to	ADP
njb-115	239	12	the	the	DET
njb-115	239	13	resistance	resistance	NOUN
njb-115	239	14	encoded	encode	VERB
njb-115	239	15	in	in	ADP
njb-115	239	16	erythromycin	erythromycin	PROPN
njb-115	239	17	methylase	methylase	NOUN
njb-115	239	18	(	(	PUNCT
njb-115	239	19	erm	erm	NOUN
njb-115	239	20	)	)	PUNCT
njb-115	239	21	genes	gene	NOUN
njb-115	239	22	.	.	PUNCT
njb-115	240	1	the	the	DET
njb-115	240	2	constitutive	constitutive	ADJ
njb-115	240	3	expression	expression	NOUN
njb-115	240	4	may	may	AUX
njb-115	240	5	be	be	AUX
njb-115	240	6	due	due	ADJ
njb-115	240	7	to	to	ADP
njb-115	240	8	the	the	DET
njb-115	240	9	organism	organism	NOUN
njb-115	240	10	being	be	AUX
njb-115	240	11	resistant	resistant	ADJ
njb-115	240	12	to	to	ADP
njb-115	240	13	all	all	DET
njb-115	240	14	macrolides	macrolide	NOUN
njb-115	240	15	,	,	PUNCT
njb-115	240	16	lincosamides	lincosamide	NOUN
njb-115	240	17	and	and	CCONJ
njb-115	240	18	type	type	PROPN
njb-115	240	19	b	b	PROPN
njb-115	240	20	streptogramin	streptogramin	NOUN
njb-115	240	21	antibiotics	antibiotic	NOUN
njb-115	240	22	.	.	PUNCT
njb-115	241	1	the	the	DET
njb-115	241	2	study	study	NOUN
njb-115	241	3	resembled	resemble	VERB
njb-115	241	4	to	to	ADP
njb-115	241	5	the	the	DET
njb-115	241	6	study	study	NOUN
njb-115	241	7	carried	carry	VERB
njb-115	241	8	out	out	ADP
njb-115	241	9	by	by	ADP
njb-115	241	10	mama	mama	PROPN
njb-115	241	11	et	et	X
njb-115	241	12	al	al	PROPN
njb-115	241	13	[	[	PUNCT
njb-115	241	14	51	51	NUM
njb-115	241	15	]	]	PUNCT
njb-115	241	16	with	with	ADP
njb-115	241	17	24.1	24.1	NUM
njb-115	241	18	%	%	NOUN
njb-115	241	19	d	d	NOUN
njb-115	241	20	-	-	NOUN
njb-115	241	21	test	test	ADJ
njb-115	241	22	positive	positive	ADJ
njb-115	241	23	,	,	PUNCT
njb-115	241	24	1	1	NUM
njb-115	241	25	%	%	NOUN
njb-115	241	26	d	d	NOUN
njb-115	241	27	-	-	NOUN
njb-115	241	28	test	test	NOUN
njb-115	241	29	negative	negative	ADJ
njb-115	241	30	,	,	PUNCT
njb-115	241	31	2	2	NUM
njb-115	241	32	%	%	NOUN
njb-115	241	33	constitutive	constitutive	ADJ
njb-115	241	34	d	d	NOUN
njb-115	241	35	-	-	NOUN
njb-115	241	36	test	test	NOUN
njb-115	241	37	and	and	CCONJ
njb-115	241	38	60.85	60.85	NUM
njb-115	241	39	%	%	NOUN
njb-115	241	40	sensitive	sensitive	ADJ
njb-115	241	41	towards	towards	ADP
njb-115	241	42	erythromycin	erythromycin	PROPN
njb-115	241	43	and	and	CCONJ
njb-115	241	44	clindamycin	clindamycin	PROPN
njb-115	241	45	.	.	PUNCT
njb-115	242	1	in	in	ADP
njb-115	242	2	this	this	DET
njb-115	242	3	study	study	NOUN
njb-115	242	4	,	,	PUNCT
njb-115	242	5	d	d	NOUN
njb-115	242	6	-	-	PUNCT
njb-115	242	7	test	test	NOUN
njb-115	242	8	positive	positive	NOUN
njb-115	242	9	was	be	AUX
njb-115	242	10	also	also	ADV
njb-115	242	11	seen	see	VERB
njb-115	242	12	high	high	ADV
njb-115	242	13	in	in	ADP
njb-115	242	14	mrsa	mrsa	PROPN
njb-115	242	15	75	75	NUM
njb-115	242	16	%	%	NOUN
njb-115	242	17	(	(	PUNCT
njb-115	242	18	18/24	18/24	NUM
njb-115	242	19	)	)	PUNCT
njb-115	242	20	compare	compare	VERB
njb-115	242	21	to	to	ADP
njb-115	242	22	the	the	DET
njb-115	242	23	mssa	mssa	ADJ
njb-115	242	24	25	25	NUM
njb-115	242	25	%	%	NOUN
njb-115	242	26	(	(	PUNCT
njb-115	242	27	6/24	6/24	NUM
njb-115	242	28	)	)	PUNCT
njb-115	242	29	.	.	PUNCT
njb-115	243	1	similar	similar	ADJ
njb-115	243	2	result	result	NOUN
njb-115	243	3	was	be	AUX
njb-115	243	4	obtained	obtain	VERB
njb-115	243	5	in	in	ADP
njb-115	243	6	research	research	NOUN
njb-115	243	7	conducted	conduct	VERB
njb-115	243	8	by	by	ADP
njb-115	243	9	pal	pal	NOUN
njb-115	243	10	et	et	PROPN
njb-115	243	11	al	al	PROPN
njb-115	244	1	[	[	PUNCT
njb-115	244	2	60	60	NUM
njb-115	244	3	]	]	PUNCT
njb-115	244	4	.	.	PUNCT
njb-115	245	1	the	the	DET
njb-115	245	2	correlation	correlation	NOUN
njb-115	245	3	(	(	PUNCT
njb-115	245	4	r	r	NOUN
njb-115	245	5	)	)	PUNCT
njb-115	245	6	between	between	ADP
njb-115	245	7	d	d	NOUN
njb-115	245	8	-	-	NOUN
njb-115	245	9	test	test	NOUN
njb-115	245	10	and	and	CCONJ
njb-115	245	11	mrsa	mrsa	PROPN
njb-115	245	12	was	be	AUX
njb-115	245	13	found	find	VERB
njb-115	245	14	to	to	PART
njb-115	245	15	be	be	AUX
njb-115	245	16	0.39	0.39	NUM
njb-115	245	17	which	which	PRON
njb-115	245	18	means	mean	VERB
njb-115	245	19	d	d	NOUN
njb-115	245	20	-	-	NOUN
njb-115	245	21	test	test	NOUN
njb-115	245	22	and	and	CCONJ
njb-115	245	23	mrsa	mrsa	PROPN
njb-115	245	24	are	be	AUX
njb-115	245	25	positively	positively	ADV
njb-115	245	26	but	but	CCONJ
njb-115	245	27	lowly	lowly	ADV
njb-115	245	28	correlated	correlate	VERB
njb-115	245	29	,	,	PUNCT
njb-115	245	30	i.e.	i.e.	X
njb-115	245	31	d	d	X
njb-115	245	32	-	-	PUNCT
njb-115	245	33	test	test	NOUN
njb-115	245	34	cases	case	NOUN
njb-115	245	35	may	may	AUX
njb-115	245	36	increase	increase	VERB
njb-115	245	37	as	as	ADP
njb-115	245	38	increase	increase	NOUN
njb-115	245	39	in	in	ADP
njb-115	245	40	mrsa	mrsa	PROPN
njb-115	245	41	cases	case	NOUN
njb-115	245	42	.	.	PUNCT
njb-115	246	1	the	the	DET
njb-115	246	2	result	result	NOUN
njb-115	246	3	obtained	obtain	VERB
njb-115	246	4	was	be	AUX
njb-115	246	5	contrast	contrast	NOUN
njb-115	246	6	with	with	ADP
njb-115	246	7	the	the	DET
njb-115	246	8	study	study	NOUN
njb-115	246	9	carried	carry	VERB
njb-115	246	10	out	out	ADP
njb-115	246	11	by	by	ADP
njb-115	246	12	gosh	gosh	PROPN
njb-115	246	13	et	et	PROPN
njb-115	246	14	al	al	PROPN
njb-115	247	1	[	[	X
njb-115	247	2	61	61	NUM
njb-115	247	3	]	]	PUNCT
njb-115	247	4	.	.	PUNCT
njb-115	248	1	the	the	DET
njb-115	248	2	increase	increase	NOUN
njb-115	248	3	in	in	ADP
njb-115	248	4	reported	report	VERB
njb-115	248	5	inducible	inducible	VERB
njb-115	248	6	clindamycin	clindamycin	PROPN
njb-115	248	7	resistant	resistant	ADJ
njb-115	248	8	shows	show	VERB
njb-115	248	9	the	the	DET
njb-115	248	10	increase	increase	NOUN
njb-115	248	11	in	in	ADP
njb-115	248	12	prevalence	prevalence	NOUN
njb-115	248	13	of	of	ADP
njb-115	248	14	inducible	inducible	VERB
njb-115	248	15	clindamycin	clindamycin	PROPN
njb-115	248	16	resistance	resistance	NOUN
njb-115	248	17	along	along	ADP
njb-115	248	18	with	with	ADP
njb-115	248	19	constitutive	constitutive	ADJ
njb-115	248	20	resistant	resistant	NOUN
njb-115	248	21	among	among	ADP
njb-115	248	22	the	the	DET
njb-115	248	23	clinical	clinical	ADJ
njb-115	248	24	isolates	isolate	NOUN
njb-115	248	25	of	of	ADP
njb-115	248	26	s.	s.	PROPN
njb-115	248	27	aureus	aureus	PROPN
njb-115	248	28	.	.	PUNCT
njb-115	249	1	hence	hence	ADV
njb-115	249	2	,	,	PUNCT
njb-115	249	3	the	the	DET
njb-115	249	4	screening	screening	NOUN
njb-115	249	5	of	of	ADP
njb-115	249	6	inducible	inducible	ADJ
njb-115	249	7	clindamycin	clindamycin	PROPN
njb-115	249	8	resistant	resistant	ADJ
njb-115	249	9	should	should	AUX
njb-115	249	10	be	be	AUX
njb-115	249	11	done	do	VERB
njb-115	249	12	in	in	ADP
njb-115	249	13	every	every	DET
njb-115	249	14	clinical	clinical	ADJ
njb-115	249	15	laboratory	laboratory	NOUN
njb-115	249	16	.	.	PUNCT
njb-115	250	1	conclusion	conclusion	NOUN
njb-115	250	2	prevalence	prevalence	NOUN
njb-115	250	3	of	of	ADP
njb-115	250	4	wound	wound	ADJ
njb-115	250	5	infection	infection	NOUN
njb-115	250	6	was	be	AUX
njb-115	250	7	found	find	VERB
njb-115	250	8	to	to	PART
njb-115	250	9	be	be	AUX
njb-115	250	10	high	high	ADJ
njb-115	250	11	(	(	PUNCT
njb-115	250	12	51.48	51.48	NUM
njb-115	250	13	%	%	NOUN
njb-115	250	14	)	)	PUNCT
njb-115	250	15	in	in	ADP
njb-115	250	16	our	our	PRON
njb-115	250	17	study	study	NOUN
njb-115	250	18	.	.	PUNCT
njb-115	251	1	the	the	DET
njb-115	251	2	growth	growth	NOUN
njb-115	251	3	rate	rate	NOUN
njb-115	251	4	was	be	AUX
njb-115	251	5	found	find	VERB
njb-115	251	6	high	high	ADJ
njb-115	251	7	in	in	ADP
njb-115	251	8	opd	opd	PROPN
njb-115	251	9	patient	patient	PROPN
njb-115	251	10	than	than	ADP
njb-115	251	11	ipd	ipd	PROPN
njb-115	251	12	.	.	PROPN
njb-115	251	13	s.	s.	PROPN
njb-115	251	14	aureus	aureus	PROPN
njb-115	251	15	was	be	AUX
njb-115	251	16	predominant	predominant	ADJ
njb-115	251	17	organism	organism	NOUN
njb-115	251	18	followed	follow	VERB
njb-115	251	19	by	by	ADP
njb-115	251	20	e.	e.	PROPN
njb-115	251	21	coli	coli	PROPN
njb-115	251	22	and	and	CCONJ
njb-115	251	23	s.	s.	PROPN
njb-115	251	24	epidermidis	epidermidis	PROPN
njb-115	251	25	.	.	PUNCT
njb-115	252	1	the	the	DET
njb-115	252	2	prevalence	prevalence	NOUN
njb-115	252	3	of	of	ADP
njb-115	252	4	s.	s.	PROPN
njb-115	252	5	aureus	aureus	PROPN
njb-115	252	6	was	be	AUX
njb-115	252	7	seen	see	VERB
njb-115	252	8	high	high	ADV
njb-115	252	9	in	in	ADP
njb-115	252	10	the	the	DET
njb-115	252	11	age	age	NOUN
njb-115	252	12	group	group	NOUN
njb-115	252	13	of	of	ADP
njb-115	252	14	12	12	NUM
njb-115	252	15	-	-	SYM
njb-115	252	16	15	15	NUM
njb-115	252	17	years	year	NOUN
njb-115	252	18	.	.	PUNCT
njb-115	253	1	the	the	DET
njb-115	253	2	cases	case	NOUN
njb-115	253	3	were	be	AUX
njb-115	253	4	also	also	ADV
njb-115	253	5	seen	see	VERB
njb-115	253	6	high	high	ADV
njb-115	253	7	in	in	ADP
njb-115	253	8	the	the	DET
njb-115	253	9	department	department	NOUN
njb-115	253	10	of	of	ADP
njb-115	253	11	iicu	iicu	PROPN
njb-115	253	12	,	,	PUNCT
njb-115	253	13	picu	picu	PROPN
njb-115	253	14	,	,	PUNCT
njb-115	253	15	and	and	CCONJ
njb-115	253	16	nicu	nicu	PROPN
njb-115	253	17	.	.	PUNCT
njb-115	254	1	high	high	ADJ
njb-115	254	2	prevalence	prevalence	NOUN
njb-115	254	3	of	of	ADP
njb-115	254	4	mrsa	mrsa	PROPN
njb-115	254	5	was	be	AUX
njb-115	254	6	observed	observe	VERB
njb-115	254	7	in	in	ADP
njb-115	254	8	this	this	DET
njb-115	254	9	study	study	NOUN
njb-115	254	10	.	.	PUNCT
njb-115	255	1	the	the	DET
njb-115	255	2	isolates	isolate	NOUN
njb-115	255	3	were	be	AUX
njb-115	255	4	sensitive	sensitive	ADJ
njb-115	255	5	mainly	mainly	ADV
njb-115	255	6	towards	towards	ADP
njb-115	255	7	linezolid	linezolid	NOUN
njb-115	255	8	,	,	PUNCT
njb-115	255	9	doxycycline	doxycycline	NOUN
njb-115	255	10	,	,	PUNCT
njb-115	255	11	meropenem	meropenem	PROPN
njb-115	255	12	,	,	PUNCT
njb-115	255	13	and	and	CCONJ
njb-115	255	14	chloramphenicol	chloramphenicol	NOUN
njb-115	255	15	,	,	PUNCT
njb-115	255	16	vancomycin	vancomycin	PROPN
njb-115	255	17	.	.	PUNCT
njb-115	256	1	the	the	DET
njb-115	256	2	organism	organism	NOUN
njb-115	256	3	was	be	AUX
njb-115	256	4	found	find	VERB
njb-115	256	5	highly	highly	ADV
njb-115	256	6	resistant	resistant	ADJ
njb-115	256	7	towards	towards	ADP
njb-115	256	8	ciprofloxacin	ciprofloxacin	NOUN
njb-115	256	9	.	.	PUNCT
njb-115	257	1	50	50	NUM
njb-115	257	2	%	%	NOUN
njb-115	257	3	of	of	ADP
njb-115	257	4	isolates	isolate	NOUN
njb-115	257	5	were	be	AUX
njb-115	257	6	found	find	VERB
njb-115	257	7	to	to	PART
njb-115	257	8	be	be	AUX
njb-115	257	9	mdr	mdr	PROPN
njb-115	257	10	.	.	PUNCT
njb-115	258	1	among	among	ADP
njb-115	258	2	mdr	mdr	PROPN
njb-115	258	3	,	,	PUNCT
njb-115	258	4	one	one	NUM
njb-115	258	5	strain	strain	NOUN
njb-115	258	6	was	be	AUX
njb-115	258	7	found	find	VERB
njb-115	258	8	to	to	PART
njb-115	258	9	be	be	AUX
njb-115	258	10	xdr	xdr	PROPN
njb-115	258	11	.	.	PUNCT
njb-115	259	1	mdr	mdr	PROPN
njb-115	259	2	was	be	AUX
njb-115	259	3	mainly	mainly	ADV
njb-115	259	4	found	find	VERB
njb-115	259	5	in	in	ADP
njb-115	259	6	mrsa	mrsa	PROPN
njb-115	259	7	than	than	ADP
njb-115	259	8	mssa	mssa	ADJ
njb-115	259	9	strain	strain	NOUN
njb-115	259	10	.	.	PUNCT
njb-115	260	1	hence	hence	ADV
njb-115	260	2	,	,	PUNCT
njb-115	260	3	all	all	DET
njb-115	260	4	mrsa	mrsa	PROPN
njb-115	260	5	are	be	AUX
njb-115	260	6	considered	consider	VERB
njb-115	260	7	as	as	ADP
njb-115	260	8	mdr	mdr	PROPN
njb-115	260	9	.	.	PUNCT
njb-115	261	1	d	d	X
njb-115	261	2	-	-	PUNCT
njb-115	261	3	test	test	NOUN
njb-115	261	4	positive	positive	ADJ
njb-115	261	5	cases	case	NOUN
njb-115	261	6	was	be	AUX
njb-115	261	7	found	find	VERB
njb-115	261	8	higher	high	ADJ
njb-115	261	9	in	in	ADP
njb-115	261	10	mrsa	mrsa	PROPN
njb-115	261	11	cases	case	NOUN
njb-115	261	12	.	.	PUNCT
njb-115	262	1	since	since	SCONJ
njb-115	262	2	,	,	PUNCT
njb-115	262	3	inducible	inducible	VERB
njb-115	262	4	d	d	NOUN
njb-115	262	5	-	-	NOUN
njb-115	262	6	test	test	NOUN
njb-115	262	7	has	have	VERB
njb-115	262	8	nepal	nepal	PROPN
njb-115	262	9	j	j	PROPN
njb-115	262	10	biotechnol	biotechnol	PROPN
njb-115	262	11	.	.	PUNCT
njb-115	263	1	2	2	NUM
njb-115	263	2	0	0	NUM
njb-115	263	3	2	2	NUM
njb-115	263	4	1	1	NUM
njb-115	263	5	j	j	NOUN
njb-115	263	6	u	u	NOUN
njb-115	263	7	l	l	NOUN
njb-115	263	8	;	;	PUNCT
njb-115	263	9	9	9	NUM
njb-115	263	10	(	(	PUNCT
njb-115	263	11	1):8	1):8	NUM
njb-115	263	12	1	1	NUM
njb-115	263	13	7	7	NUM
njb-115	263	14	maharjan	maharjan	NOUN
njb-115	263	15	et	et	NOUN
njb-115	263	16	al	al	PROPN
njb-115	263	17	.	.	PUNCT
njb-115	264	1	©	©	PROPN
njb-115	264	2	njb	njb	PROPN
njb-115	264	3	,	,	PUNCT
njb-115	264	4	bsn	bsn	PROPN
njb-115	264	5	15	15	NUM
njb-115	264	6	been	be	AUX
njb-115	264	7	reported	report	VERB
njb-115	264	8	,	,	PUNCT
njb-115	264	9	it	it	PRON
njb-115	264	10	is	be	AUX
njb-115	264	11	necessary	necessary	ADJ
njb-115	264	12	to	to	PART
njb-115	264	13	screen	screen	VERB
njb-115	264	14	the	the	DET
njb-115	264	15	inducible	inducible	ADJ
njb-115	264	16	clindamycin	clindamycin	PROPN
njb-115	264	17	resistance	resistance	NOUN
njb-115	264	18	before	before	ADP
njb-115	264	19	the	the	DET
njb-115	264	20	prescription	prescription	NOUN
njb-115	264	21	of	of	ADP
njb-115	264	22	the	the	DET
njb-115	264	23	medication	medication	NOUN
njb-115	264	24	for	for	ADP
njb-115	264	25	the	the	DET
njb-115	264	26	effective	effective	ADJ
njb-115	264	27	treatment	treatment	NOUN
njb-115	264	28	of	of	ADP
njb-115	264	29	infection	infection	NOUN
njb-115	264	30	.	.	PUNCT
njb-115	265	1	vancomycin	vancomycin	PROPN
njb-115	265	2	,	,	PUNCT
njb-115	265	3	linezolid	linezolid	PROPN
njb-115	265	4	,	,	PUNCT
njb-115	265	5	doxycycline	doxycycline	NOUN
njb-115	265	6	,	,	PUNCT
njb-115	265	7	meropenem	meropenem	PROPN
njb-115	265	8	,	,	PUNCT
njb-115	265	9	and	and	CCONJ
njb-115	265	10	chloramphenicol	chloramphenicol	NOUN
njb-115	265	11	were	be	AUX
njb-115	265	12	effective	effective	ADJ
njb-115	265	13	drug	drug	NOUN
njb-115	265	14	for	for	ADP
njb-115	265	15	s.	s.	PROPN
njb-115	265	16	aureus	aureus	PROPN
njb-115	265	17	and	and	CCONJ
njb-115	265	18	mrsa	mrsa	PROPN
njb-115	265	19	.	.	PUNCT
njb-115	266	1	author	author	NOUN
njb-115	266	2	's	's	PART
njb-115	266	3	contribution	contribution	NOUN
njb-115	266	4	bm	bm	PROPN
njb-115	266	5	conducted	conduct	VERB
njb-115	266	6	laboratory	laboratory	NOUN
njb-115	266	7	experiments	experiment	NOUN
njb-115	266	8	,	,	PUNCT
njb-115	266	9	data	datum	NOUN
njb-115	266	10	analysis	analysis	NOUN
njb-115	266	11	,	,	PUNCT
njb-115	266	12	interpretation	interpretation	NOUN
njb-115	266	13	and	and	CCONJ
njb-115	266	14	manuscript	manuscript	NOUN
njb-115	266	15	writing	writing	NOUN
njb-115	266	16	;	;	PUNCT
njb-115	266	17	stk	stk	PROPN
njb-115	266	18	designed	design	VERB
njb-115	266	19	the	the	DET
njb-115	266	20	research	research	NOUN
njb-115	266	21	conception	conception	NOUN
njb-115	266	22	,	,	PUNCT
njb-115	266	23	reviewed	review	VERB
njb-115	266	24	the	the	DET
njb-115	266	25	manuscript	manuscript	NOUN
njb-115	266	26	;	;	PUNCT
njb-115	266	27	rm	rm	PROPN
njb-115	266	28	designed	design	VERB
njb-115	266	29	the	the	DET
njb-115	266	30	research	research	NOUN
njb-115	266	31	,	,	PUNCT
njb-115	266	32	contributed	contribute	VERB
njb-115	266	33	in	in	ADP
njb-115	266	34	data	datum	NOUN
njb-115	266	35	analysis	analysis	NOUN
njb-115	266	36	,	,	PUNCT
njb-115	266	37	manuscript	manuscript	NOUN
njb-115	266	38	writing	writing	NOUN
njb-115	266	39	,	,	PUNCT
njb-115	266	40	reviewing	review	VERB
njb-115	266	41	and	and	CCONJ
njb-115	266	42	editing	edit	VERB
njb-115	266	43	.	.	PUNCT
njb-115	267	1	all	all	DET
njb-115	267	2	authors	author	NOUN
njb-115	267	3	read	read	VERB
njb-115	267	4	and	and	CCONJ
njb-115	267	5	approved	approve	VERB
njb-115	267	6	the	the	DET
njb-115	267	7	final	final	ADJ
njb-115	267	8	manuscript	manuscript	NOUN
njb-115	267	9	.	.	PUNCT
njb-115	268	1	competing	compete	VERB
njb-115	268	2	interests	interest	NOUN
njb-115	268	3	we	we	PRON
njb-115	268	4	have	have	AUX
njb-115	268	5	read	read	VERB
njb-115	268	6	nepal	nepal	ADJ
njb-115	268	7	journal	journal	NOUN
njb-115	268	8	of	of	ADP
njb-115	268	9	biotechnology	biotechnology	NOUN
njb-115	268	10	policy	policy	NOUN
njb-115	268	11	on	on	ADP
njb-115	268	12	declaration	declaration	NOUN
njb-115	268	13	of	of	ADP
njb-115	268	14	competing	compete	VERB
njb-115	268	15	interest	interest	NOUN
njb-115	268	16	and	and	CCONJ
njb-115	268	17	declare	declare	VERB
njb-115	268	18	that	that	SCONJ
njb-115	268	19	we	we	PRON
njb-115	268	20	have	have	VERB
njb-115	268	21	no	no	DET
njb-115	268	22	competing	compete	VERB
njb-115	268	23	interests	interest	NOUN
njb-115	268	24	.	.	PUNCT
njb-115	269	1	funding	fund	VERB
njb-115	269	2	the	the	DET
njb-115	269	3	author(s	author(s	NOUN
njb-115	269	4	)	)	PUNCT
njb-115	269	5	declared	declare	VERB
njb-115	269	6	that	that	SCONJ
njb-115	269	7	no	no	DET
njb-115	269	8	grants	grant	NOUN
njb-115	269	9	were	be	AUX
njb-115	269	10	involved	involve	VERB
njb-115	269	11	in	in	ADP
njb-115	269	12	supporting	support	VERB
njb-115	269	13	this	this	DET
njb-115	269	14	work	work	NOUN
njb-115	269	15	.	.	PUNCT
njb-115	270	1	acknowledgements	acknowledgement	VERB
njb-115	270	2	we	we	PRON
njb-115	270	3	are	be	AUX
njb-115	270	4	very	very	ADV
njb-115	270	5	beholden	beholden	ADJ
njb-115	270	6	for	for	ADP
njb-115	270	7	the	the	DET
njb-115	270	8	support	support	NOUN
njb-115	270	9	provided	provide	VERB
njb-115	270	10	by	by	ADP
njb-115	270	11	international	international	ADJ
njb-115	270	12	friendship	friendship	NOUN
njb-115	270	13	children	child	NOUN
njb-115	270	14	's	's	PART
njb-115	270	15	hospital	hospital	NOUN
njb-115	270	16	and	and	CCONJ
njb-115	270	17	the	the	DET
njb-115	270	18	st	st	PROPN
njb-115	270	19	.	.	PROPN
njb-115	270	20	xavier	xavier	PROPN
njb-115	270	21	's	's	PART
njb-115	270	22	college	college	NOUN
njb-115	270	23	,	,	PUNCT
njb-115	270	24	kathmandu	kathmandu	PROPN
njb-115	270	25	,	,	PUNCT
njb-115	270	26	nepal	nepal	ADJ
njb-115	270	27	.	.	PUNCT
njb-115	271	1	ethical	ethical	ADJ
njb-115	271	2	approval	approval	NOUN
njb-115	271	3	and	and	CCONJ
njb-115	271	4	consent	consent	VERB
njb-115	271	5	this	this	DET
njb-115	271	6	research	research	NOUN
njb-115	271	7	was	be	AUX
njb-115	271	8	approved	approve	VERB
njb-115	271	9	by	by	ADP
njb-115	271	10	nepal	nepal	ADJ
njb-115	271	11	health	health	PROPN
njb-115	271	12	research	research	PROPN
njb-115	271	13	council	council	PROPN
njb-115	271	14	(	(	PUNCT
njb-115	271	15	nhrc	nhrc	PROPN
njb-115	271	16	)	)	PUNCT
njb-115	271	17	,	,	PUNCT
njb-115	271	18	kathmandu	kathmandu	NOUN
njb-115	271	19	,	,	PUNCT
njb-115	271	20	nepal	nepal	ADJ
njb-115	271	21	(	(	PUNCT
njb-115	271	22	ref	ref	NOUN
njb-115	271	23	.	.	PUNCT
njb-115	272	1	no.-2610	no.-2610	X
njb-115	272	2	)	)	PUNCT
njb-115	272	3	,	,	PUNCT
njb-115	272	4	international	international	ADJ
njb-115	272	5	friendship	friendship	NOUN
njb-115	272	6	children	child	NOUN
njb-115	272	7	's	's	PART
njb-115	272	8	hospital	hospital	NOUN
njb-115	272	9	,	,	PUNCT
njb-115	272	10	maharajgunj	maharajgunj	PROPN
njb-115	272	11	,	,	PUNCT
njb-115	272	12	nepal	nepal	ADJ
njb-115	272	13	and	and	CCONJ
njb-115	272	14	the	the	DET
njb-115	272	15	st	st	PROPN
njb-115	272	16	.	.	PROPN
njb-115	272	17	xavier	xavier	PROPN
njb-115	272	18	's	's	PART
njb-115	272	19	college	college	NOUN
njb-115	272	20	,	,	PUNCT
njb-115	272	21	kathmandu	kathmandu	PROPN
njb-115	272	22	,	,	PUNCT
njb-115	272	23	nepal	nepal	ADJ
njb-115	272	24	.	.	PUNCT
njb-115	273	1	informed	informed	ADJ
njb-115	273	2	consent	consent	NOUN
njb-115	273	3	was	be	AUX
njb-115	273	4	obtained	obtain	VERB
njb-115	273	5	from	from	ADP
njb-115	273	6	parents	parent	NOUN
njb-115	273	7	of	of	ADP
njb-115	273	8	participants	participant	NOUN
njb-115	273	9	before	before	ADP
njb-115	273	10	their	their	PRON
njb-115	273	11	participation	participation	NOUN
njb-115	273	12	.	.	PUNCT
njb-115	274	1	references	reference	NOUN
njb-115	274	2	1	1	NUM
njb-115	274	3	.	.	X
njb-115	274	4	mohammed	mohammed	PROPN
njb-115	274	5	a	a	PROPN
njb-115	274	6	,	,	PUNCT
njb-115	274	7	adeshina	adeshina	NOUN
njb-115	274	8	go	go	VERB
njb-115	274	9	,	,	PUNCT
njb-115	274	10	ibrahim	ibrahim	PROPN
njb-115	274	11	yke	yke	PROPN
njb-115	274	12	.	.	PUNCT
njb-115	275	1	retrospective	retrospective	ADJ
njb-115	275	2	incidence	incidence	NOUN
njb-115	275	3	of	of	ADP
njb-115	275	4	wound	wound	NOUN
njb-115	275	5	infections	infection	NOUN
njb-115	275	6	and	and	CCONJ
njb-115	275	7	antibiotic	antibiotic	ADJ
njb-115	275	8	sensitivity	sensitivity	NOUN
njb-115	275	9	pattern	pattern	NOUN
njb-115	275	10	:	:	PUNCT
njb-115	275	11	a	a	DET
njb-115	275	12	study	study	NOUN
njb-115	275	13	conducted	conduct	VERB
njb-115	275	14	at	at	ADP
njb-115	275	15	the	the	DET
njb-115	275	16	aminu	aminu	PROPN
njb-115	275	17	kano	kano	PROPN
njb-115	275	18	teaching	teaching	PROPN
njb-115	275	19	hospital	hospital	PROPN
njb-115	275	20	,	,	PUNCT
njb-115	275	21	kano	kano	PROPN
njb-115	275	22	,	,	PUNCT
njb-115	275	23	nigeria	nigeria	PROPN
njb-115	275	24	.	.	PROPN
njb-115	275	25	international	international	PROPN
njb-115	275	26	journal	journal	PROPN
njb-115	275	27	of	of	ADP
njb-115	275	28	medicine	medicine	NOUN
njb-115	275	29	and	and	CCONJ
njb-115	275	30	medical	medical	ADJ
njb-115	275	31	sciences	science	NOUN
njb-115	275	32	.	.	PUNCT
njb-115	276	1	2013;5(2):60	2013;5(2):60	NUM
njb-115	276	2	-	-	SYM
njb-115	276	3	66	66	NUM
njb-115	276	4	.	.	PUNCT
njb-115	277	1	doi	doi	PROPN
njb-115	277	2	:	:	PUNCT
njb-115	277	3	10.5897	10.5897	NUM
njb-115	277	4	/	/	SYM
njb-115	277	5	ijmms12.114	ijmms12.114	PROPN
njb-115	277	6	2	2	NUM
njb-115	277	7	.	.	PUNCT
njb-115	278	1	nirmala	nirmala	PROPN
njb-115	278	2	s	s	PROPN
njb-115	278	3	,	,	PUNCT
njb-115	278	4	sengodan	sengodan	PROPN
njb-115	278	5	r.	r.	PROPN
njb-115	278	6	aerobic	aerobic	ADJ
njb-115	278	7	bacterial	bacterial	ADJ
njb-115	278	8	isolates	isolate	NOUN
njb-115	278	9	and	and	CCONJ
njb-115	278	10	their	their	PRON
njb-115	278	11	antibiotic	antibiotic	ADJ
njb-115	278	12	susceptibility	susceptibility	NOUN
njb-115	278	13	pattern	pattern	NOUN
njb-115	278	14	from	from	ADP
njb-115	278	15	pus	pus	NOUN
njb-115	278	16	samples	sample	NOUN
njb-115	278	17	in	in	ADP
njb-115	278	18	a	a	DET
njb-115	278	19	tertiary	tertiary	ADJ
njb-115	278	20	care	care	NOUN
njb-115	278	21	government	government	NOUN
njb-115	278	22	hospital	hospital	NOUN
njb-115	278	23	in	in	ADP
njb-115	278	24	tamilnadu	tamilnadu	PROPN
njb-115	278	25	,	,	PUNCT
njb-115	278	26	india	india	PROPN
njb-115	278	27	.	.	PUNCT
njb-115	279	1	int	int	PROPN
njb-115	279	2	j	j	PROPN
njb-115	279	3	curr	curr	PROPN
njb-115	279	4	microbiol	microbiol	PROPN
njb-115	279	5	app	app	PROPN
njb-115	279	6	sci	sci	PROPN
njb-115	279	7	.	.	PROPN
njb-115	279	8	2017	2017	NUM
njb-115	280	1	jun	jun	PROPN
njb-115	280	2	10;6(6):423	10;6(6):423	NUM
njb-115	280	3	-	-	SYM
njb-115	280	4	442	442	NUM
njb-115	280	5	.	.	PUNCT
njb-115	280	6	https://doi.org/10.20546/ijcmas.2017.606.050	https://doi.org/10.20546/ijcmas.2017.606.050	PROPN
njb-115	280	7	3	3	NUM
njb-115	280	8	.	.	PUNCT
njb-115	281	1	paul	paul	PROPN
njb-115	281	2	w	w	PROPN
njb-115	281	3	,	,	PUNCT
njb-115	281	4	sharma	sharma	PROPN
njb-115	281	5	cp	cp	PROPN
njb-115	281	6	.	.	PROPN
njb-115	282	1	advanced	advance	VERB
njb-115	282	2	in	in	ADP
njb-115	282	3	wound	wound	ADJ
njb-115	282	4	healing	healing	NOUN
njb-115	282	5	materials	material	NOUN
njb-115	282	6	:	:	PUNCT
njb-115	282	7	science	science	NOUN
njb-115	282	8	and	and	CCONJ
njb-115	282	9	skin	skin	NOUN
njb-115	282	10	engineering	engineering	NOUN
njb-115	282	11	.	.	PUNCT
njb-115	283	1	1st	1st	PROPN
njb-115	283	2	ed	ed	PROPN
njb-115	283	3	.	.	PROPN
njb-115	284	1	united	united	PROPN
njb-115	284	2	kingdom	kingdom	PROPN
njb-115	284	3	:	:	PUNCT
njb-115	284	4	a	a	DET
njb-115	284	5	smithers	smither	NOUN
njb-115	284	6	group	group	NOUN
njb-115	284	7	company	company	NOUN
njb-115	284	8	;	;	PUNCT
njb-115	284	9	2015.25	2015.25	NUM
njb-115	284	10	p.	p.	NOUN
njb-115	284	11	4	4	NUM
njb-115	284	12	.	.	PUNCT
njb-115	284	13	aftab	aftab	PROPN
njb-115	284	14	s	s	PROPN
njb-115	284	15	,	,	PUNCT
njb-115	284	16	yusuf	yusuf	PROPN
njb-115	284	17	ma	ma	PROPN
njb-115	284	18	,	,	PUNCT
njb-115	284	19	siddique	siddique	PROPN
njb-115	284	20	ma	ma	PROPN
njb-115	284	21	,	,	PUNCT
njb-115	284	22	tarik	tarik	PROPN
njb-115	284	23	mm	mm	PROPN
njb-115	284	24	.	.	PUNCT
njb-115	285	1	clinical	clinical	ADJ
njb-115	285	2	and	and	CCONJ
njb-115	285	3	microbiological	microbiological	ADJ
njb-115	285	4	aspect	aspect	NOUN
njb-115	285	5	of	of	ADP
njb-115	285	6	wound	wound	ADJ
njb-115	285	7	infection	infection	NOUN
njb-115	285	8	:	:	PUNCT
njb-115	285	9	a	a	DET
njb-115	285	10	review	review	NOUN
njb-115	285	11	update	update	NOUN
njb-115	285	12	.	.	PUNCT
njb-115	286	1	bangladesh	bangladesh	PROPN
njb-115	286	2	journal	journal	PROPN
njb-115	286	3	of	of	ADP
njb-115	286	4	infectious	infectious	ADJ
njb-115	286	5	diseases	disease	NOUN
njb-115	286	6	.	.	PUNCT
njb-115	287	1	2015;1(2	2015;1(2	NUM
njb-115	287	2	):	):	PUNCT
njb-115	288	1	3237.https://doi.org/10.3329/bjid.v1i2.24903	3237.https://doi.org/10.3329/bjid.v1i2.24903	NUM
njb-115	288	2	5	5	NUM
njb-115	288	3	.	.	PUNCT
njb-115	289	1	swanson	swanson	PROPN
njb-115	289	2	t	t	PROPN
njb-115	289	3	,	,	PUNCT
njb-115	289	4	angel	angel	PROPN
njb-115	289	5	d	d	PROPN
njb-115	289	6	,	,	PUNCT
njb-115	289	7	sussman	sussman	PROPN
njb-115	289	8	g	g	PROPN
njb-115	289	9	,	,	PUNCT
njb-115	289	10	cooper	cooper	PROPN
njb-115	289	11	r	r	PROPN
njb-115	289	12	et	et	PROPN
njb-115	289	13	al	al	PROPN
njb-115	289	14	.	.	PUNCT
njb-115	290	1	international	international	PROPN
njb-115	290	2	wound	wound	PROPN
njb-115	290	3	infection	infection	PROPN
njb-115	290	4	institute	institute	PROPN
njb-115	290	5	.	.	PUNCT
njb-115	291	1	wound	wound	ADJ
njb-115	291	2	infection	infection	NOUN
njb-115	291	3	in	in	ADP
njb-115	291	4	clinical	clinical	ADJ
njb-115	291	5	practice	practice	NOUN
njb-115	291	6	:	:	PUNCT
njb-115	291	7	principles	principle	NOUN
njb-115	291	8	of	of	ADP
njb-115	291	9	best	good	ADJ
njb-115	291	10	practice	practice	NOUN
njb-115	291	11	.	.	PUNCT
njb-115	292	1	london	london	PROPN
njb-115	292	2	:	:	PUNCT
njb-115	292	3	a	a	DET
njb-115	292	4	wound	wound	ADJ
njb-115	292	5	international	international	ADJ
njb-115	292	6	publication	publication	NOUN
njb-115	292	7	.	.	PUNCT
njb-115	293	1	international	international	ADJ
njb-115	293	2	consensus	consensus	PROPN
njb-115	293	3	update	update	NOUN
njb-115	293	4	2016	2016	NUM
njb-115	293	5	;	;	PUNCT
njb-115	293	6	2016	2016	NUM
njb-115	293	7	.	.	PUNCT
njb-115	294	1	7p	7p	NUM
njb-115	294	2	.	.	PUNCT
njb-115	295	1	http://eprints.hud.ac.uk/id/eprint/30637/1/iwiiconsensus_final-web.pdf	http://eprints.hud.ac.uk/id/eprint/30637/1/iwiiconsensus_final-web.pdf	PROPN
njb-115	295	2	6	6	NUM
njb-115	295	3	.	.	PUNCT
njb-115	296	1	medical	medical	ADJ
njb-115	296	2	news	news	NOUN
njb-115	296	3	today	today	NOUN
njb-115	297	1	[	[	X
njb-115	297	2	internet	internet	X
njb-115	297	3	]	]	X
njb-115	297	4	.	.	PUNCT
njb-115	298	1	pus	pus	PROPN
njb-115	298	2	:	:	PUNCT
njb-115	298	3	what	what	PRON
njb-115	298	4	is	be	AUX
njb-115	298	5	it	it	PRON
njb-115	298	6	and	and	CCONJ
njb-115	298	7	why	why	SCONJ
njb-115	298	8	does	do	AUX
njb-115	298	9	it	it	PRON
njb-115	298	10	happen	happen	VERB
njb-115	298	11	?	?	PUNCT
njb-115	299	1	2017	2017	NUM
njb-115	299	2	(	(	PUNCT
njb-115	299	3	updated	update	VERB
njb-115	299	4	we	we	PRON
njb-115	299	5	d	d	ADP
njb-115	299	6	21	21	NUM
njb-115	299	7	june	june	PROPN
njb-115	299	8	2017).https://www.medicalnewstoday.com	2017).https://www.medicalnewstoday.com	NUM
njb-115	299	9	/	/	SYM
njb-115	299	10	articles/249182.php	articles/249182.php	PROPN
njb-115	299	11	.	.	PUNCT
njb-115	300	1	7	7	X
njb-115	300	2	.	.	X
njb-115	300	3	kindt	kindt	PROPN
njb-115	300	4	tj	tj	PROPN
njb-115	300	5	,	,	PUNCT
njb-115	300	6	goldsby	goldsby	PROPN
njb-115	300	7	ra	ra	PROPN
njb-115	300	8	,	,	PUNCT
njb-115	300	9	osborne	osborne	PROPN
njb-115	300	10	ba	ba	PROPN
njb-115	300	11	.	.	PROPN
njb-115	300	12	kuby	kuby	PROPN
njb-115	300	13	immunology	immunology	NOUN
njb-115	300	14	.	.	PUNCT
njb-115	301	1	6th	6th	NOUN
njb-115	301	2	ed	ed	NOUN
njb-115	301	3	.	.	PROPN
njb-115	302	1	united	united	PROPN
njb-115	302	2	state	state	PROPN
njb-115	302	3	of	of	ADP
njb-115	302	4	america	america	PROPN
njb-115	302	5	:	:	PUNCT
njb-115	302	6	sara	sara	PROPN
njb-115	302	7	tenney	tenney	PROPN
njb-115	302	8	;	;	PUNCT
njb-115	302	9	2007	2007	NUM
njb-115	302	10	.	.	PUNCT
njb-115	303	1	340p	340p	NOUN
njb-115	303	2	.	.	PUNCT
njb-115	304	1	8	8	X
njb-115	304	2	.	.	PUNCT
njb-115	304	3	sethi	sethi	PROPN
njb-115	304	4	d	d	PROPN
njb-115	304	5	,	,	PUNCT
njb-115	304	6	towner	towner	PROPN
njb-115	304	7	e	e	PROPN
njb-115	304	8	,	,	PUNCT
njb-115	304	9	vincenten	vincenten	PROPN
njb-115	304	10	j	j	PROPN
njb-115	304	11	,	,	PUNCT
njb-115	304	12	segui	segui	PROPN
njb-115	304	13	-	-	PUNCT
njb-115	304	14	gomez	gomez	NOUN
njb-115	304	15	m	m	PROPN
njb-115	304	16	and	and	CCONJ
njb-115	304	17	racioppi	racioppi	PROPN
njb-115	304	18	f.	f.	PROPN
njb-115	304	19	european	european	PROPN
njb-115	304	20	report	report	PROPN
njb-115	304	21	on	on	ADP
njb-115	304	22	child	child	NOUN
njb-115	304	23	injury	injury	NOUN
njb-115	304	24	prevention	prevention	NOUN
njb-115	304	25	.	.	PUNCT
njb-115	305	1	world	world	NOUN
njb-115	305	2	health	health	NOUN
njb-115	305	3	organization	organization	NOUN
njb-115	305	4	.	.	PUNCT
njb-115	306	1	2008	2008	NUM
njb-115	306	2	.	.	PUNCT
njb-115	307	1	9	9	NUM
njb-115	307	2	.	.	PUNCT
njb-115	307	3	shriyan	shriyan	PROPN
njb-115	307	4	p	p	PROPN
njb-115	307	5	,	,	PUNCT
njb-115	307	6	prabhu	prabhu	PROPN
njb-115	307	7	v	v	PROPN
njb-115	307	8	,	,	PUNCT
njb-115	307	9	aithal	aithal	PROPN
njb-115	307	10	k	k	PROPN
njb-115	307	11	,	,	PUNCT
njb-115	307	12	yadav	yadav	PROPN
njb-115	307	13	un	un	PROPN
njb-115	307	14	,	,	PUNCT
njb-115	307	15	orgochukwumj	orgochukwumj	PROPN
njb-115	307	16	.	.	PUNCT
njb-115	308	1	profile	profile	NOUN
njb-115	308	2	of	of	ADP
njb-115	308	3	unintentional	unintentional	ADJ
njb-115	308	4	injury	injury	NOUN
njb-115	308	5	among	among	ADP
njb-115	308	6	under	under	ADP
njb-115	308	7	five	five	NUM
njb-115	308	8	children	child	NOUN
njb-115	308	9	in	in	ADP
njb-115	308	10	coastal	coastal	PROPN
njb-115	308	11	karnataka	karnataka	PROPN
njb-115	308	12	,	,	PUNCT
njb-115	308	13	india	india	PROPN
njb-115	308	14	:	:	PUNCT
njb-115	308	15	a	a	DET
njb-115	308	16	cross	cross	ADJ
njb-115	308	17	-	-	ADJ
njb-115	308	18	sectional	sectional	ADJ
njb-115	308	19	study	study	NOUN
njb-115	308	20	.	.	PUNCT
njb-115	309	1	int	int	NOUN
njb-115	309	2	j	j	PROPN
njb-115	309	3	med	med	PROPN
njb-115	309	4	sci	sci	PROPN
njb-115	309	5	public	public	ADJ
njb-115	309	6	health	health	NOUN
njb-115	309	7	.	.	PUNCT
njb-115	310	1	2014	2014	NUM
njb-115	310	2	jan;3(11):13171319.https://www.researchgate.net	jan;3(11):13171319.https://www.researchgate.net	NOUN
njb-115	310	3	/	/	SYM
njb-115	310	4	publication/271186756	publication/271186756	NOUN
njb-115	310	5	.	.	PUNCT
njb-115	311	1	10	10	NUM
njb-115	311	2	.	.	PUNCT
njb-115	311	3	rai	rai	PROPN
njb-115	311	4	s	s	PROPN
njb-115	311	5	,	,	PUNCT
njb-115	311	6	yadav	yadav	PROPN
njb-115	311	7	un	un	PROPN
njb-115	311	8	,	,	PUNCT
njb-115	311	9	pant	pant	PROPN
njb-115	311	10	nd	nd	PROPN
njb-115	311	11	,	,	PUNCT
njb-115	311	12	yakha	yakha	PROPN
njb-115	311	13	jk	jk	PROPN
njb-115	311	14	,	,	PUNCT
njb-115	311	15	tripathi	tripathi	PROPN
njb-115	311	16	pp	pp	PROPN
njb-115	311	17	,	,	PUNCT
njb-115	311	18	poudel	poudel	PROPN
njb-115	311	19	a	a	PROPN
njb-115	311	20	,	,	PUNCT
njb-115	311	21	et	et	PROPN
njb-115	311	22	al	al	PROPN
njb-115	311	23	.	.	PROPN
njb-115	311	24	bacteriological	bacteriological	PROPN
njb-115	311	25	profile	profile	NOUN
njb-115	311	26	and	and	CCONJ
njb-115	311	27	antimicrobial	antimicrobial	ADJ
njb-115	311	28	susceptibility	susceptibility	NOUN
njb-115	311	29	patterns	pattern	NOUN
njb-115	311	30	of	of	ADP
njb-115	311	31	bacteria	bacteria	NOUN
njb-115	311	32	isolated	isolate	VERB
njb-115	311	33	from	from	ADP
njb-115	311	34	pus	pus	PROPN
njb-115	311	35	/	/	SYM
njb-115	311	36	wound	wound	NOUN
njb-115	311	37	swab	swab	NOUN
njb-115	311	38	samples	sample	NOUN
njb-115	311	39	from	from	ADP
njb-115	311	40	children	child	NOUN
njb-115	311	41	attending	attend	VERB
njb-115	311	42	a	a	DET
njb-115	311	43	tertiary	tertiary	ADJ
njb-115	311	44	care	care	NOUN
njb-115	311	45	hospital	hospital	NOUN
njb-115	311	46	in	in	ADP
njb-115	311	47	kathmandu	kathmandu	NOUN
njb-115	311	48	,	,	PUNCT
njb-115	311	49	nepal	nepal	ADJ
njb-115	311	50	.	.	PUNCT
njb-115	312	1	intj	intj	PROPN
njb-115	312	2	microbiol.2017	microbiol.2017	NOUN
njb-115	312	3	mar	mar	PROPN
njb-115	312	4	6;2017:2529085	6;2017:2529085	NUM
njb-115	312	5	.	.	PUNCT
njb-115	313	1	doi	doi	PROPN
njb-115	313	2	:	:	PUNCT
njb-115	313	3	10.1155/2017/2529085	10.1155/2017/2529085	NUM
njb-115	313	4	.	.	PUNCT
njb-115	313	5	11	11	NUM
njb-115	313	6	.	.	PUNCT
njb-115	314	1	manikandan	manikandan	PROPN
njb-115	314	2	c	c	PROPN
njb-115	314	3	,	,	PUNCT
njb-115	314	4	amsath	amsath	PROPN
njb-115	314	5	a.	a.	NOUN
njb-115	314	6	antibiotic	antibiotic	ADJ
njb-115	314	7	susceptibility	susceptibility	NOUN
njb-115	314	8	of	of	ADP
njb-115	314	9	bacterial	bacterial	ADJ
njb-115	314	10	strains	strain	NOUN
njb-115	314	11	isolated	isolate	VERB
njb-115	314	12	from	from	ADP
njb-115	314	13	wound	wound	ADJ
njb-115	314	14	infection	infection	NOUN
njb-115	314	15	patients	patient	NOUN
njb-115	314	16	in	in	ADP
njb-115	314	17	pattukkottai	pattukkottai	PROPN
njb-115	314	18	,	,	PUNCT
njb-115	314	19	tamilnadu	tamilnadu	PROPN
njb-115	314	20	,	,	PUNCT
njb-115	314	21	india	india	PROPN
njb-115	314	22	.	.	PUNCT
njb-115	315	1	int	int	PROPN
njb-115	315	2	j	j	PROPN
njb-115	315	3	currmicrobiol	currmicrobiol	PROPN
njb-115	315	4	app	app	PROPN
njb-115	315	5	sci	sci	PROPN
njb-115	315	6	.	.	PUNCT
njb-115	316	1	2013;2(6):195	2013;2(6):195	NUM
njb-115	316	2	-	-	SYM
njb-115	316	3	203	203	NUM
njb-115	316	4	.	.	PUNCT
njb-115	316	5	http://www.ijcmas.com/	http://www.ijcmas.com/	NUM
njb-115	316	6	12	12	NUM
njb-115	316	7	.	.	PUNCT
njb-115	317	1	alebachew	alebachew	PROPN
njb-115	317	2	t	t	PROPN
njb-115	317	3	,	,	PUNCT
njb-115	317	4	yismaw	yismaw	PROPN
njb-115	317	5	g	g	PROPN
njb-115	317	6	,	,	PUNCT
njb-115	317	7	derabe	derabe	PROPN
njb-115	317	8	a	a	PROPN
njb-115	317	9	,	,	PUNCT
njb-115	317	10	sisay	sisay	PROPN
njb-115	317	11	z.	z.	PROPN
njb-115	317	12	staphylococcus	staphylococcus	PROPN
njb-115	317	13	aureus	aureus	PROPN
njb-115	317	14	burn	burn	VERB
njb-115	317	15	wound	wind	VERB
njb-115	317	16	infectionamong	infectionamong	NOUN
njb-115	317	17	patients	patient	NOUN
njb-115	317	18	attending	attend	VERB
njb-115	317	19	yekatit	yekatit	PROPN
njb-115	317	20	12	12	NUM
njb-115	317	21	hospital	hospital	NOUN
njb-115	317	22	burn	burn	NOUN
njb-115	317	23	unit	unit	NOUN
njb-115	317	24	,	,	PUNCT
njb-115	317	25	addis	addis	PROPN
njb-115	317	26	ababa	ababa	PROPN
njb-115	317	27	,	,	PUNCT
njb-115	317	28	ethiopia	ethiopia	PROPN
njb-115	317	29	.	.	PUNCT
njb-115	318	1	ethiop	ethiop	PROPN
njb-115	318	2	j	j	PROPN
njb-115	318	3	health	health	PROPN
njb-115	318	4	sci	sci	PROPN
njb-115	318	5	.	.	PROPN
njb-115	318	6	2012	2012	NUM
njb-115	318	7	nov;22(3):209	nov;22(3):209	NOUN
njb-115	318	8	-	-	PUNCT
njb-115	318	9	213	213	NUM
njb-115	318	10	.	.	PUNCT
njb-115	318	11	https://www.ncbi.nlm.nih.gov/pubmed/23209356	https://www.ncbi.nlm.nih.gov/pubmed/23209356	NUM
njb-115	318	12	13	13	NUM
njb-115	318	13	.	.	PUNCT
njb-115	319	1	thanni	thanni	PROPN
njb-115	319	2	loa	loa	PROPN
njb-115	319	3	,	,	PUNCT
njb-115	319	4	osinupebi	osinupebi	PROPN
njb-115	319	5	oa	oa	PROPN
njb-115	319	6	,	,	PUNCT
njb-115	319	7	deji	deji	PROPN
njb-115	319	8	m.	m.	PROPN
njb-115	319	9	prevalence	prevalence	NOUN
njb-115	319	10	of	of	ADP
njb-115	319	11	bacterial	bacterial	ADJ
njb-115	319	12	pathogens	pathogen	NOUN
njb-115	319	13	in	in	ADP
njb-115	319	14	infectedwounds	infectedwound	NOUN
njb-115	319	15	in	in	ADP
njb-115	319	16	a	a	DET
njb-115	319	17	tertiary	tertiary	ADJ
njb-115	319	18	hospital	hospital	NOUN
njb-115	319	19	,	,	PUNCT
njb-115	319	20	1995	1995	NUM
njb-115	319	21	-	-	SYM
njb-115	319	22	2001	2001	NUM
njb-115	319	23	:	:	PUNCT
njb-115	319	24	any	any	DET
njb-115	319	25	change	change	NOUN
njb-115	319	26	in	in	ADP
njb-115	319	27	trend	trend	NOUN
njb-115	319	28	?	?	PUNCT
njb-115	320	1	jnatilmed	jnatilmed	PROPN
njb-115	320	2	assoc	assoc	PROPN
njb-115	320	3	.	.	PUNCT
njb-115	321	1	2003	2003	NUM
njb-115	321	2	dec	dec	PROPN
njb-115	321	3	;	;	PUNCT
njb-115	321	4	95(12):1189	95(12):1189	NUM
njb-115	321	5	-	-	SYM
njb-115	321	6	1195	1195	NUM
njb-115	321	7	.	.	PUNCT
njb-115	322	1	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2594861/	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2594861/	NUM
njb-115	322	2	14	14	NUM
njb-115	322	3	.	.	PUNCT
njb-115	323	1	carson	carson	PROPN
njb-115	323	2	ja	ja	PROPN
njb-115	323	3	.	.	PUNCT
njb-115	324	1	wound	wound	ADJ
njb-115	324	2	cultures	culture	NOUN
njb-115	324	3	:	:	PUNCT
njb-115	324	4	in	in	ADP
njb-115	324	5	leber	leber	PROPN
njb-115	324	6	a	a	DET
njb-115	324	7	(	(	PUNCT
njb-115	324	8	ed	ed	NOUN
njb-115	324	9	)	)	PUNCT
njb-115	324	10	.	.	PUNCT
njb-115	325	1	clinical	clinical	ADJ
njb-115	325	2	microbiology	microbiology	NOUN
njb-115	325	3	procedures	procedure	NOUN
njb-115	325	4	handbook	handbook	NOUN
njb-115	325	5	.	.	PUNCT
njb-115	326	1	4th	4th	ADJ
njb-115	326	2	ed	ed	PROPN
njb-115	326	3	.	.	PROPN
njb-115	327	1	washington	washington	PROPN
njb-115	327	2	,	,	PUNCT
njb-115	327	3	dc	dc	PROPN
njb-115	327	4	:	:	PUNCT
njb-115	327	5	asm	asm	PROPN
njb-115	327	6	;	;	PUNCT
njb-115	327	7	2016	2016	NUM
njb-115	327	8	.	.	PUNCT
njb-115	328	1	3.13.1.1	3.13.1.1	NUM
njb-115	328	2	-	-	SYM
njb-115	328	3	3.13.2.4	3.13.2.4	NUM
njb-115	328	4	p.	p.	NOUN
njb-115	328	5	15	15	NUM
njb-115	328	6	.	.	PUNCT
njb-115	329	1	gordon	gordon	PROPN
njb-115	329	2	rj	rj	PROPN
njb-115	329	3	,	,	PUNCT
njb-115	329	4	lowy	lowy	PROPN
njb-115	329	5	fd	fd	PROPN
njb-115	329	6	.	.	PROPN
njb-115	329	7	pathogenesis	pathogenesis	PROPN
njb-115	329	8	of	of	ADP
njb-115	329	9	methicillin	methicillin	NOUN
njb-115	329	10	-	-	PUNCT
njb-115	329	11	resistant	resistant	ADJ
njb-115	329	12	staphylococcus	staphylococcus	NOUN
njb-115	329	13	aureus	aureus	NOUN
njb-115	329	14	infection	infection	NOUN
njb-115	329	15	.	.	PUNCT
njb-115	330	1	clin	clin	PROPN
njb-115	330	2	infect	infect	PROPN
njb-115	330	3	dis	dis	PROPN
njb-115	330	4	.	.	PROPN
njb-115	330	5	2008	2008	NUM
njb-115	330	6	jun	jun	PROPN
njb-115	330	7	1;46suppl	1;46suppl	PROPN
njb-115	331	1	5(suppl5):s350	5(suppl5):s350	NUM
njb-115	331	2	-	-	PUNCT
njb-115	331	3	s359	s359	PROPN
njb-115	331	4	.	.	PUNCT
njb-115	332	1	doi	doi	PROPN
njb-115	332	2	:	:	PUNCT
njb-115	332	3	10.1086/533591	10.1086/533591	NUM
njb-115	332	4	.	.	PROPN
njb-115	332	5	16	16	NUM
njb-115	332	6	.	.	PUNCT
njb-115	333	1	yasmeen	yasmeen	PROPN
njb-115	333	2	f	f	PROPN
njb-115	333	3	,	,	PUNCT
njb-115	333	4	sarwar	sarwar	PROPN
njb-115	333	5	mi	mi	PROPN
njb-115	333	6	,	,	PUNCT
njb-115	333	7	hakeem	hakeem	PROPN
njb-115	333	8	a	a	PROPN
njb-115	333	9	,	,	PUNCT
njb-115	333	10	sherwani	sherwani	PROPN
njb-115	333	11	sk	sk	PROPN
njb-115	333	12	,	,	PUNCT
njb-115	333	13	hussain	hussain	PROPN
njb-115	333	14	ms	ms	PROPN
njb-115	333	15	,	,	PUNCT
njb-115	333	16	zeb	zeb	PROPN
njb-115	333	17	m	m	PROPN
njb-115	333	18	,	,	PUNCT
njb-115	333	19	irfan	irfan	PROPN
njb-115	333	20	s	s	PROPN
njb-115	333	21	,	,	PUNCT
njb-115	333	22	khan	khan	PROPN
njb-115	333	23	mm	mm	PROPN
njb-115	333	24	.	.	PUNCT
njb-115	334	1	identification	identification	NOUN
njb-115	334	2	of	of	ADP
njb-115	334	3	staphylococcus	staphylococcus	NOUN
njb-115	334	4	aureus	aureus	PROPN
njb-115	334	5	in	in	ADP
njb-115	334	6	pus	pus	NOUN
njb-115	334	7	samples	sample	NOUN
njb-115	334	8	and	and	CCONJ
njb-115	334	9	its	its	PRON
njb-115	334	10	anti	anti	ADJ
njb-115	334	11	-	-	ADJ
njb-115	334	12	microbial	microbial	ADJ
njb-115	334	13	susceptibility	susceptibility	NOUN
njb-115	334	14	against	against	ADP
njb-115	334	15	imipenem	imipenem	PROPN
njb-115	334	16	,	,	PUNCT
njb-115	334	17	tobramycin	tobramycin	PROPN
njb-115	334	18	and	and	CCONJ
njb-115	334	19	linezolid	linezolid	PROPN
njb-115	334	20	.	.	PUNCT
njb-115	335	1	international	international	ADJ
njb-115	335	2	ijbmsp	ijbmsp	PROPN
njb-115	335	3	.	.	PUNCT
njb-115	336	1	2014	2014	NUM
njb-115	336	2	jun;4(1):912	jun;4(1):912	NOUN
njb-115	336	3	.	.	PUNCT
njb-115	337	1	https://www.ijbmsp.org/index.php/ijbmsp/article/view/56/4	https://www.ijbmsp.org/index.php/ijbmsp/article/view/56/4	X
njb-115	338	1	3	3	NUM
njb-115	338	2	17	17	NUM
njb-115	338	3	.	.	PUNCT
njb-115	339	1	kumar	kumar	PROPN
njb-115	339	2	ar	ar	PROPN
njb-115	339	3	.	.	PROPN
njb-115	339	4	antimicrobial	antimicrobial	ADJ
njb-115	339	5	sensitivity	sensitivity	NOUN
njb-115	339	6	pattern	pattern	NOUN
njb-115	339	7	of	of	ADP
njb-115	339	8	klebsiella	klebsiella	PROPN
njb-115	339	9	pneumonia	pneumonia	PROPN
njb-115	339	10	isolated	isolate	VERB
njb-115	339	11	from	from	ADP
njb-115	339	12	pus	pus	NOUN
njb-115	339	13	from	from	ADP
njb-115	339	14	tertiary	tertiary	ADJ
njb-115	339	15	care	care	NOUN
njb-115	339	16	hospital	hospital	NOUN
njb-115	339	17	and	and	CCONJ
njb-115	339	18	issues	issue	NOUN
njb-115	339	19	related	relate	VERB
njb-115	339	20	to	to	ADP
njb-115	339	21	the	the	DET
njb-115	339	22	rational	rational	ADJ
njb-115	339	23	selection	selection	NOUN
njb-115	339	24	of	of	ADP
njb-115	339	25	antimicrobials	antimicrobial	NOUN
njb-115	339	26	.	.	PUNCT
njb-115	340	1	jchem	jchem	PROPN
njb-115	340	2	pharmres	pharmres	PROPN
njb-115	340	3	.	.	PUNCT
njb-115	341	1	2013;5(11):326	2013;5(11):326	NUM
njb-115	341	2	-	-	SYM
njb-115	341	3	331	331	NUM
njb-115	341	4	.	.	PROPN
njb-115	341	5	http://www.jocpr.com/	http://www.jocpr.com/	NUM
njb-115	341	6	18	18	NUM
njb-115	341	7	.	.	PUNCT
njb-115	342	1	gillespie	gillespie	PROPN
njb-115	342	2	sh	sh	PROPN
njb-115	342	3	,	,	PUNCT
njb-115	342	4	hawkey	hawkey	NOUN
njb-115	342	5	pm	pm	NOUN
njb-115	342	6	.	.	PUNCT
njb-115	343	1	principle	principle	NOUN
njb-115	343	2	and	and	CCONJ
njb-115	343	3	practice	practice	NOUN
njb-115	343	4	of	of	ADP
njb-115	343	5	clinical	clinical	ADJ
njb-115	343	6	bacteriology	bacteriology	NOUN
njb-115	343	7	.	.	PUNCT
njb-115	344	1	2nd	2nd	PROPN
njb-115	344	2	ed	ed	PROPN
njb-115	344	3	.	.	PROPN
njb-115	345	1	england	england	PROPN
njb-115	345	2	:	:	PUNCT
njb-115	345	3	john	john	PROPN
njb-115	345	4	wiley	wiley	PROPN
njb-115	345	5	and	and	CCONJ
njb-115	345	6	sons	sons	PROPN
njb-115	345	7	ltd	ltd	PROPN
njb-115	345	8	;	;	PUNCT
njb-115	345	9	2006	2006	NUM
njb-115	345	10	.	.	PUNCT
njb-115	345	11	7398	7398	NUM
njb-115	346	1	p.	p.	NOUN
njb-115	346	2	19	19	NUM
njb-115	346	3	.	.	PUNCT
njb-115	347	1	parija	parija	PROPN
njb-115	347	2	sc	sc	PROPN
njb-115	347	3	.	.	PROPN
njb-115	347	4	textbook	textbook	NOUN
njb-115	347	5	of	of	ADP
njb-115	347	6	microbiology	microbiology	NOUN
njb-115	347	7	and	and	CCONJ
njb-115	347	8	immunology	immunology	NOUN
njb-115	347	9	.	.	PUNCT
njb-115	348	1	2nd	2nd	PROPN
njb-115	348	2	ed	ed	PROPN
njb-115	348	3	.	.	PROPN
njb-115	348	4	india	india	PROPN
njb-115	348	5	:	:	PUNCT
njb-115	348	6	elsevier	elsevier	PROPN
njb-115	348	7	,	,	PUNCT
njb-115	348	8	a	a	DET
njb-115	348	9	division	division	NOUN
njb-115	348	10	of	of	ADP
njb-115	348	11	reed	reed	PROPN
njb-115	348	12	elsevier	elsevier	PROPN
njb-115	348	13	india	india	PROPN
njb-115	348	14	private	private	PROPN
njb-115	348	15	limited	limited	PROPN
njb-115	348	16	;	;	PUNCT
njb-115	348	17	2013	2013	NUM
njb-115	348	18	.	.	PUNCT
njb-115	349	1	173	173	NUM
njb-115	349	2	-	-	SYM
njb-115	349	3	181	181	NUM
njb-115	349	4	p.	p.	NOUN
njb-115	349	5	20	20	NUM
njb-115	349	6	.	.	PUNCT
njb-115	350	1	muluye	muluye	PROPN
njb-115	350	2	d	d	PROPN
njb-115	350	3	,	,	PUNCT
njb-115	350	4	wondimeneh	wondimeneh	PROPN
njb-115	350	5	y	y	PROPN
njb-115	350	6	,	,	PUNCT
njb-115	350	7	ferede	ferede	PROPN
njb-115	350	8	g	g	PROPN
njb-115	350	9	,	,	PUNCT
njb-115	350	10	nega	nega	PROPN
njb-115	350	11	t	t	PROPN
njb-115	350	12	,	,	PUNCT
njb-115	350	13	adane	adane	PROPN
njb-115	350	14	k	k	PROPN
njb-115	350	15	,	,	PUNCT
njb-115	350	16	biadgo	biadgo	PROPN
njb-115	350	17	b	b	PROPN
njb-115	350	18	,	,	PUNCT
njb-115	350	19	et	et	PROPN
njb-115	350	20	al	al	PROPN
njb-115	350	21	.	.	PUNCT
njb-115	351	1	bacterial	bacterial	ADJ
njb-115	351	2	isolates	isolate	NOUN
njb-115	351	3	and	and	CCONJ
njb-115	351	4	their	their	PRON
njb-115	351	5	antibiotic	antibiotic	ADJ
njb-115	351	6	susceptibility	susceptibility	NOUN
njb-115	351	7	patterns	pattern	NOUN
njb-115	351	8	among	among	ADP
njb-115	351	9	patients	patient	NOUN
njb-115	351	10	with	with	ADP
njb-115	351	11	pus	pus	NOUN
njb-115	351	12	and/or	and/or	CCONJ
njb-115	351	13	wound	wound	ADJ
njb-115	351	14	discharge	discharge	NOUN
njb-115	351	15	at	at	ADP
njb-115	351	16	gondar	gondar	PROPN
njb-115	351	17	university	university	PROPN
njb-115	351	18	hospital	hospital	NOUN
njb-115	351	19	.	.	PUNCT
njb-115	352	1	bmc	bmc	PROPN
njb-115	352	2	resnotes	resnotes	PROPN
njb-115	352	3	.	.	PUNCT
njb-115	353	1	2014	2014	NUM
njb-115	353	2	sep	sep	PROPN
njb-115	353	3	9;7:619	9;7:619	PROPN
njb-115	353	4	.	.	PUNCT
njb-115	354	1	doi:10.1186/1756	doi:10.1186/1756	NUM
njb-115	354	2	-	-	PUNCT
njb-115	354	3	0500	0500	NUM
njb-115	354	4	-	-	SYM
njb-115	354	5	7	7	NUM
njb-115	354	6	-	-	NUM
njb-115	354	7	619	619	NUM
njb-115	354	8	.	.	PUNCT
njb-115	354	9	21	21	NUM
njb-115	354	10	.	.	PUNCT
njb-115	355	1	magiorakos	magiorakos	PROPN
njb-115	355	2	ap	ap	PROPN
njb-115	355	3	,	,	PUNCT
njb-115	355	4	srinivasan	srinivasan	VERB
njb-115	355	5	a	a	PRON
njb-115	355	6	,	,	PUNCT
njb-115	355	7	carey	carey	NOUN
njb-115	355	8	rb	rb	NOUN
njb-115	355	9	,	,	PUNCT
njb-115	355	10	carmeli	carmeli	PROPN
njb-115	355	11	y	y	PROPN
njb-115	355	12	,	,	PUNCT
njb-115	355	13	falagas	falagas	VERB
njb-115	355	14	me	i	PRON
njb-115	355	15	,	,	PUNCT
njb-115	355	16	giske	giske	PROPN
njb-115	355	17	cg	cg	PROPN
njb-115	355	18	,	,	PUNCT
njb-115	355	19	et	et	PROPN
njb-115	355	20	al	al	PROPN
njb-115	355	21	.	.	PUNCT
njb-115	356	1	multidrug	multidrug	PROPN
njb-115	356	2	-	-	PUNCT
njb-115	356	3	resistant	resistant	ADJ
njb-115	356	4	,	,	PUNCT
njb-115	356	5	extensively	extensively	ADV
njb-115	356	6	drug	drug	NOUN
njb-115	356	7	-	-	PUNCT
njb-115	356	8	resistant	resistant	ADJ
njb-115	356	9	and	and	CCONJ
njb-115	356	10	pandrug	pandrug	NOUN
njb-115	356	11	-	-	PUNCT
njb-115	356	12	resistant	resistant	ADJ
njb-115	356	13	bacteria	bacteria	NOUN
njb-115	356	14	:	:	PUNCT
njb-115	356	15	an	an	DET
njb-115	356	16	international	international	ADJ
njb-115	356	17	expert	expert	NOUN
njb-115	356	18	proposal	proposal	NOUN
njb-115	356	19	for	for	ADP
njb-115	356	20	interim	interim	ADJ
njb-115	356	21	standard	standard	ADJ
njb-115	356	22	definitions	definition	NOUN
njb-115	356	23	for	for	ADP
njb-115	356	24	acquired	acquire	VERB
njb-115	356	25	resistance	resistance	NOUN
njb-115	356	26	.	.	PUNCT
njb-115	357	1	clinmicrobiol	clinmicrobiol	PROPN
njb-115	357	2	infect	infect	VERB
njb-115	357	3	.	.	PUNCT
njb-115	358	1	2012;18(3):268	2012;18(3):268	NUM
njb-115	358	2	-	-	SYM
njb-115	358	3	281	281	NUM
njb-115	358	4	.	.	PUNCT
njb-115	358	5	https://doi.org/10.1111/j.1469-0691.2011.03570.x	https://doi.org/10.1111/j.1469-0691.2011.03570.x	PROPN
njb-115	358	6	22	22	NUM
njb-115	358	7	.	.	PUNCT
njb-115	359	1	harkins	harkin	NOUN
njb-115	359	2	cp	cp	PROPN
njb-115	359	3	,	,	PUNCT
njb-115	359	4	pichon	pichon	PROPN
njb-115	359	5	b	b	PROPN
njb-115	359	6	,	,	PUNCT
njb-115	359	7	doumith	doumith	NUM
njb-115	359	8	m	m	PROPN
njb-115	359	9	,	,	PUNCT
njb-115	359	10	parkhill	parkhill	PROPN
njb-115	359	11	j	j	PROPN
njb-115	359	12	,	,	PUNCT
njb-115	359	13	westh	westh	PROPN
njb-115	359	14	h	h	PROPN
njb-115	359	15	,	,	PUNCT
njb-115	359	16	tomasz	tomasz	VERB
njb-115	359	17	a	a	PRON
njb-115	359	18	,	,	PUNCT
njb-115	359	19	et	et	PROPN
njb-115	359	20	al	al	PROPN
njb-115	359	21	.	.	PUNCT
njb-115	360	1	methicillin	methicillin	PROPN
njb-115	360	2	-	-	PUNCT
njb-115	360	3	resistant	resistant	ADJ
njb-115	360	4	staphylococcus	staphylococcus	NOUN
njb-115	360	5	aureus	aureus	NOUN
njb-115	360	6	emerged	emerge	VERB
njb-115	360	7	long	long	ADV
njb-115	360	8	before	before	ADP
njb-115	360	9	the	the	DET
njb-115	360	10	introduction	introduction	NOUN
njb-115	360	11	of	of	ADP
njb-115	360	12	methicillin	methicillin	NOUN
njb-115	360	13	into	into	ADP
njb-115	360	14	clinical	clinical	ADJ
njb-115	360	15	practice	practice	NOUN
njb-115	360	16	.	.	PUNCT
njb-115	361	1	genome	genome	NOUN
njb-115	361	2	biol	biol	NOUN
njb-115	361	3	.	.	PUNCT
njb-115	362	1	2017jul	2017jul	NUM
njb-115	363	1	20;18(1):130.doi	20;18(1):130.doi	NUM
njb-115	363	2	:	:	PUNCT
njb-115	363	3	10.1186	10.1186	NUM
njb-115	363	4	/	/	SYM
njb-115	363	5	s13059	s13059	PROPN
njb-115	363	6	-	-	PUNCT
njb-115	363	7	017	017	NUM
njb-115	363	8	-	-	NUM
njb-115	363	9	1252	1252	NUM
njb-115	363	10	-	-	SYM
njb-115	363	11	9	9	NUM
njb-115	363	12	.	.	PUNCT
njb-115	364	1	https://doi.org/10.20546/ijcmas.2017.606.050	https://doi.org/10.20546/ijcmas.2017.606.050	PROPN
njb-115	365	1	https://doi.org/10.3329/bjid.v1i2.24903	https://doi.org/10.3329/bjid.v1i2.24903	X
njb-115	365	2	http://eprints.hud.ac.uk/id/eprint/30637/1/iwii-consensus_final-web.pdf	http://eprints.hud.ac.uk/id/eprint/30637/1/iwii-consensus_final-web.pdf	PROPN
njb-115	365	3	http://eprints.hud.ac.uk/id/eprint/30637/1/iwii-consensus_final-web.pdf	http://eprints.hud.ac.uk/id/eprint/30637/1/iwii-consensus_final-web.pdf	X
njb-115	365	4	https://www.researchgate.net/publication/271186756	https://www.researchgate.net/publication/271186756	PROPN
njb-115	365	5	http://www.ijcmas.com/	http://www.ijcmas.com/	ADV
njb-115	365	6	https://www.ncbi.nlm.nih.gov/pubmed/23209356	https://www.ncbi.nlm.nih.gov/pubmed/23209356	NUM
njb-115	365	7	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2594861/	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2594861/	NUM
njb-115	365	8	https://www.ijbmsp.org/index.php/ijbmsp/article/view/56/43	https://www.ijbmsp.org/index.php/ijbmsp/article/view/56/43	X
njb-115	365	9	https://www.ijbmsp.org/index.php/ijbmsp/article/view/56/43	https://www.ijbmsp.org/index.php/ijbmsp/article/view/56/43	X
njb-115	365	10	http://www.jocpr.com/	http://www.jocpr.com/	X
njb-115	366	1	https://doi.org/10.1111/j.1469-0691.2011.03570.x	https://doi.org/10.1111/j.1469-0691.2011.03570.x	PROPN
njb-115	366	2	nepal	nepal	PROPN
njb-115	366	3	j	j	PROPN
njb-115	366	4	biotechnol	biotechnol	PROPN
njb-115	366	5	.	.	PUNCT
njb-115	367	1	2	2	NUM
njb-115	367	2	0	0	NUM
njb-115	367	3	2	2	NUM
njb-115	367	4	1	1	NUM
njb-115	367	5	j	j	NOUN
njb-115	367	6	u	u	NOUN
njb-115	367	7	l	l	NOUN
njb-115	367	8	;	;	PUNCT
njb-115	367	9	9	9	NUM
njb-115	367	10	(	(	PUNCT
njb-115	367	11	1):8	1):8	NUM
njb-115	367	12	1	1	NUM
njb-115	367	13	7	7	NUM
njb-115	367	14	maharjan	maharjan	NOUN
njb-115	367	15	et	et	NOUN
njb-115	367	16	al	al	PROPN
njb-115	367	17	.	.	PUNCT
njb-115	368	1	©	©	PROPN
njb-115	368	2	njb	njb	PROPN
njb-115	368	3	,	,	PUNCT
njb-115	368	4	bsn	bsn	PROPN
njb-115	368	5	16	16	NUM
njb-115	368	6	23	23	NUM
njb-115	368	7	.	.	PUNCT
njb-115	369	1	kayastha	kayastha	PROPN
njb-115	369	2	bb	bb	PROPN
njb-115	369	3	,	,	PUNCT
njb-115	369	4	manandhar	manandhar	PROPN
njb-115	369	5	s	s	PROPN
njb-115	369	6	and	and	CCONJ
njb-115	369	7	shrestha	shrestha	X
njb-115	369	8	b.	b.	PROPN
njb-115	369	9	methicillin	methicillin	PROPN
njb-115	369	10	resistant	resistant	ADJ
njb-115	369	11	staphylococcus	staphylococcus	NOUN
njb-115	369	12	aureus	aureus	NOUN
njb-115	369	13	(	(	PUNCT
njb-115	369	14	mrsa	mrsa	PROPN
njb-115	369	15	)	)	PUNCT
njb-115	369	16	in	in	ADP
njb-115	369	17	different	different	ADJ
njb-115	369	18	clinical	clinical	ADJ
njb-115	369	19	samples	sample	NOUN
njb-115	369	20	from	from	ADP
njb-115	369	21	patients	patient	NOUN
njb-115	369	22	presenting	present	VERB
njb-115	369	23	at	at	ADP
njb-115	369	24	kathmandu	kathmandu	PROPN
njb-115	369	25	model	model	PROPN
njb-115	369	26	hospital	hospital	PROPN
njb-115	369	27	.	.	PUNCT
njb-115	370	1	research	research	NOUN
njb-115	370	2	gate	gate	NOUN
njb-115	370	3	.	.	PUNCT
njb-115	371	1	2010	2010	NUM
njb-115	371	2	jan	jan	PROPN
njb-115	371	3	1.https://www.researchgate.net/publication/216834367	1.https://www.researchgate.net/publication/216834367	NUM
njb-115	371	4	_	_	NUM
njb-115	371	5	24	24	NUM
njb-115	371	6	.	.	PUNCT
njb-115	372	1	raut	raut	PROPN
njb-115	372	2	s	s	PROPN
njb-115	372	3	,	,	PUNCT
njb-115	372	4	bajracharya	bajracharya	PROPN
njb-115	372	5	k	k	PROPN
njb-115	372	6	,	,	PUNCT
njb-115	372	7	adhikari	adhikari	PROPN
njb-115	372	8	j	j	PROPN
njb-115	372	9	,	,	PUNCT
njb-115	372	10	pant	pant	PROPN
njb-115	372	11	ss	ss	PROPN
njb-115	372	12	,	,	PUNCT
njb-115	372	13	adhikari	adhikari	PROPN
njb-115	372	14	b.	b.	PROPN
njb-115	372	15	prevalence	prevalence	PROPN
njb-115	372	16	of	of	ADP
njb-115	372	17	methicillin	methicillin	NOUN
njb-115	372	18	resistant	resistant	ADJ
njb-115	372	19	staphylococcus	staphylococcus	NOUN
njb-115	372	20	aureus	aureus	NOUN
njb-115	372	21	in	in	ADP
njb-115	372	22	lumbini	lumbini	PROPN
njb-115	372	23	medical	medical	PROPN
njb-115	372	24	college	college	PROPN
njb-115	372	25	and	and	CCONJ
njb-115	372	26	teaching	teaching	NOUN
njb-115	372	27	hospital	hospital	NOUN
njb-115	372	28	,	,	PUNCT
njb-115	372	29	palpa	palpa	ADJ
njb-115	372	30	,	,	PUNCT
njb-115	372	31	western	western	ADJ
njb-115	372	32	nepal	nepal	NOUN
njb-115	372	33	.	.	PUNCT
njb-115	373	1	bmc	bmc	PROPN
njb-115	373	2	res	res	PROPN
njb-115	373	3	notes	note	NOUN
njb-115	373	4	10	10	NUM
njb-115	373	5	.	.	PUNCT
njb-115	373	6	2017	2017	NUM
njb-115	374	1	jun	jun	PROPN
njb-115	374	2	2;187(2017):187	2;187(2017):187	NUM
njb-115	374	3	.	.	PUNCT
njb-115	375	1	https://doi.org/10.1186/s13104-017-2515-y	https://doi.org/10.1186/s13104-017-2515-y	PROPN
njb-115	375	2	25	25	NUM
njb-115	375	3	.	.	PUNCT
njb-115	376	1	bamigboye	bamigboye	PROPN
njb-115	376	2	bt	bt	PROPN
njb-115	376	3	,	,	PUNCT
njb-115	376	4	olowe	olowe	PROPN
njb-115	376	5	oa	oa	PROPN
njb-115	376	6	,	,	PUNCT
njb-115	376	7	taiwo	taiwo	PROPN
njb-115	376	8	ss	ss	PROPN
njb-115	376	9	.	.	PUNCT
njb-115	377	1	phenotypic	phenotypic	ADJ
njb-115	377	2	and	and	CCONJ
njb-115	377	3	molecular	molecular	ADJ
njb-115	377	4	identification	identification	NOUN
njb-115	377	5	of	of	ADP
njb-115	377	6	vancomycin	vancomycin	PROPN
njb-115	377	7	resistance	resistance	NOUN
njb-115	377	8	in	in	ADP
njb-115	377	9	clinical	clinical	ADJ
njb-115	377	10	staphylococcus	staphylococcus	NOUN
njb-115	377	11	aureus	aureus	NOUN
njb-115	377	12	isolates	isolate	VERB
njb-115	377	13	in	in	ADP
njb-115	377	14	osogbo	osogbo	PROPN
njb-115	377	15	,	,	PUNCT
njb-115	377	16	nigeria	nigeria	PROPN
njb-115	377	17	.	.	PROPN
njb-115	377	18	eur	eur	PROPN
njb-115	377	19	j	j	PROPN
njb-115	377	20	microbiolimmunol	microbiolimmunol	PROPN
njb-115	377	21	(	(	PUNCT
njb-115	377	22	bp	bp	PROPN
njb-115	377	23	)	)	PUNCT
njb-115	377	24	.	.	PUNCT
njb-115	378	1	2018;8(1):25–30.https://doi.org/10.1556/1886.2018.00003	2018;8(1):25–30.https://doi.org/10.1556/1886.2018.00003	NUM
njb-115	378	2	26	26	NUM
njb-115	378	3	.	.	PUNCT
njb-115	379	1	lama	lama	PROPN
njb-115	379	2	u	u	PROPN
njb-115	379	3	,	,	PUNCT
njb-115	379	4	shah	shah	PROPN
njb-115	379	5	d	d	PROPN
njb-115	379	6	,	,	PUNCT
njb-115	379	7	shrestha	shrestha	PROPN
njb-115	379	8	u.	u.	PROPN
njb-115	379	9	vancomycin	vancomycin	PROPN
njb-115	379	10	resistant	resistant	ADJ
njb-115	379	11	staphylococcus	staphylococcus	NOUN
njb-115	379	12	aureus	aureus	NOUN
njb-115	379	13	reported	report	VERB
njb-115	379	14	from	from	ADP
njb-115	379	15	tertiary	tertiary	ADJ
njb-115	379	16	care	care	NOUN
njb-115	379	17	hospital	hospital	NOUN
njb-115	379	18	in	in	ADP
njb-115	379	19	nepal	nepal	ADJ
njb-115	379	20	.	.	PUNCT
njb-115	380	1	tribhuvan	tribhuvan	PROPN
njb-115	380	2	university	university	PROPN
njb-115	380	3	journal	journal	PROPN
njb-115	380	4	of	of	ADP
njb-115	380	5	microbiology	microbiology	NOUN
njb-115	380	6	.	.	PUNCT
njb-115	381	1	2018	2018	NUM
njb-115	382	1	nov	nov	PROPN
njb-115	382	2	6;4:63	6;4:63	PROPN
njb-115	382	3	-	-	SYM
njb-115	382	4	72	72	NUM
njb-115	382	5	.	.	PUNCT
njb-115	382	6	https://doi.org/10.3126/tujm.v4i0.21679	https://doi.org/10.3126/tujm.v4i0.21679	PROPN
njb-115	382	7	27	27	NUM
njb-115	382	8	.	.	PUNCT
njb-115	383	1	shrestha	shrestha	PROPN
njb-115	383	2	b	b	PROPN
njb-115	383	3	,	,	PUNCT
njb-115	383	4	pokhrel	pokhrel	PROPN
njb-115	383	5	bm	bm	PROPN
njb-115	383	6	,	,	PUNCT
njb-115	383	7	mohapatra	mohapatra	PROPN
njb-115	383	8	t.	t.	PROPN
njb-115	383	9	phenotypic	phenotypic	ADJ
njb-115	383	10	characterization	characterization	NOUN
njb-115	383	11	of	of	ADP
njb-115	383	12	nosocomial	nosocomial	ADJ
njb-115	383	13	isolates	isolate	NOUN
njb-115	383	14	of	of	ADP
njb-115	383	15	staphylococcus	staphylococcus	NOUN
njb-115	383	16	aureus	aureus	NOUN
njb-115	383	17	with	with	ADP
njb-115	383	18	reference	reference	NOUN
njb-115	383	19	to	to	ADP
njb-115	383	20	mrsa	mrsa	PROPN
njb-115	383	21	.	.	PUNCT
njb-115	384	1	j	j	PROPN
njb-115	384	2	infect	infect	PROPN
njb-115	384	3	dev	dev	PROPN
njb-115	384	4	ctries.2009	ctries.2009	X
njb-115	384	5	aug	aug	PROPN
njb-115	384	6	30;3(7):554560	30;3(7):554560	PROPN
njb-115	384	7	.	.	PUNCT
njb-115	385	1	doi	doi	PROPN
njb-115	385	2	:	:	PUNCT
njb-115	385	3	10.3855	10.3855	NUM
njb-115	385	4	/	/	SYM
njb-115	385	5	jidc.474	jidc.474	PROPN
njb-115	385	6	28	28	NUM
njb-115	385	7	.	.	PUNCT
njb-115	386	1	shrestha	shrestha	PROPN
njb-115	386	2	j	j	PROPN
njb-115	386	3	,	,	PUNCT
njb-115	386	4	khanal	khanal	PROPN
njb-115	386	5	s	s	PROPN
njb-115	386	6	,	,	PUNCT
njb-115	386	7	poudel	poudel	PROPN
njb-115	386	8	p	p	PROPN
njb-115	386	9	,	,	PUNCT
njb-115	386	10	panta	panta	NOUN
njb-115	386	11	op	op	PROPN
njb-115	386	12	,	,	PUNCT
njb-115	386	13	prajapati	prajapati	PROPN
njb-115	386	14	kg	kg	PROPN
njb-115	386	15	.	.	PUNCT
njb-115	387	1	methicillin	methicillin	PROPN
njb-115	387	2	resistant	resistant	ADJ
njb-115	387	3	staphylococcus	staphylococcus	NOUN
njb-115	387	4	aureus	aureus	NOUN
njb-115	387	5	isolated	isolate	VERB
njb-115	387	6	from	from	ADP
njb-115	387	7	wound	wound	ADJ
njb-115	387	8	infections	infection	NOUN
njb-115	387	9	.	.	PUNCT
njb-115	388	1	tribhuvan	tribhuvan	PROPN
njb-115	388	2	university	university	PROPN
njb-115	388	3	journal	journal	PROPN
njb-115	388	4	of	of	ADP
njb-115	388	5	microbiology	microbiology	NOUN
njb-115	388	6	.	.	PUNCT
njb-115	389	1	2018	2018	NUM
njb-115	389	2	sep	sep	ADP
njb-115	389	3	26;5:1924	26;5:1924	NUM
njb-115	389	4	.	.	PUNCT
njb-115	390	1	https://doi.org/10.3126/tujm.v5i0.22297	https://doi.org/10.3126/tujm.v5i0.22297	PROPN
njb-115	390	2	29	29	NUM
njb-115	390	3	.	.	PUNCT
njb-115	391	1	shrestha	shrestha	PROPN
njb-115	391	2	b	b	PROPN
njb-115	391	3	,	,	PUNCT
njb-115	391	4	rana	rana	PROPN
njb-115	391	5	ss	ss	NOUN
njb-115	391	6	.	.	PUNCT
njb-115	392	1	d	d	PROPN
njb-115	392	2	test	test	PROPN
njb-115	392	3	:	:	PUNCT
njb-115	392	4	a	a	DET
njb-115	392	5	simple	simple	ADJ
njb-115	392	6	test	test	NOUN
njb-115	392	7	with	with	ADP
njb-115	392	8	big	big	ADJ
njb-115	392	9	implication	implication	NOUN
njb-115	392	10	for	for	ADP
njb-115	392	11	staphylococcusaureus	staphylococcusaureus	PROPN
njb-115	392	12	macrolide	macrolide	PROPN
njb-115	392	13	-	-	PUNCT
njb-115	392	14	lincosamide	lincosamide	PROPN
njb-115	392	15	-	-	PUNCT
njb-115	392	16	streptogramin	streptogramin	NOUN
njb-115	392	17	b	b	PROPN
njb-115	392	18	resistance	resistance	NOUN
njb-115	392	19	pattern	pattern	NOUN
njb-115	392	20	.	.	PUNCT
njb-115	393	1	nepal	nepal	ADJ
njb-115	393	2	medcollj	medcollj	NOUN
njb-115	393	3	.	.	PUNCT
njb-115	394	1	2014	2014	NUM
njb-115	394	2	sep;16(1):88	sep;16(1):88	PROPN
njb-115	394	3	-	-	PUNCT
njb-115	394	4	94	94	NUM
njb-115	394	5	.	.	PUNCT
njb-115	395	1	pmid	pmid	NOUN
njb-115	395	2	:	:	PUNCT
njb-115	395	3	25799821	25799821	NUM
njb-115	395	4	30	30	NUM
njb-115	395	5	.	.	PUNCT
njb-115	395	6	cheesbrough	cheesbrough	PROPN
njb-115	395	7	m.	m.	PROPN
njb-115	395	8	district	district	PROPN
njb-115	395	9	laboratory	laboratory	NOUN
njb-115	395	10	practice	practice	NOUN
njb-115	395	11	in	in	ADP
njb-115	395	12	tropical	tropical	ADJ
njb-115	395	13	countries	country	NOUN
njb-115	395	14	.	.	PUNCT
njb-115	396	1	2nded	2nded	NUM
njb-115	396	2	.	.	PUNCT
njb-115	397	1	new	new	PROPN
njb-115	397	2	york	york	PROPN
njb-115	397	3	:	:	PUNCT
njb-115	397	4	cambridge	cambridge	PROPN
njb-115	397	5	university	university	PROPN
njb-115	397	6	press	press	NOUN
njb-115	397	7	;	;	PUNCT
njb-115	397	8	2016.80	2016.80	NUM
njb-115	397	9	-	-	SYM
njb-115	397	10	85	85	NUM
njb-115	397	11	,	,	PUNCT
njb-115	397	12	132143	132143	NUM
njb-115	397	13	,	,	PUNCT
njb-115	397	14	62	62	NUM
njb-115	397	15	-	-	SYM
njb-115	397	16	70	70	NUM
njb-115	397	17	,	,	PUNCT
njb-115	397	18	385	385	NUM
njb-115	397	19	-	-	PUNCT
njb-115	397	20	400p	400p	NOUN
njb-115	397	21	.	.	PROPN
njb-115	397	22	31	31	NUM
njb-115	397	23	.	.	PUNCT
njb-115	398	1	clsi	clsi	PROPN
njb-115	398	2	(	(	PUNCT
njb-115	398	3	clinical	clinical	ADJ
njb-115	398	4	and	and	CCONJ
njb-115	398	5	laboratory	laboratory	PROPN
njb-115	398	6	standards	standards	PROPN
njb-115	398	7	institute	institute	PROPN
njb-115	398	8	)	)	PUNCT
njb-115	398	9	guidelines	guideline	NOUN
njb-115	398	10	.	.	PUNCT
njb-115	399	1	m100	m100	PROPN
njb-115	399	2	performance	performance	NOUN
njb-115	399	3	standards	standard	NOUN
njb-115	399	4	for	for	ADP
njb-115	399	5	antimicrobial	antimicrobial	ADJ
njb-115	399	6	susceptibility	susceptibility	NOUN
njb-115	399	7	testing	testing	NOUN
njb-115	399	8	.	.	PUNCT
njb-115	400	1	27th	27th	ADJ
njb-115	400	2	ed	ed	NOUN
njb-115	400	3	.	.	PROPN
njb-115	400	4	950	950	NUM
njb-115	400	5	west	west	PROPN
njb-115	400	6	valley	valley	PROPN
njb-115	400	7	road	road	NOUN
njb-115	400	8	,	,	PUNCT
njb-115	400	9	suite	suite	NOUN
njb-115	400	10	2500	2500	NUM
njb-115	400	11	,	,	PUNCT
njb-115	400	12	wayne	wayne	PROPN
njb-115	400	13	,	,	PUNCT
njb-115	400	14	pa	pa	PROPN
njb-115	400	15	19087	19087	NUM
njb-115	400	16	usa	usa	PROPN
njb-115	400	17	;	;	PUNCT
njb-115	400	18	2017	2017	NUM
njb-115	400	19	32	32	NUM
njb-115	400	20	.	.	PUNCT
njb-115	401	1	hanumanthappa	hanumanthappa	PROPN
njb-115	401	2	p	p	PROPN
njb-115	401	3	,	,	PUNCT
njb-115	401	4	vishalakshi	vishalakshi	PROPN
njb-115	401	5	b	b	PROPN
njb-115	401	6	,	,	PUNCT
njb-115	401	7	krishna	krishna	PROPN
njb-115	401	8	s.	s.	PROPN
njb-115	401	9	a	a	DET
njb-115	401	10	study	study	NOUN
njb-115	401	11	on	on	ADP
njb-115	401	12	aerobic	aerobic	ADJ
njb-115	401	13	bacteriological	bacteriological	ADJ
njb-115	401	14	profile	profile	NOUN
njb-115	401	15	and	and	CCONJ
njb-115	401	16	drug	drug	NOUN
njb-115	401	17	sensitivity	sensitivity	NOUN
njb-115	401	18	pattern	pattern	NOUN
njb-115	401	19	of	of	ADP
njb-115	401	20	pus	pus	NOUN
njb-115	401	21	samples	sample	NOUN
njb-115	401	22	in	in	ADP
njb-115	401	23	a	a	DET
njb-115	401	24	tertiary	tertiary	ADJ
njb-115	401	25	care	care	NOUN
njb-115	401	26	hospital	hospital	NOUN
njb-115	401	27	.	.	PUNCT
njb-115	402	1	int	int	PROPN
njb-115	402	2	j	j	PROPN
njb-115	402	3	currmicrobiol	currmicrobiol	PROPN
njb-115	402	4	app	app	PROPN
njb-115	402	5	sci	sci	PROPN
njb-115	402	6	.	.	PROPN
njb-115	402	7	2016	2016	NUM
njb-115	403	1	jan:5(1):95	jan:5(1):95	PROPN
njb-115	403	2	-	-	PUNCT
njb-115	403	3	102.http://dx.doi.org/10.20546	102.http://dx.doi.org/10.20546	NUM
njb-115	403	4	/	/	SYM
njb-115	403	5	ijcmas.2016	ijcmas.2016	PROPN
njb-115	403	6	33	33	NUM
njb-115	403	7	.	.	PUNCT
njb-115	404	1	khan	khan	PROPN
njb-115	404	2	ra	ra	PROPN
njb-115	404	3	,	,	PUNCT
njb-115	404	4	jawaid	jawaid	VERB
njb-115	404	5	m	m	PROPN
njb-115	404	6	,	,	PUNCT
njb-115	404	7	khaleel	khaleel	PROPN
njb-115	404	8	m.	m.	PROPN
njb-115	404	9	bacteriological	bacteriological	PROPN
njb-115	404	10	profile	profile	NOUN
njb-115	404	11	and	and	CCONJ
njb-115	404	12	antibiogram	antibiogram	ADV
njb-115	404	13	of	of	ADP
njb-115	404	14	isolates	isolate	NOUN
njb-115	404	15	from	from	ADP
njb-115	404	16	pus	pus	NOUN
njb-115	404	17	samples	sample	NOUN
njb-115	404	18	in	in	ADP
njb-115	404	19	a	a	DET
njb-115	404	20	tertiary	tertiary	ADJ
njb-115	404	21	care	care	NOUN
njb-115	404	22	centre	centre	NOUN
njb-115	404	23	.	.	PUNCT
njb-115	405	1	int	int	PROPN
njb-115	405	2	j	j	PROPN
njb-115	405	3	currmicrobiol	currmicrobiol	PROPN
njb-115	405	4	app	app	PROPN
njb-115	405	5	sci	sci	PROPN
njb-115	405	6	.	.	PROPN
njb-115	405	7	2018	2018	NUM
njb-115	405	8	jan	jan	PROPN
njb-115	405	9	10;7(01	10;7(01	NUM
njb-115	405	10	):	):	PUNCT
njb-115	405	11	387	387	NUM
njb-115	405	12	-	-	SYM
njb-115	405	13	394	394	NUM
njb-115	405	14	.	.	PUNCT
njb-115	406	1	doi	doi	PROPN
njb-115	406	2	:	:	PUNCT
njb-115	406	3	https://doi.org/10.20546/ijcmas.2018.701.044	https://doi.org/10.20546/ijcmas.2018.701.044	PROPN
njb-115	406	4	34	34	NUM
njb-115	406	5	.	.	PUNCT
njb-115	407	1	patil	patil	PROPN
njb-115	407	2	sb	sb	PROPN
njb-115	407	3	,	,	PUNCT
njb-115	407	4	paramne	paramne	PROPN
njb-115	407	5	a	a	DET
njb-115	407	6	,	,	PUNCT
njb-115	407	7	harsh	harsh	ADJ
njb-115	407	8	s.	s.	PROPN
njb-115	407	9	antibiotic	antibiotic	ADJ
njb-115	407	10	susceptibility	susceptibility	NOUN
njb-115	407	11	of	of	ADP
njb-115	407	12	wound	wound	NOUN
njb-115	407	13	isolates	isolate	NOUN
njb-115	407	14	in	in	ADP
njb-115	407	15	plastic	plastic	ADJ
njb-115	407	16	surgery	surgery	NOUN
njb-115	407	17	patients	patient	NOUN
njb-115	407	18	at	at	ADP
njb-115	407	19	a	a	DET
njb-115	407	20	tertiary	tertiary	ADJ
njb-115	407	21	care	care	NOUN
njb-115	407	22	centre	centre	NOUN
njb-115	407	23	.	.	PUNCT
njb-115	408	1	indian	indian	PROPN
njb-115	408	2	j	j	PROPN
njb-115	408	3	plast	plast	PROPN
njb-115	408	4	surg	surg	NOUN
njb-115	408	5	.	.	PUNCT
njb-115	409	1	2016	2016	NUM
njb-115	409	2	may;49(2):198	may;49(2):198	PROPN
njb-115	409	3	-	-	PUNCT
njb-115	409	4	205	205	NUM
njb-115	409	5	.	.	PUNCT
njb-115	410	1	doi	doi	PROPN
njb-115	410	2	:	:	PUNCT
njb-115	410	3	10.4103/09700358.191324	10.4103/09700358.191324	NUM
njb-115	410	4	.	.	PUNCT
njb-115	410	5	35	35	NUM
njb-115	410	6	.	.	PUNCT
njb-115	411	1	kc	kc	PROPN
njb-115	411	2	r	r	NOUN
njb-115	411	3	,	,	PUNCT
njb-115	411	4	shrestha	shrestha	PROPN
njb-115	411	5	a	a	DET
njb-115	411	6	,	,	PUNCT
njb-115	411	7	sharma	sharma	PROPN
njb-115	411	8	vk	vk	PROPN
njb-115	411	9	.	.	PROPN
njb-115	411	10	bacteriological	bacteriological	ADJ
njb-115	411	11	study	study	NOUN
njb-115	411	12	of	of	ADP
njb-115	411	13	wound	wound	NOUN
njb-115	411	14	infection	infection	NOUN
njb-115	411	15	and	and	CCONJ
njb-115	411	16	antibiotic	antibiotic	ADJ
njb-115	411	17	susceptibility	susceptibility	NOUN
njb-115	411	18	pattern	pattern	NOUN
njb-115	411	19	of	of	ADP
njb-115	411	20	the	the	DET
njb-115	411	21	isolates	isolate	NOUN
njb-115	411	22	.	.	PUNCT
njb-115	412	1	nepal	nepal	ADJ
njb-115	412	2	journal	journal	NOUN
njb-115	412	3	of	of	ADP
njb-115	412	4	science	science	NOUN
njb-115	412	5	and	and	CCONJ
njb-115	412	6	technology	technology	NOUN
njb-115	412	7	.	.	PUNCT
njb-115	413	1	2013	2013	NUM
njb-115	413	2	may	may	AUX
njb-115	413	3	15;14(2):143	15;14(2):143	NUM
njb-115	413	4	-	-	PUNCT
njb-115	413	5	150	150	NUM
njb-115	413	6	.	.	PUNCT
njb-115	413	7	https://doi.org/10.3126/njst.v14i2.10428	https://doi.org/10.3126/njst.v14i2.10428	X
njb-115	414	1	36	36	NUM
njb-115	414	2	.	.	PUNCT
njb-115	415	1	pant	pant	PROPN
njb-115	415	2	m	m	PROPN
njb-115	415	3	,	,	PUNCT
njb-115	415	4	shrestha	shrestha	PROPN
njb-115	415	5	d	d	PROPN
njb-115	415	6	,	,	PUNCT
njb-115	415	7	thapa	thapa	PROPN
njb-115	415	8	s.	s.	PROPN
njb-115	415	9	antibiogram	antibiogram	PROPN
njb-115	415	10	of	of	ADP
njb-115	415	11	bacterial	bacterial	ADJ
njb-115	415	12	species	specie	NOUN
njb-115	415	13	causing	cause	VERB
njb-115	415	14	skin	skin	NOUN
njb-115	415	15	wound	wound	NOUN
njb-115	415	16	infections	infection	NOUN
njb-115	415	17	.	.	PUNCT
njb-115	416	1	novel	novel	ADJ
njb-115	416	2	research	research	NOUN
njb-115	416	3	in	in	ADP
njb-115	416	4	microbiology	microbiology	NOUN
njb-115	416	5	journal	journal	NOUN
njb-115	416	6	.	.	PUNCT
njb-115	417	1	2018	2018	NUM
njb-115	417	2	jun	jun	PROPN
njb-115	417	3	25;2(3):53	25;2(3):53	NUM
njb-115	417	4	-	-	SYM
njb-115	417	5	60	60	NUM
njb-115	417	6	.	.	PUNCT
njb-115	418	1	doi	doi	X
njb-115	418	2	:	:	PUNCT
njb-115	418	3	10.21608	10.21608	NUM
njb-115	418	4	/	/	SYM
njb-115	418	5	nrmj.2018.8153	nrmj.2018.8153	NOUN
njb-115	418	6	37	37	NUM
njb-115	418	7	.	.	PUNCT
njb-115	419	1	devi	devi	PROPN
njb-115	419	2	pn	pn	PROPN
njb-115	419	3	,	,	PUNCT
njb-115	419	4	saikumar	saikumar	PROPN
njb-115	419	5	c.	c.	PROPN
njb-115	419	6	prevalence	prevalence	PROPN
njb-115	419	7	and	and	CCONJ
njb-115	419	8	antimicrobial	antimicrobial	ADJ
njb-115	419	9	susceptibility	susceptibility	NOUN
njb-115	419	10	of	of	ADP
njb-115	419	11	methicillin	methicillin	NOUN
njb-115	419	12	resistant	resistant	ADJ
njb-115	419	13	staphylococcus	staphylococcus	NOUN
njb-115	419	14	aureus	aureus	NOUN
njb-115	419	15	in	in	ADP
njb-115	419	16	wound	wound	ADJ
njb-115	419	17	infections	infection	NOUN
njb-115	419	18	in	in	ADP
njb-115	419	19	a	a	DET
njb-115	419	20	tertiary	tertiary	ADJ
njb-115	419	21	care	care	NOUN
njb-115	419	22	hospital	hospital	NOUN
njb-115	419	23	.	.	PUNCT
njb-115	420	1	int	int	PROPN
njb-115	420	2	j	j	PROPN
njb-115	420	3	currmicrobiol	currmicrobiol	PROPN
njb-115	420	4	app	app	PROPN
njb-115	420	5	sci	sci	PROPN
njb-115	420	6	.	.	PROPN
njb-115	420	7	2017	2017	NUM
njb-115	421	1	sep	sep	PROPN
njb-115	421	2	28;6(10):3472	28;6(10):3472	NUM
njb-115	421	3	-	-	SYM
njb-115	421	4	3479	3479	NUM
njb-115	421	5	https://doi.org/10.20546/ijcmas.2017.610.409	https://doi.org/10.20546/ijcmas.2017.610.409	VERB
njb-115	421	6	38	38	NUM
njb-115	421	7	.	.	PUNCT
njb-115	422	1	sultana	sultana	PROPN
njb-115	422	2	s	s	PROPN
njb-115	422	3	,	,	PUNCT
njb-115	422	4	mawlan	mawlan	PROPN
njb-115	422	5	,	,	PUNCT
njb-115	422	6	kawser	kawser	PROPN
njb-115	422	7	s	s	PROPN
njb-115	422	8	,	,	PUNCT
njb-115	422	9	akhtar	akhtar	PROPN
njb-115	422	10	n	n	PROPN
njb-115	422	11	,	,	PUNCT
njb-115	422	12	ali	ali	PROPN
njb-115	422	13	mk	mk	PROPN
njb-115	422	14	.	.	PROPN
njb-115	423	1	current	current	ADJ
njb-115	423	2	microbial	microbial	ADJ
njb-115	423	3	isolates	isolate	NOUN
njb-115	423	4	from	from	ADP
njb-115	423	5	wound	wound	ADJ
njb-115	423	6	swab	swab	NOUN
njb-115	423	7	and	and	CCONJ
njb-115	423	8	their	their	PRON
njb-115	423	9	susceptibility	susceptibility	NOUN
njb-115	423	10	pattern	pattern	NOUN
njb-115	423	11	in	in	ADP
njb-115	423	12	a	a	DET
njb-115	423	13	private	private	ADJ
njb-115	423	14	medical	medical	ADJ
njb-115	423	15	college	college	NOUN
njb-115	423	16	hospital	hospital	NOUN
njb-115	423	17	in	in	ADP
njb-115	423	18	dhaka	dhaka	PROPN
njb-115	423	19	city	city	NOUN
njb-115	423	20	.	.	PUNCT
njb-115	424	1	delta	delta	PROPN
njb-115	424	2	medical	medical	PROPN
njb-115	424	3	college	college	PROPN
njb-115	424	4	journal	journal	PROPN
njb-115	424	5	.	.	PUNCT
njb-115	424	6	2015	2015	NUM
njb-115	425	1	feb	feb	PROPN
njb-115	425	2	14;3(1):25	14;3(1):25	NUM
njb-115	425	3	-	-	SYM
njb-115	425	4	30	30	NUM
njb-115	425	5	.	.	PUNCT
njb-115	426	1	https://doi.org/10.3329/dmcj.v3i1.22236	https://doi.org/10.3329/dmcj.v3i1.22236	PROPN
njb-115	426	2	39	39	NUM
njb-115	426	3	.	.	PUNCT
njb-115	427	1	barakoti	barakoti	VERB
njb-115	427	2	a	a	DET
njb-115	427	3	,	,	PUNCT
njb-115	427	4	guragain	guragain	NOUN
njb-115	427	5	a	a	PRON
njb-115	427	6	,	,	PUNCT
njb-115	427	7	adhikari	adhikari	PROPN
njb-115	427	8	rp	rp	PROPN
njb-115	427	9	,	,	PUNCT
njb-115	427	10	amatya	amatya	PROPN
njb-115	427	11	r.profile	r.profile	ADJ
njb-115	427	12	and	and	CCONJ
njb-115	427	13	antimicrobial	antimicrobial	ADJ
njb-115	427	14	susceptibility	susceptibility	NOUN
njb-115	427	15	pattern	pattern	NOUN
njb-115	427	16	of	of	ADP
njb-115	427	17	aerobic	aerobic	ADJ
njb-115	427	18	bacterial	bacterial	ADJ
njb-115	427	19	isolates	isolate	NOUN
njb-115	427	20	from	from	ADP
njb-115	427	21	pus	pus	NOUN
njb-115	427	22	/	/	SYM
njb-115	427	23	wound	wound	NOUN
njb-115	427	24	swab	swab	NOUN
njb-115	427	25	samples	sample	NOUN
njb-115	427	26	in	in	ADP
njb-115	427	27	a	a	DET
njb-115	427	28	tertiary	tertiary	ADJ
njb-115	427	29	care	care	NOUN
njb-115	427	30	hospital	hospital	PROPN
njb-115	427	31	,	,	PUNCT
njb-115	427	32	kathmandu	kathmandu	PROPN
njb-115	427	33	.	.	PUNCT
njb-115	428	1	nepal	nepal	PROPN
njb-115	428	2	med	med	PROPN
njb-115	428	3	coll	coll	PROPN
njb-115	428	4	j.	j.	PROPN
njb-115	428	5	2017	2017	PROPN
njb-115	428	6	jan;19(4):179183.https://www.researchgate.net	jan;19(4):179183.https://www.researchgate.net	PROPN
njb-115	428	7	/	/	SYM
njb-115	428	8	publication/329266887	publication/329266887	PROPN
njb-115	428	9	40	40	NUM
njb-115	428	10	.	.	PUNCT
njb-115	429	1	bankar	bankar	PROPN
njb-115	429	2	n	n	PROPN
njb-115	429	3	,	,	PUNCT
njb-115	429	4	wankhade	wankhade	VERB
njb-115	429	5	a	a	PRON
njb-115	429	6	,	,	PUNCT
njb-115	429	7	bramhane	bramhane	PROPN
njb-115	429	8	rb	rb	PROPN
njb-115	429	9	,	,	PUNCT
njb-115	429	10	hathiwala	hathiwala	PROPN
njb-115	429	11	r	r	PROPN
njb-115	429	12	,	,	PUNCT
njb-115	429	13	chandi	chandi	PROPN
njb-115	429	14	dh	dh	PROPN
njb-115	429	15	.	.	PUNCT
njb-115	429	16	bacteriological	bacteriological	PROPN
njb-115	429	17	profile	profile	NOUN
njb-115	429	18	of	of	ADP
njb-115	429	19	pus	pus	NOUN
njb-115	429	20	/	/	SYM
njb-115	429	21	wound	wound	NOUN
njb-115	429	22	swab	swab	NOUN
njb-115	429	23	and	and	CCONJ
njb-115	429	24	antimicrobial	antimicrobial	ADJ
njb-115	429	25	susceptibility	susceptibility	NOUN
njb-115	429	26	of	of	ADP
njb-115	429	27	staphylococcusaureus	staphylococcusaureus	NOUN
njb-115	429	28	isolated	isolate	VERB
njb-115	429	29	from	from	ADP
njb-115	429	30	of	of	ADP
njb-115	429	31	pus	pus	NOUN
njb-115	429	32	&	&	CCONJ
njb-115	429	33	wound	wound	PROPN
njb-115	429	34	swab	swab	NOUN
njb-115	429	35	of	of	ADP
njb-115	429	36	indoor	indoor	ADJ
njb-115	429	37	patients	patient	NOUN
njb-115	429	38	of	of	ADP
njb-115	429	39	tertiary	tertiary	ADJ
njb-115	429	40	care	care	NOUN
njb-115	429	41	hospital	hospital	NOUN
njb-115	429	42	in	in	ADP
njb-115	429	43	durg	durg	PROPN
njb-115	429	44	,	,	PUNCT
njb-115	429	45	chhattisgarh	chhattisgarh	PROPN
njb-115	429	46	india	india	PROPN
njb-115	429	47	.	.	PUNCT
njb-115	430	1	ijirms	ijirm	VERB
njb-115	430	2	[	[	X
njb-115	430	3	internet	internet	X
njb-115	430	4	]	]	X
njb-115	430	5	.	.	PUNCT
njb-115	430	6	2018	2018	NUM
njb-115	430	7	apr	apr	VERB
njb-115	430	8	9;3(04):1976	9;3(04):1976	NUM
njb-115	430	9	to	to	ADP
njb-115	430	10	1980.https://ijirms.in/index.php/ijirms/article/view/356	1980.https://ijirms.in/index.php/ijirms/article/view/356	NUM
njb-115	430	11	41	41	NUM
njb-115	430	12	.	.	PUNCT
njb-115	431	1	shahi	shahi	PROPN
njb-115	431	2	k	k	PROPN
njb-115	431	3	,	,	PUNCT
njb-115	431	4	rijal	rijal	PROPN
njb-115	431	5	k	k	PROPN
njb-115	431	6	,	,	PUNCT
njb-115	431	7	adhikari	adhikari	PROPN
njb-115	431	8	n	n	PROPN
njb-115	431	9	,	,	PUNCT
njb-115	431	10	shrestha	shrestha	PROPN
njb-115	431	11	u	u	PROPN
njb-115	431	12	,	,	PUNCT
njb-115	431	13	banjara	banjara	PROPN
njb-115	431	14	m	m	PROPN
njb-115	431	15	,	,	PUNCT
njb-115	431	16	sharma	sharma	PROPN
njb-115	431	17	v	v	PROPN
njb-115	431	18	,	,	PUNCT
njb-115	431	19	et	et	PROPN
njb-115	431	20	al	al	PROPN
njb-115	431	21	.	.	PUNCT
njb-115	432	1	methicillin	methicillin	PROPN
njb-115	432	2	resistant	resistant	ADJ
njb-115	432	3	staphylococcus	staphylococcus	NOUN
njb-115	432	4	aureus	aureus	NOUN
njb-115	432	5	:	:	PUNCT
njb-115	433	1	prevalence	prevalence	NOUN
njb-115	433	2	and	and	CCONJ
njb-115	433	3	antibiogram	antibiogram	PROPN
njb-115	433	4	in	in	ADP
njb-115	433	5	various	various	ADJ
njb-115	433	6	clinical	clinical	ADJ
njb-115	433	7	specimens	specimen	NOUN
njb-115	433	8	at	at	ADP
njb-115	433	9	alka	alka	PROPN
njb-115	433	10	hospital	hospital	PROPN
njb-115	433	11	.	.	PUNCT
njb-115	434	1	tujm	tujm	PROPN
njb-115	434	2	.	.	PROPN
njb-115	435	1	2018;5(1):77	2018;5(1):77	NUM
njb-115	435	2	-	-	PUNCT
njb-115	435	3	82.https://doi.org/10.3126	82.https://doi.org/10.3126	NUM
njb-115	435	4	/	/	SYM
njb-115	435	5	tujm.v5i0.22316	tujm.v5i0.22316	NUM
njb-115	435	6	42	42	NUM
njb-115	435	7	.	.	PUNCT
njb-115	436	1	mahat	mahat	PROPN
njb-115	436	2	p	p	PROPN
njb-115	436	3	,	,	PUNCT
njb-115	436	4	manandhar	manandhar	PROPN
njb-115	436	5	s	s	PROPN
njb-115	436	6	,	,	PUNCT
njb-115	436	7	baidya	baidya	PROPN
njb-115	436	8	r.	r.	PROPN
njb-115	436	9	bacteriological	bacteriological	PROPN
njb-115	436	10	profile	profile	PROPN
njb-115	436	11	of	of	ADP
njb-115	436	12	wound	wound	NOUN
njb-115	436	13	infection	infection	NOUN
njb-115	436	14	and	and	CCONJ
njb-115	436	15	antibiotic	antibiotic	ADJ
njb-115	436	16	susceptibility	susceptibility	NOUN
njb-115	436	17	pattern	pattern	NOUN
njb-115	436	18	of	of	ADP
njb-115	436	19	the	the	DET
njb-115	436	20	isolates	isolate	NOUN
njb-115	436	21	.	.	PUNCT
njb-115	437	1	j	j	PROPN
njb-115	437	2	microbiol	microbiol	PROPN
njb-115	437	3	exp	exp	PROPN
njb-115	437	4	.	.	PROPN
njb-115	437	5	2017	2017	NUM
njb-115	437	6	apr	apr	PROPN
njb-115	437	7	17;4(5):00126	17;4(5):00126	NUM
njb-115	437	8	.	.	PUNCT
njb-115	438	1	doi	doi	PROPN
njb-115	438	2	:	:	PUNCT
njb-115	438	3	10.15406	10.15406	NUM
njb-115	438	4	/	/	SYM
njb-115	438	5	jmen.2017.04.00126	jmen.2017.04.00126	NOUN
njb-115	438	6	43	43	NUM
njb-115	438	7	.	.	PUNCT
njb-115	439	1	pokhrel	pokhrel	PROPN
njb-115	439	2	p	p	PROPN
njb-115	439	3	,	,	PUNCT
njb-115	439	4	shrestha	shrestha	PROPN
njb-115	439	5	a	a	PRON
njb-115	439	6	,	,	PUNCT
njb-115	439	7	panthi	panthi	PROPN
njb-115	439	8	p	p	PROPN
njb-115	439	9	,	,	PUNCT
njb-115	439	10	manandhar	manandhar	PROPN
njb-115	439	11	s	s	PROPN
njb-115	439	12	,	,	PUNCT
njb-115	439	13	chaudhary	chaudhary	ADJ
njb-115	439	14	dk	dk	PROPN
njb-115	439	15	.	.	PROPN
njb-115	439	16	bacteriological	bacteriological	ADJ
njb-115	439	17	profile	profile	NOUN
njb-115	439	18	and	and	CCONJ
njb-115	439	19	antibiotic	antibiotic	ADJ
njb-115	439	20	susceptibility	susceptibility	NOUN
njb-115	439	21	pattern	pattern	NOUN
njb-115	439	22	of	of	ADP
njb-115	439	23	wound	wound	ADJ
njb-115	439	24	infection	infection	NOUN
njb-115	439	25	in	in	ADP
njb-115	439	26	children	child	NOUN
njb-115	439	27	.	.	PUNCT
njb-115	440	1	ec	ec	PROPN
njb-115	440	2	microbiology	microbiology	NOUN
njb-115	440	3	.	.	PUNCT
njb-115	441	1	2017	2017	NUM
njb-115	442	1	jan	jan	PROPN
njb-115	442	2	18;5.3(2017):93	18;5.3(2017):93	NUM
njb-115	442	3	-	-	PUNCT
njb-115	442	4	100	100	NUM
njb-115	442	5	.	.	PUNCT
njb-115	442	6	https://www.researchgate.net/publication/312497749	https://www.researchgate.net/publication/312497749	PROPN
njb-115	442	7	44	44	NUM
njb-115	442	8	.	.	PUNCT
njb-115	443	1	bhatt	bhatt	PROPN
njb-115	443	2	c	c	PROPN
njb-115	443	3	,	,	PUNCT
njb-115	443	4	karki	karki	PROPN
njb-115	443	5	b	b	PROPN
njb-115	443	6	,	,	PUNCT
njb-115	443	7	baral	baral	PROPN
njb-115	443	8	b	b	PROPN
njb-115	443	9	,	,	PUNCT
njb-115	443	10	gautam	gautam	PROPN
njb-115	443	11	s	s	PROPN
njb-115	443	12	,	,	PUNCT
njb-115	443	13	shah	shah	VERB
njb-115	443	14	a	a	DET
njb-115	443	15	,	,	PUNCT
njb-115	443	16	chaudhary	chaudhary	ADJ
njb-115	443	17	a.	a.	NOUN
njb-115	443	18	antibiotic	antibiotic	ADJ
njb-115	443	19	susceptibility	susceptibility	NOUN
njb-115	443	20	pattern	pattern	NOUN
njb-115	443	21	of	of	ADP
njb-115	443	22	staphylococcus	staphylococcus	NOUN
njb-115	443	23	aureus	aureus	PROPN
njb-115	443	24	and	and	CCONJ
njb-115	443	25	methicillin	methicillin	NOUN
njb-115	443	26	-	-	PUNCT
njb-115	443	27	resistant	resistant	ADJ
njb-115	443	28	staphylococcus	staphylococcus	NOUN
njb-115	443	29	aureus	aureus	NOUN
njb-115	443	30	in	in	ADP
njb-115	443	31	a	a	DET
njb-115	443	32	tertiary	tertiary	ADJ
njb-115	443	33	care	care	NOUN
njb-115	443	34	hospital	hospital	NOUN
njb-115	443	35	.	.	PUNCT
njb-115	444	1	journal	journal	PROPN
njb-115	444	2	of	of	ADP
njb-115	444	3	pathology	pathology	NOUN
njb-115	444	4	of	of	ADP
njb-115	444	5	nepal	nepal	NOUN
njb-115	444	6	.	.	PUNCT
njb-115	445	1	2014;4(7):548551.https://doi.org/10.3126	2014;4(7):548551.https://doi.org/10.3126	NUM
njb-115	445	2	/	/	SYM
njb-115	445	3	jpn.v4i7.10297	jpn.v4i7.10297	PROPN
njb-115	445	4	45	45	NUM
njb-115	445	5	.	.	PUNCT
njb-115	446	1	garoy	garoy	PROPN
njb-115	446	2	ey	ey	PROPN
njb-115	446	3	,	,	PUNCT
njb-115	446	4	gebreab	gebreab	PROPN
njb-115	446	5	yb	yb	PROPN
njb-115	446	6	,	,	PUNCT
njb-115	446	7	achila	achila	PROPN
njb-115	446	8	oo	oo	PROPN
njb-115	446	9	,	,	PUNCT
njb-115	446	10	tekeste	tekeste	PROPN
njb-115	446	11	dg	dg	PROPN
njb-115	446	12	,	,	PUNCT
njb-115	446	13	kesete	kesete	PROPN
njb-115	446	14	r	r	PROPN
njb-115	446	15	,	,	PUNCT
njb-115	446	16	ghirmay	ghirmay	PROPN
njb-115	446	17	r	r	PROPN
njb-115	446	18	,	,	PUNCT
njb-115	446	19	et	et	PROPN
njb-115	446	20	al	al	PROPN
njb-115	446	21	.	.	PUNCT
njb-115	447	1	methicillin	methicillin	PROPN
njb-115	447	2	-	-	PUNCT
njb-115	447	3	resistant	resistant	ADJ
njb-115	447	4	staphylococcus	staphylococcus	NOUN
njb-115	447	5	aureus	aureus	NOUN
njb-115	447	6	(	(	PUNCT
njb-115	447	7	mrsa	mrsa	PROPN
njb-115	447	8	):	):	PUNCT
njb-115	447	9	prevalence	prevalence	NOUN
njb-115	447	10	and	and	CCONJ
njb-115	447	11	antimicrobial	antimicrobial	ADJ
njb-115	447	12	sensitivity	sensitivity	NOUN
njb-115	447	13	pattern	pattern	NOUN
njb-115	447	14	among	among	ADP
njb-115	447	15	patients	patient	NOUN
njb-115	447	16	_	_	NOUN
njb-115	448	1	a	a	DET
njb-115	448	2	multicenter	multicenter	NOUN
njb-115	448	3	study	study	NOUN
njb-115	448	4	in	in	ADP
njb-115	448	5	asmara	asmara	PROPN
njb-115	448	6	,	,	PUNCT
njb-115	448	7	eritrea	eritrea	PROPN
njb-115	448	8	.	.	PUNCT
njb-115	449	1	can	can	AUX
njb-115	449	2	j	j	PROPN
njb-115	449	3	infect	infect	PROPN
njb-115	449	4	dis	dis	PROPN
njb-115	449	5	med	med	PROPN
njb-115	449	6	microbiol	microbiol	PROPN
njb-115	449	7	.	.	PUNCT
njb-115	450	1	2019	2019	NUM
njb-115	450	2	feb	feb	PROPN
njb-115	450	3	6;2019:8321834	6;2019:8321834	NUM
njb-115	450	4	.	.	PUNCT
njb-115	451	1	doi	doi	PROPN
njb-115	451	2	:	:	PUNCT
njb-115	451	3	10.1155/2019/8321834	10.1155/2019/8321834	NUM
njb-115	451	4	.	.	PUNCT
njb-115	451	5	46	46	NUM
njb-115	451	6	.	.	PUNCT
njb-115	452	1	tadesse	tadesse	PROPN
njb-115	452	2	s	s	PROPN
njb-115	452	3	,	,	PUNCT
njb-115	452	4	alemayehu	alemayehu	PROPN
njb-115	452	5	h	h	PROPN
njb-115	452	6	,	,	PUNCT
njb-115	452	7	tenna	tenna	PROPN
njb-115	452	8	a	a	PRON
njb-115	452	9	,	,	PUNCT
njb-115	452	10	tadesse	tadesse	PROPN
njb-115	452	11	g	g	PROPN
njb-115	452	12	,	,	PUNCT
njb-115	452	13	tessema	tessema	PROPN
njb-115	452	14	ts	ts	PROPN
njb-115	452	15	,	,	PUNCT
njb-115	452	16	shibeshi	shibeshi	PROPN
njb-115	452	17	w	w	PROPN
njb-115	452	18	et	et	PROPN
njb-115	452	19	al	al	PROPN
njb-115	452	20	.	.	PUNCT
njb-115	453	1	antimicrobial	antimicrobial	ADJ
njb-115	453	2	resistance	resistance	NOUN
njb-115	453	3	profile	profile	NOUN
njb-115	453	4	of	of	ADP
njb-115	453	5	staphylococcus	staphylococcus	NOUN
njb-115	453	6	aureus	aureus	NOUN
njb-115	453	7	isolated	isolate	VERB
njb-115	453	8	from	from	ADP
njb-115	453	9	patients	patient	NOUN
njb-115	453	10	with	with	ADP
njb-115	453	11	infection	infection	NOUN
njb-115	453	12	at	at	ADP
njb-115	453	13	tikuranbessa	tikuranbessa	ADJ
njb-115	453	14	specialized	specialized	PROPN
njb-115	453	15	hospital	hospital	NOUN
njb-115	453	16	,	,	PUNCT
njb-115	453	17	addis	addis	PROPN
njb-115	453	18	ababa	ababa	PROPN
njb-115	453	19	,	,	PUNCT
njb-115	453	20	ethiopia	ethiopia	PROPN
njb-115	453	21	.	.	PUNCT
njb-115	454	1	bmc	bmc	PROPN
njb-115	454	2	pharmacoltoxicol	pharmacoltoxicol	PROPN
njb-115	454	3	.	.	PUNCT
njb-115	455	1	2018	2018	NUM
njb-115	455	2	may	may	PROPN
njb-115	455	3	21;19(1):24	21;19(1):24	NUM
njb-115	455	4	.	.	PUNCT
njb-115	456	1	doi	doi	PROPN
njb-115	456	2	:	:	PUNCT
njb-115	456	3	10.1186	10.1186	NUM
njb-115	456	4	/	/	SYM
njb-115	456	5	s40360	s40360	PROPN
njb-115	456	6	-	-	PUNCT
njb-115	456	7	0180210	0180210	NUM
njb-115	456	8	-	-	SYM
njb-115	456	9	9	9	NUM
njb-115	456	10	.	.	NUM
njb-115	456	11	47	47	NUM
njb-115	456	12	.	.	PUNCT
njb-115	457	1	nikaido	nikaido	NOUN
njb-115	457	2	h.	h.	PROPN
njb-115	457	3	multidrug	multidrug	VERB
njb-115	457	4	resistance	resistance	NOUN
njb-115	457	5	in	in	ADP
njb-115	457	6	bacteria	bacteria	NOUN
njb-115	457	7	.	.	PUNCT
njb-115	458	1	annu	annu	PROPN
njb-115	458	2	rev	rev	VERB
njb-115	458	3	biochem	biochem	NOUN
njb-115	458	4	.	.	PUNCT
njb-115	459	1	2009;78:119–146	2009;78:119–146	NUM
njb-115	459	2	.	.	PUNCT
njb-115	460	1	doi	doi	PROPN
njb-115	460	2	:	:	PUNCT
njb-115	460	3	10.1146	10.1146	NUM
njb-115	460	4	/	/	SYM
njb-115	460	5	annurev.biochem.78.082907.145923	annurev.biochem.78.082907.145923	PROPN
njb-115	460	6	48	48	NUM
njb-115	460	7	.	.	PUNCT
njb-115	461	1	upreti	upreti	PROPN
njb-115	461	2	n	n	PROPN
njb-115	461	3	,	,	PUNCT
njb-115	461	4	rayamajhee	rayamajhee	PROPN
njb-115	461	5	b	b	PROPN
njb-115	461	6	,	,	PUNCT
njb-115	461	7	sherchan	sherchan	PROPN
njb-115	461	8	sp	sp	PROPN
njb-115	461	9	,	,	PUNCT
njb-115	461	10	choudhari	choudhari	PROPN
njb-115	461	11	mk	mk	PROPN
njb-115	461	12	,	,	PUNCT
njb-115	461	13	banjara	banjara	PROPN
njb-115	461	14	mr	mr	PROPN
njb-115	461	15	.	.	PROPN
njb-115	461	16	prevalence	prevalence	PROPN
njb-115	461	17	of	of	ADP
njb-115	461	18	methicillin	methicillin	NOUN
njb-115	461	19	resistant	resistant	ADJ
njb-115	461	20	staphylococcus	staphylococcus	NOUN
njb-115	461	21	aureus	aureus	NOUN
njb-115	461	22	,	,	PUNCT
njb-115	461	23	multidrug	multidrug	VERB
njb-115	461	24	resistant	resistant	ADJ
njb-115	461	25	and	and	CCONJ
njb-115	461	26	extended	extended	ADJ
njb-115	461	27	spectrum	spectrum	NOUN
njb-115	461	28	beta	beta	NOUN
njb-115	461	29	-	-	PUNCT
njb-115	461	30	lactamase	lactamase	NOUN
njb-115	461	31	producing	produce	VERB
njb-115	461	32	gram	gram	ADJ
njb-115	461	33	negative	negative	ADJ
njb-115	461	34	bacilli	bacilli	NOUN
njb-115	461	35	causing	cause	VERB
njb-115	461	36	wound	wound	NOUN
njb-115	461	37	infections	infection	NOUN
njb-115	461	38	at	at	ADP
njb-115	461	39	a	a	DET
njb-115	461	40	tertiary	tertiary	ADJ
njb-115	461	41	care	care	NOUN
njb-115	461	42	hospital	hospital	NOUN
njb-115	461	43	of	of	ADP
njb-115	461	44	nepal	nepal	NOUN
njb-115	461	45	.	.	PUNCT
njb-115	462	1	antimicrob	antimicrob	PROPN
njb-115	462	2	resist	resist	VERB
njb-115	462	3	infect	infect	ADJ
njb-115	462	4	control	control	NOUN
njb-115	462	5	.	.	PUNCT
njb-115	463	1	2018	2018	NUM
njb-115	463	2	oct	oct	PROPN
njb-115	463	3	8;7:121	8;7:121	NUM
njb-115	463	4	.	.	PUNCT
njb-115	464	1	doi	doi	PROPN
njb-115	464	2	:	:	PUNCT
njb-115	464	3	10.1186	10.1186	NUM
njb-115	464	4	/	/	SYM
njb-115	464	5	s13756	s13756	X
njb-115	464	6	-	-	PUNCT
njb-115	464	7	018	018	NUM
njb-115	464	8	-	-	PUNCT
njb-115	464	9	0408	0408	NUM
njb-115	464	10	-	-	PUNCT
njb-115	464	11	z.	z.	NOUN
njb-115	464	12	49	49	NUM
njb-115	464	13	.	.	PUNCT
njb-115	465	1	pahadi	pahadi	PROPN
njb-115	465	2	p	p	PROPN
njb-115	465	3	,	,	PUNCT
njb-115	465	4	shrestha	shrestha	PROPN
njb-115	465	5	u	u	PROPN
njb-115	465	6	,	,	PUNCT
njb-115	465	7	adhikari	adhikari	PROPN
njb-115	465	8	n	n	PROPN
njb-115	465	9	,	,	PUNCT
njb-115	465	10	shah	shah	PROPN
njb-115	465	11	p	p	PROPN
njb-115	465	12	,	,	PUNCT
njb-115	465	13	amatya	amatya	PROPN
njb-115	465	14	r.	r.	PROPN
njb-115	465	15	growing	grow	VERB
njb-115	465	16	resistance	resistance	NOUN
njb-115	465	17	to	to	ADP
njb-115	465	18	vancomycin	vancomycin	PROPN
njb-115	465	19	among	among	ADP
njb-115	465	20	methicillin	methicillin	NOUN
njb-115	465	21	resistant	resistant	ADJ
njb-115	465	22	staphylococcus	staphylococcus	NOUN
njb-115	465	23	aureus	aureus	NOUN
njb-115	465	24	isolates	isolate	VERB
njb-115	465	25	from	from	ADP
njb-115	465	26	different	different	ADJ
njb-115	465	27	clinical	clinical	ADJ
njb-115	465	28	samples	sample	NOUN
njb-115	465	29	.	.	PUNCT
njb-115	466	1	journal	journal	PROPN
njb-115	466	2	of	of	ADP
njb-115	466	3	nepal	nepal	PROPN
njb-115	466	4	medical	medical	PROPN
njb-115	466	5	association	association	PROPN
njb-115	466	6	.	.	PUNCT
njb-115	467	1	2014	2014	NUM
njb-115	468	1	dec	dec	PROPN
njb-115	468	2	31;52(196):977981.https://doi.org/10.31729	31;52(196):977981.https://doi.org/10.31729	NUM
njb-115	468	3	/	/	SYM
njb-115	468	4	jnma.2797	jnma.2797	NOUN
njb-115	468	5	50	50	NUM
njb-115	468	6	.	.	PUNCT
njb-115	469	1	kadariya	kadariya	PROPN
njb-115	469	2	j	j	PROPN
njb-115	469	3	,	,	PUNCT
njb-115	469	4	thapaliya	thapaliya	PROPN
njb-115	469	5	d	d	PROPN
njb-115	469	6	,	,	PUNCT
njb-115	469	7	bhatta	bhatta	PROPN
njb-115	469	8	s	s	PROPN
njb-115	469	9	,	,	PUNCT
njb-115	469	10	mahatara	mahatara	PROPN
njb-115	469	11	rl	rl	PROPN
njb-115	469	12	,	,	PUNCT
njb-115	469	13	bempah	bempah	PROPN
njb-115	469	14	s	s	PROPN
njb-115	469	15	,	,	PUNCT
njb-115	469	16	dhakal	dhakal	PROPN
njb-115	469	17	n	n	PROPN
njb-115	469	18	,	,	PUNCT
njb-115	469	19	et	et	PROPN
njb-115	469	20	al	al	PROPN
njb-115	469	21	.	.	PUNCT
njb-115	470	1	multidrug	multidrug	PROPN
njb-115	470	2	-	-	PUNCT
njb-115	470	3	resistant	resistant	ADJ
njb-115	470	4	staphylococcus	staphylococcus	NOUN
njb-115	470	5	aureus	aureus	NOUN
njb-115	470	6	colonization	colonization	NOUN
njb-115	470	7	in	in	ADP
njb-115	470	8	healthy	healthy	ADJ
njb-115	470	9	adults	adult	NOUN
njb-115	470	10	is	be	AUX
njb-115	470	11	more	more	ADV
njb-115	470	12	common	common	ADJ
njb-115	470	13	in	in	ADP
njb-115	470	14	bhutanese	bhutanese	ADJ
njb-115	470	15	refugees	refugee	NOUN
njb-115	470	16	in	in	ADP
njb-115	470	17	nepal	nepal	ADJ
njb-115	470	18	than	than	ADP
njb-115	470	19	those	those	PRON
njb-115	470	20	resettled	resettle	VERB
njb-115	470	21	in	in	ADP
njb-115	470	22	ohio	ohio	PROPN
njb-115	470	23	.	.	PUNCT
njb-115	471	1	biomed	biomed	PROPN
njb-115	471	2	res	res	PROPN
njb-115	471	3	int	int	PROPN
njb-115	471	4	.	.	PUNCT
njb-115	472	1	2019	2019	NUM
njb-115	472	2	jul	jul	PROPN
njb-115	472	3	1;2019:5739247	1;2019:5739247	NUM
njb-115	472	4	.	.	PUNCT
njb-115	473	1	https://doi	https://doi	X
njb-115	473	2	:	:	PUNCT
njb-115	473	3	10.1155/2019/5739247	10.1155/2019/5739247	NUM
njb-115	473	4	51	51	NUM
njb-115	473	5	.	.	PUNCT
njb-115	474	1	mama	mama	PROPN
njb-115	474	2	m	m	PROPN
njb-115	474	3	,	,	PUNCT
njb-115	474	4	aklilu	aklilu	VERB
njb-115	474	5	a	a	PRON
njb-115	474	6	,	,	PUNCT
njb-115	474	7	misgna	misgna	PROPN
njb-115	474	8	k	k	PROPN
njb-115	474	9	,	,	PUNCT
njb-115	474	10	tadesse	tadesse	PROPN
njb-115	474	11	m	m	PROPN
njb-115	474	12	,	,	PUNCT
njb-115	474	13	alemayehu	alemayehu	PROPN
njb-115	474	14	e.	e.	PROPN
njb-115	474	15	methicillinand	methicillinand	PROPN
njb-115	474	16	inducible	inducible	VERB
njb-115	474	17	clindamycin	clindamycin	PROPN
njb-115	474	18	-	-	PUNCT
njb-115	474	19	resistant	resistant	ADJ
njb-115	474	20	staphylococcus	staphylococcus	NOUN
njb-115	474	21	aureus	aureus	NOUN
njb-115	474	22	among	among	ADP
njb-115	474	23	patients	patient	NOUN
njb-115	474	24	with	with	ADP
njb-115	474	25	wound	wound	NOUN
njb-115	474	26	infection	infection	NOUN
njb-115	474	27	attending	attend	VERB
njb-115	474	28	arba	arba	PROPN
njb-115	474	29	minch	minch	PROPN
njb-115	474	30	hospital	hospital	PROPN
njb-115	474	31	,	,	PUNCT
njb-115	474	32	south	south	PROPN
njb-115	474	33	ethiopia	ethiopia	PROPN
njb-115	474	34	.	.	PUNCT
njb-115	475	1	international	international	ADJ
njb-115	475	2	journal	journal	PROPN
njb-115	475	3	of	of	ADP
njb-115	475	4	microbiology	microbiology	NOUN
njb-115	475	5	.	.	PUNCT
njb-115	476	1	2019	2019	NUM
njb-115	476	2	apr	apr	ADP
njb-115	476	3	1;2019:2965490	1;2019:2965490	NUM
njb-115	476	4	.	.	PUNCT
njb-115	477	1	https://doi.org/10.1155/2019/2965490	https://doi.org/10.1155/2019/2965490	PROPN
njb-115	477	2	52	52	NUM
njb-115	477	3	.	.	PUNCT
njb-115	478	1	joachim	joachim	VERB
njb-115	478	2	a	a	PRON
njb-115	478	3	,	,	PUNCT
njb-115	478	4	moyo	moyo	NOUN
njb-115	478	5	sj	sj	PROPN
njb-115	478	6	,	,	PUNCT
njb-115	478	7	nkinda	nkinda	PROPN
njb-115	478	8	l	l	PROPN
njb-115	478	9	,	,	PUNCT
njb-115	478	10	majigo	majigo	PROPN
njb-115	478	11	m	m	PROPN
njb-115	478	12	,	,	PUNCT
njb-115	478	13	mmbaga	mmbaga	PROPN
njb-115	478	14	e	e	PROPN
njb-115	478	15	,	,	PUNCT
njb-115	478	16	mbembati	mbembati	PROPN
njb-115	478	17	n	n	PROPN
njb-115	478	18	,	,	PUNCT
njb-115	478	19	et	et	PROPN
njb-115	478	20	al	al	PROPN
njb-115	478	21	.	.	PUNCT
njb-115	479	1	prevalence	prevalence	NOUN
njb-115	479	2	of	of	ADP
njb-115	479	3	methicillin	methicillin	NOUN
njb-115	479	4	-	-	PUNCT
njb-115	479	5	resistant	resistant	ADJ
njb-115	479	6	staphylococcus	staphylococcus	NOUN
njb-115	479	7	aureus	aureus	NOUN
njb-115	479	8	carriage	carriage	NOUN
njb-115	479	9	on	on	ADP
njb-115	479	10	admission	admission	NOUN
njb-115	479	11	among	among	ADP
njb-115	479	12	patients	patient	NOUN
njb-115	479	13	attending	attend	VERB
njb-115	479	14	regional	regional	ADJ
njb-115	479	15	hospitals	hospital	NOUN
njb-115	479	16	in	in	ADP
njb-115	479	17	dar	dar	PROPN
njb-115	479	18	es	es	PROPN
njb-115	479	19	salaam	salaam	PROPN
njb-115	479	20	,	,	PUNCT
njb-115	479	21	tanzania	tanzania	PROPN
njb-115	479	22	.	.	PUNCT
njb-115	480	1	bmc	bmc	PROPN
njb-115	480	2	research	research	PROPN
njb-115	480	3	notes	note	NOUN
njb-115	480	4	.	.	PUNCT
njb-115	481	1	2017	2017	NUM
njb-115	481	2	aug;10(1):417	aug;10(1):417	PROPN
njb-115	481	3	.	.	PUNCT
njb-115	482	1	doi.10.1186	doi.10.1186	PROPN
njb-115	482	2	/	/	SYM
njb-115	482	3	s13104	s13104	NOUN
njb-115	482	4	-	-	PUNCT
njb-115	482	5	017	017	NUM
njb-115	482	6	-	-	NUM
njb-115	482	7	2668	2668	NUM
njb-115	482	8	-	-	SYM
njb-115	482	9	8	8	NUM
njb-115	482	10	53	53	NUM
njb-115	482	11	.	.	PUNCT
njb-115	483	1	ansari	ansari	PROPN
njb-115	483	2	s	s	PROPN
njb-115	483	3	,	,	PUNCT
njb-115	483	4	nepal	nepal	ADJ
njb-115	483	5	hp	hp	PROPN
njb-115	483	6	,	,	PUNCT
njb-115	483	7	gautam	gautam	PROPN
njb-115	483	8	r	r	PROPN
njb-115	483	9	,	,	PUNCT
njb-115	483	10	rayamajhi	rayamajhi	PROPN
njb-115	483	11	n	n	PROPN
njb-115	483	12	,	,	PUNCT
njb-115	483	13	shrestha	shrestha	PROPN
njb-115	483	14	s	s	PROPN
njb-115	483	15	,	,	PUNCT
njb-115	483	16	upadhyay	upadhyay	PROPN
njb-115	483	17	g	g	PROPN
njb-115	483	18	,	,	PUNCT
njb-115	483	19	et	et	PROPN
njb-115	483	20	al	al	PROPN
njb-115	483	21	.	.	PROPN
njb-115	484	1	threat	threat	NOUN
njb-115	484	2	of	of	ADP
njb-115	484	3	drug	drug	NOUN
njb-115	484	4	resistant	resistant	ADJ
njb-115	484	5	staphylococcus	staphylococcus	NOUN
njb-115	484	6	aureus	aureus	NOUN
njb-115	484	7	to	to	ADP
njb-115	484	8	health	health	NOUN
njb-115	484	9	in	in	ADP
njb-115	484	10	nepal	nepal	NOUN
njb-115	484	11	.	.	PUNCT
njb-115	485	1	bmc	bmc	PROPN
njb-115	485	2	infect	infect	PROPN
njb-115	485	3	dis	dis	PROPN
njb-115	485	4	.	.	PROPN
njb-115	485	5	2014	2014	NUM
njb-115	485	6	mar	mar	PROPN
njb-115	485	7	22;157	22;157	NUM
njb-115	486	1	(	(	PUNCT
njb-115	486	2	2014).https://doi.org/10.1186/1471	2014).https://doi.org/10.1186/1471	NOUN
njb-115	486	3	-	-	PUNCT
njb-115	486	4	2334	2334	NUM
njb-115	486	5	-	-	SYM
njb-115	486	6	14	14	NUM
njb-115	486	7	-	-	SYM
njb-115	486	8	157	157	NUM
njb-115	486	9	54	54	NUM
njb-115	486	10	.	.	PUNCT
njb-115	486	11	jaiswal	jaiswal	PROPN
njb-115	486	12	s	s	PROPN
njb-115	486	13	,	,	PUNCT
njb-115	486	14	thapa	thapa	VERB
njb-115	486	15	a	a	PRON
njb-115	486	16	,	,	PUNCT
njb-115	486	17	mali	mali	PROPN
njb-115	486	18	g	g	PROPN
njb-115	486	19	,	,	PUNCT
njb-115	486	20	magar	magar	PROPN
njb-115	486	21	s	s	PROPN
njb-115	486	22	,	,	PUNCT
njb-115	486	23	gurung	gurung	PROPN
njb-115	486	24	s	s	PROPN
njb-115	486	25	,	,	PUNCT
njb-115	486	26	shakya	shakya	PROPN
njb-115	486	27	s	s	PROPN
njb-115	486	28	,	,	PUNCT
njb-115	486	29	et	et	PROPN
njb-115	486	30	al	al	PROPN
njb-115	486	31	.	.	PUNCT
njb-115	487	1	a	a	DET
njb-115	487	2	study	study	NOUN
njb-115	487	3	of	of	ADP
njb-115	487	4	methicillin	methicillin	NOUN
njb-115	487	5	resistant	resistant	ADJ
njb-115	487	6	pattern	pattern	NOUN
njb-115	487	7	on	on	ADP
njb-115	487	8	clinical	clinical	ADJ
njb-115	487	9	isolates	isolate	NOUN
njb-115	487	10	of	of	ADP
njb-115	487	11	staphylococcus	staphylococcus	NOUN
njb-115	487	12	aureus	aureus	NOUN
njb-115	487	13	in	in	ADP
njb-115	487	14	tertiary	tertiary	ADJ
njb-115	487	15	care	care	NOUN
njb-115	487	16	hospitals	hospital	NOUN
njb-115	487	17	of	of	ADP
njb-115	487	18	pokhara	pokhara	PROPN
njb-115	487	19	.	.	PUNCT
njb-115	488	1	bmr	bmr	PROPN
njb-115	488	2	microbiology	microbiology	NOUN
njb-115	488	3	.	.	PUNCT
njb-115	489	1	2016	2016	NUM
njb-115	489	2	sep	sep	PROPN
njb-115	489	3	24;2(1).https://www.researchgate.net	24;2(1).https://www.researchgate.net	NUM
njb-115	489	4	/	/	SYM
njb-115	489	5	publication/310331234	publication/310331234	ADJ
njb-115	489	6	55	55	NUM
njb-115	489	7	.	.	PUNCT
njb-115	490	1	adhikari	adhikari	PROPN
njb-115	490	2	r	r	PROPN
njb-115	490	3	,	,	PUNCT
njb-115	490	4	pant	pant	PROPN
njb-115	490	5	nd	nd	PROPN
njb-115	490	6	,	,	PUNCT
njb-115	490	7	neupane	neupane	PROPN
njb-115	490	8	s	s	PROPN
njb-115	490	9	,	,	PUNCT
njb-115	490	10	neupane	neupane	PROPN
njb-115	490	11	m	m	PROPN
njb-115	490	12	,	,	PUNCT
njb-115	490	13	bhattarai	bhattarai	PROPN
njb-115	490	14	r	r	PROPN
njb-115	490	15	,	,	PUNCT
njb-115	490	16	bhatta	bhatta	PROPN
njb-115	490	17	s	s	PROPN
njb-115	490	18	,	,	PUNCT
njb-115	490	19	et	et	PROPN
njb-115	490	20	al	al	PROPN
njb-115	490	21	.	.	PROPN
njb-115	491	1	detection	detection	NOUN
njb-115	491	2	of	of	ADP
njb-115	491	3	methicillin	methicillin	NOUN
njb-115	491	4	resistant	resistant	ADJ
njb-115	491	5	staphylococcus	staphylococcus	NOUN
njb-115	491	6	aureus	aureus	NOUN
njb-115	491	7	and	and	CCONJ
njb-115	491	8	determination	determination	NOUN
njb-115	491	9	of	of	ADP
njb-115	491	10	minimum	minimum	ADJ
njb-115	491	11	inhibitory	inhibitory	ADJ
njb-115	491	12	concentration	concentration	NOUN
njb-115	491	13	of	of	ADP
njb-115	491	14	https://www.researchgate.net/publication/216834367_methicillin_resistant_staphylococcus_aureus_mrsa_in_different_clinical_samples_from_patients_presenting_at_kathmandu_model_hospital	https://www.researchgate.net/publication/216834367_methicillin_resistant_staphylococcus_aureus_mrsa_in_different_clinical_samples_from_patients_presenting_at_kathmandu_model_hospital	PROPN
njb-115	491	15	https://doi.org/10.1186/s13104-017-2515-y	https://doi.org/10.1186/s13104-017-2515-y	PROPN
njb-115	491	16	https://doi.org/10.1556/1886.2018.00003	https://doi.org/10.1556/1886.2018.00003	PUNCT
njb-115	492	1	https://doi.org/10.3126/tujm.v4i0.21679	https://doi.org/10.3126/tujm.v4i0.21679	PROPN
njb-115	492	2	https://doi.org/10.3126/tujm.v5i0.22297	https://doi.org/10.3126/tujm.v5i0.22297	INTJ
njb-115	492	3	http://dx.doi.org/10.20546/ijcmas.2016	http://dx.doi.org/10.20546/ijcmas.2016	PUNCT
njb-115	493	1	https://doi.org/10.20546/ijcmas.2018.701.044	https://doi.org/10.20546/ijcmas.2018.701.044	PROPN
njb-115	493	2	https://doi.org/10.3126/njst.v14i2.10428	https://doi.org/10.3126/njst.v14i2.10428	X
njb-115	494	1	https://doi.org/10.20546/ijcmas.2017.610.409	https://doi.org/10.20546/ijcmas.2017.610.409	X
njb-115	495	1	https://doi.org/10.3329/dmcj.v3i1.22236	https://doi.org/10.3329/dmcj.v3i1.22236	PROPN
njb-115	495	2	https://www.researchgate.net/publication/329266887	https://www.researchgate.net/publication/329266887	PROPN
njb-115	495	3	https://ijirms.in/index.php/ijirms/article/view/356	https://ijirms.in/index.php/ijirms/article/view/356	X
njb-115	496	1	https://doi.org/10.3126/tujm.v5i0.22316	https://doi.org/10.3126/tujm.v5i0.22316	NUM
njb-115	496	2	https://doi.org/10.15406/jmen.2017.04.00126	https://doi.org/10.15406/jmen.2017.04.00126	NOUN
njb-115	496	3	https://www.researchgate.net/publication/312497749	https://www.researchgate.net/publication/312497749	VERB
njb-115	497	1	https://doi.org/10.3126/jpn.v4i7.10297	https://doi.org/10.3126/jpn.v4i7.10297	PROPN
njb-115	497	2	https://doi.org/10.31729/jnma.2797	https://doi.org/10.31729/jnma.2797	X
njb-115	498	1	https://doi.org/10.1155/2019/2965490	https://doi.org/10.1155/2019/2965490	VERB
njb-115	498	2	https://doi.org/10.1186/s13104-017-2668-8	https://doi.org/10.1186/s13104-017-2668-8	X
njb-115	499	1	https://doi.org/10.1186/1471-2334-14-157	https://doi.org/10.1186/1471-2334-14-157	PROPN
njb-115	499	2	https://www.researchgate.net/publication/310331234	https://www.researchgate.net/publication/310331234	PROPN
njb-115	499	3	nepal	nepal	PROPN
njb-115	499	4	j	j	PROPN
njb-115	499	5	biotechnol	biotechnol	PROPN
njb-115	499	6	.	.	PUNCT
njb-115	500	1	2	2	NUM
njb-115	500	2	0	0	NUM
njb-115	500	3	2	2	NUM
njb-115	500	4	1	1	NUM
njb-115	500	5	j	j	NOUN
njb-115	500	6	u	u	NOUN
njb-115	500	7	l	l	NOUN
njb-115	500	8	;	;	PUNCT
njb-115	500	9	9	9	NUM
njb-115	500	10	(	(	PUNCT
njb-115	500	11	1):8	1):8	NUM
njb-115	500	12	1	1	NUM
njb-115	500	13	7	7	NUM
njb-115	500	14	maharjan	maharjan	NOUN
njb-115	500	15	et	et	NOUN
njb-115	500	16	al	al	PROPN
njb-115	500	17	.	.	PUNCT
njb-115	501	1	©	©	PROPN
njb-115	501	2	njb	njb	PROPN
njb-115	501	3	,	,	PUNCT
njb-115	501	4	bsn	bsn	PROPN
njb-115	501	5	17	17	NUM
njb-115	501	6	vancomycin	vancomycin	PROPN
njb-115	501	7	for	for	ADP
njb-115	501	8	staphylococcus	staphylococcus	PROPN
njb-115	501	9	aureus	aureus	PROPN
njb-115	501	10	isolated	isolate	VERB
njb-115	501	11	from	from	ADP
njb-115	501	12	pus	pus	PROPN
njb-115	501	13	/	/	SYM
njb-115	501	14	wound	wound	NOUN
njb-115	501	15	swab	swab	NOUN
njb-115	501	16	samples	sample	NOUN
njb-115	501	17	of	of	ADP
njb-115	501	18	the	the	DET
njb-115	501	19	patients	patient	NOUN
njb-115	501	20	attending	attend	VERB
njb-115	501	21	a	a	DET
njb-115	501	22	tertiary	tertiary	ADJ
njb-115	501	23	care	care	NOUN
njb-115	501	24	hospital	hospital	NOUN
njb-115	501	25	in	in	ADP
njb-115	501	26	kathmandu	kathmandu	NOUN
njb-115	501	27	,	,	PUNCT
njb-115	501	28	nepal	nepal	ADJ
njb-115	501	29	.	.	PUNCT
njb-115	502	1	can	can	AUX
njb-115	502	2	j	j	PROPN
njb-115	502	3	infect	infect	PROPN
njb-115	502	4	dis	dis	PROPN
njb-115	502	5	med	med	PROPN
njb-115	502	6	microbiol	microbiol	PROPN
njb-115	502	7	.	.	PUNCT
njb-115	503	1	2017	2017	NUM
njb-115	503	2	jan	jan	PROPN
njb-115	503	3	5;2017:2191532	5;2017:2191532	PROPN
njb-115	503	4	.	.	PUNCT
njb-115	503	5	https://doi.org/10.1155/2017/2191532	https://doi.org/10.1155/2017/2191532	PROPN
njb-115	503	6	56	56	NUM
njb-115	503	7	.	.	PUNCT
njb-115	504	1	khanal	khanal	PROPN
njb-115	504	2	lk	lk	PROPN
njb-115	504	3	,	,	PUNCT
njb-115	504	4	jha	jha	VERB
njb-115	504	5	bk	bk	PROPN
njb-115	504	6	.	.	PUNCT
njb-115	505	1	prevalence	prevalence	NOUN
njb-115	505	2	of	of	ADP
njb-115	505	3	methicillin	methicillin	NOUN
njb-115	505	4	resistant	resistant	ADJ
njb-115	505	5	staphylococcus	staphylococcus	NOUN
njb-115	505	6	aureus	aureus	NOUN
njb-115	505	7	(	(	PUNCT
njb-115	505	8	mrsa	mrsa	PROPN
njb-115	505	9	)	)	PUNCT
njb-115	505	10	among	among	ADP
njb-115	505	11	skin	skin	NOUN
njb-115	505	12	infection	infection	NOUN
njb-115	505	13	cases	case	NOUN
njb-115	505	14	at	at	ADP
njb-115	505	15	a	a	DET
njb-115	505	16	hospital	hospital	NOUN
njb-115	505	17	in	in	ADP
njb-115	505	18	chitwan	chitwan	PROPN
njb-115	505	19	,	,	PUNCT
njb-115	505	20	nepal	nepal	ADJ
njb-115	505	21	.	.	PUNCT
njb-115	506	1	nepal	nepal	ADJ
njb-115	506	2	medical	medical	PROPN
njb-115	506	3	college	college	PROPN
njb-115	506	4	journal	journal	NOUN
njb-115	506	5	:	:	PUNCT
njb-115	506	6	nmcj	nmcj	PROPN
njb-115	506	7	.	.	PUNCT
njb-115	506	8	2010	2010	NUM
njb-115	507	1	dec;12(4):224	dec;12(4):224	NOUN
njb-115	507	2	-	-	SYM
njb-115	507	3	228	228	NUM
njb-115	507	4	.	.	PUNCT
njb-115	508	1	pmid	pmid	NOUN
njb-115	508	2	:	:	PUNCT
njb-115	508	3	21744763	21744763	NUM
njb-115	508	4	57	57	NUM
njb-115	508	5	.	.	PUNCT
njb-115	509	1	neopane	neopane	PROPN
njb-115	509	2	p	p	PROPN
njb-115	509	3	,	,	PUNCT
njb-115	509	4	nepal	nepal	ADJ
njb-115	509	5	hp	hp	PROPN
njb-115	509	6	,	,	PUNCT
njb-115	509	7	shrestha	shrestha	PROPN
njb-115	509	8	r	r	PROPN
njb-115	509	9	,	,	PUNCT
njb-115	509	10	uehara	uehara	PROPN
njb-115	509	11	o	o	PROPN
njb-115	509	12	,	,	PUNCT
njb-115	509	13	abiko	abiko	PROPN
njb-115	509	14	y.	y.	PROPN
njb-115	509	15	in	in	ADP
njb-115	509	16	vitro	vitro	X
njb-115	509	17	biofilm	biofilm	NOUN
njb-115	509	18	formation	formation	NOUN
njb-115	509	19	by	by	ADP
njb-115	509	20	staphylococcus	staphylococcus	PROPN
njb-115	509	21	aureus	aureus	PROPN
njb-115	509	22	isolated	isolate	VERB
njb-115	509	23	from	from	ADP
njb-115	509	24	wounds	wound	NOUN
njb-115	509	25	of	of	ADP
njb-115	509	26	hospital	hospital	NOUN
njb-115	509	27	-	-	PUNCT
njb-115	509	28	admitted	admit	VERB
njb-115	509	29	patients	patient	NOUN
njb-115	509	30	and	and	CCONJ
njb-115	509	31	their	their	PRON
njb-115	509	32	association	association	NOUN
njb-115	509	33	with	with	ADP
njb-115	509	34	antimicrobial	antimicrobial	ADJ
njb-115	509	35	resistance	resistance	NOUN
njb-115	509	36	.	.	PUNCT
njb-115	510	1	int	int	PROPN
njb-115	510	2	j	j	PROPN
njb-115	510	3	gen	gen	PROPN
njb-115	510	4	med	me	VERB
njb-115	510	5	.	.	PROPN
njb-115	510	6	2018	2018	NUM
njb-115	510	7	jan	jan	PROPN
njb-115	510	8	18;11:25	18;11:25	NUM
njb-115	510	9	-	-	SYM
njb-115	510	10	32	32	NUM
njb-115	510	11	.	.	PUNCT
njb-115	511	1	doi	doi	PROPN
njb-115	511	2	:	:	PUNCT
njb-115	511	3	10.2147	10.2147	NUM
njb-115	511	4	/	/	SYM
njb-115	511	5	ijgm.s153268	ijgm.s153268	NOUN
njb-115	511	6	.	.	PUNCT
njb-115	512	1	58	58	NUM
njb-115	512	2	.	.	PUNCT
njb-115	513	1	choudhury	choudhury	PROPN
njb-115	513	2	d	d	PROPN
njb-115	513	3	,	,	PUNCT
njb-115	513	4	chakravarty	chakravarty	PROPN
njb-115	513	5	p.	p.	NOUN
njb-115	513	6	prevalence	prevalence	NOUN
njb-115	513	7	and	and	CCONJ
njb-115	513	8	antimicrobial	antimicrobial	ADJ
njb-115	513	9	susceptibility	susceptibility	NOUN
njb-115	513	10	pattern	pattern	NOUN
njb-115	513	11	of	of	ADP
njb-115	513	12	methicillin	methicillin	NOUN
njb-115	513	13	resistant	resistant	ADJ
njb-115	513	14	staphylococcus	staphylococcus	NOUN
njb-115	513	15	aureusin	aureusin	PROPN
njb-115	513	16	silchar	silchar	PROPN
njb-115	513	17	medical	medical	PROPN
njb-115	513	18	college	college	PROPN
njb-115	513	19	and	and	CCONJ
njb-115	513	20	hospital	hospital	NOUN
njb-115	513	21	,	,	PUNCT
njb-115	513	22	assam	assam	PROPN
njb-115	513	23	,	,	PUNCT
njb-115	513	24	india	india	PROPN
njb-115	513	25	.	.	PUNCT
njb-115	514	1	int	int	PROPN
njb-115	514	2	j	j	PROPN
njb-115	514	3	basic	basic	ADJ
njb-115	514	4	clinpharmacol	clinpharmacol	NOUN
njb-115	514	5	.	.	PUNCT
njb-115	514	6	2016	2016	NUM
njb-115	514	7	oct;5(5	oct;5(5	NOUN
njb-115	514	8	):	):	PUNCT
njb-115	514	9	2174	2174	NUM
njb-115	514	10	-	-	SYM
njb-115	514	11	2177	2177	NUM
njb-115	514	12	.	.	PUNCT
njb-115	515	1	https://dx.doi.org/10.18203/2319-2003.ijbcp20163257	https://dx.doi.org/10.18203/2319-2003.ijbcp20163257	NOUN
njb-115	515	2	59	59	NUM
njb-115	515	3	.	.	PUNCT
njb-115	516	1	kshetry	kshetry	PROPN
njb-115	516	2	ao	ao	PROPN
njb-115	516	3	,	,	PUNCT
njb-115	516	4	pant	pant	PROPN
njb-115	516	5	nd	nd	PROPN
njb-115	516	6	,	,	PUNCT
njb-115	516	7	bhandari	bhandari	PROPN
njb-115	516	8	r	r	PROPN
njb-115	516	9	,	,	PUNCT
njb-115	516	10	khatri	khatri	PROPN
njb-115	516	11	s	s	PROPN
njb-115	516	12	,	,	PUNCT
njb-115	516	13	shrestha	shrestha	PROPN
njb-115	516	14	kl	kl	PROPN
njb-115	516	15	,	,	PUNCT
njb-115	516	16	upadhaya	upadhaya	PROPN
njb-115	516	17	sk	sk	PROPN
njb-115	516	18	,	,	PUNCT
njb-115	516	19	et	et	PROPN
njb-115	516	20	al	al	PROPN
njb-115	516	21	.	.	PUNCT
njb-115	517	1	minimum	minimum	ADJ
njb-115	517	2	inhibitory	inhibitory	ADJ
njb-115	517	3	concentration	concentration	NOUN
njb-115	517	4	of	of	ADP
njb-115	517	5	vancomycin	vancomycin	PROPN
njb-115	517	6	to	to	ADP
njb-115	517	7	methicillin	methicillin	NOUN
njb-115	517	8	resistant	resistant	ADJ
njb-115	517	9	staphylococcus	staphylococcus	NOUN
njb-115	517	10	aureus	aureus	NOUN
njb-115	517	11	isolated	isolate	VERB
njb-115	517	12	from	from	ADP
njb-115	517	13	different	different	ADJ
njb-115	517	14	clinical	clinical	ADJ
njb-115	517	15	samples	sample	NOUN
njb-115	517	16	at	at	ADP
njb-115	517	17	a	a	DET
njb-115	517	18	tertiary	tertiary	ADJ
njb-115	517	19	care	care	NOUN
njb-115	517	20	hospital	hospital	NOUN
njb-115	517	21	in	in	ADP
njb-115	517	22	nepal	nepal	ADJ
njb-115	517	23	.	.	PUNCT
njb-115	518	1	antimicrobial	antimicrobial	ADJ
njb-115	518	2	resistance	resistance	NOUN
njb-115	518	3	and	and	CCONJ
njb-115	518	4	infection	infection	NOUN
njb-115	518	5	control	control	NOUN
njb-115	518	6	.	.	PUNCT
njb-115	519	1	2016;5:27	2016;5:27	NUM
njb-115	519	2	.	.	NOUN
njb-115	519	3	https://doi.org/10.1186/s13756-016-0126-3	https://doi.org/10.1186/s13756-016-0126-3	NUM
njb-115	519	4	60	60	NUM
njb-115	519	5	.	.	PUNCT
njb-115	520	1	pal	pal	PROPN
njb-115	520	2	n	n	PROPN
njb-115	520	3	,	,	PUNCT
njb-115	520	4	sharma	sharma	PROPN
njb-115	520	5	b	b	PROPN
njb-115	520	6	,	,	PUNCT
njb-115	520	7	sharma	sharma	PROPN
njb-115	520	8	r	r	PROPN
njb-115	520	9	,	,	PUNCT
njb-115	520	10	vyas	vyas	PROPN
njb-115	520	11	l.	l.	PROPN
njb-115	520	12	detection	detection	PROPN
njb-115	520	13	of	of	ADP
njb-115	520	14	inducible	inducible	ADJ
njb-115	520	15	clindamycin	clindamycin	PROPN
njb-115	520	16	resistance	resistance	NOUN
njb-115	520	17	among	among	ADP
njb-115	520	18	staphylococcal	staphylococcal	ADJ
njb-115	520	19	isolates	isolate	NOUN
njb-115	520	20	from	from	ADP
njb-115	520	21	different	different	ADJ
njb-115	520	22	clinical	clinical	ADJ
njb-115	520	23	specimens	specimen	NOUN
njb-115	520	24	in	in	ADP
njb-115	520	25	western	western	PROPN
njb-115	520	26	india	india	PROPN
njb-115	520	27	.	.	PUNCT
njb-115	521	1	j	j	PROPN
njb-115	521	2	postgrad	postgrad	PROPN
njb-115	521	3	med	me	VERB
njb-115	521	4	.	.	PUNCT
njb-115	522	1	2010;56(3):182	2010;56(3):182	PROPN
njb-115	522	2	-	-	PUNCT
njb-115	522	3	185	185	NUM
njb-115	522	4	.	.	PUNCT
njb-115	523	1	http://www.jpgmonline.com/text.asp?2010/	http://www.jpgmonline.com/text.asp?2010/	X
njb-115	523	2	56/3/182/68637	56/3/182/68637	NUM
njb-115	523	3	61	61	NUM
njb-115	523	4	.	.	PUNCT
njb-115	524	1	ghosh	ghosh	PROPN
njb-115	524	2	s	s	PROPN
njb-115	524	3	,	,	PUNCT
njb-115	524	4	banerjee	banerjee	PROPN
njb-115	524	5	m.	m.	PROPN
njb-115	524	6	methicillin	methicillin	PROPN
njb-115	524	7	resistance	resistance	PROPN
njb-115	524	8	&	&	CCONJ
njb-115	524	9	inducible	inducible	VERB
njb-115	524	10	clindamycin	clindamycin	PROPN
njb-115	524	11	resistance	resistance	NOUN
njb-115	524	12	in	in	ADP
njb-115	524	13	staphylococcus	staphylococcus	NOUN
njb-115	524	14	aureus	aureus	PROPN
njb-115	524	15	.	.	PUNCT
njb-115	525	1	the	the	DET
njb-115	525	2	indian	indian	PROPN
njb-115	525	3	j	j	PROPN
njb-115	525	4	med	med	PROPN
njb-115	525	5	research	research	PROPN
njb-115	525	6	.	.	PUNCT
njb-115	526	1	2016	2016	NUM
njb-115	526	2	mar;143(3):362	mar;143(3):362	NUM
njb-115	526	3	-	-	SYM
njb-115	526	4	364	364	NUM
njb-115	526	5	.	.	PUNCT
njb-115	527	1	doi	doi	PROPN
njb-115	527	2	:	:	PUNCT
njb-115	527	3	10.4103/0971	10.4103/0971	NUM
njb-115	527	4	-	-	SYM
njb-115	527	5	5916.182628	5916.182628	NUM
njb-115	527	6	.	.	PUNCT
njb-115	527	7	https://doi.org/10.1155/2017/2191532	https://doi.org/10.1155/2017/2191532	PROPN
njb-115	528	1	https://dx.doi.org/10.18203/2319-2003.ijbcp20163257	https://dx.doi.org/10.18203/2319-2003.ijbcp20163257	NOUN
njb-115	528	2	https://doi.org/10.1186/s13756-016-0126-3	https://doi.org/10.1186/s13756-016-0126-3	X